<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:z="http://www.zotero.org/namespaces/export#"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:bib="http://purl.org/net/biblio#"
 xmlns:foaf="http://xmlns.com/foaf/0.1/"
 xmlns:link="http://purl.org/rss/1.0/modules/link/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
    <bib:Article rdf:about="#item_60374">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf rdf:resource="urn:issn:0301-0082"/>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brown</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60375"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electroencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electromyography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetoencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Muscle, Skeletal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myoclonus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Periodicity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cortical drives to human muscle: the Piper and related rhythms</dc:title>
        <dcterms:abstract>During voluntary activity in humans, motor units are exposed to a number of descending drives that tend to synchronize motor unit activity at particular frequencies. In particular, the contralateral motor cortex drives muscle discharge in the beta (15-30 Hz) and Piper (30-60 Hz) bands. The cortical activity in these bands is task-specific, somatopicly distributed and generally precedes muscle discharge by an interval appropriate for conduction in fast pyramidal pathways. Coherence between cortex and muscle in the beta band is found during isometric contractions of weak to moderate strength. Thus oscillations within the beta band seem to coincide with a stable, relatively immutable state--a free running mode of the motor cortex that may maintain stable motor output with a minimum of computational effort. In contrast, coherence between cortex and muscle in the Piper band is most evident during strong isometric contractions or during movement. Demands on the motor cortex are likely to be greater and more mutable under these circumstances. Synchronisation in the gamma band may provide a means of binding together those particular, often spatially distributed, cortical elements involved in movement execution under conditions that vary from moment to moment and require some attention. Mechanisms both intrinsic and extrinsic to the cortex determine the pattern of rhythmic cortical activity. The basal ganglia have a pivotal role in this regard, and inadequate output from these nuclei leads to a disappearance of the beta and Piper drives to muscle. This may in turn contribute to slowness and weakness in Parkinson's disease.</dcterms:abstract>
        <bib:pages>97-108</bib:pages>
        <dc:date>Jan 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Cortical drives to human muscle</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10622378</dc:description>
    </bib:Article>
    <bib:Journal rdf:about="urn:issn:0301-0082">
        <dc:title>Progress in Neurobiology</dc:title>
        <prism:volume>60</prism:volume>
        <prism:number>1</prism:number>
        <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
        <dc:identifier>ISSN 0301-0082</dc:identifier>
    </bib:Journal>
    <z:Attachment rdf:about="#item_60375">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10622378</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60382">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grimaldi</foaf:surname>
                        <foaf:givenname>B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fillion</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60383"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroimmunomodulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oligopeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Serotonin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>5-HT-moduline controls serotonergic activity: implication in neuroimmune reciprocal regulation mechanisms</dc:title>
        <dcterms:abstract>The serotonergic neurotransmission is known as a neuromodulatory system exerting its activity in the central nervous system (CNS) as well as at the periphery. The anatomical and morphological organization of the system based on a marked centralization of the cellular bodies and the large, almost ubiquitary, presence of axonal projections of the neurons is in good agreement with this modulatory role. Furthermore, a very high number of varicosities located along the axonal branches are capable of releasing serotonin (5-HT). The amine stimulates a number of different specific receptor types which allows 5-HT to exert different activities on its various cellular targets. Among these receptors, the 5-HT1B subtypes play a particular role as they are autoreceptors located on 5-HT neurons terminals and heteroreceptors located on non-serotonergic terminals where they control the release of the neurotransmitter. 5-HT-moduline, an endogenous tetrapeptide, regulates the efficacy of these 5-HT1B receptors, hence, is able to control the serotonergic activity in a synchronous manner for the various varicosities from a single neuron and thus may favour the differential effect of that neuron on distinct cerebral functions. Accordingly, the peptide allows the 'fine tuning' of the cerebral activity by the serotonergic system to elaborate the response given by the brain to a particular stimulus, that is, stress situations. At the periphery, the serotonergic system also appears to possess a regulatory activity via 5-HT1B receptors. In particular, the receptors located on immunocompetent cells control their activity and are themselves regulated by 5-HT-moduline likely originating from adrenal medulla and released after acute stress. The serotonergic system appears to play a major role in the reciprocal signalling existing between the neuronal and the immune system. The participation of 5-HT-moduline is likely in physiological functions as well as in pathological disorders affecting central and peripheral activities.</dcterms:abstract>
        <bib:pages>1-12</bib:pages>
        <dc:date>Jan 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>5-HT-moduline controls serotonergic activity</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10622374</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60383">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10622374</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60378">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ojika</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mitake</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tohdoh</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Appel</foaf:surname>
                        <foaf:givenname>S. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Otsuka</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Katada</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Matsukawa</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60379"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Base Sequence</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Precursors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>RNA, Messenger</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tissue Distribution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Hippocampal cholinergic neurostimulating peptides (HCNP)</dc:title>
        <dcterms:abstract>Neuronal development and differentiation require a variety of cell interactions. Diffusible molecules from target neurons play an important part in mediating such interactions. Our early studies used explant culture technique to examine the factors that enhance the differentiation of septo-hippocampal cholinergic neurons, and they revealed that several components resident in the hippocampus are involved in the differentiation of presynaptic cholinergic neurons in the medial septal nucleus. One of these components, originally purified from young rat hippocampus, is a novel undecapeptide (hippocampal cholinergic neurostimulating peptide; HCNP); this enhances the production of ChAT, but not of AchE. Later experiments revealed that: (1) a specific receptor appears to mediate this effect; (2) NGF and HCNP act cooperatively to regulate cholinergic phenotype development in the medial septal nucleus in culture; and (3) these two molecules differ both in their mechanism of release from the hippocampus and their mechanism of action on cholinergic neurons. The amino acid sequence deduced from base sequence analysis of cloned HCNP-precursor protein cDNA shows that HCNP is located at the N-terminal domain of its precursor protein. The 21 kDa HCNP precursor protein shows homology with other proteins, and it functions not only as an HCNP precursor, but also as a binding protein for ATP, opioids and phosphatidylethanolamine. The distribution and localization of HCNP-related components and the expression of their mRNAs support the notion that the precursor protein is multifunctional. In keeping with its multiple functions, the multiple enhancers and promoters found in the genomic DNA for HCNP precursor protein may be involved in the regulation of its gene in a variety of cells and at different stages of development. Furthermore, several lines of evidence obtained from studies of humans and animal models suggest that certain types of memory and learning disorders are associated with abnormal accumulation and expression of HCNP analogue peptide and/or its precursor protein mRNA in the hippocampus.</dcterms:abstract>
        <bib:pages>37-83</bib:pages>
        <dc:date>Jan 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10622376</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60379">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10622376</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60380">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Portas</foaf:surname>
                        <foaf:givenname>C. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bjorvatn</foaf:surname>
                        <foaf:givenname>B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ursin</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60381"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microdialysis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Serotonin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep Stages</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Wakefulness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies</dc:title>
        <dcterms:abstract>Several areas in the brainstem and forebrain are important for the modulation and expression of the sleep/wake cycle. Even if the first observations of biochemical events in relation to sleep were made only 40 years ago, it is now well established that several neurotransmitters, neuropeptides, and neurohormones are involved in the modulation of the sleep/wake cycle. Serotonin has been known for many years to play a role in the modulation of sleep, however, it is still very controversial how and where serotonin may operate this modulation. Early studies suggested that serotonin is necessary to obtain and maintain behavioral sleep (permissive role on sleep). However, more recent microdialysis experiments provide evidence that the level of serotonin during W is higher in most cortical and subcortical areas receiving serotonergic projections. In this view the level of extracellular serotonin would be consistent with the pattern of discharge of the DRN serotonergic neurons which show the highest firing rate during W, followed by a decrease in slow wave sleep and by virtual electrical silence during REM sleep. This suggests that during waking serotonin may complement the action of noradrenaline and acetylcholine in promoting cortical responsiveness and participate to the inhibition of REM-sleep effector neurons in the brainstem (inhibitory role on REM sleep). The apparent inconsistency between an inhibitory and a facilitatory role played by serotonin on sleep has at least two possible explanations. On the one hand serotonergic modulation on the sleep/wake cycle takes place through a multitude of post-synaptic receptors which mediate different or even opposite responses; on the other hand the achievement of a behavioral state depends on the complex interaction between the serotonergic and other neurotransmitter systems. The main aim of this commentary is to review the role of brain serotonin in relation to the sleep/wake cycle. In particular we highlight the importance of microdialysis for on-line monitoring of the level of serotonin in different areas of the brain across the sleep/wake cycle.</dcterms:abstract>
        <bib:pages>13-35</bib:pages>
        <dc:date>Jan 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Serotonin and the sleep/wake cycle</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10622375</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60381">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10622375</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60376">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Proske</foaf:surname>
                        <foaf:givenname>U.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wise</foaf:surname>
                        <foaf:givenname>A. K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gregory</foaf:surname>
                        <foaf:givenname>J. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60377"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Joints</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mechanoreceptors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motion</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Movement</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Muscles</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Muscle Spindles</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of muscle receptors in the detection of movements</dc:title>
        <dcterms:abstract>This review discusses the role of muscle receptors, in particular, that of muscle spindles, in the detection of movements, both passive and active. Emphasis is placed on the importance of conditioning the muscles acting at a joint before making measurements of thresholds to passive movements, to take into account muscle's thixotropic property. The detection threshold:movement velocity relation is discussed and described for a number of different joints. Implications for muscle spindles are considered from the generalisation that, when expressed in terms of proportion of muscle fascicle length change, detection thresholds are about the same at different joints. It is concluded that the available data supports the view that muscle spindles lie in parallel with only a portion of a muscle fascicle and not the whole fascicle. At the elbow joint, where it has been tested, movement detection threshold is lower during passive movements than during contraction of elbow muscles. Both peripheral mechanisms and mechanisms operating within the central nervous system may be responsible for the rise in threshold. The signalling of movements by spindles during a contraction raises the question of how the central nervous system is able to extract the length signal under such circumstances, given that there is likely to be co-activation of alpha and gamma motoneurones. The evidence for a central subtraction of fusimotor-evoked impulses and some recent experiments relevant to this idea are described. In conclusion, a number of points of uncertainly have been revealed in this area and these should be the subject of future experiments.</dcterms:abstract>
        <bib:pages>85-96</bib:pages>
        <dc:date>Jan 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10622377</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60377">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10622377</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60372">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bennett</foaf:surname>
                        <foaf:givenname>M. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60373"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The concept of long term potentiation of transmission at synapses</dc:title>
        <dcterms:abstract>The phenomenon of long term potentiation (LTP) of synaptic transmission, whereby a series of conditioning trains of impulses potentiate the size of synaptic potentials for periods in excess of hours, was discovered in the mammalian hippocampus by Lomo [1966, Acta Physiol. Scand. 68(Suppl. 277), 128] and subsequently characterized by Bliss and Lomo (1970, J. Physiol. 207, 61P). The search for the underlying mechanisms of LTP makes for fascinating reading. The induction of associative LTP was shown by Collingridge et al. (1982, J. Physiol. 334, 33-46) to be dependent on the presence of N-methyl-D-aspartate receptors, following the discovery of these receptors by Watkins and Evans (1981, A. Rev. Pharmac. Toxic. 21, 165-204). There has, however, been continuing controversy as to whether the maintenance phase of LTP over periods of hours may be attributed to an increase in the amount of transmitter released or to an increase in the number of glutamate receptors or both. There is more agreement on the important role or protein kinases in the maintenance phase of LTP. The role of LTP in memory is just now being elucidated.</dcterms:abstract>
        <bib:pages>109-137</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10639051</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60373">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10639051</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60364">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Blanquet</foaf:surname>
                        <foaf:givenname>P. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60365"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Casein Kinase II</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein-Serine-Threonine Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Casein kinase 2 as a potentially important enzyme in the nervous system</dc:title>
        <dcterms:abstract>Protein kinase CK2 is a ubiquitous and pleiotropic seryl/threonyl protein kinase which is highly conserved in evolution indicating a vital cellular role for this kinase. The holoenzyme is generally composed of two catalytic (alpha and/or alpha') and two regulatory (beta) subunits, but the free alpha/alpha' subunits are catalytically active by themselves and can be present in cells under some circumstances. Special attention has been devoted to phosphorylation status and structure of these enzymic molecules, however, their regulation and roles remain intriguing. Until recently, CK2 was believed to represent a kinase especially required for cell cycle progression in non-neural cells. At present, with respect to recent findings, four essential features suggest potentially important roles for this enzyme in specific neural functions: (1) CK2 is much more abundant in brain than in any other tissue; (2) there appear to be a myriad of substrates for CK2 in both synaptic and nuclear compartments that have clear implications in development, neuritogenesis, synaptic transmission, synaptic plasticity, information storage and survival; (3) CK2 seems to be associated with mechanisms underlying long-term potentiation in hippocampus; and (4) neurotrophins stimulate activity of CK2 in hippocampus. In addition, some data are suggestive that CK2 might play a role in processes underlying progressive disorders due to Alzheimer's disease, ischemia, chronic alcohol exposure or immunodeficiency virus HIV. The present review focuses mainly on the latest data concerning the regulatory mechanisms and the possible neurophysiological functions of this enzyme.</dcterms:abstract>
        <bib:pages>211-246</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10658642</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60365">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10658642</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60362">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Frings</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Reuter</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kleene</foaf:surname>
                        <foaf:givenname>S. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60363"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Chloride Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuronal Ca2+ -activated Cl- channels--homing in on an elusive channel species</dc:title>
        <dcterms:abstract>Ca2+ -activated Cl- channels control electrical excitability in various peripheral and central populations of neurons. Ca2+ influx through voltage-gated or ligand-operated channels, as well as Ca2+ release from intracellular stores, have been shown to induce substantial Cl- conductances that determine the response to synaptic input, spike rate, and the receptor current of various kinds of neurons. In some neurons, Ca2+ -activated Cl- channels are localized in the dendritic membrane, and their contribution to signal processing depends on the local Cl- equilibrium potential which may differ considerably from those at the membranes of somata and axons. In olfactory sensory neurons, the channels are expressed in ciliary processes of dendritic endings where they serve to amplify the odor-induced receptor current. Recent biophysical studies of signal transduction in olfactory sensory neurons have yielded some insight into the functional properties of Ca2+ -activated Cl- channels expressed in the chemosensory membrane of these cells. Ion selectivity, channel conductance, and Ca2+ sensitivity have been investigated, and the role of the channels in the generation of receptor currents is well understood. However, further investigation of neuronal Ca2+ -activated Cl- channels will require information about the molecular structure of the channel protein, the regulation of channel activity by cellular signaling pathways, as well as the distribution of channels in different compartments of the neuron. To understand the physiological role of these channels it is also important to know the Cl- equilibrium potential in cells or in distinct cell compartments that express Ca2+ -activated Cl- channels. The state of knowledge about most of these aspects is considerably more advanced in non-neuronal cells, in particular in epithelia and smooth muscle. This review, therefore, collects results both from neuronal and from non-neuronal cells with the intent of facilitating research into Ca2+ -activated Cl- channels and their physiological functions in neurons.</dcterms:abstract>
        <bib:pages>247-289</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10658643</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60363">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10658643</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60360">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>R. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Magnaghi</foaf:surname>
                        <foaf:givenname>V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Martini</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60361"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gonadal Steroid Hormones</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nerves</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Steroids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones</dc:title>
        <dcterms:abstract>The process of aging deeply influences morphological and functional parameters of the peripheral nerves. Interestingly, recent observations performed in our laboratory on the rat sciatic nerves have indicated that the deterioration of myelin occurring in the peripheral nerves during aging may be explained by the fall of the messenger levels of the major peripheral myelin proteins (glycoprotein Po, myelin basic protein and peripheral myelin protein 22). At least in the case of the Po, the low levels of its messengers and of the protein itself found in aged animals are increased by the treatment with a physiological progesterone derivative like dihydroprogesterone. It has also been found that in normal adult male rats the levels of the messengers for Po in the sciatic nerve are increased by progesterone, dihydroprogesterone and tetrahydroprogesterone; surprisingly, the gene expression of peripheral myelin protein 22 is stimulated only by tetrahydroprogesterone. These observations have been confirmed in parallel studies performed on Schwann cell cultures. Since tetrahydroprogesterone does not bind to the progesterone receptor but is a ligand for the GABAA receptor, the hypothesis has been put forward that part of the steroidal effects reported might occur not through the classical progesterone receptor, but rather via an interaction with the GABAA receptor. In other experiments it has been found that the gene expression of Po may be decreased by orchidectomy and restored by treatment with the androgen dihydrotestosterone. Altogether, these observations suggest the future use of physiological and/ or synthetic steroid hormones as a possible therapeutic approach for some pathological situations occurring in peripheral nerves during aging and demyelinating diseases.</dcterms:abstract>
        <bib:pages>291-308</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Aging in peripheral nerves</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10658644</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60361">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10658644</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60368">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Quinn</foaf:surname>
                        <foaf:givenname>J. P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dalziel</foaf:surname>
                        <foaf:givenname>R. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nash</foaf:surname>
                        <foaf:givenname>A. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60369"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Sensory</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Viral</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Herpes Simplex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Herpesvirus 1, Human</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Virus Latency</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Herpes virus latency in sensory ganglia--a comparison with endogenous neuronal gene expression</dc:title>
        <dcterms:abstract>Central to infection by a majority of DNA viruses is the expression of encoded proteins that modify cell cycle. Viruses such as SV40 and Adenovirus viruses encode proteins that interact directly, or indirectly, with key cell cycle proteins such as CBP300 and the retinoblastoma gene product. However, neurons do not have a cell cycle as we generally describe it and this is also reflected in the difficulty in obtaining immortalised neuronal cultures. The replication strategies of viruses that infect post-mitotic cells such as neurons may be different from infection of other somatic cells. The life cycle for viral latency or slow infection of neurons appears to involve silencing or restricting expression of the viral genome until such times as dictated by the environment. These signals from the environment usually reflect cell stress, otherwise the cell appears to tolerate the existence of the virus genome. We will review the genomic structure of alphaherpesviruses in neurons and transcriptional control mechanisms that may regulate expression. Where appropriate we will contrast and compare virus and endogenous neuronal gene expression.</dcterms:abstract>
        <bib:pages>167-179</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10639053</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60369">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10639053</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60370">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vickers</foaf:surname>
                        <foaf:givenname>J. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dickson</foaf:surname>
                        <foaf:givenname>T. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Adlard</foaf:surname>
                        <foaf:givenname>P. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saunders</foaf:surname>
                        <foaf:givenname>H. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>King</foaf:surname>
                        <foaf:givenname>C. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McCormack</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60371"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The cause of neuronal degeneration in Alzheimer's disease</dc:title>
        <dcterms:abstract>Alzheimer's disease is associated with a specific pattern of pathological changes in the brain that result in neurodegeneration and the progressive development of dementia. Pathological hallmarks common to the disease include beta-amyloid plaques, dystrophic neurites associated with plaques and neurofibrillary tangles within nerve cell bodies. The exact relationship between these pathological features has been elusive, although it is clear that beta-amyloid plaques precede neurofibrillary tangles in neocortical areas. Examination of the brains of individuals in the preclinical stage of the disease have shown that the earliest form of neuronal pathology associated with beta-amyloid plaques resembles the cellular changes that follow structural injury to axons. Thus, the development of beta-amyloid plaques in the brain may cause physical damage to axons, and the abnormally prolonged stimulation of the neuronal response to this kind of injury ultimately results in the profound cytoskeletal alterations that underlie neurofibrillary pathology and neurodegeneration. Therapeutically, inhibition of the neuronal reaction to physical trauma may be a useful neuroprotective strategy in the earliest stages of Alzheimer's disease.</dcterms:abstract>
        <bib:pages>139-165</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10639052</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60371">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10639052</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60366">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Waterman</foaf:surname>
                        <foaf:givenname>S. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60367"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Autonomic Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroeffector Junction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Voltage-gated calcium channels in autonomic neuroeffector transmission</dc:title>
        <dcterms:abstract>Calcium influx through voltage-gated calcium channels (VGCCs) is required for neurotransmitter release. Recent research has characterised several pharmacologically and electrophysiologically distinct VGCC subtypes, some of which are involved in neurotransmitter release. Transmitter release from autonomic neurons can be coupled to calcium entry through N-, P/Q- and/or R-type VGCCs; the precise combination of VGCC subtypes appears to vary according to the neurotransmitter, tissue and species. L-type channels rarely appear to be important in autonomic neurotransmitter release. There does not appear to be a general rule regarding the nature of the VGCCs coupled to release of a particular transmitter in different tissues or species. Release of the same neurotransmitter from different populations of neurons often reveals a different pattern of involvement of VGCCs. Transmitters released from the same population of neurons are sometimes coupled to calcium influx through different VGCC subtypes. However, release of transmitters thought to be co-localised within vesicles is coupled to calcium influx through the same VGCCs. The role of VGCC subtypes in transmitter release can be altered by mode of nerve stimulation. Different VGCC subtypes may be coupled to transmitter release at low versus high electrical stimulation frequencies, or in response to potassium depolarization or chemical stimulation. In certain disease processes, voltage-gated calcium channels on autonomic neurons can be targeted; for example antibodies to P/Q-type VGCCs in Lambert-Eaton myasthenic syndrome downregulate VGCCs, thereby inhibiting autonomic neuroeffector transmission.</dcterms:abstract>
        <bib:pages>181-210</bib:pages>
        <dc:date>Feb 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10639054</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60367">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10639054</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60354">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Czech</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tremp</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pradier</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60355"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>pregnancy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Presenilin-1</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Presenilin-2</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms</dc:title>
        <dcterms:abstract>Alzheimer's disease (AD) is the most common cause of dementia in the elderly population. Dementia is associated with massive accumulation of fibrillary aggregates in various cortical and subcortical regions of the brain. These aggregates appear intracellularly as neurofibrillary tangles, extracellularly as amyloid plaques and perivascular amyloid in cerebral blood vessels. The causative factors in AD etiology implicate both, genetic and environmental factors. The large majority of early-onset familial Alzheimer's disease (FAD) cases are linked to mutations in the genes coding for presenilin 1 (PS1) and presenilin 2 (PS2). The corresponding proteins are 467 (PS1) and 448 (PS2) amino-acids long, respectively. Both are membrane proteins with multiple transmembrane regions. Presenilins show a high degree of conservation between species and a presenilin homologue with definite conservation of the hydrophobic structure has been identified even in the plant Arabidopsis thaliana. More than 50 missense mutations in PS1 and two missense mutations in PS2 were identified which are causative for FAD. PS mutations lead to the same functional consequence as mutations on amyloid precursor protein (APP), altering the processing of APP towards the release of the more amyloidogenic form 1-42 of Abeta (Abeta42). In this regard, the physical interaction between APP and presenilins in the endoplasmic reticulum has been demonstrated and might play a key role in Abeta42 production. It was hypothesized that PS1 might directly cleave APP. However, extracellular amyloidogenesis and Abeta production might not be the sole factor involved in AD pathology and several lines of evidence support a role of apoptosis in the massive neuronal loss observed. Presenilins were shown to modify the apoptotic response in several cellular systems including primary neuronal cultures. Some evidence is accumulating which points towards the beta-catenin signaling pathways to be causally involved in presenilin mediated cell death. Increased degradation of beta-catenin has been shown in brain of AD patients with PS1 mutations and reduced beta-catenin signaling increased neuronal vulnerability to apoptosis in cell culture models. The study of presenilin physiological functions and the pathological mechanisms underlying their role in pathogenesis clearly advanced our understanding of cellular mechanisms underlying the neuronal cell death and will contribute to the identification of novel drug targets for the treatment of AD.</dcterms:abstract>
        <bib:pages>363-384</bib:pages>
        <dc:date>Mar 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Presenilins and Alzheimer's disease</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10670705</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60355">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10670705</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60356">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dahchour</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>De Witte</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60357"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alcohol Deterrents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alcohol-Induced Disorders, Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Alcoholism</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ethanol</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taurine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate</dc:title>
        <dcterms:abstract>Ethanol induces alterations in the central nervous system by differentially interfering with a number of neurotransmitter systems, although the mechanisms by which such effects are executed are not well understood. The present review therefore, is designed to ascertain the effect of ethanol on both excitatory and inhibitory amino acid neurotransmitters, as well as the sulphonated amino acid taurine, assayed by the microdialysis technique within specific brain regions of rat during different types of alcohol intoxication, acute and chronic, as well as during the withdrawal period. Such an understanding of these pharmacological actions of ethanol on neurotransmitters is essential in order to provide the impetus for the development of appropriate therapeutic intervention to ameliorate the multitude of neurochemical disorders induced by ethanol. In addition the possible mode of action of a new therapeutic drug for the treatment of alcoholism, acamprosate will be discussed. The first part of this review will be limited to studies of the effect of ethanol on both amino acid neurotransmitters and the sulphonated amino acid taurine, a possible neuromodulator. While, the second part will seek to establish the possible mechanism of action of a new therapeutic drug, acamprosate, which is used to combat the effects of ethanol, particularly during the craving period, as well as maintaining abstinence in weaned alcoholics.</dcterms:abstract>
        <bib:pages>343-362</bib:pages>
        <dc:date>Mar 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Ethanol and amino acids in the central nervous system</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10670704</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60357">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10670704</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60358">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Horváth</foaf:surname>
                        <foaf:givenname>E. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Horváth</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hámori</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fekete</foaf:surname>
                        <foaf:givenname>M. I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sólyom</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Palkovits</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60359"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anti-Anxiety Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Benzodiazepines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Binding Sites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia</dc:title>
        <dcterms:abstract>Over the past 20 years, several members of the 2,3-benzodiazepine family have been synthesized. Some of these compounds--tofisopam (Grandaxin), girisopam, nerisopam--exert significant anxiolytic and antipsychotic activities. Sites where actions of 2,3-benzodiazepines are mediated differ from those of 1,4-benzodiazepines. Binding of 2,3-benzodiazepines to neuronal cells in the central nervous system shows a unique and specific distribution pattern: their binding sites are located exclusively to the basal ganglia. Chemical lesioning of the striato-pallido-nigral system, surgical transections of the striato nigral pathway and the activation of c-fos expression in the basal ganglia after application of 2,3-benzodiazepines suggest that these compounds mainly bind to projecting neurons of the striatum. The binding sites are transported from the striatum to the substantia nigra and the entopeduncular nucleus. Recent studies on mechanism of action of 2,3-benzodiazepines indicate their possible role in opioid signal transduction since 2,3-benzodiazepines augment the agonist potency of morphine to induce catalepsy and analgesia, and their action is diminished in morphine tolerant animals. The possible biochemical target of 2,3-benzodiazepines is an alteration in the phosphorylation of protein(s) important in the signal transduction process. Agents affecting emotional responses evoked by endogenous opioids without danger of tolerance and dependence may represent a new therapeutic tool in the treatment of addiction and affective disorders.</dcterms:abstract>
        <bib:pages>309-342</bib:pages>
        <dc:date>Mar 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10670703</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60359">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10670703</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60352">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>van den Buuse</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Webber</foaf:surname>
                        <foaf:givenname>K. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60353"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Endothelins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Endothelin and dopamine release</dc:title>
        <dcterms:abstract>Endothelins and endothelin receptors are widespread in the brain. There is increasing evidence that endothelins play a role in brain mechanisms associated with behaviour and neuroendocrine regulation as well as cardiovascular control. We review the evidence for an interaction of endothelin with brain dopaminergic mechanisms. Our work has shown that particularly endothelin-1 and ET(B) receptors are present at significant levels in typical brain dopaminergic regions such as the striatum. Moreover, lesion studies showed that ET(B) receptors are present on dopaminergic neuronal terminals in striatum and studies with local administration of endothelins into the ventral striatum showed that activation of these receptors causes dopamine release, as measured both with in vivo voltammetry and behavioural methods. While several previous studies have focussed on the possible role of very high levels of endothelins in ischemic and pathological mechanisms in the brain, possibly mediated by ET(A) receptors, we propose that physiological levels of these peptides play an important role in normal brain function, at least partly by interacting with dopamine release through ET(B) receptors.</dcterms:abstract>
        <bib:pages>385-405</bib:pages>
        <dc:date>Mar 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10670706</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60353">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10670706</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60350">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Alexi</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Borlongan</foaf:surname>
                        <foaf:givenname>C. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Faull</foaf:surname>
                        <foaf:givenname>R. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Williams</foaf:surname>
                        <foaf:givenname>C. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Clark</foaf:surname>
                        <foaf:givenname>R. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gluckman</foaf:surname>
                        <foaf:givenname>P. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hughes</foaf:surname>
                        <foaf:givenname>P. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60351"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Huntington Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases</dc:title>
        <dcterms:abstract>There are three main mechanisms of neuronal cell death which may act separately or cooperatively to cause neurodegeneration. This lethal triplet of metabolic compromise, excitotoxicity, and oxidative stress causes neuronal cell death that is both necrotic and apoptotic in nature. Aspects of each of these three mechanisms are believed to play a role in the neurodegeneration that occurs in both Parkinson's and Huntington's diseases. Strategies to rescue or protect injured neurons usually involve promoting neuronal growth and function or interfering with neurotoxic processes. Considerable research has been done on testing a large array of neuroprotective agents using animal models which mimic these disorders. Some of these approaches have progressed to the clinical arena. Here, we review neuroprotective strategies which have been found to successfully ameliorate the neurodegeneration associated with Parkinson's and Huntington's diseases. First, we will give an overview of the mechanisms of cell death and the background of Parkinson's and Huntington's diseases. Then we will elaborate on a range of neuroprotective strategies, including neurotrophic factors, anti-excitotoxins, antioxidants, bioenergetic supplements, anti-apoptotics, immunosuppressants, and cell transplantation techniques. Most of these approaches hold promise as potential therapies in the treatment of these disorders.</dcterms:abstract>
        <bib:pages>409-470</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neuroprotective strategies for basal ganglia degeneration</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10697073</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60351">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10697073</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60340">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bennett</foaf:surname>
                        <foaf:givenname>M. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kearns</foaf:surname>
                        <foaf:givenname>J. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60341"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Kinetics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Likelihood Functions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Endings</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuromuscular Junction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Statistics of transmitter release at nerve terminals</dc:title>
        <dcterms:abstract>This review presents an historical account of the developments of the statistical analysis of quantal transmission over the past half century and of the progress made in using this approach to reveal new properties of nerve terminals. In the early 1950s, Katz and his colleagues showed that evoked transmitter release occurred in quanta at the neuromuscular junction, opening up the study of transmitter release at nerve terminals to statistical analysis. In the subsequent two decades attempts were made to see if evoked quantal release could be described by binomial or compound binomial statistics, as originally suggested by Katz, and to relate the parameters of the statistic to various structures of the nerve terminal. During this period two hypotheses were enunciated, namely the 'vesicle hypothesis', which states that quanta arise as a consequence of the packaging of transmitter in vesicles; and the 'active zone hypothesis', which states that vesicles undergo exocytosis at discrete sites on the nerve terminal. Unsuccessful attempts were made to relate the binomial parameter n to the elements in these hypotheses, that is to the number of active zones possessed by the terminal or the number of vesicles available for release at these zones. This difficulty was part resolved in the late 1970s with the application of non-uniform binomial statistics to transmitter release from nerve terminals, in which n is the number of active zones each with their individual probabilities, p(j). Autocorrelation functions were subsequently introduced to detect if transmitter release is quantised at a particular nerve terminal. Statistical methods which would allow discrimination between different models of transmitter release over the active zones of a terminal were then developed. The introduction of maximum likelihood estimation procedures then allowed estimates to be made of the parameters in the statistical models of quantal release. The application of these procedures to experimental data from a variety of nerve terminals provided evidence for the concept that each synapse, taken as possessing a single active zone, possesses its own individual probability of secretion of a quantum by the exocytosis of a vesicle. In the late 1960s Stevens introduced the first stochastic approach to the analysis of the kinetics of the release of a quantum of transmitter at the neuromuscular junction following an impulse. In the subsequent decades this was developed into an explicit theory for the interaction of proteins involved in regulated exocytosis of a vesicle at an active zone. The parameters were the number of transition steps in the release process (k), each occurring at the same rate (alpha), with the possibility of each of these steps becoming blocked at the same rate (gamma). Maximum likelihood estimation procedures could then be used to obtain these parameter values. The discovery was made in the 1990s of the core proteins of the SNARE complex that govern regulated exocytosis. This offers the possibility in the near future of identifying the kinetic interaction of these proteins with the parameters of the stochastic process of exocytosis which confer a particular probability on individual synapses.</dcterms:abstract>
        <bib:pages>545-606</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10739089</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60341">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10739089</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60342">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Frank</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60343"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Glycosphingolipids</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Immune System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Transport Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Conformation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Multigene Family</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
                <rdf:value>Myelin and Lymphocyte-Associated Proteolipid Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Sheath</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteolipids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond</dc:title>
        <dcterms:abstract>The myelin and lymphocyte protein MAL (VIP17/MVP17) is a proteolipid of 17 kD with a hydrophobicity pattern that indicates a four transmembrane domain structure. The MAL cDNA has been cloned from human T-cells, rat oligodendrocytes and the Madin-Darby canine kidney (MDCK) cell line. In the nervous system both myelinating cells, oligodendrocytes and Schwann cells, express MAL protein. MAL expression parallels myelin formation, and MAL is predominantly localized in compact myelin. Prior to myelin formation MAL is also found in immature Schwann cells. Outside the nervous system MAL expression is found in T-cells and in distinct epithelial cells, e.g. in kidney, stomach and thyroid gland, where MAL is localised in the apical plasma membrane. Specific glycosphingolipids, e.g. galactosylceramide and sulfatide, are enriched in such apical kidney and stomach membranes as well as in myelin. MAL copurifies with these glycosphingolipids in detergent insoluble domains, indicating a close association and possible functional interactions of MAL with glycosphingolipids in these tissues. Moreover, recent reports point to additional functions of MAL-glycosphingolipid complexes in signalling, cell differentiation and apical sorting. The role of MAL in the formation, stabilisation and maintenance of glycosphingolipid-enriched membrane microdomains and its contribution to specific membrane properties in myelin and epithelial cells are discussed.</dcterms:abstract>
        <bib:pages>531-544</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>MAL, a proteolipid in glycosphingolipid enriched domains</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10739088</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60343">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10739088</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60348">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hydén</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rapallino</foaf:surname>
                        <foaf:givenname>M. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cupello</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60349"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rabbits</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vestibular Nuclei</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Unraveling of important neurobiological mechanisms by the use of pure, fully differentiated neurons obtained from adult animals</dc:title>
        <dcterms:abstract>An important, and often overlooked, problem in the neurochemical approach to neurobiological problems is that analysis of tissue involves almost always a heterogeneous population of cells (neurons, glia and other types of tissue cells). The use of cell cultures has obvious limitations such as that they derive from embryonic or immediately postnatal animals; in addition, the cell culture conditions most certainly are quite different from the real tissue environment for the nerve cells. We underline here an alternative strategy, which is not new, but which, in our view, has already given formidable contributions to neurobiological studies and still is giving results of great importance. This is the technique proposed and used since the late fifties and early sixties by the senior author (H. Hydén). The method involves the isolation of the big vestibular neurons from the adult rabbit vestibular nucleus. The neurons, fully differentiated and performing a precisely defined function, are obtained rapidly and completely free from surrounding glial cells. The separate microbiochemical study of these cells and their surrounding glia has yielded already in 1962, the information that modifications in gene expression are associated with plastic modifications of the function of the relevant neurons, which take place in the behavioral event of learning. Another important concept was formulated in the same time period following determination of the activities of energy metabolism related enzymes separately in vestibular neurons and their glia under vestibular stimulation. This is the concept that, under increased functional activity glia increases its anaerobic metabolism and passes then on the resulting metabolites to the neurons for aerobic metabolism. Both these concepts (RNA and memory; metabolic cooperation between glia and neurons) are nowadays widely accepted. In addition, this approach with pure big nerve cells has allowed in recent years the discovery of a novel mechanism for chloride extrusion in these cells. This mechanism utilizes structures similar to GABA activated chloride channels in cyclic modifications resulting in the final extrusion of chloride ions. The energy for the process is provided by a protein phosphorylation step. Future approaches are warranted such as the possibility of recognizing by RT-PCR specific neuronal mRNAs and their modification in expression in relation to function and plastic modifications (learning). Another possible interesting application appears to be the recognition of the mRNAs for GABA(A) receptor subunits expressed here in these neurons in relation to the physiological and pharmacological characteristics of these native neuronal GABA(A) receptors.</dcterms:abstract>
        <bib:pages>471-499</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10697074</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60349">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10697074</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60338">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mack</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Robitzki</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60339"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Butyrylcholinesterase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Transformation, Neoplastic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Embryo, Mammalian</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Embryonic and Fetal Development</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neoplasms</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study</dc:title>
        <dcterms:abstract>The wide tissue distribution of butyrylcholinesterase (BChE) in organisms makes specific roles possible, although no clear physiologic function has yet been assigned to this enzyme. In vertebrates, it appears e.g. in serum, hemopoietic cells, liver, lung, heart, at cholinergic synapses, in the central nervous system. in tumors and not at least (besides acetylcholinesterase, AChE) in developing embryonic tissues. Here, a functional role of BChE can be found in regulation of cell proliferation and the onset of differentiation during early neuronal development--independent of its enzymatic activity. For studies concerning this point, we have established a strategy for a specific and efficient inhibition of BChE to investigate how the expected decrease of enzyme and, therefore, the manipulation of cellular cholinesterase-equilibrium influences embryonic neurogenesis--among others to gain information about the significance of noncholinergic, activity-independent and cell growth functions of BChE. The antisense-5'BChE-DNA strategy is based on inhibition of BChE mRNA transcription and protein synthesis. For this, the BChE gene is cloned into a suitable vector system; this is done in antisense-orientation, so that a transfected cell will produce their own antisense mRNA to inhibit gene expression. For such investigations in neurogenesis, the developing retina is a good model and we are able to create organotypic, three-dimensional retinal aggregates in vitro (retinospheroids) using isolated retinal cells of 6-day-old chicken embryos. Using this in vitro retina and &quot;knock out&quot; of BChE gene expression, we could show a key role of BChE during neurogenesis. The results are of great interest because in tumorigenesis and some neuronal disorders, the BChE gene is amplified or abnormally expressed. It has to be discussed how the antisense-5'BChE strategy can play a role in the development of new and efficient therapy forms.</dcterms:abstract>
        <bib:pages>607-628</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The key role of butyrylcholinesterase during neurogenesis and neural disorders</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10739090</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60339">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10739090</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60344">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stefano</foaf:surname>
                        <foaf:givenname>G. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Goumon</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bilfinger</foaf:surname>
                        <foaf:givenname>T. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Welters</foaf:surname>
                        <foaf:givenname>I. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cadet</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60345"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Base Sequence</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cardiovascular Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>endothelium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Immune System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Opioid, mu</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor</dc:title>
        <dcterms:abstract>Nitric oxide (NO) is a major signaling molecule in the immune, cardiovascular and nervous systems. The synthesizing enzyme, nitric oxide synthase (NOS) occurs in three forms: endothelial (e), neuronal (n) and inducible (i) NOS. The first two are constitutively expressed. We surmise that in many tissues there is a basal level of NO and that the actions of several signaling molecules initiate increases in cNOS-derived NO to enhance momentary basal levels that exerts inhibitory cellular actions, via cellular conformational changes. It is our contention that much of the literature concerning the actions of NO really deal with i-NOS-derived NO. We make the case that cNOS is responsible for a basal or 'tonal' level of NO; that this NO keeps particular types of cells in a state of inhibition and that activation of these cells occurs through disinhibition. Furthermore, naturally occurring signaling molecules such as morphine, anandamide, interleukin-10 and 17-beta-estradiol appear to exert, in part, their beneficial physiological actions, i.e., immune and endothelial down regulation by the stimulation of cNOS. In regard to opiates, we demonstrate the presence of a human endothelial mu opiate receptor by RT-PCR and sequence determination, further substantiating the role of opiates in vascular coupling to NO release. Taken together, cNOS derived NO enhances basal NO actions, i.e., cellular activation state, and these actions are further enhanced by iNOS derived NO.</dcterms:abstract>
        <bib:pages>513-530</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Basal nitric oxide limits immune, nervous and cardiovascular excitation</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10739087</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60345">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10739087</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60346">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>60</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Xia</foaf:surname>
                        <foaf:givenname>Z.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ying</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hansson</foaf:surname>
                        <foaf:givenname>A. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Karlsson</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Xie</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bergstrand</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>DePierre</foaf:surname>
                        <foaf:givenname>J. W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nässberger</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60347"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antidepressive Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antidepressive Agents, Tricyclic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Lipidoses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Phospholipids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Antidepressant-induced lipidosis with special reference to tricyclic compounds</dc:title>
        <dcterms:abstract>Cationic amphiphilic drugs, in general, induce phospholipid disturbances. Tricyclic, as well as other antidepressants belong to this group. In experimental animals, antidepressants induce lipid storage disorders in cells of most organs, a so-called generalized phospholipidosis. This disorder is conveniently detected by electron microscopic examination revealing myelin figures. Myelin figures or myeloid bodies are subcellular organelles containing unicentric lamellar layers. The lipidotic induction potency during in vivo is related to the apolarity of the compound. Metabolism of phospholipids takes place within the cell continuously. Several underlying mechanisms may be responsible for the induction of the phospholipid disturbance. For instance, it has been suggested that the compounds bind to phospholipids and such binding may alter the phospholipid's suitability as a substrate for phospholipases. Free TCA or metabolites thereof may also inhibit phospholipases directly, as has been demonstrated for sphingomyelinase in glioma and neuroblastoma cells. Both these mechanisms might result in phospholipidosis. Interaction between drug and phospholipid bilayer has been investigated by nuclear magnetic resonance technique. There seems to be large differences in the sensitivities amongst different organs. Steroid-producing cells of the adrenal cortex, testis and ovaries are in particular susceptible to drug-induced lipidosis. The so-called foam cells are lung macrophages located in the interstitium which become densely packed with myelin figures during TCA exposure. It requires about 3-6 weeks of treatment to develop this converted cell. In cell cultures however, phospholipidosis is demonstrated already after 24 h only. It appears that the cells that undergo TCA-induced lipidosis may recover after withdrawal of the drug. The time required to achieve complete recovery ranges from 3-4 weeks to several months, depending on the organ affected. Little is known about the functional significance of lipidosis. Even if TCA and other antidepressants show other effects, it has not been possible to exclusively relate it to phospholipidosis. However, few attempts have been made to correlate the physiological effects of TCAs in experimental animals to the morphological changes associated with phospholipidosis. There is an increasing evidence however, that cationic amphiphilic drugs may have effects on immune function, signal transduction and receptor-mediated events, effects that to some extent might be related to disturbances in phospholipid metabolism.</dcterms:abstract>
        <bib:pages>501-512</bib:pages>
        <dc:date>Apr 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10739086</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60347">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10739086</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60332">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Glynn</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60333"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Carboxylic Ester Hydrolases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neural development and neurodegeneration: two faces of neuropathy target esterase</dc:title>
        <dcterms:abstract>Neuropathy target esterase (NTE) is an integral membrane protein in vertebrate neurons. Recent evidence suggests that NTE plays an important role in neural development, possibly via involvement in a signalling pathway between neurons and glial cells. NTE is a member of a novel protein family, represented in organisms from bacteria to man. NTE comprises an N-terminal regulatory domain (with some sequence similarity to cyclic nucleotide-binding proteins) and a C-terminal catalytic domain: the latter has three predicted transmembrane segments and requires membrane-association for activity. In vitro, NTE potently catalyses hydrolysis of phenyl valerate: however, its physiological substrate is likely to be a metabolite of a much longer chain carboxylic acid, possibly associated with cell membranes. NTE was discovered originally as the primary target for those organophosphorus esters (OPs) which cause a delayed neuropathy with degeneration of long axons in peripheral nerves and spinal cord. Paradoxically, NTE's catalytic activity appears redundant in adult vertebrates. Neuropathic OPs react covalently with NTE in a rapid two-step process which not only inhibits catalytic activity but also leaves a negatively-charged OP group attached to the active site serine. The latter event is proposed to induce a toxic gain of function in NTE. OP-modified NTE somehow engenders a &quot;chemical transection of the axon&quot;. In turn, this leads to calcium entry, elevation of axonal calpain activity and Wallerian-type degeneration. The net damage to peripheral nerve axons is a balance between ongoing degenerative and repair processes: the latter involve serine hydrolases which can be inhibited by the same OPs used to modify NTE.</dcterms:abstract>
        <bib:pages>61-74</bib:pages>
        <dc:date>May 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neural development and neurodegeneration</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10759065</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60333">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10759065</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60334">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mielke</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Herdegen</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60335"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mitogen-Activated Protein Kinase 8</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mitogen-Activated Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>p38 Mitogen-Activated Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system</dc:title>
        <dcterms:abstract>The c-Jun N-terminal kinases (JNKs, also called stress activated protein kinases. SAPKs) and p38 kinases constitute together with extracellular signal-regulated kinases (ERKs) the family of MAP kinases. Whereas the functions of JNKs under physiological conditions are largely unknown, there is raising evidence that JNKs are potent effectors of apoptosis or degeneration of neurons in vitro and in the brain. The activation of the inducible transcription factor c-Jun by N-terminal phosphorylation is a central event in JNK-mediated degenerative processes that depend on de novo protein synthesis. At the post-translational level, cytoplasmic degenerative actions of JNKs might comprise inhibition of Bcl-2 and steroid hormone-receptor signaling or hyperphosphorylation of tau; and at transcriptional level, JNKs might trigger the induction of the apoptotic effectors p53 and Fas-Ligand by phosphorylation of c-Jun. The role of p38 is the nervous system is poorly understood, but its activation is also considered as part of the neuronal stress response. This review informs about the genetic processing, the regulation of activity and the biochemical actions of JNK and p38 isoforms in general. In the second part, we summarize the findings on expression and activation of JNKs and p38 under neurodegenerative condition. A particular focus is also put on the putative function of JNK under physiological conditions and for neuroprotection.</dcterms:abstract>
        <bib:pages>45-60</bib:pages>
        <dc:date>May 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10759064</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60335">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10759064</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60336">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakagawa</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Matsumoto</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60337"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ranidae</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Retina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Superior Colliculi</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Visual Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Current source density analysis of ON/OFF channels in the frog optic tectum</dc:title>
        <dcterms:abstract>In the vertebrate retina, it is well known that an ON/OFF dichotomy is present. In other words, ON-center and OFF-center cells participate in segregated pathways morphologically and physiologically. However, there is no doubt that integration of both channels is necessary to generate the complicated response properties of visual neurons in higher optic centers. So far, functional organization of the ON and OFF channels in the optic centers has not been demonstrated at the level of neuronal populations. In this review article, we summarize our experimental approaches to demonstrate functional organization of the ON and OFF channels using current source density (CSD) analysis in the frog optic tectum. First, we show that one-dimensional CSD analysis, assuming constant conductivity, is applicable in the tectal laminated structure. The CSD depth profile of a response to electrical stimulation of the optic tract is composed of three current sinks (A, B, and D) in the retinorecipient layers and two current sinks (C and E) below those layers. This result is in agreement with previous morphological and physiological findings, and shows that CSD analysis is very useful to demonstrate the flow of visual information processing. Second, CSD analysis of tectal responses evoked by diffuse light ON and OFF stimuli reveals obviously different distributions of synaptic activity in the laminar structure. Two or three current sinks (I, II and III) are generated in response to ON stimulation only in the retinorecipient layers, while up to six current sinks (IV, V, VI, VII, VIII and IX) to OFF stimulation throughout the tectal layers. Based on well known properties of retinal ganglion cells of the frog, possible neuronal mechanisms underlying each current sinks and their functional roles in visually guided behavior are considered.</dcterms:abstract>
        <bib:pages>1-44</bib:pages>
        <dc:date>May 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10759063</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60337">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10759063</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60330">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Paterson</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nordberg</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60331"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Radioligand Assay</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nicotinic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuronal nicotinic receptors in the human brain</dc:title>
        <dcterms:abstract>Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand gated ion channels which are widely distributed in the human brain. Multiple subtypes of these receptors exist, each with individual pharmacological and functional profiles. They mediate the effects of nicotine, a widely used drug of abuse, are involved in a number of physiological and behavioural processes and are additionally implicated in a number of pathological conditions such as Alzheimer's disease, Parkinson's disease and schizophrenia. The nAChRs have a pentameric structure composed of five membrane spanning subunits, of which nine different types have thus far been identified and cloned. The multiple subunits identified provide the basis for the heterogeneity of structure and function observed in the nAChR subtypes and are responsible for the individual characteristics of each. A substantial amount of information on human nAChR structure and function has come from studies on neuroblastoma cell lines which naturally express nAChRs and from recombinant nAChRs expressed in Xenopus oocytes. In vitro brain nAChR distribution can be mapped with a number of appropriate agonist and antagonist radioligands and subunit distribution may be mapped by in situ hybridization using subunit specific mRNA probes. Receptor distribution in the living human brain can be studied with noninvasive imaging techniques such as PET and SPECT, with a significant reduction in nAChRs in the brains of Alzheimer's patients having been identified with [11C] nicotine in PET studies. Despite the significant body of knowledge now accumulated about nAChRs, much remains to be elucidated. This review will attempt to describe the current knowledge on the nAChR subtypes in the human brain, their functional roles and neuropathological involvement.</dcterms:abstract>
        <bib:pages>75-111</bib:pages>
        <dc:date>May 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10759066</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60331">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10759066</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60322">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Barrett</foaf:surname>
                        <foaf:givenname>G. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60323"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Axonal Transport</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain-Derived Neurotrophic Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ceramides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>JNK Mitogen-Activated Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ligands</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mice, Transgenic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mitogen-Activated Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>NF-kappa B</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Structure, Tertiary</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor, Nerve Growth Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Tumor Necrosis Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptor, trkA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recombinant Fusion Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Second Messenger Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sequence Alignment</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sequence Homology, Amino Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Structure-Activity Relationship</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tumor Necrosis Factor-alpha</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The p75 neurotrophin receptor and neuronal apoptosis</dc:title>
        <dcterms:abstract>Although evidence continues to accumulate for the apoptosis-inducing role of the p75 neurotrophin receptor, several outstanding questions remain. One of these concerns the signal transduction pathway of p75, which continues to be elusive. The evidence for the roles of ceramide, c-jun kinase and NF-kappaB is discussed: none of these are able to account satisfactorily for p75 death signalling. Negative modulation of Trk signalling by p75 could account for part of the pro-apoptotic effect, but is unlikely to be a major component. Although recent evidence indicates that the juxtamembrane region is critical for causing cell death, p75 has a well-conserved death domain. This may be important for functions other than killing. In glial cells and some neurons that express p75 but not TrkA, p75 causes cell death in response to nerve growth factor (NGF) binding. In sensory neurons and PC12 cells, p75 appears to signal constitutively. In cholinergic forebrain neurons, p75 expression leads to atrophy and downregulation of cholinergic markers, rather than cell death. The major challenges in p75 research are to define its signalling pathways, and particularly the intracellular proteins with which it interacts. Another major challenge is to develop a model that reconciles the different facets of p75, such as its ability in some situations to assist TrkA to rescue NGF-dependent neurons, but to stimulate apoptosis in others.</dcterms:abstract>
        <bib:pages>205-229</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10704998</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60323">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10704998</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60328">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bovolenta</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fernaud-Espinosa</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60329"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Chondroitin Sulfate Proteoglycans</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Dermatan Sulfate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>extracellular matrix</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Glycosaminoglycans</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Heparan Sulfate Proteoglycans</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteoglycans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vertebrates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Nervous system proteoglycans as modulators of neurite outgrowth</dc:title>
        <dcterms:abstract>The proteoglycans are multifunctional macromolecules composed of a core polypeptide and a variable number of glycosaminoglycan chains. The structural diversity and complexities of proteoglycan expression in the developing and adult Nervous System underlies the variety of biological functions that these molecules fulfill. Thus, in the Nervous System, proteoglycans regulate the structural organisation of the extracellular matrix, modulate growth factor activities and cellular adhesive and motility events, such as cell migration and axon outgrowth. This review summarises the evidences indicating that proteoglycans have an important role as modulators of neurite outgrowth and neuronal polarity. Special emphasis will be placed on those studies that have shown that proteoglycans of certain subtypes inhibit neurite extension either during the development and/or the regeneration of the vertebrate Central Nervous System.</dcterms:abstract>
        <bib:pages>113-132</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10704995</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60329">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10704995</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60320">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Calabresi</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Centonze</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gubellini</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marfia</foaf:surname>
                        <foaf:givenname>G. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pisani</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sancesario</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bernardi</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60321"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neostriatum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Synaptic transmission in the striatum: from plasticity to neurodegeneration</dc:title>
        <dcterms:abstract>Striatal neurones receive myriad of synaptic inputs originating from different sources. Massive afferents from all areas of the cortex and the thalamus represent the most important source of excitatory amino acids, whereas the nigrostriatal pathway and intrinsic circuits provide the striatum with dopamine, acetylcholine, GABA, nitric oxide and adenosine. All these neurotransmitter systems interact each other and with voltage-dependent conductances to regulate the efficacy of the synaptic transmission within this nucleus. The integrative action exerted by striatal projection neurones on this converging information dictates the final output of the striatum to the other basal ganglia structures. Recent morphological, immunohistochemical and electrophysiological findings demonstrated that the striatum also contains different interneurones, whose role in physiological and pathological conditions represents an intriguing challenge in these years. The use of the in vitro brain slice preparation has allowed not only the detailed investigation of the direct pre- and postsynaptic electrophysiological actions of several neurotransmitters in striatal neurones, but also the understanding of their role in two different forms of corticostriatal synaptic plasticity, long-term depression and long-term potentiation. These long-lasting changes in the efficacy of excitatory transmission have been proposed to represent the cellular basis of some forms of motor learning and are altered in animal models of human basal ganglia disorders, such as Parkinson's disease. The striatum also expresses high sensitivity to hypoxic-aglycemic insults. During these pathological conditions, striatal synaptic transmission is altered depending on presynaptic inhibition of transmitter release and opposite membrane potential changes occur in projection neurones and in cholinergic interneurones. These ionic mechanisms might partially explain the selective neuronal vulnerability observed in the striatum during global ischemia and Huntington's disease.</dcterms:abstract>
        <bib:pages>231-265</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Synaptic transmission in the striatum</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727775</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60321">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727775</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60318">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garbay</foaf:surname>
                        <foaf:givenname>B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Heape</foaf:surname>
                        <foaf:givenname>A. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sargueil</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cassagne</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60319"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Myelin Basic Protein</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Sheath</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Schwann Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Myelin synthesis in the peripheral nervous system</dc:title>
        <dcterms:abstract>By imposing saltatory conduction on the nervous impulse, the principal role of the myelin sheath is to allow the faster propagation of action potentials along the axons which it surrounds. Peripheral nervous system (PNS) myelin is formed by the differentiation of the plasma membrane of Schwann cells. One of the biochemical characteristics that distinguishes myelin from other biological membranes is its high lipid-to-protein ratio. All the major lipid classes are represented in the myelin membrane, while several myelin-specific proteins have been identified. During development, the presence of axons is required for the initiation of myelination, but the nature of the axonal signal is still unknown. The only certainties are that this signal is synthesized by axons whose diameter is greater than 0.7 microm, and that the signal(s) include(s) a diffusible molecule. Morphological studies have provided us with information concerning the timing of myelination, the mechanism by which immature Schwann cells differentiate into a myelinating phenotype and lay down the myelin sheath around the axon, and the accumulation and the structure of the myelin membrane. The last 20 years have seen the identification and the cDNA and gene cloning of the major PNS myelin proteins, which signalled the beginning of the knock-out decade: transgenic null-mutant mice have been created for almost every protein gene. The study of these animals shows that the formation of myelin is considerably less sensitive to molecular alterations than the maintenance of myelin. During the same period, important data has been gathered concerning the synthesis and function of lipids in PNS myelin, although this field has received relatively little attention compared with that of their protein counterparts.</dcterms:abstract>
        <bib:pages>267-304</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727776</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60319">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727776</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60324">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Herrero</foaf:surname>
                        <foaf:givenname>J. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Laird</foaf:surname>
                        <foaf:givenname>J. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>López-García</foaf:surname>
                        <foaf:givenname>J. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60325"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Afferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Analgesics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anesthetics, Local</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anti-Inflammatory Agents, Non-Steroidal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hyperalgesia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Inflammation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Transport</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Morphine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Fibers</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuralgia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurons, Afferent</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nociceptors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Metabotropic Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neurokinin-1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reflex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Substance P</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Viscera</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Wind-up of spinal cord neurones and pain sensation: much ado about something?</dc:title>
        <dcterms:abstract>Wind-up is a frequency-dependent increase in the excitability of spinal cord neurones, evoked by electrical stimulation of afferent C-fibres. Although it has been studied over the past thirty years, there are still uncertainties about its physiological meaning. Glutamate (NMDA) and tachykinin NK1 receptors are required to generate wind-up and therefore a positive modulation between these two receptor types has been suggested by some authors. However, most drugs capable of reducing the excitability of spinal cord neurones, including opioids and NSAIDs, can also reduce or even abolish wind-up. Thus, other theories involving synaptic efficacy, potassium channels, calcium channels, etc. have also been proposed for the generation of this phenomenon. Whatever the mechanisms involved in its generation, wind-up has been interpreted as a system for the amplification in the spinal cord of the nociceptive message that arrives from peripheral nociceptors connected to C-fibres. This probably reflects the physiological system activated in the spinal cord after an intense or persistent barrage of afferent nociceptive impulses. On the other hand, wind-up, central sensitisation and hyperalgesia are not the same phenomena, although they may share common properties. Wind-up can be an important tool to study the processing of nociceptive information in the spinal cord, and the central effects of drugs that modulate the nociceptive system. This paper reviews the physiological and pharmacological data on wind-up of spinal cord neurones, and the perceptual correlates of wind-up in human subjects, in the context of its possible relation to the triggering of hyperalgesic states, and also the multiple factors which contribute to the generation of wind-up.</dcterms:abstract>
        <bib:pages>169-203</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Wind-up of spinal cord neurones and pain sensation</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10704997</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60325">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10704997</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60314">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakao</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Itakura</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60315"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Fetal Tissue Transplantation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Huntington Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neostriatum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits</dc:title>
        <dcterms:abstract>Accumulating evidence indicates that grafts of embryonic neurons achieve the anatomical and functional reconstruction of damaged neuronal circuitry. The restorative capacity of grafted embryonic neural tissue is most illustrated by studies with striatal tissue transplantation in animals with striatal lesions. Striatal neurons implanted into the lesioned striatum receive some of the major striatal afferents such as the nigrostriatal dopaminergic inputs and the gluatmatergic afferents from the neocortex and thalamus. The grafted neurons also send efferents to the primary striatal targets, including the globus pallidus (GP, the rodent homologue of the external segment of the globus pallidus) and the entopeduncular nucleus (EP, the rodent homologue of the internal segment of the globus pallidus). These anatomical connections provide the reversal of the lesion-induced alterations in neuronal activities of primary and secondary striatal targets. Furthermore, intrastriatal striatal grafts improve motor and cognitive deficits seen in animals with striatal lesions. Since the grafts affect motor and cognitive behaviors that are critically dependent on the integrity of neuronal circuits of the basal ganglia, the graft-mediated recovery in these behavioral deficits is most likely attributable to the functional reconstruction of the damaged neuronal circuits. The fact that the extent of the behavioral recovery is positively correlated to the amount of grafted neurons surviving in the striatum encourages this view. Based on the animal studies, embryonic striatal tissue grafting could be a viable strategy to alleviate motor and cognitive disorders seen in patients with Huntington's disease where massive degeneration of striatal neurons occurs.</dcterms:abstract>
        <bib:pages>313-338</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Fetal tissue transplants in animal models of Huntington's disease</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727778</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60315">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727778</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60326">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sánchez</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Díaz-Nido</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Avila</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60327"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Axonal Transport</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cytoskeleton</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Microtubule-Associated Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microtubules</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Morphogenesis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Phosphoprotein Phosphatases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>phosphorylation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Isoforms</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Protein Kinases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Processing, Post-Translational</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function</dc:title>
        <dcterms:abstract>Neurons, the basic information processing units of the nervous system, are characterized by a complex polar morphology which is essential for their function. To attain their precise morphology, neurons extend cytoplasmatic processes (axons and dendrites) and establish synaptic connections in a highly regulated way. Additionally, neurons are also subjected to small plastic changes at the adult stage which serve to regulate synaptic transmission. Every step of neuronal development is genetically controlled by endogenous determinants, as well as by environmental signals including intercellular contacts, extracellular matrix and diffusible signals. Cytoskeletal components are among the main protein targets modified in response to most of those extracellular signals which ultimately determine neuronal morphology. One of the major mechanisms controlling the neuronal cytoskeleton is the modification of the phosphorylation state of cytoskeletal proteins via changes in the relative activities of protein kinases and phosphatases within neurons. In particular, the microtubule-associated protein 2 (MAP2) family of proteins is an abundant group of cytoskeletal components which are predominantly expressed in neurons and serve as substrates for most of protein kinases and phosphatases present in neurons. MAP2 phosphorylation seems to control its association with the cytoskeleton and it is developmentally regulated. Moreover, MAP2 may perform many functions including the nucleation and stabilization of microtubules (and maybe microfilaments), the regulation of organelle transport within axons and dendrites, as well as the anchorage of regulatory proteins such as protein kinases which may be important for signal transduction. These putative functions of MAP2 have also been proposed to play important roles in the outgrowth of neuronal processes, synaptic plasticity and neuronal cell death. Thus, MAP2 constitutes an interesting case to understand the regulation of neuronal function by the alteration of the phosphorylation state of cytoskeletal proteins in response to different extracellular signals. Here we will review the current knowledge about the regulation of MAP2 function through phosphorylation/dephosphorylation and its relevance in the broader context of neuronal functions.</dcterms:abstract>
        <bib:pages>133-168</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10704996</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60327">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10704996</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60316">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>van Leuven</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60317"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mice, Transgenic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Single and multiple transgenic mice as models for Alzheimer's disease</dc:title>
        <dcterms:abstract>Transgenic mice expressing in brain different mutant forms of the Amyloid Precursor Protein, develop functional, cognitive and pathological defects which resemble or are reminiscent of symptoms observed in Alzheimer's disease (AD) patients. The late development of amyloid plaques in aging transgenic APP mice is needed to warrant that the earlier behavioural and cognitive defects are informative for the human disorder. We describe and discuss our work, the rationale behind the approach and the techniques used to generate these APP transgenic mice, including specific experimental problems. The APP transgenic mouse models are being comprehensively characterized and offer excellent perspectives for the study and definition of early biochemical and pathological aspects that are not accessible in human AD patients. The ongoing combination by breeding with other transgenic mouse strains, i.e. mice overexpressing human Presenilin 1, ApoE 4 and protein tau to generate &quot;multiple&quot; transgenic mice, offer additional potential to define the pathological interactions of these genetic factors, known to be involved, directly or indirectly, in dementia of the Alzheimer type. Finally, it must be the aim to obtain transgenic mice that not only model amyloidogenesis, but also the neurofibrillary tangle pathology and the involvement of protein tau.</dcterms:abstract>
        <bib:pages>305-312</bib:pages>
        <dc:date>Jun 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727777</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60317">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727777</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60310">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gareri</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Falconi</foaf:surname>
                        <foaf:givenname>U.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>De Fazio</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>De Sarro</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60311"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Affect</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antidepressive Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Depression</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Incidence</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>liver</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Monoamine Oxidase Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prevalence</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Adrenergic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Dopamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, GABA-B</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Serotonin</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Conventional and new antidepressant drugs in the elderly</dc:title>
        <dcterms:abstract>Depression in the elderly is nowadays a predominant health care problem, mainly due to the progressive aging of the population. It results from psychosocial stress, polypathology, as well as some biochemical changes which occur in the aged brain and can lead to cognitive impairments, increased symptoms from medical illness, higher utilization of health care services and increased rates of suicide and nonsuicide mortality. Therefore, it is very important to make an early diagnosis and a suitable pharmacological treatment, not only for resolving the acute episode, but also for preventing relapse and enhancing the quality of life. Age-related changes in pharmacokinetics and in pharmacodynamics have to be kept into account before prescribing an antidepressant therapy in an old patient. In this paper some of the most important and tolerated drugs in the elderly are reviewed. Tricyclic antidepressants have to be used carefully for their important side effects. Nortriptyline, amytriptiline, clomipramine and desipramine as well, seem to be the best tolerated tricyclics in old people. Second generation antidepressants are preferred for the elderly and those patients with heart disease as they have milder side effects and are less toxic in overdose and include the so called atypicals, such as selective serotonin reuptake inhibitors, serotonin noradrenalene reuptake inhibitors and noradrenaline reuptake inhibitors. Monoamine oxidase (MAO) inhibitors are useful drugs in resistant forms of depression in which the above mentioned drugs have no efficacy; the last generation drugs (reversible MAO inhibitors), such as meclobemide, seem to be very successful. Mood stabilizing drugs are widely used for preventing recurrences of depression and for preventing and treating bipolar illness. They include lithium, which is sometimes used especially to prevent recurrence of depression, even if its use is limited in old patients for its side effects, the anticonvulsants carbamazepine and valproic acid. Putative last generation mood stabilizing drugs include the dihydropyridine L-type calcium channel blockers and the anticonvulsants phenytoin, lamotrigine, gabapentin and topiramate, which have unique mechanisms of action and also merit further systematic study. Psychotherapy is often used as an adjunct to pharmacotherapy, while electroconvulsant therapy is used only in the elderly patients with severe depression, high risk of suicide or drug resistant forms.</dcterms:abstract>
        <bib:pages>353-396</bib:pages>
        <dc:date>Jul 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727780</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60311">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727780</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60312">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hendricks</foaf:surname>
                        <foaf:givenname>J. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sehgal</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pack</foaf:surname>
                        <foaf:givenname>A. I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60313"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aplysia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Circadian Rhythm</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Drosophila melanogaster</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Research Design</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sensory Thresholds</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Xenopus laevis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Zebrafish</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The need for a simple animal model to understand sleep</dc:title>
        <dcterms:abstract>Simple animal models have allowed biologists to apply the tools of modern molecular genetics to such complex behaviors as circadian rhythms and long-term memory consolidation. The mechanisms and molecules discovered in these simple animals are evolutionarily conserved in other species, including mammals. Sleep research lacks a simple animal model because criteria based on the electroencephalogram have been met only in birds and mammals. We argue that straightforward behavioral criteria could allow the identification of a sleep-like rest state that might be useful for molecular investigations to understand the regulation and function of sleep. Candidate model systems are discussed, leading to the conclusion that several species have complementary strengths. Specifically, techniques developed for larval zebrafish can be used to visualize neural firing patterns in the living animal, and the fruit fly Drosophila melanogaster has been used successfully for molecular and genetic dissection of complex behaviors. We conclude with a hypothesis that one putative function of sleep, the optimization of neural plasticity, would also have adaptive value in simple organisms and might therefore be evolutionarily conserved.</dcterms:abstract>
        <bib:pages>339-351</bib:pages>
        <dc:date>Jul 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727779</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60313">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727779</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60308">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ide</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Secher</foaf:surname>
                        <foaf:givenname>N. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60309"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>blood pressure</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cardiac Output</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebrovascular Circulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>exercise</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>MAP Kinase Signaling System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microspheres</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Middle Cerebral Artery</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Oxygen Consumption</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Regional Blood Flow</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Spectroscopy, Near-Infrared</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tomography, Emission-Computed</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ultrasonography, Doppler, Transcranial</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Cerebral blood flow and metabolism during exercise</dc:title>
        <dcterms:abstract>During exercise regional cerebral blood flow (rCBF), as blood velocity in major cerebral arteries and also blood flow in the internal carotid artery increase, suggesting an increase in blood flow to a large part of the brain. Such an increase in CBF is independent of the concomitant increase in blood pressure but is modified by the alteration in arterial carbon dioxide tension (PaCO(2)). Also, the increase in middle cerebral artery mean blood velocity (MCA V(mean)) reported with exercise appears to depend on the ability to increase cardiac output (CO), as demonstrated in response to beta-1 blockade and in patients with cardiac insufficiency or atrial fibrillation.Near-infrared spectroscopy (NIRS) determined cerebral oxygenation supports the alterations in MCA V(mean) during exercise. Equally, the observation that the cerebrovascular CO(2)-reactivity appears to be smaller in the standing than in the sitting and especially in the supine position could relate to the progressively smaller CO. In contrast, during exercise &quot;global&quot; cerebral blood flow (gCBF), as determined by the Kety-Schmidt technique is regarded as being constant. One limitation of the Kety-Schmidt method for measuring CBF is that blood flow in the two internal jugular veins depends on the origin of drainage and it has not been defined which internal jugular venous flow is evaluated. Such a consideration is equally relevant for an evaluation of cerebral metabolism during exercise. While the regional cerebral uptake of oxygen (O(2)) increases during exercise, the global value is regarded as being constant. Yet, during high intensity exercise lactate is taken up by the brain and its O(2) uptake also increases. Furthermore, in the initial minutes of recovery immediately following exercise, brain glucose and O(2) uptake are elevated and lactate uptake remains high.A maintained substrate uptake by the brain after exercise suggests a role for brain glycogen in cerebral activation, but the fate of brain substrate uptake has not yet been determined.</dcterms:abstract>
        <bib:pages>397-414</bib:pages>
        <dc:date>Jul 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727781</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60309">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727781</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60306">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Koshimura</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Murakami</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tanaka</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kato</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60307"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Biopterin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Survival</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>PC12 Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of 6R-tetrahydrobiopterin in the nervous system</dc:title>
        <dcterms:abstract>In addition to its cofactor activities for aromatic L-amino acid hydroxylases and nitric oxide synthase (NOS), 6R-tetrahydrobiopterin (6R-BH(4)) shows diverse actions on neurons. Dopamine release from the rat striatum or PC12 cells was stimulated by 6R-BH(4). The action of 6R-BH(4) was independent of its cofactor activities and stereospecific. Ca(2+) channels in rat brain and PC12 cells were activated by 6R-BH(4) via cAMP-protein kinase A pathway. Membrane potential of PC12 cells was deplorized by 6R-BH(4). Thus, it is assumed that 6R-BH(4) acts on its specific action site (possibly outside of the cell membrane) to stimulate dopamine release by activating Ca(2+) channels. Apoptosis induced by depletion of serum and nerve growth factor in PC12 cells was prevented by 6R-BH(4). The cell surviving effect of 6R-BH(4) was also mediated by activation of Ca(2+) channels and cAMP-protein kinase A pathway. However, since 6R-BH(4) did not activate mitogen activated protein kinase, it did not support neuronal differentiation. Nitric oxide (NO)-induced cell death was prevented by 6R-BH(4) in PC12 cells. NOS activity was not changed by exogenous 6R-BH(4), but NO metabolites in culture medium were decreased by 6R-BH(4). When endogenous 6R-BH(4) was reduced by inhibition of biosynthesis, cell death was induced in PC12 cells. Superoxide is observed to be generated during autoxidation of 6R-BH(4). Superoxide producing system mimicked the cell protective action of 6R-BH(4) against NO toxicity. Thus, it is considered that 6R-BH(4) protects PC12 cells against NO toxicity by generating superoxide during its autoxidation. These results raised the possibility that 6R-BH(4) is a self-protective factor against NO toxicity in NO producing neurons. Our findings indicate that 6R-BH(4) regulates neuronal activities in the brain and that 6R-BH(4) can be a promising drug for neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.</dcterms:abstract>
        <bib:pages>415-438</bib:pages>
        <dc:date>Jul 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10727782</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60307">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10727782</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60298">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Andreassen</foaf:surname>
                        <foaf:givenname>O. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jørgensen</foaf:surname>
                        <foaf:givenname>H. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60299"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antipsychotic Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Dyskinesia, Drug-Induced</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neostriatum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>oxidative stress</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?</dc:title>
        <dcterms:abstract>Tardive dyskinesia is a serious motor side effect of long-term treatment with neuroleptics, with an unknown pathophysiologic basis. Brain damage and aging are prominent risk-factors, and together with the persistent character of the disorder, it is likely that long-lasting neuronal changes are involved in the pathogenesis. It has been hypothesized that striatal neurodegeneration caused by excitotoxic mechanisms and oxidative stress may play an important role in the development of the disorder, and the scope of the present work is to review the evidence supporting this hypothesis. The rat model of tardive dyskinesia has been used extensively in the field, and the usefulness of this model will be discussed. Neuroleptics are able to induce oxidative stress in vitro and increase striatal glutamatergic activity in rats, which may lead to toxic effects in the striatum. Drugs that block excitotoxicity inhibit the development of persistent oral dyskinesia in the rat model, and impaired energy metabolism leads to increased frequency of oral dyskinesia. There are also signs of altered striatal histology in rats with high frequency of oral dyskinesia. Furthermore, markers of increased oxidative stress and glutamatergic neurotransmission have been found in the cerebrospinal fluid of patients with tardive dyskinesia. In conclusion, several lines of evidence implicate neurotoxic events in the development of neuroleptic induced tardive dyskinesia.</dcterms:abstract>
        <bib:pages>525-541</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10748322</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60299">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10748322</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60292">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grothe</foaf:surname>
                        <foaf:givenname>B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60293"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Auditory Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Chiroptera</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hearing</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Olivary Nucleus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sound Localization</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time Perception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The evolution of temporal processing in the medial superior olive, an auditory brainstem structure</dc:title>
        <dcterms:abstract>A basic concept in neuroscience is to correlate specific functions with specific neuronal structures. By discussing a specific example, an alternative concept is proposed: structures may be linked to rules of processing and these rules may serve different functions in different species or at different stages of evolution. The medial superior olive (MSO), a mammalian auditory brainstem structure, has been thought to solely process interaural time differences (ITD), the main cue for localizing low frequency sounds. Recent findings, however, indicate that this is not its only function since mammals that do not hear low frequencies and do not use ITDs for sound localization also possess a MSO. Recordings from the bat MSO indicate that it processes temporal cues in the milli- and submillisecond range, based on monaural or binaural inputs. In bats, and most likely in other small mammals, this temporal processing is related to pattern recognition and echo suppression rather than sound localization. However, the underlying mechanism, coincidence detection of several inputs, creates an epiphenomenal ITD sensitivity that is of no use for small mammals like bats or ancestral mammals. Such an epiphenomenal ITD sensitivity would have been a pre-adaptation which, when mammals grew larger during evolution and when localization of low frequency sounds became a question of survival, suddenly gained relevance. This way the MSO became involved in a new function without changing its basic rules of processing.</dcterms:abstract>
        <bib:pages>581-610</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10775798</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60293">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10775798</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60300">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kakigi</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hoshiyama</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shimojo</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Naka</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yamasaki</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Watanabe</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Xiang</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maeda</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lam</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Itomi</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakamura</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60301"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Evoked Potentials, Somatosensory</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetoencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Somatosensory Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The somatosensory evoked magnetic fields</dc:title>
        <dcterms:abstract>Averaged magnetoencephalography (MEG) following somatosensory stimulation, somatosensory evoked magnetic field(s) (SEF), in humans are reviewed. The equivalent current dipole(s) (ECD) of the primary and the following middle-latency components of SEF following electrical stimulation within 80-100 ms are estimated in area 3b of the primary somatosensory cortex (SI), the posterior bank of the central sulcus, in the hemisphere contralateral to the stimulated site. Their sites are generally compatible with the homunculus which was reported by Penfield using direct cortical stimulation during surgery. SEF to passive finger movement is generated in area 3a or 2 of SI, unlike with electrical stimulation. Long-latency components with peaks of approximately 80-120 ms are recorded in the bilateral hemispheres and their ECD are estimated in the secondary somatosensory cortex (SII) in the bilateral hemispheres. We also summarized (1) the gating effects on SEF by interference tactile stimulation or movement applied to the stimulus site, (2) clinical applications of SEF in the fields of neurosurgery and neurology and (3) cortical plasticity (reorganization) of the SI. SEF specific to painful stimulation is also recorded following painful stimulation by CO(2) laser beam. Pain-specific components are recorded over 150 ms after the stimulus and their ECD are estimated in the bilateral SII and the limbic system. We introduced a newly-developed multi (12)-channel gradiometer system with the smallest and highest quality superconducting quantum interference device (micro-SQUID) available to non-invasively detect the magnetic fields of a human peripheral nerve. Clear nerve action fields (NAFs) were consistently recorded from all subjects.</dcterms:abstract>
        <bib:pages>495-523</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10748321</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60301">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10748321</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60304">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lesort</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tucholski</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Miller</foaf:surname>
                        <foaf:givenname>M. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Johnson</foaf:surname>
                        <foaf:givenname>G. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60305"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GTP-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transglutaminases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Tissue transglutaminase: a possible role in neurodegenerative diseases</dc:title>
        <dcterms:abstract>Tissue transglutaminase is a multifunctional protein that is likely to play a role in numerous processes in the nervous system. Tissue transglutaminase posttranslationally modifies proteins by transamidation of specific polypeptide bound glutamines. This action results in the formation of protein crosslinks or the incorporation of polyamines into substrate proteins, modifications that likely have significant effects on neural function. Tissue transglutaminase is a unique member of the transglutaminase family as in addition to catalyzing the calcium-dependent transamidation reaction, it also binds and hydrolyzes ATP and Guanosine 5'-triphosphate and may play a role in signal transduction. Tissue transglutaminase is a highly regulated and inducible enzyme that is developmentally regulated in the nervous system. In vitro, numerous substrates of tissue transglutaminase have been identified, and several of these proteins have been shown to be in situ substrates as well. Several specific roles for tissue transglutaminase have been described and there is evidence that tissue transglutaminase may also play a role in apoptosis. Recent findings have provided evidence that dysregulation of tissue transglutaminase may contribute to the pathology of several neurodegenerative conditions including Alzheimer's disease and Huntington's disease. In both of these diseases tissue transglutaminase and transglutaminase activity are elevated compared to age-matched controls. Further, immunohistochemical studies have demonstrated that there is an increase in tissue transglutaminase reactivity in affected neurons in both Alzheimer's and Huntington's disease. Although intriguing, many issues remain to be addressed to definitively establish a role for tissue transglutaminase in these neurodegenerative diseases.</dcterms:abstract>
        <bib:pages>439-463</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Tissue transglutaminase</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10748319</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60305">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10748319</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60296">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lowrie</foaf:surname>
                        <foaf:givenname>M. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lawson</foaf:surname>
                        <foaf:givenname>S. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60297"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interneurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cell death of spinal interneurones</dc:title>
        <dcterms:abstract>The occurrence of neuronal death during development is well documented for some neuronal populations, such as motoneurones and dorsal root ganglion cells, whose connecting pathways are clearly defined. Cell survival is thought to be regulated largely by target and input connections, a process that serves to match the size of synaptically linked neuronal populations. Far less is known about interneurones. It is assumed that most interneurone populations are excluded from this process because their connections are more diffuse. Recent studies on the rat spinal cord have indicated that interneurone death does occur, both naturally during development and induced following peripheral nerve injury. Here the evidence for spinal interneurone death is reviewed and the factors influencing it are discussed. There are many functional types of interneurones in the spinal cord that may differ in vulnerability to cell death, but it is concluded that for most spinal interneurones the traditional view of target regulation is unlikely. Instead it is proposed that developmental interneurone death in the spinal cord forms part of a plastic response to altered sensory activation rather than a size-matching exercise. There is also emerging evidence that interneurone death may play a more direct role in some neurodegenerative diseases than hitherto considered.</dcterms:abstract>
        <bib:pages>543-555</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10775796</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60297">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10775796</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60302">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pesheva</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Probstmeier</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60303"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Tenascin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The yin and yang of tenascin-R in CNS development and pathology</dc:title>
        <dcterms:abstract>An important biological consequence of the initial interactions between the cell surface and its extracellular environment is the diversity of cellular responses ranging from overt repulsion or avoidance reaction to stable adhesion or final positioning. It is now evident that positive and negative guiding mechanisms are equally relevant to normal pattern formation during development and decisive for the outcome of a regenerative process. In this context, the present review summarizes the knowledge about the extracellular matrix glycoprotein tenascin-R, a member of the tenascin gene family. In contrast to all other known family members, tenascin-R is exclusively expressed in the central nervous system of vertebrates by oligodendrocytes and neuronal subsets at later developmental stages and in adulthood. We focus on the glycoprotein's structure, tissue distribution and functional implications in the molecular control of axon targeting, neural cell adhesion, migration and differentiation during nervous system morphogenesis and pathology.</dcterms:abstract>
        <bib:pages>465-493</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10748320</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60303">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10748320</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60290">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Redies</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60291"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cadherins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Chromosome Mapping</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Embryo, Mammalian</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Structure</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cadherins in the central nervous system</dc:title>
        <dcterms:abstract>The central nervous system (CNS) is divided into diverse embryological and functional compartments. The early embryonic CNS consists of a series of transverse subdivisions (neuromeres) and longitudinal domains. These embryonic subdivisions represent histogenetic fields in which neurons are born and aggregate in distinct cell groups (brain nuclei and layers). Different subsets of these aggregates become selectively connected by nerve fiber tracts and, finally, by synapses, thus forming the neural circuits of the functional systems in the CNS. Recent work has shown that 30 or more members of the cadherin family of morphoregulatory molecules are differentially expressed in the developing and mature brain at almost all stages of development. In a regionally specific fashion, most cadherins studied to date are expressed by the embryonic subdivisions of the early embryonic brain, by developing brain nuclei, cortical layers and regions, and by fiber tracts, neural circuits and synapses. Each cadherin shows a unique expression pattern that is distinct from that of other cadherins. Experimental evidence suggests that cadherins contribute to CNS regionalization, morphogenesis and fiber tract formation, possibly by conferring preferentially homotypic adhesiveness (or other types of interactions) between the diverse structural elements of the CNS. Cadherin-mediated adhesive specificity may thus provide a molecular code for early embryonic CNS regionalization as well as for the development and maintenance of functional structures in the CNS, from embryonic subdivisions to brain nuclei, cortical layers and neural circuits, down to the level of individual synapses.</dcterms:abstract>
        <bib:pages>611-648</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10775799</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60291">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10775799</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60294">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>61</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rolls</foaf:surname>
                        <foaf:givenname>E. T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stringer</foaf:surname>
                        <foaf:givenname>S. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60295"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Algorithms</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Computer Simulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Evolution, Molecular</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>genes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>On the design of neural networks in the brain by genetic evolution</dc:title>
        <dcterms:abstract>Hypotheses are presented of what could be specified by genes to enable the different functional architectures of the neural networks found in the brain to be built during ontogenesis. It is suggested that for each class of neuron (e.g., hippocampal CA3 pyramidal cells) a small number of genes specify the generic properties of that neuron class (e.g., the number of neurons in the class, and the firing threshold), while a larger number of genes specify the properties of the synapses onto that class of neuron from each of the other classes that makes synapses with it. These properties include not only which other neuron classes the synapses come from, but whether they are excitatory or inhibitory, the nature of the learning rule implemented at the synapse, and the initial strength of such synapses. In a demonstration of the feasibility of the hypotheses to specify the architecture of different types of neuronal network, a genetic algorithm is used to allow the evolution of genotypes which are capable of specifying neural networks that can learn to solve particular computational tasks, including pattern association, autoassociation, and competitive learning. This overall approach allows such hypotheses to be further tested, improved, and extended with the help of neuronal network simulations with genetically specified architectures in order to develop further our understanding of how the architecture and operation of different parts of brains are specified by genes, and how different parts of our brains have evolved to perform particular functions.</dcterms:abstract>
        <bib:pages>557-579</bib:pages>
        <dc:date>Aug 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10775797</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60295">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10775797</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60288">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Alvarez</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Giuditta</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Koenig</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60289"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Phenotype</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synaptosomes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Protein synthesis in axons and terminals: significance for maintenance, plasticity and regulation of phenotype. With a critique of slow transport theory</dc:title>
        <dcterms:abstract>This article focuses on local protein synthesis as a basis for maintaining axoplasmic mass, and expression of plasticity in axons and terminals. Recent evidence of discrete ribosomal domains, subjacent to the axolemma, which are distributed at intermittent intervals along axons, are described. Studies of locally synthesized proteins, and proteins encoded by RNA transcripts in axons indicate that the latter comprise constituents of the so-called slow transport rate groups. A comprehensive review and analysis of published data on synaptosomes and identified presynaptic terminals warrants the conclusion that a cytoribosomal machinery is present, and that protein synthesis could play a role in long-term changes of modifiable synapses. The concept that all axonal proteins are supplied by slow transport after synthesis in the perikaryon is challenged because the underlying assumptions of the model are discordant with known metabolic principles. The flawed slow transport model is supplanted by a metabolic model that is supported by evidence of local synthesis and turnover of proteins in axons. A comparison of the relative strengths of the two models shows that, unlike the local synthesis model, the slow transport model fails as a credible theoretical construct to account for axons and terminals as we know them. Evidence for a dynamic anatomy of axons is presented. It is proposed that a distributed &quot;sprouting program,&quot; which governs local plasticity of axons, is regulated by environmental cues, and ultimately depends on local synthesis. In this respect, nerve regeneration is treated as a special case of the sprouting program. The term merotrophism is proposed to denote a class of phenomena, in which regional phenotype changes are regulated locally without specific involvement of the neuronal nucleus.</dcterms:abstract>
        <bib:pages>1-62</bib:pages>
        <dc:date>Sep 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Protein synthesis in axons and terminals</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10821981</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60289">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10821981</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60286">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Blandini</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nappi</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tassorelli</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Martignoni</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60287"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebral Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Functional changes of the basal ganglia circuitry in Parkinson's disease</dc:title>
        <dcterms:abstract>The basal ganglia circuitry processes the signals that flow from the cortex, allowing the correct execution of voluntary movements. In Parkinson's disease, the degeneration of dopaminergic neurons of the substantia nigra pars compacta triggers a cascade of functional changes affecting the whole basal ganglia network. The most relevant alterations affect the output nuclei of the circuit, the medial globus pallidus and substantia nigra pars reticulata, which become hyperactive. Such hyperactivity is sustained by the enhanced glutamatergic inputs that the output nuclei receive from the subthalamic nucleus. The mechanisms leading to the subthalamic disinhibition are still poorly understood. According to the current model of basal ganglia organization, the phenomenon is due to a decrease in the inhibitory control exerted over the subthalamic nucleus by the lateral globus pallidus. Recent data, however, suggest that additional if not alternative mechanisms may underlie subthalamic hyperactivity. In particular, given the reciprocal innervation of the substantia nigra pars compacta and the subthalamic nucleus, the dopaminergic deficit might influence the subthalamic activity, directly. In addition, the increased excitatory drive to the dopaminergic nigral neurons originating from the hyperactive subthalamic nucleus might sustain the progression of the degenerative process. The identification of the role of the subthalamic nucleus and, more in general, of the glutamatergic mechanisms in the pathophysiology of Parkinson's disease might lead to a new approach in the pharmacological treatment of the disease. Current therapeutic strategies rely on the use of L-DOPA and/or dopamine agonists to correct the dopaminergic deficit. Drugs capable of antagonizing the effects of glutamate might represent, in the next future, a valuable tool for the development of new symptomatic and neuroprotective strategies for therapy of Parkinson's disease.</dcterms:abstract>
        <bib:pages>63-88</bib:pages>
        <dc:date>Sep 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10821982</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60287">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10821982</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60284">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tissot</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stocker</foaf:surname>
                        <foaf:givenname>R. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60285"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Drosophila</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Metamorphosis, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Metamorphosis in drosophila and other insects: the fate of neurons throughout the stages</dc:title>
        <dcterms:abstract>The nervous system of insects is profoundly reorganised during metamorphosis, affecting the fate of different types of neuron in different ways. Almost all adult motor neurons derive from larval motor neurons that are respecified for adult functions. A subset of larval motor neurons, those which mediate larval- or ecdysis-specific behaviours, die before and immediately after eclosion, respectively. Many adult interneurons develop from larval interneurons, whereas those related to complex adult sense organs originate during larval life from persisting embryonic neuroblasts. Sensory neurons of larvae and adults derive from essentially two distinct sources. Larval sensory neurons are formed in the embryonic integument and - with few exceptions - die during metamorphosis. Their adult counterparts, on the other hand, arise from imaginal discs. Special emphasis is given in this review to the metamorphic remodelling of persisting neurons, both at the input and output levels, and to the associated behavioural changes. Other sections deal with the programmed death of motor neurons and its causes, as well as with the metamorphic interactions between motor neurons and their target muscles. Remodelling and apoptosis of these two elements appear to be under independent ecdysteroid control. This review focusses on the two most thoroughly studied holometabolous species, the fruitfly Drosophila melanogaster and the tobacco hornworm moth Manduca sexta. While Manduca has a long tradition in neurodevelopmental studies due to the identification of many of its neurons, Drosophila has been increasingly used to investigate neural reorganisation thanks to neurogenetic tools and molecular approaches. The wealth of information available emphasises the strength of the insect model system used in developmental studies, rendering it clearly the most important system for studies at the cellular level.</dcterms:abstract>
        <bib:pages>89-111</bib:pages>
        <dc:date>Sep 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Metamorphosis in drosophila and other insects</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10821983</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60285">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10821983</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60270">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Banasiak</foaf:surname>
                        <foaf:givenname>K. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Xia</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Haddad</foaf:surname>
                        <foaf:givenname>G. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60271"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hypoxia-Ischemia, Brain</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Mechanisms underlying hypoxia-induced neuronal apoptosis</dc:title>
        <dcterms:abstract>In vivo models of cerebral hypoxia-ischemia have shown that neuronal death may occur via necrosis or apoptosis. Necrosis is, in general, a rapidly occurring form of cell death that has been attributed, in part, to alterations in ionic homeostasis. In contrast, apoptosis is a delayed form of cell death that occurs as the result of activation of a genetic program. In the past decade, we have learned considerably about the mechanisms underlying apoptotic neuronal death following cerebral hypoxia-ischemia. With this growth in knowledge, we are coming to the realization that apoptosis and necrosis, although morphologically distinct, are likely part of a continuum of cell death with similar operative mechanisms. For example, following hypoxia-ischemia, excitatory amino acid release and alterations in ionic homeostasis contribute to both necrotic and apoptotic neuronal death. However, apoptosis is distinguished from necrosis in that gene activation is the predominant mechanism regulating cell survival. Following hypoxic-ischemic episodes in the brain, genes that promote as well as inhibit apoptosis are activated. It is the balance in the expression of pro- and anti-apoptotic genes that likely determines the fate of neurons exposed to hypoxia. The balance in expression of pro- and anti-apoptotic genes may also account for the regional differences in vulnerability to hypoxic insults. In this review, we will examine the known mechanisms underlying apoptosis in neurons exposed to hypoxia and hypoxia-ischemia.</dcterms:abstract>
        <bib:pages>215-249</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10840148</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60271">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10840148</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60268">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Christensen</foaf:surname>
                        <foaf:givenname>L. O.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Petersen</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Andersen</foaf:surname>
                        <foaf:givenname>J. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sinkjaer</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nielsen</foaf:surname>
                        <foaf:givenname>J. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60269"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Gait</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Leg</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Muscle, Skeletal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reflex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Somatosensory Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Evidence for transcortical reflex pathways in the lower limb of man</dc:title>
        <dcterms:abstract>The existence of transcortical reflex pathways in the control of distal arm and hand muscles in man is now widely accepted. Much more controversy exists regarding a possible contribution of such reflexes to the control of leg muscles. It is often assumed that transcortical reflex pathways play no, or only a minor, role in the control of leg muscles. Transcortical reflex pathways according to this view are reserved for the control of the distal upper limb and are seen in close relation to the evolution of the primate hand. Here we review data, which provide evidence that transcortical reflexes do exist for lower limb muscles and may play a significant role in the control of at least some of these muscles. This evidence is based on animal research, recent experiments combining transcranial magnetic stimulation with peripheral electrical and mechanical stimulation in healthy subjects and neurological patients. We propose that afferent activity from muscle and skin may play a role in the regulation of bipedal gait through transcortical pathways.</dcterms:abstract>
        <bib:pages>251-272</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10840149</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60269">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10840149</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60266">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Darlington</foaf:surname>
                        <foaf:givenname>C. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Smith</foaf:surname>
                        <foaf:givenname>P. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60267"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vestibular Nerve</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vestibular Nuclei</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vestibule, Labyrinth</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Molecular mechanisms of recovery from vestibular damage in mammals: recent advances</dc:title>
        <dcterms:abstract>The aim of this review is to summarise and critically evaluate studies of vestibular compensation published over the last 2 years, with emphasis on those concerned with the molecular mechanisms of this process of lesion-induced plasticity. Recent studies of vestibular compensation have confirmed and extended the previous findings that: (i) compensation of the static ocular motor and postural symptoms occurs relatively rapidly and completely compared to the dynamic symptoms, many of which either do not compensate substantially or else compensate variably due to sensory substitution and the development of sensori-motor strategies which suppress or minimize symptoms; (ii) static compensation is associated with, and may be at least partially caused by a substantial recovery of resting activity in the ipsilateral vestibular nucleus complex (VNC), which starts to develop very quickly following the unilateral vestibular deafferentation (UVD) but does not correlate perfectly with the development of some aspects of static compensation (e.g., postural compensation); and (iii) many complex biochemical changes are occurring in the VNC, cerebellum and even areas of the central nervous system like the hippocampus, following UVD. However, despite many recent studies which suggest the importance of excitatory amino acid receptors such as the N-methyl-D-aspartate receptor, expression of immediate early gene proteins, glucocorticoids, neurotrophins and nitric oxide in the vestibular compensation process, how these various factors are linked and which of them may have a causal relationship with the physiological changes underlying compensation, remains to be determined.</dcterms:abstract>
        <bib:pages>313-325</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Molecular mechanisms of recovery from vestibular damage in mammals</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10840152</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60267">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10840152</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60282">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hussy</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Deleuze</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Desarménien</foaf:surname>
                        <foaf:givenname>M. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Moos</foaf:surname>
                        <foaf:givenname>F. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60283"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hypothalamo-Hypophyseal System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taurine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Water-Electrolyte Balance</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure</dc:title>
        <dcterms:abstract>Maintenance of osmotic pressure is a primary regulatory process essential for normal cell function. The osmolarity of extracellular fluids is regulated by modifying the intake and excretion of salts and water. A major component of this regulatory process is the neuroendocrine hypothalamo-neurohypophysial system, which consists of neurons located in the paraventricular and supraoptic nuclei. These neurons synthesize the neurohormones vasopressin and oxytocin and release them in the blood circulation. We here review the mechanisms responsible for the osmoregulation of the activity of these neurons. Notably, the osmosensitivity of the supraoptic nucleus is described including the recent data that suggests an important participation of taurine in the transmission of the osmotic information. Taurine is an amino acid mainly known for its involvement in cell volume regulation, as it is one of the major inorganic osmolytes used by cells to compensate for changes in extracellular osmolarity. In the supraoptic nucleus, taurine is highly concentrated in astrocytes, and released in an osmodependent manner through volume-sensitive anion channels. Via its agonist action on neuronal glycine receptors, taurine is likely to contribute to the inhibition of neuronal activity induced by hypotonic stimuli. This inhibitory influence would complement the intrinsic osmosensitivity of supraoptic neurons, mediated by excitatory mechanoreceptors activated under hypertonic conditions. These observations extend the role of taurine from the regulation of cell volume to that of the whole body fluid balance. They also point to a new role of supraoptic glial cells as active components in a neuroendocrine regulatory loop.</dcterms:abstract>
        <bib:pages>113-134</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Osmotic regulation of neuronal activity</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10828380</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60283">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10828380</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60280">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Miyamoto</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fujiyama</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Okada</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sato</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60281"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Salts</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taste</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taste Buds</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Acid and salt responses in mouse taste cells</dc:title>
        <dcterms:abstract>Acid and salt responses of taste cells induced by natural stimulation have not been investigated with exception of early studies with conventional microelectrode method, due to the toxicity of high concentration of salt or low pH of acid stimuli applied to isolated taste cells. This indicates that the application of rapid and localized stimulation to the apical membrane of taste cells is necessary for recording of natural responses to salt or acid stimuli using patch clamp technique. Recently we have developed a procedure to accomplish the quasi-natural condition including rapid, localized stimuli to the apical receptive membrane and the maintenance of taste bud polarity. In this review, we present our recent results obtained under quasi-natural condition using patch clamp techniques, comparing with the previously proposed hypothesis. One of our major finding is the fact that the acid-induced responses of taste cells in the mouse fungiform papillae are never suppressed by amiloride but an apical proton-gated conductance and a basolateral Cl(-) conductance possibly contribute to sour transduction. On the other hand, salt-induced responses are suppressed by amiloride, although the salt-induced responses recorded from a single cell involve both amiloride-sensitive and -insensitive components. Furthermore, the amiloride-insensitive component of salt responses possibly consists of multiple subcomponents including an apical sodium-gated nonselective cation conductance and a basolateral Cl(-) conductance. Recent reports also support the hypothesis that both acid and salt responses require specific receptor mechanisms of inorganic cations such as H(+) and Na(+) at the apical receptive membrane.</dcterms:abstract>
        <bib:pages>135-157</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10828381</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60281">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10828381</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60272">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ohki-Hamazaki</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60273"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Digestive System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurokinin B</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuromedin B</dc:title>
        <dcterms:abstract>Neuromedin B (NMB) is one of the bombesin (BN)-related peptides in mammals. It was originally purified from pig spinal cords, and it has been shown to be present in central nervous system as well as in gastrointestinal tract. BN and its related peptides have various physiological effects. These include regulation of exocrine and endocrine secretions, smooth muscle contraction, feeding, blood pressure, blood glucose, body temperature and cell growth. NMB exerts its effect by binding to the cell surface receptor. A high affinity receptor, NMB receptor (NMB-R) has been identified. This is a G-protein coupled receptor with seven membrane-spanning regions. Upon agonist binding, several intracellular signaling cascades including phospholipase activation, calcium mobilization and protein kinase C (PKC) activation lead to expression of several genes, DNA synthesis or cellular effects such as secretion. Existence of NMB-R has been demonstrated in several brain regions, notably in olfactory and thalamic regions, and in gastrointestinal tracts. Recent analysis using NMB-R-deficient mice, generated by gene-targeting technique, enables to distinguish functional properties of NMB-R from GRP-R. In this review, molecular characterization, anatomical distribution and pharmacological properties of NMB and NMB-R will be presented. Moreover, physiological roles of NMB and its receptor demonstrated by the analysis of NMB-R-deficient mice will be reported. Comparison with GRP/GRP-R system will provide important information about BN-like peptide systems in mammals.</dcterms:abstract>
        <bib:pages>297-312</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10840151</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60273">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10840151</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60276">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stuermer</foaf:surname>
                        <foaf:givenname>C. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bastmeyer</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60277"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Optic Disk</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Retinal Ganglion Cells</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The retinal axon's pathfinding to the optic disk</dc:title>
        <dcterms:abstract>Retinal ganglion cell (RGC) axons travel in radial routes unerringly toward the optic disk, their first intermediate target in the center of the eye. The path of the RGC growth cone is restricted to a narrow zone subjacent to the endfeet of Müller glial cells and the vitreal basal lamina. The present survey indicates that RGC growth cones are guided by many molecular cues along their pathway which are recognized by receptors on their surface. Growth-promoting molecules on Müller glial endfeet and in the basal lamina assist growth cones in maintaining contact with these elements. The repellant character of deeper retinal laminae discourages them from escaping the RGC axon layer. Cell adhesion/recognition proteins enable growth cones to fasciculate with preformed axons in their vicinity. It is still unclear whether the optic disk emits long range guidance components which enable the growth cones to steer toward it. Recent evidence in fish indicates the existence of an axonal receptor (neurolin) for a guidance component of unknown identity. Receptor blockade causes RGC axons to course in aberrant routes before they reach the disk. At the disk, axons receive signals to exit the retina. Contact with netrin-1 at the optic disk/nerve head encourages growth cones to turn into the nerve. This response requires the axonal netrin receptor DCC, laminin-1, beta-integrin and most likely the UNC5H netrin receptors which convert the growth encouraging signal into a repulsive one which drives growth cones into the nerve.</dcterms:abstract>
        <bib:pages>197-214</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10828383</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60277">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10828383</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60278">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Thomson</foaf:surname>
                        <foaf:givenname>A. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60279"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Molecular frequency filters at central synapses</dc:title>
        <dcterms:abstract>During the 1950s to 70s most of the mechanisms that control transmitter release from presynaptic nerve terminals were described at the neuromuscular junction. It was not, however, until the 1990s that the multiplicity of protein-protein interactions that govern this process began to be identified. The sheer numbers of proteins and the complexity of their interactions at first appears excessive, even redundant. However, studies of identified central synapses indicate that this molecular diversity may underlie a important functional diversity. The task of the neuromuscular junction is to relay faithfully the rate and pattern code generated by the motoneurone. To demonstrate phenomena such as facilitation and augmentation that are apparent only when the probability of release is low, experimental manipulation is required. In the cortex, however, low probability synapses displaying facilitation can be recorded in parallel with high probability synapses displaying depression. The mechanisms are largely the same as those displayed by the neuromuscular junction, but some are differentially expressed and controlled. Central synapses demonstrate exquisitely fine tuned information transfer, each of the many types displaying its own repertoire of pattern- and frequency-dependent properties. These appear tuned to match both the discharge pattern in the presynaptic neurone and the integrative requirements of the postsynaptic cell. The molecular identification of these differentially expressed frequency filters is now just coming into sight. This review attempts to correlate these two aspects of synaptic physiology and to identify the components of the release process that are responsible for the diversity of function.</dcterms:abstract>
        <bib:pages>159-196</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10828382</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60279">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10828382</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60274">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yamashima</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60275"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Calpain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Caspases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cathepsins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Primates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pyramidal Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates</dc:title>
        <dcterms:abstract>Although more than 8000 papers of apoptosis are published annually, there are very few reports concerning necrosis in the past few years. A number of recent studies using lower species animals have suggested that the cornu Ammonis (CA) 1 neuronal death after brief global cerebral ischemia occurs by apoptosis, an active and genetically controlled cell suicide process. However, the studies of monkeys and humans rather support necrosis, the calpain-mediated release of lysosomal enzyme cathepsin after ischemia conceivably contributes to the cell degeneration of CA1 neurons. This paper provides an overview of recent developments in ischemic neuronal death, presents the cascade of the primate neuronal death with particular attentions to the cysteine proteases, and also indicates selective cathepsin inhibitors as a novel neuroprotectant. Furthermore, the possible interaction of calpain, cathepsin, and caspase in the cascade of ischemic neuronal death is discussed.</dcterms:abstract>
        <bib:pages>273-295</bib:pages>
        <dc:date>Oct 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10840150</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60275">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10840150</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60262">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Köbbert</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Apps</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bechmann</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lanciego</foaf:surname>
                        <foaf:givenname>J. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mey</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Thanos</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60263"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Coloring Agents</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Fluorescent Dyes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Current concepts in neuroanatomical tracing</dc:title>
        <dcterms:abstract>The development of new axonal tract tracing and cell labelling methods has revolutionised neurobiology in the last 30 years. The aim of this review is to consider some of the key methods of neuroanatomical tracing that are currently in use and have proved invaluable in charting the complex interconnections of the central nervous system. The review begins with a short overview of the most frequently used tracers, including enzymes, peptides, biocytin, latex beads, plant lectins and the ever-increasing number of fluorescent dyes. This is followed by a more detailed consideration of both well established and more recently introduced neuroanatomical tracing methods. Technical aspects of the application, uptake mechanisms, intracellular transport of tracers, and the problems of subsequent signal detection, are also discussed. The methods that are presented and discussed in detail include: (1) anterograde and retrograde neuroanatomical labelling with fluorescent dyes in vivo, (2) labelling of post mortem tissue, (3) developmental studies, (4) transcellular tracing (phagocytosis-dependent staining of glial cells), (5) electrophysiological mapping combined with neuronal tract tracing, and (6) simultaneous detection of more than one axonal tracer. (7) Versatile protocols for three-colour labelling have been developed to study complex patterns of connections. It is envisaged that this review will be used to guide the readers in their selection of the most appropriate techniques to apply to their own particular area of interest.</dcterms:abstract>
        <bib:pages>327-351</bib:pages>
        <dc:date>Nov 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10856608</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60263">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10856608</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60256">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mansvelder</foaf:surname>
                        <foaf:givenname>H. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kits</foaf:surname>
                        <foaf:givenname>K. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60257"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biophysical Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Biophysics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Exocytosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurosecretory Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Calcium channels and the release of large dense core vesicles from neuroendocrine cells: spatial organization and functional coupling</dc:title>
        <dcterms:abstract>The release of large dense core vesicles (LDCV) by neuroendocrine cells displays a very similar calcium dependence as found in synapses, yet, the organization of channels and vesicles is quite different. Various biophysical properties of the release process, notably a large delay (&gt;10 ms) between excitation and release and a high impact of mobile calcium buffers, suggest that, generally, vesicles and channels do not co-localize as in synapses, but are separated by a distance of 100-300 nm. This review focuses on the consequences of this organization for the functional coupling of calcium channels to LDCV-release in neuroendocrine cells. The large distance between LDCV and calcium channels in neuroendocrine cells obviates molecular interactions between channels and fusion peptides and implies that each type of calcium channel may be involved in release. Thus, preferential functional coupling of specific calcium channel types to the exocytotic process may be completely lacking, as in melanotropes. Alternatively, it may be present to some extent to induce differences in coupling efficacy between channel types, as in calf chromaffin cells and mouse pancreatic beta-cells. Physiological mechanisms, like recruitment of channels through facilitation processes or suppression of channels through inactivation, may change coupling characteristics during activity. Due to the large distance between channels and vesicles, single action potentials (APs) are usually insufficient to elicit release, and the coupling between individual APs and release is loose. Most neuroendocrine cells are therefore seen to fire in bursts, like pancreatic beta-cells. Furthermore, a large variation in shape and duration of the APs, with APs of up to 300 ms as in melanotropes, acts as another mechanism to enhance stimulus secretion coupling.</dcterms:abstract>
        <bib:pages>427-441</bib:pages>
        <dc:date>Nov 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Calcium channels and the release of large dense core vesicles from neuroendocrine cells</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10856612</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60257">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10856612</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60264">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nicolau</foaf:surname>
                        <foaf:givenname>M. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Akaârir</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gamundí</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>González</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rial</foaf:surname>
                        <foaf:givenname>R. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60265"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Why we sleep: the evolutionary pathway to the mammalian sleep</dc:title>
        <dcterms:abstract>The cause of sleep is a complex question, which needs first, a clear distinction amongst the different meanings of a causal relationship in the study of a given behavior, second, the requisites to be met by a suggested cause, and third, a precise definition of sleep to distinguish behavioral from polygraphic sleep. This review aims at clarifying the meaning of the question and at showing the phylogenetic origin of the mammalian and avian sleep. The phylogenetic appearance of sleep can be approached through a study of the evolution of the vertebrate brain. This began as an undifferentiated dorsal nerve, which was followed by the development of an anterior simplified brain and ended with the formation of the multilayered mammalian neocortex or the avian neostriate. The successive stages in the differentiation of the vertebrate brain produced, at least, two different waking types. The oldest one is the diurnal activity, bound to the light phase of the circadian cycle. Poikilotherms control the waking from the whole brainstem, where their main sensorymotor areas lie. Mammals developed the thalamocortical lines, which displaced the waking up to the cortex after acquiring homeothermy and nocturnal lifestyle. In order to avoid competence between duplicate systems, the early waking type, controlled from the brainstem, was suppressed, and by necessity was turned into inactivity, probably slow wave sleep. On the other hand, the nocturnal rest of poikilotherms most probably resulted in rapid eye movement sleep. The complex structure of the mammalian sleep should thus be considered an evolutionary remnant; the true acquisition of mammals is the cortical waking and not the sleep.</dcterms:abstract>
        <bib:pages>379-406</bib:pages>
        <dc:date>Nov 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Why we sleep</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10856610</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60265">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10856610</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60258">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Oja</foaf:surname>
                        <foaf:givenname>S. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saransaari</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60259"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taurine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Modulation of taurine release by glutamate receptors and nitric oxide</dc:title>
        <dcterms:abstract>Taurine is held to function as a modulator and osmoregulator in the central nervous system, being of particular importance in the immature brain. In view of the possible involvement of excitatory pathways in the regulation of taurine function in the brain, the interference of glutamate receptors with taurine release from different tissue preparations in vitro and from the brain in vivo is of special interest. The release of taurine from the brain is enhanced by glutamate receptor agonists. This enhancement is inhibited by the respective receptor antagonists both in vitro and in vivo. The ionotropic N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor agonists appear to be the most effective in enhancing taurine release, their effects being receptor-mediated. Kainate is less effective, particularly in adults. Of the glutamate receptors, the NMDA class seems to be the most susceptible to modulation by nitric oxide. Nitric oxide also modulates taurine release, enhancing the basal release in both immature and mature hippocampus, whereas the K(+)-stimulated release is generally inhibited. Metabotropic glutamate receptors also participate in the regulation of taurine release, group I metabotropic glutamate receptors potentiating the release in the developing hippocampus, while group III receptors may be involved in the adult. Under various cell-damaging conditions, including ischemia, hypoxia and hypoglycemia, taurine release is enhanced, together with an enhanced release of excitatory amino acids. The increase in extracellular taurine upon excessive stimulation of glutamate receptors and under cell-damaging conditions may serve as an important protective mechanism against excitotoxicity, being particularly effective in the immature brain.</dcterms:abstract>
        <bib:pages>407-425</bib:pages>
        <dc:date>Nov 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10856611</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60259">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10856611</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60260">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yadid</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakash</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Deri</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tamar</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kinor</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gispan</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Zangen</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60261"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Depressive Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Elucidation of the neurobiology of depression: insights from a novel genetic animal model</dc:title>
        <dcterms:abstract>Development of drugs for the effective treatment of depressive disorders requires elucidation of factors that are critical for clinically antidepressant effects. During the past 4 years, we have studied in situ neurochemical alterations in the brain that may underlie depressive behavior. This was achieved using the genetically-selected Flinders Sensitive Line (FSL) of rats (a unique animal model of depression), before and after chronic antidepressant treatment. This line of rats exhibits behavioral features characteristic of depression, and responds to chronic, but not acute, antidepressant treatments. This review summarizes our findings concerning the local neuro-dynamics in the brain during manifestation of depressive behavior and effective antidepressant treatment in this animal model of depression. Understanding the abnormalities manifested in neurochemical pathways during depressive disorders and the dynamic effects of these abnormalities on the onset of action and efficacy of pharmacological treatments are crucial for the development of effective antidepresssant drugs and therapeutic strategies.</dcterms:abstract>
        <bib:pages>353-378</bib:pages>
        <dc:date>Nov 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Elucidation of the neurobiology of depression</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10856609</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60261">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10856609</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60246">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carmignoto</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60247"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Signaling</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cells, Cultured</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>In Vitro Techniques</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ligands</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Reciprocal communication systems between astrocytes and neurones</dc:title>
        <dcterms:abstract>Over the past decade, a growing body of evidence has emerged on the existence in the brain of a close bidirectional communication system between neurones and astrocytes. This article reviews recent advances in understanding the rules governing these interactions and describes putative, novel functions attributable to astrocytes in neuronal transmission. Astrocytes can respond to the neurotransmitter released from active synaptic terminals, with cytosolic Ca(2+) oscillations whose frequency is under the dynamic control of neuronal activity. In response to these neuronal signals, astrocytes can signal back to neurones by releasing various neurone active compounds, such as the excitatory neurotransmitter glutamate. Interestingly, there is accumulating evidence that glutamate is released via a Ca(2+)-dependent mechanism which may share common properties with neurotransmitter exocytosis in neurones. This bidirectional communication system between neurones and astrocytes may lead to profound changes in neuronal excitability and synaptic transmission. While there clearly is an enormous amount of experimental and theoretical work yet to figure out, a coherent view is now emerging which incorporates the astrocyte, with the presynaptic terminal and the postsynaptic target neurone, as a possible third functional element of the synapse.</dcterms:abstract>
        <bib:pages>561-581</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10880851</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60247">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10880851</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60244">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cazals</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60245"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Adolescent</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Adult</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Auditory Threshold</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Chinchilla</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cochlea</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hearing Loss, High-Frequency</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hearing Loss, Sensorineural</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hearing Tests</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Middle Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pitch Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>salicylates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Speech Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Tinnitus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Auditory sensori-neural alterations induced by salicylate</dc:title>
        <dcterms:abstract>Early after the development of aspirin, almost 150 years ago, its auditory toxicity has been associated with high doses employed in the treatment of chronic inflammatory diseases. Tinnitus, loss of absolute acoustic sensitivity and alterations of perceived sounds are the three auditory alterations described by human subjects after ingestion of large doses of salicylate. They develop over the initials days of treatment but may then level off, fluctuate or decrease, and are reversible within a few days of cessation of treatment. They may also occur within hours of ingestion of an extremely large dose. Individual subjects vary notably as to their susceptibility to salicylate-induced auditory toxicity. Tinnitus may be the first subjective symptom, and is often described as a continuous high pitch sound of mild loudness. The hearing loss is slight to moderate, bilaterally symmetrical and affects all frequencies with often a predominance at the high frequencies. Alterations of perceived sounds include broadening of frequency filtering, alterations in temporal detection, deterioration of speech understanding and hypersensitivity to noise. Behavioral conditioning of animals provides evidence for mild and reversible hearing loss and tinnitus, similar to those observed in humans. Anatomical examinations revealed significant alterations only at outer hair cell lateral membrane. Electrophysiological investigations showed no change in endocochlear resting potential, and small changes in the compound sensory potentials, cochlear microphonic and summating potential, at low acoustic levels. Measures of cochlear mechanical responses to sounds indicated a clear loss of absolute sensitivity and an associated broadening of frequency filtering, both of a magnitude similar to audiometric alterations in humans, but at extremely high salicylate levels. Otoacoustic emissions demonstrated changes in the mechano-sensory functioning of the cochlea in the form of decrease of spontaneous emissions and reduced nonlinearities. In vitro measures of isolated outer hair cells showed reduction of their fast motile responses which are thought to be at the origin of cochlear absolute sensitivity and associated fine filtering. Acoustically evoked neural responses from the eighth nerve to the auditory cortex showed reversible and mild losses of absolute sensitivity and associated broadening of frequency filtering. There is no evidence of a direct alteration of cochlear efferent innervation. Evidence was obtained for decreases in cochlear blood supply under control of autonomous innervation. Spontaneous neural activity of the auditory nerve revealed increases in firings and/or in underlying temporal synchronies. Similar effects were found at the inferior colliculus, mostly at the external nucleus, and at the cortex, mostly at the anterior and less at the secondary auditory cortex but not at the primary auditory cortex. These changes in spontaneous activity might underlie tinnitus as they affect mostly neural elements coding high frequencies, can occur without a loss of sensitivity, are dose dependent, develop progressively, and are reversible. Biochemical cochlear alterations are poorly known. Modifications of oxydative phosphorylation does not seem to occur, involvement of inhibition of prostaglandin synthesis appears controversial but could underlie changes in blood supply. Other biochemical alterations certainly also occur at outer hair cells and at afferent nerve fibers but remain unknown.</dcterms:abstract>
        <bib:pages>583-631</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10880852</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60245">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10880852</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60240">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dringen</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60241"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Transport</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cells, Cultured</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Extracellular Space</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutathione</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oligodendroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Oxidation-Reduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reactive Oxygen Species</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Metabolism and functions of glutathione in brain</dc:title>
        <dcterms:abstract>The tripeptide glutathione is the thiol compound present in the highest concentration in cells of all organs. Glutathione has many physiological functions including its involvement in the defense against reactive oxygen species. The cells of the human brain consume about 20% of the oxygen utilized by the body but constitute only 2% of the body weight. Consequently, reactive oxygen species which are continuously generated during oxidative metabolism will be generated in high rates within the brain. Therefore, the detoxification of reactive oxygen species is an essential task within the brain and the involvement of the antioxidant glutathione in such processes is very important. The main focus of this review article will be recent results on glutathione metabolism of different brain cell types in culture. The glutathione content of brain cells depends strongly on the availability of precursors for glutathione. Different types of brain cells prefer different extracellular glutathione precursors. Glutathione is involved in the disposal of peroxides by brain cells and in the protection against reactive oxygen species. In coculture astroglial cells protect other neural cell types against the toxicity of various compounds. One mechanism for this interaction is the supply by astroglial cells of glutathione precursors to neighboring cells. Recent results confirm the prominent role of astrocytes in glutathione metabolism and the defense against reactive oxygen species in brain. These results also suggest an involvement of a compromised astroglial glutathione system in the oxidative stress reported for neurological disorders.</dcterms:abstract>
        <bib:pages>649-671</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10880854</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60241">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10880854</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60250">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Goadsby</foaf:surname>
                        <foaf:givenname>P. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60251"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Headache</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Serotonin Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The pharmacology of headache</dc:title>
        <dcterms:abstract>Headache is a common problem which besets most of us at some time or the other. The pharmacology of headache is complex in an overall sense but can be understood in terms of the anatomy and physiology of the pain-producing structures. Migraine can be used as a template to understand the activation of nociceptive systems in the head and thus their neurotransmitter mediation and modulation. In recent years, the role of serotonin (5-HT) in headache pharmacology has been unravelled in the context of both understanding its role in the nociceptive systems related to headache and by exploiting its 5-HT1 receptor subtypes in headache therapeutics. The pharmacology of the head pain systems, as they are known and as they might evolve, are explored in the context of both, the anatomy and physiology of trigeminovascular nociception and in the context of clinical questions, such as those of efficacy, headache recurrence and adverse events.</dcterms:abstract>
        <bib:pages>509-525</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10869781</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60251">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10869781</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60252">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jacobs</foaf:surname>
                        <foaf:givenname>J. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60253"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Drosophila</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Genes, Insect</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Models, Animal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The midline glia of Drosophila: a molecular genetic model for the developmental functions of glia</dc:title>
        <dcterms:abstract>The Midline Glia of Drosophila are required for nervous system morphogenesis and midline axon guidance during embryogenesis. In origin, gene expression and function, this lineage is analogous to the floorplate of the vertebrate neural tube. The expression or function of over 50 genes, summarised here, has been linked to the Midline Glia. Like the floorplate, the cells which generate the Midline Glia lineage, the mesectoderm, are determined by the interaction of ectoderm and mesoderm during gastrulation. Determination and differentiation of the Midline Glia involves the Drosophila EGF, Notch and segment polarity signaling pathways, as well as twelve identified transcription factors. The Midline Glia lineage has two phases of cell proliferation and of programmed cell death. During embryogenesis, the EGF receptor pathway signaling and Wrapper protein both function to suppress apoptosis only in those MG which are appropriately positioned to separate and ensheath midline axonal commissures. Apoptosis during metamorphosis is regulated by the insect steroid, Ecdysone. The Midline Glia participate in both the attraction of axonal growth cones towards the midline, as well as repulsion of growth cones from the midline. Midline axon guidance requires the Drosophila orthologs of vertebrate genes expressed in the floorplate, which perform the same function. Genetic and molecular evidence of the interaction of attractive (Netrin) and repellent (Slit) signaling is reviewed and summarised in a model. The Midline Glia participate also in the generation of extracellular matrix and in trophic interactions with axons. Genetic evidence for these functions is reviewed.</dcterms:abstract>
        <bib:pages>475-508</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The midline glia of Drosophila</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10869780</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60253">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10869780</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60254">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Junier</foaf:surname>
                        <foaf:givenname>M. P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60255"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sequence Homology, Amino Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transforming Growth Factor alpha</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>What role(s) for TGFalpha in the central nervous system?</dc:title>
        <dcterms:abstract>Transforming growth factor alpha (TGFalpha) is a member of the epidermal growth factor (EGF) family with which it shares the same receptor, the EGF receptor (EGFR or erbB1). Identified since 1985 in the central nervous system (CNS), its functions in this organ have started to be determined during the past decade although numerous questions remain unanswered. TGFalpha is widely distributed in the nervous system, both glial and neuronal cells contributing to its synthesis. Although astrocytes appear as its main targets, mediating in part TGFalpha effects on different neuronal populations, results from different studies have raised the possibility for a direct action of this growth factor on neurons. A large array of experimental data have thus pointed to TGFalpha as a multifunctional factor in the CNS. This review is an attempt to present, in a comprehensive manner, the very diverse works performed in vitro and in vivo which have provided evidences for (i) an intervention of TGFalpha in the control of developmental events such as neural progenitors proliferation/cell fate choice, neuronal survival/differentiation, and neuronal control of female puberty onset, (ii) its role as a potent regulator of astroglial metabolism including astrocytic reactivity, (iii) its neuroprotective potential, and (iv) its participation to neuropathological processes as exemplified by astroglial neoplasia. In addition, informations regarding the complex modes of TGFalpha action at the molecular level are provided, and its place within the large EGF family is precised with regard to the potential interactions and substitutions which may take place between TGFalpha and its kindred.</dcterms:abstract>
        <bib:pages>443-473</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10869779</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60255">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10869779</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60248">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mackay-Sima</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chuahb</foaf:surname>
                        <foaf:givenname>M. I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60249"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Olfactory Bulb</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Olfactory Mucosa</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nerve Growth Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurotrophic factors in the primary olfactory pathway</dc:title>
        <dcterms:abstract>The number of identified growth factors continues to increase rapidly with many being implicated in the development of the nervous system, although for most of them the autocrine and paracrine pathways of cellular regulation still remain to be elucidated. The primary olfactory pathway, consisting of the olfactory epithelium and olfactory bulb, is presented here as a very useful model for the analysis of growth factor function. Review of the available literature suggests that a large proportion of neuroactive growth factors and their receptors are present in the olfactory epithelium or olfactory bulb. Furthermore, the primary olfactory pathway is one of the most plastic in the nervous system with neurogenesis continuing to contribute new sensory neurones in the olfactory epithelium and new interneurones in the olfactory bulb throughout adult life. The rich diversity of growth factors and their receptors in the olfactory system indicates that it will be useful in elucidating how these molecules regulate the formation of the nervous system. The olfactory epithelium in particular is proving useful as a model for the actions of growth factors in directing the neuronal lineage from stem cell to mature neurone.</dcterms:abstract>
        <bib:pages>527-559</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10869782</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60249">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:53:24</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10869782</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60242">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>62</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Miranda</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Opazo</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Larrondo</foaf:surname>
                        <foaf:givenname>L. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Muñoz</foaf:surname>
                        <foaf:givenname>F. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ruiz</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Leighton</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Inestrosa</foaf:surname>
                        <foaf:givenname>N. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60243"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid beta-Peptides</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Antioxidants</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Membrane Lipids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Metals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nucleic Acids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>oxidative stress</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reactive Oxygen Species</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cell Surface</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease</dc:title>
        <dcterms:abstract>One of the theories involved in the etiology of Alzheimer's disease (AD) is the oxidative stress hypothesis. The amyloid beta-peptide (A beta), a hallmark in the pathogenesis of AD and the main component of senile plaques, generates free radicals in a metal-catalyzed reaction inducing neuronal cell death by a reactive oxygen species mediated process which damage neuronal membrane lipids, proteins and nucleic acids. Therefore, the interest in the protective role of different antioxidants in AD such as vitamin E, melatonin and estrogens is growing up. In this review we summarize data that support the involvement of oxidative stress as an active factor in A beta-mediated neuropathology, by triggering or facilitating neurodegeneration, through a wide range of molecular events that disturb neuronal cell homeostasis.</dcterms:abstract>
        <bib:pages>633-648</bib:pages>
        <dc:date>Dec 2000</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 10880853</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60243">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/10880853</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60236">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garcia-Segura</foaf:surname>
                        <foaf:givenname>L. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azcoitia</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>DonCarlos</foaf:surname>
                        <foaf:givenname>L. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60237"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Estradiol</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Estrogen</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Risk Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Schizophrenic Psychology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuroprotection by estradiol</dc:title>
        <dcterms:abstract>This review highlights recent evidence from clinical and basic science studies supporting a role for estrogen in neuroprotection. Accumulated clinical evidence suggests that estrogen exposure decreases the risk and delays the onset and progression of Alzheimer's disease and schizophrenia, and may also enhance recovery from traumatic neurological injury such as stroke. Recent basic science studies show that not only does exogenous estradiol decrease the response to various forms of insult, but the brain itself upregulates both estrogen synthesis and estrogen receptor expression at sites of injury. Thus, our view of the role of estrogen in neural function must be broadened to include not only its function in neuroendocrine regulation and reproductive behaviors, but also to include a direct protective role in response to degenerative disease or injury. Estrogen may play this protective role through several routes. Key among these are estrogen dependent alterations in cell survival, axonal sprouting, regenerative responses, enhanced synaptic transmission and enhanced neurogenesis. Some of the mechanisms underlying these effects are independent of the classically defined nuclear estrogen receptors and involve unidentified membrane receptors, direct modulation of neurotransmitter receptor function, or the known anti-oxidant activities of estrogen. Other neuroprotective effects of estrogen do depend on the classical nuclear estrogen receptor, through which estrogen alters expression of estrogen responsive genes that play a role in apoptosis, axonal regeneration, or general trophic support. Yet another possibility is that estrogen receptors in the membrane or cytoplasm alter phosphorylation cascades through direct interactions with protein kinases or that estrogen receptor signaling may converge with signaling by other trophic molecules to confer resistance to injury. Although there is clear evidence that estradiol exposure can be deleterious to some neuronal populations, the potential clinical benefits of estrogen treatment for enhancing cognitive function may outweigh the associated central and peripheral risks. Exciting and important avenues for future investigation into the protective effects of estrogen include the optimal ligand and doses that can be used clinically to confer benefit without undue risk, modulation of neurotrophin and neurotrophin receptor expression, interaction of estrogen with regulated cofactors and coactivators that couple estrogen receptors to basal transcriptional machinery, interactions of estrogen with other survival and regeneration promoting factors, potential estrogenic effects on neuronal replenishment, and modulation of phenotypic choices by neural stem cells.</dcterms:abstract>
        <bib:pages>29-60</bib:pages>
        <dc:date>Jan 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11040417</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60237">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11040417</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60238">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kerkhoff</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60239"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Awareness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Processes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Perceptual Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Spatial hemineglect in humans</dc:title>
        <dcterms:abstract>The paper reviews the main findings of studies of hemispatial neglect after acquired brain lesions in people. The behavioral consequences of experimentally induced lesions in animals and electrophysiological studies, which shed light on the nature of the disorder, are briefly considered. Neglect is behaviorally defined as a deficit in processing or responding to sensory stimuli in the contralateral hemispace, a part of the own body, the part of an imagined scene, or may include the failure to act with the contralesional limbs despite intact motor functions. Neglect in humans is frequently encountered after right parieto-temporal lesions and leads to a multicomponent syndrome of sensory, motor and representational deficits. Relevant findings relating to neglect, extinction and unawareness are reviewed and include the following topics: etiological and anatomical basis, recovery; allocentric, egocentric, object-centered and representational neglect; motor neglect and directional hypokinesia; elementary sensorimotor and associated disorders; subdivisions of space and frames of reference; extinction versus neglect; covert processing of information; unawareness of deficits; human and animal models; effects of sensory stimulation and rehabilitation techniques.</dcterms:abstract>
        <bib:pages>1-27</bib:pages>
        <dc:date>Jan 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11040416</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60239">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11040416</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60232">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Murer</foaf:surname>
                        <foaf:givenname>M. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yan</foaf:surname>
                        <foaf:givenname>Q.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Raisman-Vozari</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60233"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain-Derived Neurotrophic Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reference Values</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tissue Distribution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease</dc:title>
        <dcterms:abstract>Brain-derived neurotrophic factor (BDNF) is a small dimeric protein, structurally related to nerve growth factor, which is abundantly and widely expressed in the adult mammalian brain. BDNF has been found to promote survival of all major neuronal types affected in Alzheimer's disease and Parkinson's disease, like hippocampal and neocortical neurons, cholinergic septal and basal forebrain neurons, and nigral dopaminergic neurons. In this article, we summarize recent work on the molecular and cellular biology of BDNF, including current ideas about its intracellular trafficking, regulated synthesis and release, and actions at the synaptic level, which have considerably expanded our conception of BDNF actions in the central nervous system. But our primary aim is to review the literature regarding BDNF distribution in the human brain, and the modifications of BDNF expression which occur in the brain of individuals with Alzheimer's disease and Parkinson's disease. Our knowledge concerning BDNF actions on the neuronal populations affected in these pathological states is also reviewed, with an aim at understanding its pathogenic and pathophysiological relevance.</dcterms:abstract>
        <bib:pages>71-124</bib:pages>
        <dc:date>Jan 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11040419</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60233">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11040419</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60234">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Segal</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60235"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dendrites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Rapid plasticity of dendritic spine: hints to possible functions?</dc:title>
        <dcterms:abstract>Contrary to a century-old belief that dendritic spines are stable storage sites of long term memory, the emerging picture from a recent flurry of exciting observations using novel high resolution imaging methods of living cells in culture is that of a dynamic structure, which undergoes fast morphological changes over periods of hours and even minutes. Concurrently, the nature of stimuli which cause formation or collapse of dendritic spines has changed from a mysterious Hebbian-governed plasticity producing stimulus to the more trivial activation of the synapse by strong/weak stimulation. The molecular mechanisms underlying spine plasticity are beginning to emerge; the role of presynaptic and/or postsynaptic activity, genetic, central or local factors in the formation and retraction of spines are currently being analyzed. A common mechanism for both, formation/elongation and pruning/retraction of spines, involving changes in intracellular calcium concentration ([Ca(2+)](i)), is emerging. It appears that [Ca(2+)](i) is related to changes in spines in a bell shape form: lack of synaptic activity causes transient outgrowth of filopodia but eventual elimination of spines, a moderate rise in [Ca(2+)](i) causes elongation of existing spines and formation of new ones, while a massive increase in [Ca(2+)](i) such as that seen in seizure activity, causes fast shrinkage and eventual collapse of spines. Nuclear signals (e.g. CREB), activated by an increase in [Ca(2+)](i), are involved in the central regulation of spine formation, while spine shrinkage and elongation are probably triggered by local [Ca(2+)](i) changes. This hypothesis provides a parsimonious explanation for conflicting reports on activity-dependent changes in dendritic spine morphology. Still, the many differences between cultured neurons, with which most of current studies are conducted, and the neuron in the real brain, require a cautious extrapolation of current assumptions on the regulation of spine formation.</dcterms:abstract>
        <bib:pages>61-70</bib:pages>
        <dc:date>Jan 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Rapid plasticity of dendritic spine</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11040418</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60235">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11040418</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60220">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cattaert</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Le Ray</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60221"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astacoidea</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Feedback</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mechanoreceptors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Posture</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proprioception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reflex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sense Organs</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Stress, Mechanical</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Adaptive motor control in crayfish</dc:title>
        <dcterms:abstract>This article reviews the principles that rule the organization of motor commands that have been described over the past five decades in crayfish. The adaptation of motor behaviors requires the integration of sensory cues into the motor command. The respective roles of central neural networks and sensory feedback are presented in the order of increasing complexity. The simplest circuits described are those involved in the control of a single joint during posture (negative feedback-resistance reflex) and movement (modulation of sensory feedback and reversal of the reflex into an assistance reflex). More complex integration is required to solve problems of coordination of joint movements in a pluri-segmental appendage, and coordination of different limbs and different motor systems. In addition, beyond the question of mechanical fitting, the motor command must be appropriate to the behavioral context. Therefore, sensory information is used also to select adequate motor programs. A last aspect of adaptability concerns the possibility of neural networks to change their properties either temporarily (such on-line modulation exerted, for example, by presynaptic mechanisms) or more permanently (such as plastic changes that modify the synaptic efficacy). Finally, the question of how &quot;automatic&quot; local component networks are controlled by descending pathways, in order to achieve behaviors, is discussed.</dcterms:abstract>
        <bib:pages>199-240</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11124446</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60221">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11124446</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60224">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jankowsky</foaf:surname>
                        <foaf:givenname>J. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Patterson</foaf:surname>
                        <foaf:givenname>P. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60225"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain-Derived Neurotrophic Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cytokines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Growth Substances</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mossy Fibers, Hippocampal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Regeneration</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>RNA, Messenger</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Seizures</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Up-Regulation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of cytokines and growth factors in seizures and their sequelae</dc:title>
        <dcterms:abstract>Although the neuropathological changes caused by severe or repeated seizures have been well characterized, many questions about the molecular mechanisms involved remain unanswered. Neuronal cell death, reactive gliosis, enhanced neurogenesis, and axonal sprouting are four of the best-studied sequelae of seizures. In vitro, each of these pathological processes can be substantially influenced by soluble protein factors, including neurotrophins, cytokines, and growth factors. Furthermore, many of these proteins and their receptors are expressed in the adult brain and are up-regulated in response to neuronal activity and injury. We review the evidence that these intercellular signaling proteins regulate seizure activity as well as subsequent pathology in vivo. As nerve growth factor and brain derived neurotrophic factor are the best-studied proteins of this class, we begin by discussing the evidence linking these neurotrophins to epilepsy and seizure. More than a dozen additional cytokines, growth factors, and neurotrophins that have been examined in the context of epilepsy models are then considered. We discuss the effect of seizure on expression of cytokines and growth factors, and explore the regulation of seizure development and aftermath by exogenous application or antagonist perturbation of these proteins. The experimental evidence supports a role for these factors in each aspect of seizure and pathology, and suggests potential targets for future therapeutics.</dcterms:abstract>
        <bib:pages>125-149</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11124444</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60225">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11124444</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60226">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mehler</foaf:surname>
                        <foaf:givenname>M. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gokhan</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60227"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Developmental mechanisms in the pathogenesis of neurodegenerative diseases</dc:title>
        <dcterms:abstract>Cellular genes that are mutated in neurodegenerative diseases code for proteins that are expressed throughout neural development. Genetic analysis suggests that these genes are essential for a broad range of normal neurodevelopmental processes. The proteins they code for interact with numerous other cellular proteins that are components of signaling pathways involved in patterning of the neural tube and in regional specification of neuronal subtypes. Further, pathogenetic mutations of these genes can cause progressive, sublethal alterations in the cellular homeostasis of evolving regional neuronal subpopulations, culminating in late-onset cell death. Therefore, as a consequence of the disease mutations, targeted cell populations may retain molecular traces of abnormal interactions with disease-associated proteins by exhibiting changes in a spectrum of normal cellular functions and enhanced vulnerability to a host of environmental stressors. These observations suggest that the normal functions of these disease-associated proteins are to ensure the fidelity and integration of developmental events associated with the progressive elaboration of neuronal subtypes as well as the maintenance of mature neuronal populations during adult life. The ability to identify alterations within vulnerable neuronal precursors present in pre-symptomatic individuals prior to the onset of irrevocable cellular injury may help foster the development of effective therapeutic interventions using evolving pharmacologic, gene and stem cell technologies.</dcterms:abstract>
        <bib:pages>337-363</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11115729</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60227">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11115729</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60222">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Momose-Sato</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sato</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kamino</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60223"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Stem</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Chick Embryo</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Coloring Agents</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electric Stimulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Agonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Postsynaptic Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Optics and Photonics</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, GABA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glycine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sodium Channel Blockers</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Solitary Nucleus</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Optical approaches to embryonic development of neural functions in the brainstem</dc:title>
        <dcterms:abstract>The ontogenetic approach to physiological events is a useful strategy for understanding the functional organization/architecture of the vertebrate brainstem. However, conventional electrophysiological techniques are difficult or impossible to employ in the early embryonic central nervous system. Optical techniques using voltage-sensitive dyes have made it possible to monitor neural activities from multiple regions of living systems, and have proven to be a useful tool for analyzing the embryogenetic expression of brainstem neural function. This review describes recent progress in optical studies made on embryonic chick and rat brainstems. Several technical issues concerning optical recording from the embryonic brainstem preparations are discussed, and characteristics of the optical signals evoked by cranial nerve stimulation or occurring spontaneously are described. Special attention is paid to the chronological analyses of embryogenetic expression of brainstem function and to the spatial patterning of the functional organization/architecture of the brainstem nuclei. In addition, optical analyses of glutamate, GABA, and glycine receptor functions during embryogenesis are described in detail for the chick nucleus tractus solitarius. This review also discusses intrinsic optical signals associated with neuronal depolarization. Some emphases are also placed on the physiological properties of embryonic brainstem neurons, which may be of interest from the viewpoint of developmental neurobiology.</dcterms:abstract>
        <bib:pages>151-197</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11124445</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60223">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11124445</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60230">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tzschentke</foaf:surname>
                        <foaf:givenname>T. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60231"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Prefrontal Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ventral Tegmental Area</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Pharmacology and behavioral pharmacology of the mesocortical dopamine system</dc:title>
        <dcterms:abstract>The prefrontal cortex (PFC) has long been known to be involved in the mediation of complex behavioral responses. Considerable research efforts are directed towards refining the knowledge about the function of this brain area and the role it plays in cognitive performance and behavioral output. In the first part, this review provides, from a pharmacological perspective, an overview of anatomical, electrophysiological and neurochemical aspects of the function of the PFC, with an emphasis on the mesocortical dopamine system. Anatomy of the mesocortical system, basic physiological and pharmacological properties of neurotransmission within the PFC, and interactions between dopamine and glutamate as well as other transmitters within the mesocorticolimbic circuit are included. The coverage of these data is largely restricted to what is relevant for the second part of the review which focuses on behavioral studies that have examined the role of the PFC in a variety of phenomena, behaviors and paradigms. These include reward and addiction, locomotor activity and sensitization, learning, cognition, and schizophrenia. Although the focus of this review is on the mesocortical dopamine system, given the intricate interactions of dopamine with other transmitter systems within the PFC and the importance of the PFC as a source of glutamate in subcortical areas, these aspects are also covered in some detail where appropriate. Naturally, a topic as complex as this cannot be covered comprehensively in its entirety. Therefore this review is largely limited to data derived from studies using rats, and it is also specifically restricted to data concerning the medial PFC (mPFC). Since in several fields of research the findings concerning the function or role of the mPFC are relatively inconsistent, the question is addressed whether these inconsistencies might, at least in part, be related to the anatomical and functional heterogeneity of this brain area.</dcterms:abstract>
        <bib:pages>241-320</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11115727</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60231">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11115727</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60228">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Venero</foaf:surname>
                        <foaf:givenname>J. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vizuete</foaf:surname>
                        <foaf:givenname>M. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Machado</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cano</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60229"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aquaporin 4</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aquaporins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Body Water</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>RNA, Messenger</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Aquaporins in the central nervous system</dc:title>
        <dcterms:abstract>In this review, we have tried to summarize most available data dealing with the aquaporin (AQP) family of water channels in the CNS. Two aquaporins have been identified so far in the CNS, AQP1 and AQP4. AQP1 is restricted to the choroid plexus of the lateral ventricles, which raises a role for this aquaporin in cerebrospinal fluid formation. AQP4 is the predominant water channel in the brain and it is more widely distributed than originally believed, with a marked prevalence over periventricular areas. In the first part of this review, we examine the complete distribution pattern of AQP4 in the CNS including its rostro-caudal localization to end with its subcellular location. After discussing scarce data dealing with regulation of aquaporins in the CNS, we focus in potential roles for aquaporins. Novel recent data highlights very important roles for this aquaporin in the normal and pathological brain including, among others, role in potassium buffering, body fluid homeostasis, central osmoreception and development and restoration of brain edema.</dcterms:abstract>
        <bib:pages>321-336</bib:pages>
        <dc:date>Feb 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11115728</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60229">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11115728</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60216">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brodfuehrer</foaf:surname>
                        <foaf:givenname>P. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Thorogood</foaf:surname>
                        <foaf:givenname>M. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60217"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Invertebrate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interneurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Leeches</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Swimming</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Identified neurons and leech swimming behavior</dc:title>
        <dcterms:abstract>Since the experiments of Nicholls and Baylor, the initial characterization of identified neurons has provided significant insight into the circuitry transforming mechanosensory input into the motor output of swimming. From physiological characterization of only a small percentage of cells within the leech CNS, we have gained important information about how the decision to swim is processed and how the rhythmic motor pattern is generated. While many of the synaptic connections in the swim-generating circuit have been identified, the elucidation of the biophysical and biochemical mechanisms underlying these connections has only recently begun. The observation that constant input can result in variable motor output suggests that, in addition to describing a cell's identity in terms of structure and function, factors such as behavioral context and the &quot;internal state&quot; of the nervous system must also be considered. As circuits controlling other behaviors become known, one can examine the interactions between these networks to understand issues of behavioral choice at the level of identified neurons. The leech CNS has expanded our understanding of how the nervous system produces behavior and continues to serve as an excellent model in this endeavor.</dcterms:abstract>
        <bib:pages>371-381</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163683</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60217">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163683</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60210">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Buchanan</foaf:surname>
                        <foaf:givenname>J. T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60211"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Efferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interneurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Lampreys</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reticular Formation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Swimming</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Contributions of identifiable neurons and neuron classes to lamprey vertebrate neurobiology</dc:title>
        <dcterms:abstract>Among the advantages offered by the lamprey brainstem and spinal cord for studies of the structure and function of the nervous system is the unique identifiability of several pairs of reticulospinal neurons in the brainstem. These neurons have been exploited in investigations of the patterns of sensory input to these cells and the patterns of their outputs to spinal neurons, but no doubt these cells could be used much more effectively in exploring their roles in descending control of the spinal cord. The variability of cell positions of neurons in the spinal cord has precluded the recognition of unique spinal neurons. However, classes of nerve cells can be readily defined and characterized within the lamprey spinal cord and this has led to progress in understanding the cellular and synaptic mechanisms of locomotor activity. In addition, both the identifiable reticulospinal cells and the various spinal nerve cell classes and their known synaptic interactions have been used to demonstrate the degree and specificity of regeneration within the lamprey nervous system. The lack of uniquely identifiable cells within the lamprey spinal cord has hampered progress in these areas, especially in gaining a full understanding of the locomotor network and how neuromodulation of the network is accomplished.</dcterms:abstract>
        <bib:pages>441-466</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163686</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60211">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163686</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60212">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Comer</foaf:surname>
                        <foaf:givenname>C. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Robertson</foaf:surname>
                        <foaf:givenname>R. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60213"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Invertebrate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Identified nerve cells and insect behavior</dc:title>
        <dcterms:abstract>Studies of insect identified neurons over the past 25 years have provided some of the very best data on sensorimotor integration; tracing information flow from sensory to motor networks. General principles have emerged that have increased the sophistication with which we now understand both sensory processing and motor control. Two overarching themes have emerged from studies of identified sensory interneurons. First, within a species, there are profound differences in neuronal organization associated with both the sex and the social experience of the individual. Second, single neurons exhibit some surprisingly rich examples of computational sophistication in terms of (a) temporal dynamics (coding superimposed upon circadian and shorter-term rhythms), and also (b) what Kenneth Roeder called &quot;neural parsimony&quot;: that optimal information can be encoded, and complex acts of sensorimotor coordination can be mediated, by small ensembles of cells. Insect motor systems have proven to be relatively complex, and so studies of their organization typically have not yielded completely defined circuits as are known from some other invertebrates. However, several important findings have emerged. Analysis of neuronal oscillators for rhythmic behavior have delineated a profound influence of sensory feedback on interneuronal circuits: they are not only modulated by feedback, but may be substantially reconfigured. Additionally, insect motor circuits provide potent examples of neuronal restructuring during an organism's lifetime, as well as insights on how circuits have been modified across evolutionary time. Several areas where future advances seem likely to occur include: molecular genetic analyses, neuroecological syntheses, and neuroinformatics--the use of digital resources to organize databases with information on identified nerve cells and behavior.</dcterms:abstract>
        <bib:pages>409-439</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163685</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60213">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163685</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60208">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Eaton</foaf:surname>
                        <foaf:givenname>R. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lee</foaf:surname>
                        <foaf:givenname>R. K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Foreman</foaf:surname>
                        <foaf:givenname>M. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60209"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Efferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Escape Reaction</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Lampreys</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reticular Formation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Swimming</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The Mauthner cell and other identified neurons of the brainstem escape network of fish</dc:title>
        <dcterms:abstract>This paper reviews the development of our research on the motor consequences of Mauthner cell function and related brainstem neurons. These cells activate fast-start responses such as seen in fishes escaping from predatory attacks. Our goal was to devise a neuroethological theory of fish escape that accurately reconciled the underlying neural function with a correct concept of the motor act. The identified neuron concept of invertebrates greatly influenced the initial studies. Horseradish peroxidase technology allowed us and other workers to identify principal neurons in the brainstem escape system. Digital imaging technology permitted adequate kinematic characterization of the behavior. Resulting experiments showed that Mauthner system demonstrates two general principles of motor organization: (1) the Mauthner cell is a command-like higher order neuron that serially outputs to a lower level central pattern generator; and (2) the Mauthner cell participates in a larger parallel, brainstem escape network. In this network, we showed that the spatio-temporal pattern of activity codes the timing and magnitude of agonist and antagonist trunk muscle contractions during the behavior. Because the approach angle of the stimulus determines these parameters, we were able to discover the overall sensorimotor relationship between stimulus angle and motor output. This relationship is given as a set of descriptive equations written in terms of stimulus angle, magnitude and timing variables of trunk muscle contractions, and resulting escape trajectory. The equations unify the apparent variability of C-start movement patterns into a single, quantitative theory. Recent studies by other workers show how this concept can make accurate predictions about the underlying neural processes, even at the level of the single, identified cell.</dcterms:abstract>
        <bib:pages>467-485</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163687</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60209">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163687</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60214">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Murphy</foaf:surname>
                        <foaf:givenname>A. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60215"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Feeding Behavior</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Invertebrate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interneurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Snails</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The neuronal basis of feeding in the snail, Helisoma, with comparisons to selected gastropods</dc:title>
        <dcterms:abstract>Research on identified neurons during the last quarter century was forecast at a conference in 1973 that discussed &quot;neuronal mechanisms of coordination in simple systems.&quot; The focus of the conference was on the neuronal control of simple stereotyped behavioral acts. Participants discussing the future of such research called for a comparative approach; emphasis on structure-function interactions; attention to environmental and behavioral context; and the development of new techniques. Significantly, in some cases amazing progress has been made in these areas. Major conclusions of the last quarter century are that so-called simple behaviors and the neural circuitry underlying them tend to be less simple, more flexible, and more highly modulated than originally imagined. However, the comparative approach has, as yet, failed to reach its potential. Molluscan preparations, along with arthropods and annelids, have always been at the forefront of neuroethological studies. Circuitry underlying feeding has been studied in a handful of species of gastropod molluscs. These studies have contributed substantially to our understanding of sensorimotor organization, the hierarchical control of behavior and coordination of multiple behaviors, and the organization and modulation of central pattern generators. However, direct interspecific comparisons of feeding circuitry and potentially homologous neurons have been lacking. This is unfortunate because much of the vast radiation of the class Gastropoda is associated with variations in feeding behaviors and feeding apparatuses, providing ample substrates for comparative studies including the evolution of defined circuitry. Here, the neural organization of feeding in the snail, Helisoma, is examined critically. Possible direct interspecific comparisons of neural circuitry and potentially homologous neurons are made. A universal model for central pattern generators underlying rasping feeding is proposed. Future comparative studies can be expected to combine behavioral, morphological, electrophysiological, molecular and genetic techniques to identify neurons and define neural circuitry. Digital resources will undoubtedly be exploited to organize and interface databases allowing illumination of the evolution of homologous identified neurons and defined neural circuitry in the context of behavioral change.</dcterms:abstract>
        <bib:pages>383-408</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163684</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60215">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163684</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60218">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <link:link rdf:resource="#item_60219"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 20th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Invertebrates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurobiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Physiology, Comparative</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>United States</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Theodore H. Bullock and simpler systems in comparative and integrative neurobiology</dc:title>
        <bib:pages>365-485</bib:pages>
        <dc:date>Mar 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11163682</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60219">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11163682</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60200">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bouron</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60201"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dendrites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Vesicles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Modulation of spontaneous quantal release of neurotransmitters in the hippocampus</dc:title>
        <dcterms:abstract>Presynaptic action potentials trigger the exocytosis of neurotransmitters. However, even in the absence of depolarisation-dependent Ca2+ entry nearby release sites, spontaneous vesicular release still occurs. Even though this happens at low rate, such spontaneous release may play a trophic role in maintaining the shape of dendritic structures. Like evoked responses, action potential-independent release is subject to modulation. This review describes some of the regulatory factors that rapidly and presynaptically regulate the ongoing Ca2+-independent release of neurotransmitters in the hippocampus. For instance, the electrical activity of the nerve ending, neurotransmitters, hypertonic solutions, neurotoxins, polycations, neurotrophic factors, immunoglobulins, cyclothiazide and psychotropic drugs can all modify the rate of spontaneous release. This can be achieved through various mechanisms that can be Ca2+-dependent or Ca2+-independent, protein kinase-dependent or independent. Since action potential-independent release contributes to the maintenance of dendritic structures, neuromodulators are likely to influence the density and/or length of dendritic spines, which in turn may modulate information processing in the central nervous system (CNS).</dcterms:abstract>
        <bib:pages>613-635</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11164998</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60201">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11164998</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60198">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brown</foaf:surname>
                        <foaf:givenname>R. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stevens</foaf:surname>
                        <foaf:givenname>D. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Haas</foaf:surname>
                        <foaf:givenname>H. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60199"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Histamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Homeostasis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hypothalamic Area, Lateral</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Histamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The physiology of brain histamine</dc:title>
        <dcterms:abstract>Histamine-releasing neurons are located exclusively in the TM of the hypothalamus, from where they project to practically all brain regions, with ventral areas (hypothalamus, basal forebrain, amygdala) receiving a particularly strong innervation. The intrinsic electrophysiological properties of TM neurons (slow spontaneous firing, broad action potentials, deep after hyperpolarisations, etc.) are extremely similar to other aminergic neurons. Their firing rate varies across the sleep-wake cycle, being highest during waking and lowest during rapid-eye movement sleep. In contrast to other aminergic neurons somatodendritic autoreceptors (H3) do not activate an inwardly rectifying potassium channel but instead control firing by inhibiting voltage-dependent calcium channels. Histamine release is enhanced under extreme conditions such as dehydration or hypoglycemia or by a variety of stressors. Histamine activates four types of receptors. H1 receptors are mainly postsynaptically located and are coupled positively to phospholipase C. High densities are found especially in the hypothalamus and other limbic regions. Activation of these receptors causes large depolarisations via blockade of a leak potassium conductance, activation of a non-specific cation channel or activation of a sodium-calcium exchanger. H2 receptors are also mainly postsynaptically located and are coupled positively to adenylyl cyclase. High densities are found in hippocampus, amygdala and basal ganglia. Activation of these receptors also leads to mainly excitatory effects through blockade of calcium-dependent potassium channels and modulation of the hyperpolarisation-activated cation channel. H3 receptors are exclusively presynaptically located and are negatively coupled to adenylyl cyclase. High densities are found in the basal ganglia. These receptors mediated presynaptic inhibition of histamine release and the release of other neurotransmitters, most likely via inhibition of presynaptic calcium channels. Finally, histamine modulates the glutamate NMDA receptor via an action at the polyamine binding site. The central histamine system is involved in many central nervous system functions: arousal; anxiety; activation of the sympathetic nervous system; the stress-related release of hormones from the pituitary and of central aminergic neurotransmitters; antinociception; water retention and suppression of eating. A role for the neuronal histamine system as a danger response system is proposed.</dcterms:abstract>
        <bib:pages>637-672</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11164999</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60199">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11164999</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60194">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Centonze</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marfia</foaf:surname>
                        <foaf:givenname>G. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pisani</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Picconi</foaf:surname>
                        <foaf:givenname>B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Giacomini</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bernardi</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Calabresi</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60195"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Survival</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neostriatum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neurotransmitter</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons</dc:title>
        <dcterms:abstract>Brain cells express extremely different sensitivity to ischemic insults. The reason for this differential vulnerability is still largely unknown. Here we discuss the ionic bases underlying the physiological responses to in vitro ischemia in two neostriatal neuronal subtypes exhibiting respectively high sensitivity and high resistance to energy deprivation. Vulnerable neostriatal neurons respond to ischemia with a membrane depolarization. This membrane depolarization mainly depends on the increased permeability to Na+ ions. In contrast, resistant neostriatal neurons respond to ischemia with a membrane hyperpolarization due to the opening of K+ channels. Interestingly, in both neuronal subtypes the ischemia-dependent membrane potential changes can be significantly enhanced or attenuated by a variety of pharmacological agents interfering with intracellular Ca2+ entry, ATP-dependent K+ channels opening, and Na+/Ca2+ exchanger functioning. The understanding of the ionic mechanisms underlying the differential membrane responses to ischemia represents the basis for the development of rational neuroprotective treatments during acute cerebrovascular insults.</dcterms:abstract>
        <bib:pages>687-696</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11165001</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60195">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11165001</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60204">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Curtis</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Avanzini</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60205"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebral Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electroencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Epilepsies, Partial</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Periodicity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sodium Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Interictal spikes in focal epileptogenesis</dc:title>
        <dcterms:abstract>Interictal electroencephalography (EEG) potentials in focal epilepsies are sustained by synchronous paroxysmal membrane depolarization generated by assemblies of hyperexcitable neurons. It is currently believed that interictal spiking sets a condition that preludes to the onset of an ictal discharge. Such an assumption is based on little experimental evidence. Human pre-surgical studies and recordings in chronic and acute models of focal epilepsy showed that: (i) interictal spikes (IS) and ictal discharges are generated by different populations of neuron through different cellular and network mechanisms; (ii) the cortical region that generates IS (irritative area) does not coincide with the ictal-onset area; (iii) IS frequency does not increase before a seizure and is enhanced just after an ictal event; (iv) spike suppression is found to herald ictal discharges; and (v) enhancement of interictal spiking suppresses ictal events. Several experimental evidences indicate that the highly synchronous cellular discharge associated with an IS is generated by a multitude of mechanisms involving synaptic and non-synaptic communication between neurons. The synchronized neuronal discharge associated with a single IS induces and is followed by a profound and prolonged refractory period sustained by inhibitory potentials and by activity-dependent changes in the ionic composition of the extracellular space. Post-spike depression may be responsible for pacing interictal spiking periodicity commonly observed in both animal models and human focal epilepsies. It is proposed that the strong after-inhibition produced by IS protects against the occurrence of ictal discharges by maintaining a low level of excitation in a general condition of hyperexcitability determined by the primary epileptogenic dysfunction.</dcterms:abstract>
        <bib:pages>541-567</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11164621</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60205">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11164621</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60206">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grüsser-Cornehls</foaf:surname>
                        <foaf:givenname>U.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bäurle</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60207"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ataxia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebellar Ataxia</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebellum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>gamma-Aminobutyric Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glycine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mice, Mutant Strains</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Parvalbumins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Purkinje Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, GABA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Mutant mice as a model for cerebellar ataxia</dc:title>
        <dcterms:abstract>Not later than two synapses after their arrival in the cerebellar cortex all excitatory afferent signals are subsequently transformed into inhibitory ones. Guaranteed by the exceedingly ordered and stereotyped synaptic arrangement of its cellular elements, the cerebellar cortex transmits this inhibitory result of cerebellar integration exclusively via Purkinje cells (PCs) in a precise temporal succession directly onto the target neurons of the deep cerebellar and vestibular nuclei. Thus the cerebellar cortex seems to produce a temporal pattern of inhibitory influence on these target neurons that modifies their excitatory action in such a way that an activation of muscle fibers occurs which progressively integrates the intended motion into the actual condition of the motoric inventory. In consequence, disturbances that affect this cerebellar inhibition will cause uncoordinated, decomposed and ataxic movements, commonly referred to as cerebellar ataxia. Electrophysiological investigations using different cerebellar mouse mutants have shown that alterations in the cerebellar inhibitory input in the target nuclei lead to diverse neuronal responses and to different consequences for the behavioural phenotype. A dependence between the reconstitution of inhibition and the behavioural outcome seems to exist. Obviously two different basic mechanisms are responsible for these observations: (1) ineffective inhibition on target neurons by surviving PCs; and (2) enhancement of intranuclear inhibition in the deep cerebellar and vestibular nuclei. Which of the two strategies evolves is dependent upon the composition of the residual cell types in the cerebellum and on the degree of PC input loss in a given area of the target nuclei. Motor behaviour seems to deteriorate under the first of these mechanisms whereas it may benefit from the second. This is substantiated by stereotaxic removal of the remaining PC input, which eliminates the influence of the first mechanism and is able to induce the second strategy. As a consequence, motor performance improves considerably. In this review, results leading to the above conclusions are presented and links forged to human cerebellar diseases.</dcterms:abstract>
        <bib:pages>489-540</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11164620</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60207">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11164620</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60202">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pertwee</foaf:surname>
                        <foaf:givenname>R. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60203"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acute Disease</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Analgesics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cannabinoid Receptor Modulators</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cannabinoids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Chronic Disease</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Haplorhini</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ligands</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pain Measurement</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor, Cannabinoid, CB2</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cannabinoid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, Drug</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cannabinoid receptors and pain</dc:title>
        <dcterms:abstract>Mammalian tissues contain at least two types of cannabinoid receptor, CB(1) and CB(2), both coupled to G proteins. CB(1) receptors are expressed mainly by neurones of the central and peripheral nervous system whereas CB(2) receptors occur centrally and peripherally in certain non-neuronal tissues, particularly in immune cells. The existence of endogenous ligands for cannabinoid receptors has also been demonstrated. The discovery of this 'endocannabinoid system' has prompted the development of a range of novel cannabinoid receptor agonists and antagonists, including several that show marked selectivity for CB(1) or CB(2) receptors. It has also been paralleled by a renewed interest in cannabinoid-induced antinociception. This review summarizes current knowledge about the ability of cannabinoids to produce antinociception in animal models of acute pain as well as about the ability of these drugs to suppress signs of tonic pain induced in animals by nerve damage or by the injection of an inflammatory agent. Particular attention is paid to the types of pain against which cannabinoids may be effective, the distribution pattern of cannabinoid receptors in central and peripheral pain pathways and the part that these receptors play in cannabinoid-induced antinociception. The possibility that antinociception can be mediated by cannabinoid receptors other than CB(1) and CB(2) receptors, for example CB(2)-like receptors, is also discussed as is the evidence firstly that one endogenous cannabinoid, anandamide, produces antinociception through mechanisms that differ from those of other types of cannabinoid, for example by acting on vanilloid receptors, and secondly that the endocannabinoid system has physiological and/or pathophysiological roles in the modulation of pain.</dcterms:abstract>
        <bib:pages>569-611</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11164622</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60203">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11164622</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60196">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Spergel</foaf:surname>
                        <foaf:givenname>D. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Krüth</foaf:surname>
                        <foaf:givenname>U.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shimshek</foaf:surname>
                        <foaf:givenname>D. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sprengel</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Seeburg</foaf:surname>
                        <foaf:givenname>P. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60197"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Genes, Reporter</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gonadotropin-Releasing Hormone</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hypothalamus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mice, Transgenic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Promoter Regions, Genetic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Using reporter genes to label selected neuronal populations in transgenic mice for gene promoter, anatomical, and physiological studies</dc:title>
        <dcterms:abstract>This review summarizes recent work on the use of reporter genes to label selected neuronal populations in transgenic mice, with particular emphasis on gonadotropin-releasing hormone (GnRH) neurons. Reporter genes discussed are the lacZ, green fluorescent protein (GFP), luc, and bla genes, which encode the reporter proteins beta-galactosidase, GFP, luciferase, and beta-lactamase, respectively. Targeted transgenic expression of these reporter proteins is obtained by fusing the corresponding reporter gene, with or without a subcellular localization signal, to a cell type- or brain region-specific gene promoter. Mice carrying GnRH promoter-driven reporter genes have proven useful for revealing the promoter elements required for cell type-specific expression of GnRH, the full anatomical profile of the GnRH neuronal network, and its electrophysiological activity, suggesting that similar approaches will assist in elucidating the properties of other neuronal populations as well.</dcterms:abstract>
        <bib:pages>673-686</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11165000</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60197">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11165000</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60192">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>63</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yoneda</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kuramoto</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kitayama</foaf:surname>
                        <foaf:givenname>T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hinoi</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60193"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Nucleus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Kainic Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Consolidation of transient ionotropic glutamate signals through nuclear transcription factors in the brain</dc:title>
        <dcterms:abstract>Long-lasting alterations of neuronal functions could involve mechanisms associated with consolidation of transient extracellular signals through modulation of de novo synthesis of particular functional proteins in the brain. In eukaryotes, protein de novo synthesis is mainly under the control at the level of gene transcription by transcription factors in the cell nucleus. Transcription factors are nuclear proteins with an ability to recognize particular core nucleotides at the upstream and/or downstream of target genes, and thereby to modulate the activity of RNA polymerase II that is responsible for the formation of mRNA from double stranded DNA. Gel retardation electrophoresis is widely employed for conventional detection of DNA binding activities of a variety of transcription factors with different protein motifs. Extracellular ionotropic glutamate (Glu) signals lead to rapid and selective potentiation of DNA binding of the nuclear transcription factor activator protein-1 (AP1) that is a homo- and heterodimeric complex between Jun and Fos family members, in addition to inducing expression of the corresponding proteins, in a manner unique to each Glu signal in murine hippocampus. Therefore, extracellular Glu signals may be differentially transduced into the nucleus to express AP1 with different assemblies between Jun and Fos family members, and thereby to modulate de novo synthesis of the individual target proteins at the level of gene transcription in the hippocampus. Such mechanisms may be operative on synaptic plasticity as well as delayed neuronal death through consolidation of alterations of a variety of cellular functions induced by transient extracellular signals in the brain.</dcterms:abstract>
        <bib:pages>697-719</bib:pages>
        <dc:date>Apr 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11165002</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60193">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11165002</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60184">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Acampora</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gulisano</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Broccoli</foaf:surname>
                        <foaf:givenname>V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Simeone</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60185"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Drosophila Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Homeodomain Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Otx Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Trans-Activators</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Otx genes in brain morphogenesis</dc:title>
        <dcterms:abstract>Most of the gene candidates for the control of developmental programmes that underlie brain morphogenesis in vertebrates are the homologues of Drosophila genes coding for signalling molecules or transcription factors. Among these, the orthodenticle group includes the Drosophila orthodenticle (otd) and the vertebrate Otx1 and Otx2 genes, which are mostly involved in fundamental processes of anterior neural patterning. These genes encode transcription factors that recognise specific target sequences through the DNA binding properties of the homeodomain. In Drosophila, mutations of otd cause the loss of the anteriormost head neuromere where the gene is transcribed, suggesting that it may act as a segmentation &quot;gap&quot; gene. In mouse embryos, the expression patterns of Otx1 and Otx2 have shown a remarkable similarity with the Drosophila counterpart. This suggested that they could be part of a conserved control system operating in the brain and different from that coded by the HOX complexes controlling the hindbrain and spinal cord. To verify this hypothesis a series of mouse models have been generated in which the functions of the murine genes were: (i) fully inactivated, (ii) replaced with each others, (iii) replaced with the Drosophila otd gene. Otx1-/- mutants suffer from epilepsy and are affected by neurological, hormonal, and sense organ defects. Otx2-/- mice are embryonically lethal, they show gastrulation impairments and fail in specifying anterior neural plate. Analysis of the Otx1-/-; Otx2+/- double mutants has shown that a minimal threshold level of the proteins they encode is required for the correct positioning of the midbrain-hindbrain boundary (MHB). In vivo otd/Otx reciprocal gene replacement experiments have provided evidence of a general functional equivalence among otd, Otx1 and Otx2 in fly and mouse. Altogether these data highlight a crucial role for the Otx genes in specification, regionalization and terminal differentiation of rostral central nervous system (CNS) and lead to hypothesize that modification of their regulatory control may have influenced morphogenesis and evolution of the brain.</dcterms:abstract>
        <bib:pages>69-95</bib:pages>
        <dc:date>May 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11250063</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60185">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11250063</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60190">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cotterill</foaf:surname>
                        <foaf:givenname>R. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60191"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebellum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebral Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Consciousness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Creativity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Intelligence</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cooperation of the basal ganglia, cerebellum, sensory cerebrum and hippocampus: possible implications for cognition, consciousness, intelligence and creativity</dc:title>
        <dcterms:abstract>It is suggested that the anatomical structures which mediate consciousness evolved as decisive embellishments to a (non-conscious) design strategy present even in the simplest unicellular organisms. Consciousness is thus not the pinnacle of a hierarchy whose base is the primitive reflex, because reflexes require a nervous system, which the single-celled creature does not possess. By postulating that consciousness is intimately connected to self-paced probing of the environment, also prominent in prokaryotic behavior, one can make mammalian neuroanatomy amenable to dramatically straightforward rationalization. Muscular contraction is the nervous system's only externally directed product, and the signaling routes which pass through the various brain components must ultimately converge on the motor areas. The function of several components is still debatable, so it might seem premature to analyze the global operation of the circuit these routes constitute. But such analysis produces a remarkably simple picture, and it sheds new light on the roles of the individual components. The underlying principle is conditionally permitted movement, some components being able to veto muscular contraction by denying the motor areas sufficient activation. This is true of the basal ganglia (BG) and the cerebellum (Cb), which act in tandem with the sensory cerebrum, and which can prevent the latter's signals to the motor areas from exceeding the threshold for overt movement. It is also true of the anterior cingulate, which appears to play a major role in directing attention. In mammals, the result can be mere thought, provided that a second lower threshold is exceeded. The veto functions of the BG and the Cb stem from inhibition, but the countermanding disinhibition develops at markedly different rates in those two key components. It develops rapidly in the BG, control being exercised by the amygdala, which itself is governed by various other brain regions. It develops over time in the Cb, thereby permitting previously executed movements that have proved advantageous. If cognition is linked to overt or covert movement, intelligence becomes the ability to consolidate individual motor elements into more complex patterns, and creativity is the outcome of a race-to-threshold process which centers on the motor areas. Amongst the ramifications of these ideas are aspects of cortical oscillations, phantom limb sensations, amyotrophic lateral sclerosis (ALS) the difficulty of self-tickling and mirror neurons.</dcterms:abstract>
        <bib:pages>1-33</bib:pages>
        <dc:date>May 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Cooperation of the basal ganglia, cerebellum, sensory cerebrum and hippocampus</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11250060</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60191">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11250060</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60182">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ohkuma</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Katsura</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60183"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nitrates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS</dc:title>
        <dcterms:abstract>This review summarizes the stimulatory potentials of NO and peroxynitrite (OONO-) on neurotransmitter release in the central nervous system. Exogenous and endogenous NO stimulates to release neurotransmitter. NO synthesized intracellularly diffuses out through neuronal membrane and acts on the outer side of membrane to depolarize neuronal membrane, which triggers neurotransmitter release. NO-induced release of neurotransmitters is mediated by Ca2+-dependent and -independent processes. The latter process is operated by reverse process of the Na+-dependent carrier-mediated neurotransmitter uptake system or by unknown mechanisms. Ca2+-dependent release of neurotransmitter occurs in part subsequent to increase in Ca2+ influx via VDCCs, although N-type VDCCs may not involve in this action of NO because of suppression of Ca2+ influx through N-type VDCCs by NO. Participation of cGMP formation by NO on neurotransmitter release is controversial. A superoxide scavenger, Ca2+, Zn(2+)-superoxide dismutase, abolishes NO-induced neurotransmitter release and synthesized OONO- induces neurotransmitter release, indicating that OONO- participates in NO-evoked neurotransmitter release.</dcterms:abstract>
        <bib:pages>97-108</bib:pages>
        <dc:date>May 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11250064</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60183">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11250064</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60186">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Prast</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Philippu</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60187"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Nitric oxide as modulator of neuronal function</dc:title>
        <dcterms:abstract>The gas NO is a messenger that modulates neuronal function. The use of NO donors and NO synthase inhibitors as pharmacological tools revealed that this free radical is probably implicated in the regulation of excitability and firing, in long-term potentiation and long-term depression, as well as in memory processes. Moreover, NO modulates neurotransmitter release. In vivo and in vitro studies have shown that, in all brain structures investigated, endogenous NO modulates the release of several neurotransmitters, such as acetylcholine, catecholamines, excitatory and inhibitory amino acids, serotonin, histamine, and adenosine. In most cases, enhanced NO level in the tissue increases the release of neurotransmitters, although decreasing effects have also been observed. Cyclic 3'-5' guanosine monophosphate and glutamate mediate the modulation of transmitter release by NO. Recent observations suggest that the release of some transmitters is dually influenced by NO. Thus, besides modulation by presynaptically located auto- and heteroreceptors, NO released from nitrergic neurons seems to play a universal role in modulating the release of transmitters in the brain.</dcterms:abstract>
        <bib:pages>51-68</bib:pages>
        <dc:date>May 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11250062</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60187">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11250062</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60188">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Previtali</foaf:surname>
                        <foaf:givenname>S. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Feltri</foaf:surname>
                        <foaf:givenname>M. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Archelos</foaf:surname>
                        <foaf:givenname>J. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Quattrini</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wrabetz</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hartung</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60189"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Integrins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Role of integrins in the peripheral nervous system</dc:title>
        <dcterms:abstract>Integrins, a subgroup of adhesion receptors, are transmembrane glycoproteins that mediate interactions between cytoplasm and the extracellular environment. These interactions influence, among others, events such as cell migration, proliferation, and differentiation. Differential expression of integrins is developmentally regulated in the peripheral nervous system (PNS) and is associated with crucial events in both physiological and pathological processes. Preliminary studies suggest that integrin expression influences neural crest cell migration, axonal outgrowth, and Schwann cell differentiation. Similarly, the abnormal expression of integrins or their ligands, is associated with degenerative, inflammatory, and malignant disorders of the PNS. Finally, integrins participate in the complex interactions that promote repair of the PNS. A better comprehension of the role of integrins in the PNS, their protein interactions and transducing signals is being achieved by selected biochemical and genetic experiments. Here we review a large bias of evidence suggesting the key functions for integrins in the PNS.</dcterms:abstract>
        <bib:pages>35-49</bib:pages>
        <dc:date>May 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11250061</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60189">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11250061</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60166">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Eder</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>DeCoursey</foaf:surname>
                        <foaf:givenname>T. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60167"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hydrogen-Ion Concentration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Protons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Voltage-gated proton channels in microglia</dc:title>
        <dcterms:abstract>Microglia, macrophages that reside in the brain, can express at least 12 different ion channels, including voltage-gated proton channels. The properties of H+ currents in microglia are similar to those in other phagocytes. Proton currents are elicited by depolarizing the membrane potential, but activation also depends strongly on both intracellular pH (pH(i)) and extracellular pH (pH(o)). Increasing pH(o) or lowering pH(i) promotes H+ channel opening by shifting the activation threshold to more negative potentials. H+ channels in microglia open only when the pH gradient is outward, so they carry only outward current in the steady state. Time-dependent activation of H+ currents is slow, with a time constant roughly 1 s at room temperature. Microglial H+ currents are inhibited by inorganic polyvalent cations, which reduce H+ current amplitude and shift the voltage dependence of activation to more positive potentials. Cytoskeletal disruptive agents modulate H+ currents in microglia. Cytochalasin D and colchicine decrease the current density and slow the activation of H+ currents. Similar changes of H+ currents, possibly due to cytoskeletal reorganization, occur in microglia during the transformation from ameboid to ramified morphology. Phagocytes, including microglia, undergo a respiratory burst, in which NADPH oxidase releases bactericidal superoxide anions into the phagosome and stoichiometrically releases protons into the cell, tending to depolarize and acidify the cell. H+ currents may help regulate both the membrane potential and pH(i) during the respiratory burst. By compensating for the efflux of electrons and counteracting intracellular acidification, H+ channels help maintain superoxide anion production.</dcterms:abstract>
        <bib:pages>277-305</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240310</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60167">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240310</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60180">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kiefer</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kieseier</foaf:surname>
                        <foaf:givenname>B. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stoll</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hartung</foaf:surname>
                        <foaf:givenname>H. P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60181"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antigen Presentation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cytokines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Inflammation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Macrophages</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Polyradiculoneuropathy</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of macrophages in immune-mediated damage to the peripheral nervous system</dc:title>
        <dcterms:abstract>Macrophage-mediated segmental demyelination is the pathological hallmark of autoimmune demyelinating polyneuropathies, including the demyelinating form of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Macrophages serve a multitude of functions throughout the entire pathogenetic process of autoimmune neuropathy. Resident endoneurial macrophages are likely to act as local antigen-presenting cells by their capability to express major histocompatibility complex antigens and costimulatory B7-molecules, and may thus be critical in triggering the autoimmune process. Hematogenous infiltrating macrophages then find their way into the peripheral nerve together with T-cells by the concerted action of adhesion molecules, matrix metalloproteases and chemotactic signals. Within the nerve, macrophages regulate inflammation by secreting several pro-inflammatory cytokines including IL-1, IL-6, IL-12 and TNF-alpha. Autoantibodies are likely to guide macrophages towards their myelin or primarily axonal targets, which then attack in a complement-dependent and receptor-mediated manner. In addition, non-specific tissue damage occurs through the secretion of toxic mediators and cytokines. Later, macrophages contribute to the termination of inflammation by promoting T-cell apoptosis and expressing anti-inflammatory cytokines including TGF-beta1 and IL-10. During recovery, they are tightly involved in allowing Schwann cell proliferation, remyelination and axonal regeneration to proceed. Macrophages, thus, play dual roles in autoimmune neuropathy, being detrimental in attacking nervous tissue but also salutary, when aiding in the termination of the inflammatory process and the promotion of recovery.</dcterms:abstract>
        <bib:pages>109-127</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240209</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60181">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240209</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60168">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maharajan</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maharajan</foaf:surname>
                        <foaf:givenname>V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ravagnan</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Paino</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60169"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mice, Neurologic Mutants</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Substance-Related Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction</dc:title>
        <dcterms:abstract>Dopaminergic neurons and their projection-systems are important in some fundamental human activities like locomotion, feeding and sex, essential for survival and procreation, and are relevant to pathologies like Parkinson's disease and drug abuse. Three main dopaminergic projection-systems, namely the nigrostriatal, mesocortical and mesolimbic pathways are the major targets of the neuropharmacological actions of psychomotor stimulants such as cocaine and amphetamine. Studies on knockout mice for dopamine or its receptors provide substantial information but fail to reveal the role of individual dopaminergic projection-systems. Mutant animals with defects specific to one or more projection-systems might be useful for studying the role of individual dopaminergic projection-systems. We propose the weaver mutant mouse, with a defective nigrostriatal dopaminergic projection-system and dopamine depletion in the dorsal striatum but with intact mesocorticolimbic projection-systems, as a suitable model to study the role of individual dopaminergic systems in diverse biological processes including Parkinson's disease and drug abuse.</dcterms:abstract>
        <bib:pages>269-276</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The weaver mutant mouse</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240309</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60169">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240309</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60176">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marcaggi</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Coles</foaf:surname>
                        <foaf:givenname>J. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60177"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Transport</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Membrane</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Quaternary Ammonium Compounds</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Ammonium in nervous tissue: transport across cell membranes, fluxes from neurons to glial cells, and role in signalling</dc:title>
        <dcterms:abstract>Most, but not all, animal cell membranes are permeable to NH3, the neutral, minority form of ammonium which is in equilibrium with the charged majority form NH4+. NH4+ crosses many cell membranes via ion channels or on membrane transporters, and cultured mammalian astrocytes and glial cells of bee retina take up NH4+ avidly, in the latter case on a Cl(-)-cotransporter selective for NH4+ over K+. In bee retina, a flux of ammonium from neurons to glial cells is an essential component of energy metabolism, which involves a flux of alanine from glial cells to neurons. In mammalian brain, both glutamate and ammonium are taken up preferentially by astrocytes and form glutamine. Glutamine is transferred to neurons where it is deamidated to re-form glutamate; the maintenance of this cycle appears to require a substantial flux of ammonium from neurons to astrocytes. In addition to maintaining the glial cell content of fixed N (a &quot;bookkeeping&quot; function), ammonium is expected to participate in the regulation of glial cell metabolism (a signalling function): it will increase conversion of glutamate to glutamine, and, by activating phosphofructokinase and inhibiting the alpha-ketoglutarate dehydrogenase complex, it will tend to increase the formation of lactate.</dcterms:abstract>
        <bib:pages>157-183</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Ammonium in nervous tissue</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240211</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60177">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240211</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60178">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>O'Mara</foaf:surname>
                        <foaf:givenname>S. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Commins</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Anderson</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gigg</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60179"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The subiculum: a review of form, physiology and function</dc:title>
        <dcterms:abstract>We review the neuroanatomical, neurophysiological and functional properties of the mammalian subiculum in this paper. The subiculum is a pivotal structure positioned between the hippocampus proper and entorhinal and other cortices, as well as a range of subcortical structures. It is an under-investigated region that plays a key role in the mediation of hippocampal-cortical interaction. We argue that on neuroanatomical, physiological and functional grounds, the subiculum is properly part of the hippocampal formation, given its pivotal role in the hippocampal circuit. We suggest that the term &quot;subicular complex&quot; embraces a heterogenous range of distinct structures and this phrase does not connote a functionally or anatomically meaningful grouping of structures. The subiculum has a range of electrophysiological and functional properties which are quite distinct from its input areas; given the widespread set of cortical and subcortical areas with which it interacts, it is able to influence activity in quite disparate brain regions. The rules which govern the plasticity of synaptic transmission are not well-specified; it shares some properties in common with the hippocampus proper, but behaves quite differently in other respects. Equally, its functional properties are not well-understood, it plays an important but ill-defined role both in spatial navigation and in mnemonic processing. The important challenges for the future revolve around the theoretical specification of its unique contribution to hippocampal formation processing on the one hand, and the experimental investigation of the many open questions (anatomical, physiological, pharmacological, functional) regarding its properties, on the other.</dcterms:abstract>
        <bib:pages>129-155</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The subiculum</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240210</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60179">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240210</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60170">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Osterlund</foaf:surname>
                        <foaf:givenname>M. K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hurd</foaf:surname>
                        <foaf:givenname>Y. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60171"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Estrogens</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prosencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Estrogen</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders</dc:title>
        <dcterms:abstract>The steroid hormone estrogen influences brain function and neuropsychiatric disorders, but neuroanatomical information about the estrogen receptors (ERs) are rather limited. The main focus of this article is to provide an overview of the current status of the ER distribution and possible function in the human brain. The ERs are ligand activated transcription factors that belong to the steroid hormone receptors, included in the nuclear receptor superfamily. To date, there are two known ER subtypes, alpha and beta. In the human forebrain, both estrogen receptor subtypes are predominantly expressed in limbic-related areas, although they show distinct distribution patterns. The ERalpha mRNA expression appears to dominate in the hypothalamus and amygdala, indicating that the alpha-subtype might modulate neuronal cell populations involved in autonomic and reproductive neuroendocrine functions as well as emotional interpretation and processing. In contrast, the hippocampal formation, entorhinal cortex, and thalamus appear to be ERbeta dominant areas, suggesting a putative role for ERbeta in cognition, non-emotional memory and motor functions. Clinical observations of estrogenic effects together with the information available today regarding ER expression in the primate brain provide important clues as to the functional aspects of the two ER subtypes. However, further characterization of the different phenotypes of the ER expressing cells in the human brain is needed as well as the delineation of the genes which are regulated by the ERs and how this transcriptional control correlates with human behavior and mental status.</dcterms:abstract>
        <bib:pages>251-267</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240308</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60171">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240308</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60164">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Raggenbass</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60165"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>membranes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oxytocin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Second Messenger Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vasopressins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Vasopressin- and oxytocin-induced activity in the central nervous system: electrophysiological studies using in-vitro systems</dc:title>
        <dcterms:abstract>During the last two decades, it has become apparent that vasopressin and oxytocin, in addition to playing a role as peptide hormones, also act as neurotransmitters/neuromodulators. A number of arguments support this notion: (i) vasopressin and oxytocin are synthesized not only in hypothalamo-neurohypophysial cells, but also in other hypothalamic and extrahypothalamic cell bodies, whose axon projects to the limbic system, the brainstem and the spinal cord. (ii) Vasopressin and oxytocin can be shed from central axons as are classical neurotransmitters. (iii) Specific binding sites, i.e. membrane receptors having high affinity for vasopressin and oxytocin are present in the central nervous system. (iv) Vasopressin and oxytocin can alter the firing rate of selected neuronal populations. (v) In-situ injection of vasopressin and oxytocin receptor agonists and antagonists can interfere with behavior or physiological regulations. Morphological studies and electrophysiological recordings have evidenced a close anatomical correlation between the presence of vasopressin and oxytocin receptors in the brain and the neuronal responsiveness to vasopressin or oxytocin. These compounds have been found to affect membrane excitability in neurons located in the limbic system, hypothalamus, circumventricular organs, brainstem, and spinal cord. Sharp electrode intracellular recordings and whole-cell recordings, done in brainstem motoneurons or in spinal cord neurons, have revealed that vasopressin and oxytocin can directly affect neuronal excitability by opening non-specific cationic channels or by closing K(+) channels. These neuropeptides can also influence synaptic transmission, by acting either postsynaptically or upon presynaptic target neurons or axon terminals. Whereas, in cultured neurons, vasopressin and oxytocin appear to mobilize intracellular Ca(++), in brainstem slices, the action of oxytocin is mediated by a second messenger that is distinct from the second messenger activated in peripheral target cells. In this review, we will summarize studies carried out at the cellular level, i.e. we will concentrate on in-vitro approaches. Vasopressin and oxytocin will be treated together. Though acting via distinct receptors in distinct brain areas, these two neuropeptides appear to exert similar effects upon neuronal excitability.</dcterms:abstract>
        <bib:pages>307-326</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Vasopressin- and oxytocin-induced activity in the central nervous system</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240311</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60165">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240311</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60174">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stone</foaf:surname>
                        <foaf:givenname>T. W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60175"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Kynurenine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Quinolinic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Kynurenines in the CNS: from endogenous obscurity to therapeutic importance</dc:title>
        <dcterms:abstract>In just under 20 years the kynurenine family of compounds has developed from a group of obscure metabolites of the essential amino acid tryptophan into a source of intensive research, with postulated roles for quinolinic acid in neurodegenerative disorders, most especially the AIDS-dementia complex and Huntington's disease. One of the kynurenines, kynurenic acid, has become a standard tool for use in the identification of glutamate-releasing synapses, and has been used as the parent for several groups of compounds now being developed as drugs for the treatment of epilepsy and stroke. The kynurenines represent a major success in translating a basic discovery into a source of clinical understanding and therapeutic application, with around 3000 papers published on quinolinic acid or kynurenic acid since the discovery of their effects in 1981 and 1982. This review concentrates on some of the recent work most directly relevant to the understanding and applications of kynurenines in medicine.</dcterms:abstract>
        <bib:pages>185-218</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Kynurenines in the CNS</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240212</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60175">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240212</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60172">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ugarte</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Osborne</foaf:surname>
                        <foaf:givenname>N. N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60173"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Retina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Zinc</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Zinc in the retina</dc:title>
        <dcterms:abstract>Experimental evidence exists to suggest that zinc can have positive and negative effects on the physiology of cells depending on the &quot;local&quot; concentration, localisation (extracellular vs. intracellular) and/or state (bound vs. free). The retina contains particularly high amounts of zinc suggesting a pivotal role in the tissue. There is also suggestive evidence that zinc deficiency in humans may result in abnormal dark adaptation and/or age-related macular degeneration. The purpose of this article is to provide an overview of various proposed functions for zinc, particularly in the retina. Endogenous chelatable zinc in the retina is localised mainly to the photoreceptors and retinal pigment epithelial cells. Moreover, the zinc localisation in the photoreceptors varies in dark and light, suggesting a role for zinc in a light-regulated process. Some zinc is also located to other areas of the retina but clearly defined zinc-enriched neurones could not be identified as has been shown to occur in certain areas of the brain. Neurones post-synaptic to zinc-enriched neurones in the brain have been suggested to be particularly vulnerable in ischaemia. The role of zinc in retinal ischaemia has been investigated to determine how it is involved in the process. It would appear that when zinc is administered in low concentrations it generally has a positive effect on an insulted retina as in ischaemia. However, higher concentrations of zinc exacerbates the influence of the insult and also acts as a toxin. Use of zinc supplements in diet must, therefore, be taken with caution.</dcterms:abstract>
        <bib:pages>219-249</bib:pages>
        <dc:date>Jun 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11240307</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60173">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11240307</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60162">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vanegas</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schaible</foaf:surname>
                        <foaf:givenname>H. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60163"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anti-Inflammatory Agents, Non-Steroidal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclooxygenase 1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclooxygenase 2</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclooxygenase 2 Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclooxygenase Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ganglia, Spinal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Isoenzymes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pain Measurement</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Prostaglandin-Endoperoxide Synthases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prostaglandins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Prostaglandin</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord</dc:title>
        <dcterms:abstract>The spinal cord is one of the sites where non-steroidal anti-inflammatory drugs (NSAIDs) act to produce analgesia and antinociception. Expression of cyclooxygenase(COX)-1 and COX-2 in the spinal cord and primary afferents suggests that NSAIDs act here by inhibiting the synthesis of prostaglandins (PGs). Basal release of PGD(2), PGE(2), PGF(2alpha) and PGI(2) occurs in the spinal cord and dorsal root ganglia. Prostaglandins then bind to G-protein-coupled receptors located in intrinsic spinal neurons (receptor types DP and EP2) and primary afferent neurons (EP1, EP3, EP4 and IP). Acute and chronic peripheral inflammation, interleukins and spinal cord injury increase the expression of COX-2 and release of PGE(2) and PGI(2). By activating the cAMP and protein kinase A pathway, PGs enhance tetrodotoxin-resistant sodium currents, inhibit voltage-dependent potassium currents and increase voltage-dependent calcium inflow in nociceptive afferents. This decreases firing threshold, increases firing rate and induces release of excitatory amino acids, substance P, calcitonin gene-related peptide (CGRP) and nitric oxide. Conversely, glutamate, substance P and CGRP increase PG release. Prostaglandins also facilitate membrane currents and release of substance P and CGRP induced by low pH, bradykinin and capsaicin. All this should enhance elicitation and synaptic transfer of pain signals in the spinal cord. Direct administration of PGs to the spinal cord causes hyperalgesia and allodynia, and some studies have shown an association between induction of COX-2, increased PG release and enhanced nociception. NSAIDs diminish both basal and enhanced PG release in the spinal cord. Correspondingly, spinal application of NSAIDs generally diminishes neuronal and behavioral responses to acute nociceptive stimulation, and always attenuates behavioral responses to persistent nociception. Spinal application of specific COX-2 inhibitors sometimes diminishes behavioral responses to persistent nociception.</dcterms:abstract>
        <bib:pages>327-363</bib:pages>
        <dc:date>Jul 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11275357</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60163">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11275357</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60160">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wiesinger</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60161"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Arginine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Citrulline</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nitric Oxide Synthase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Arginine metabolism and the synthesis of nitric oxide in the nervous system</dc:title>
        <dcterms:abstract>The biochemistry and physiology of L-arginine have to be reconsidered in the light of the recent discovery that the amino acid is the only substrate of all isoforms of nitric oxide synthase (NOS). Generation of nitric oxide, NO, a versatile molecule in signaling processes and unspecific immune defense, is intertwined with synthesis, catabolism and transport of arginine which thus ultimately participates in the regulation of a fine-tuned balance between normal and pathophysiological consequences of NO production. The complex composition of the brain at the cellular level is reflected in a complex differential distribution of the enzymes of arginine metabolism. Argininosuccinate synthetase (ASS) and argininosuccinate lyase which together can recycle the NOS coproduct L-citrulline to L-arginine are expressed constitutively in neurons, but hardly colocalize with each other or with NOS in the same neuron. Therefore, trafficking of citrulline and arginine between neurons necessitates transport capacities in these cells which are fulfilled by well-described carriers for cationic and neutral amino acids. The mechanism of intercellular exchange of argininosuccinate, a prerequisite also for its proposed function as a neuromodulator, remains to be elucidated. In cultured astrocytes transcription and protein expression of arginine transport system y(+) and of ASS are upregulated concomittantly with immunostimulant-mediated induction of NOS-2. In vivo ASS-immunoreactivity was found in microglial cells in a rat model of brain inflammation and in neurons and glial cells in the brains of Alzheimer patients. Any attempt to estimate the contributions of arginine transport and synthesis to substrate supply for NOS has to consider competition for arginine between NOS and arginase, the latter enzyme being expressed as mitochondrial isoform II in nervous tissue. Generation of NOS inhibitors agmatine and methylarginines is documented for the nervous system. Suboptimal supply of NOS with arginine leads to production of detrimental peroxynitrite which may result in neuronal cell death. Data have been gathered recently which point to a particular role of astrocytes in neural arginine metabolism. Arginine appears to be accumulated in astroglial cells and can be released after stimulation with a variety of signals. It is proposed that an intercellular citrulline-NO cycle is operating in brain with astrocytes storing arginine for the benefit of neighbouring cells in need of the amino acid for a proper synthesis of NO.</dcterms:abstract>
        <bib:pages>365-391</bib:pages>
        <dc:date>Jul 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11275358</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60161">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11275358</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60158">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wood</foaf:surname>
                        <foaf:givenname>S. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Slater</foaf:surname>
                        <foaf:givenname>C. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60159"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Postsynaptic Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Muscle Fibers, Skeletal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuromuscular Junction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuromuscular Junction Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cholinergic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Schwann Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Vesicles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Safety factor at the neuromuscular junction</dc:title>
        <dcterms:abstract>Reliable transmission of activity from nerve to muscle is necessary for the normal function of the body. The term 'safety factor' refers to the ability of neuromuscular transmission to remain effective under various physiological conditions and stresses. This is a result of the amount of transmitter released per nerve impulse being greater than that required to trigger an action potential in the muscle fibre. The safety factor is a measure of this excess of released transmitter. In this review we discuss the practical difficulties involved in estimating the safety factor in vitro. We then consider the factors that influence the safety factor in vivo. While presynaptic transmitter release may be modulated on a moment to moment basis, the postsynaptic features that determine the effect of released transmitter are not so readily altered to meet changing demands. Different strategies are used by different species to ensure reliable neuromuscular transmission. Some, like frogs, rely on releasing a large amount of transmitter while others, like man, rely on elaborate postsynaptic specialisations to enhance the response to transmitter. In normal adult mammals, the safety factor is generally 3-5. Both pre- and postsynaptic components change during development and may show plasticity in response to injury or disease. Thus, both acquired autoimmune and inherited congenital diseases of the neuromuscular junction (NMJ) can significantly reduce, or even transiently increase, safety factor.</dcterms:abstract>
        <bib:pages>393-429</bib:pages>
        <dc:date>Jul 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11275359</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60159">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11275359</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60150">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Farkas</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Luiten</foaf:surname>
                        <foaf:givenname>P. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60151"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Basement Membrane</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Blood-Brain Barrier</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Capillaries</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebrovascular Circulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cholinergic Fibers</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Microcirculation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Cerebral microvascular pathology in aging and Alzheimer's disease</dc:title>
        <dcterms:abstract>The aging of the central nervous system and the development of incapacitating neurological diseases like Alzheimer's disease (AD) are generally associated with a wide range of histological and pathophysiological changes eventually leading to a compromised cognitive status. Although the diverse triggers of the neurodegenerative processes and their interactions are still the topic of extensive debate, the possible contribution of cerebrovascular deficiencies has been vigorously promoted in recent years. Various forms of cerebrovascular insufficiency such as reduced blood supply to the brain or disrupted microvascular integrity in cortical regions may occupy an initiating or intermediate position in the chain of events ending with cognitive failure. When, for example, vasoconstriction takes over a dominating role in the cerebral vessels, the perfusion rate of the brain can considerably decrease causing directly or through structural vascular damage a drop in cerebral glucose utilization. Consequently, cerebral metabolism can suffer a setback leading to neuronal damage and a concomitant suboptimal cognitive capacity. The present review focuses on the microvascular aspects of neurodegenerative processes in aging and AD with special attention to cerebral blood flow, neural metabolic changes and the abnormalities in microvascular ultrastructure. In this context, a few of the specific triggers leading to the prominent cerebrovascular pathology, as well as the potential neurological outcome of the compromised cerebral microvascular system are also going to be touched upon to a certain extent, without aiming at total comprehensiveness. Finally, a set of animal models are going to be presented that are frequently used to uncover the functional relationship between cerebrovascular factors and the damage to neural networks.</dcterms:abstract>
        <bib:pages>575-611</bib:pages>
        <dc:date>Aug 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11311463</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60151">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11311463</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60152">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Freitas da Rocha</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pereira</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bezerra Coutinho</foaf:surname>
                        <foaf:givenname>F. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60153"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebral Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Consciousness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Magnesium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Perception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pyramidal Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>N-methyl-D-aspartate channel and consciousness: from signal coincidence detection to quantum computing</dc:title>
        <dcterms:abstract>Research on Blindsight, Neglect/Extinction and Phantom limb syndromes, as well as electrical measurements of mammalian brain activity, have suggested the dependence of vivid perception on both incoming sensory information at primary sensory cortex and reentrant information from associative cortex. Coherence between incoming and reentrant signals seems to be a necessary condition for (conscious) perception. General reticular activating system and local electrical synchronization are some of the tools used by the brain to establish coarse coherence at the sensory cortex, upon which biochemical processes are coordinated. Besides electrical synchrony and chemical modulation at the synapse, a central mechanism supporting such a coherence is the N-methyl-D-aspartate channel, working as a 'coincidence detector' for an incoming signal causing the depolarization necessary to remove Mg(2+), and reentrant information releasing the glutamate that finally prompts Ca(2+) entry. We propose that a signal transduction pathway activated by Ca(2+) entry into cortical neurons is in charge of triggering a quantum computational process that accelerates inter-neuronal communication, thus solving systemic conflict and supporting the unity of consciousness.</dcterms:abstract>
        <bib:pages>555-573</bib:pages>
        <dc:date>Aug 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>N-methyl-D-aspartate channel and consciousness</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11311462</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60153">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11311462</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60154">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grassi</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pettorossi</foaf:surname>
                        <foaf:givenname>V. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60155"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Afferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Stem</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>nitric oxide</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Platelet Activating Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Metabotropic Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vestibular Nuclei</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices</dc:title>
        <dcterms:abstract>The analysis of cellular-molecular events mediating synaptic plasticity within vestibular nuclei is an attempt to explain the mechanisms underlying vestibular plasticity phenomena. The present review is meant to illustrate the main results, obtained in vitro, on the mechanisms underlying long-term changes in synaptic strength within the medial vestibular nuclei. The synaptic plasticity phenomena taking place at the level of vestibular nuclei could be useful for adapting and consolidating the efficacy of vestibular neuron responsiveness to environmental requirements, as during visuo-vestibular recalibration and vestibular compensation. Following a general introduction on the most salient features of vestibular compensation and visuo-vestibular adaptation, which are two plastic events involving neuronal circuitry within the medial vestibular nuclei, the second and third sections describe the results from rat brainstem slice studies, demonstrating the possibility to induce long-term potentiation and depression in the medial vestibular nuclei, following high frequency stimulation of the primary vestibular afferents. In particular the mechanisms sustaining the induction and expression of vestibular long-term potentiation and depression, such as the role of various glutamate receptors and retrograde messengers have been described. The relevant role of the interaction between the platelet-activating factor, acting as a retrograde messenger, and the presynaptic metabotropic glutamate receptors, in determining the full expression of vestibular long-term potentiation is also underlined. In addition, the mechanisms involved in vestibular long-term potentiation have been compared with those leading to long-term potentiation in the hippocampus to emphasize the most significant differences emerging from vestibular studies. The fourth part, describes recent results demonstrating the essential role of nitric oxide, another retrograde messenger, in the induction of vestibular potentiation. Finally the fifth part suggests the possible functional significance of different action times of the two retrograde messengers and metabotropic glutamate receptors, which are involved in mediating the presynaptic mechanism sustaining vestibular long-term potentiation.</dcterms:abstract>
        <bib:pages>527-553</bib:pages>
        <dc:date>Aug 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Synaptic plasticity in the medial vestibular nuclei</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11311461</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60155">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11311461</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60148">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Orendácová</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cízková</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kafka</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lukácová</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marsala</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sulla</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marsala</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Katsube</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60149"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cauda Equina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Compression Syndromes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Polyradiculopathy</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Cauda equina syndrome</dc:title>
        <dcterms:abstract>Single or double-level compression of the lumbosacral nerve roots located in the dural sac results in a polyradicular symptomatology clinically diagnosed as cauda equina syndrome. The cauda equina nerve roots provide the sensory and motor innervation of most of the lower extremities, the pelvic floor and the sphincters. Therefore, in a fully developed cauda equina syndrome, multiple signs of sensory disorders may appear. These disorders include low-back pain, saddle anesthesia, bilateral sciatica, then motor weakness of the lower extremities or chronic paraplegia and, bladder dysfunction. Multiple etiologies can cause the cauda equina syndrome. Among them, non-neoplastic compressive etiologies such as herniated lumbosacral discs and spinal stenosis and spinal neoplasms play a significant role in the development of the cauda equina syndrome. Non-compressive etiologies of the cauda equina syndrome include ischemic insults, inflammatory conditions, spinal arachnoiditis and other infectious etiologies. The use of canine, porcine and rat models mimicking the cauda equina syndrome enabled discovery of the effects of the compression on nerve root neural and vascular anatomy, the impairment of impulse propagation and the changes of the neurotransmitters in the spinal cord after compression of cauda equina. The involvement of intrinsic spinal cord neurons in the compression-induced cauda equina syndrome includes anterograde, retrograde and transneuronal degeneration in the lumbosacral segments. Prominent changes of NADPH diaphorase exhibiting, Fos-like immunoreactive and heat shock protein HSP72 were detected in the lumbosacral segments in a short-and long-lasting compression of the cauda equina in the dog. Developments in the diagnosis and treatment of patients with back pain, sciatica and with a herniated lumbar disc are mentioned, including many treatment options available.</dcterms:abstract>
        <bib:pages>613-637</bib:pages>
        <dc:date>Aug 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11311464</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60149">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11311464</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60156">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>64</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wicher</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Walther</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wicher</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60157"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Chloride Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cockroaches</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Drosophila</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Drosophila Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Enzyme Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Grasshoppers</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mechanoreceptors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Muscle, Skeletal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurons, Afferent</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Potassium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Shaker Superfamily of Potassium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sodium Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Non-synaptic ion channels in insects--basic properties of currents and their modulation in neurons and skeletal muscles</dc:title>
        <dcterms:abstract>Insects are favoured objects for studying information processing in restricted neuronal networks, e.g. motor pattern generation or sensory perception. The analysis of the underlying processes requires knowledge of the electrical properties of the cells involved. These properties are determined by the expression pattern of ionic channels and by the regulation of their function, e.g. by neuromodulators. We here review the presently available knowledge on insect non-synaptic ion channels and ionic currents in neurons and skeletal muscles. The first part of this article covers genetic and structural informations, the localization of channels, their electrophysiological and pharmacological properties, and known effects of second messengers and modulators such as neuropeptides or biogenic amines. In a second part we describe in detail modulation of ionic currents in three particularly well investigated preparations, i.e. Drosophila photoreceptor, cockroach DUM (dorsal unpaired median) neuron and locust jumping muscle. Ion channel structures are almost exclusively known for the fruitfly Drosophila, and most of the information on their function has also been obtained in this animal, mainly based on mutational analysis and investigation of heterologously expressed channels. Now the entire genome of Drosophila has been sequenced, it seems almost completely known which types of channel genes--and how many of them--exist in this animal. There is much knowledge of the various types of channels formed by 6-transmembrane--spanning segments (6TM channels) including those where four 6TM domains are joined within one large protein (e.g. classical Na+ channel). In comparison, two TM channels and 4TM (or tandem) channels so far have hardly been explored. There are, however, various well characterized ionic conductances, e.g. for Ca2+, Cl- or K+, in other insect preparations for which the channels are not yet known. In some of the larger insects, i.e. bee, cockroach, locust and moth, rather detailed information has been established on the role of ionic currents in certain physiological or behavioural contexts. On the whole, however, knowledge of non-synaptic ion channels in such insects is still fragmentary. Modulation of ion currents usually involves activation of more or less elaborate signal transduction cascades. The three detailed examples for modulation presented in the second part indicate, amongst other things, that one type of modulator usually leads to concerted changes of several ion currents and that the effects of different modulators in one type of cell may overlap. Modulators participate in the adaptive changes of the various cells responsible for different physiological or behavioural states. Further study of their effects on the single cell level should help to understand how small sets of cells cooperate in order to produce the appropriate output.</dcterms:abstract>
        <bib:pages>431-525</bib:pages>
        <dc:date>Aug 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11301158</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60157">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11301158</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60146">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Danbolt</foaf:surname>
                        <foaf:givenname>N. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60147"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Transport System X-AG</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Anesthetics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>ATP-Binding Cassette Transporters</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Bone and Bones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Carrier Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ethanol</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Extracellular Space</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hepatic Encephalopathy</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>HIV Infections</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Intracellular Fluid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Transport</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mammals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mercury Poisoning</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Monocarboxylic Acid Transporters</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Organ Specificity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Placenta</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>potassium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>pregnancy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Conformation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>sodium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Viscera</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Glutamate uptake</dc:title>
        <dcterms:abstract>Brain tissue has a remarkable ability to accumulate glutamate. This ability is due to glutamate transporter proteins present in the plasma membranes of both glial cells and neurons. The transporter proteins represent the only (significant) mechanism for removal of glutamate from the extracellular fluid and their importance for the long-term maintenance of low and non-toxic concentrations of glutamate is now well documented. In addition to this simple, but essential glutamate removal role, the glutamate transporters appear to have more sophisticated functions in the modulation of neurotransmission. They may modify the time course of synaptic events, the extent and pattern of activation and desensitization of receptors outside the synaptic cleft and at neighboring synapses (intersynaptic cross-talk). Further, the glutamate transporters provide glutamate for synthesis of e.g. GABA, glutathione and protein, and for energy production. They also play roles in peripheral organs and tissues (e.g. bone, heart, intestine, kidneys, pancreas and placenta). Glutamate uptake appears to be modulated on virtually all possible levels, i.e. DNA transcription, mRNA splicing and degradation, protein synthesis and targeting, and actual amino acid transport activity and associated ion channel activities. A variety of soluble compounds (e.g. glutamate, cytokines and growth factors) influence glutamate transporter expression and activities. Neither the normal functioning of glutamatergic synapses nor the pathogenesis of major neurological diseases (e.g. cerebral ischemia, hypoglycemia, amyotrophic lateral sclerosis, Alzheimer's disease, traumatic brain injury, epilepsy and schizophrenia) as well as non-neurological diseases (e.g. osteoporosis) can be properly understood unless more is learned about these transporter proteins. Like glutamate itself, glutamate transporters are somehow involved in almost all aspects of normal and abnormal brain activity.</dcterms:abstract>
        <bib:pages>1-105</bib:pages>
        <dc:date>Sep 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11369436</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60147">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11369436</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60142">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Blum</foaf:surname>
                        <foaf:givenname>D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Torch</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lambeng</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nissou</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Benabid</foaf:surname>
                        <foaf:givenname>A. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sadoul</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Verna</foaf:surname>
                        <foaf:givenname>J. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60143"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>MPTP Poisoning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oxidopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sympatholytics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease</dc:title>
        <dcterms:abstract>Parkinson's disease (PD) is a neurodegenerative disorder characterized by a preferential loss of the dopaminergic neurons of the substantia nigra pars compacta. Although the etiology of PD is unknown, major biochemical processes such as oxidative stress and mitochondrial inhibition are largely described. However, despite these findings, the actual therapeutics are essentially symptomatical and are not able to block the degenerative process. Recent histological studies performed on brains from PD patients suggest that nigral cell death could be apoptotic. However, since post-mortem studies do not allow precise determination of the sequence of events leading to this apoptotic cell death, the molecular pathways involved in this process have been essentially studied on experimental models reproducing the human disease. These latter are created by using neurotoxic compounds such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or dopamine (DA). Extensive study of these models have shown that they mimick, in vitro and in vivo, the histological and/or the biochemical characteristics of PD and thus help to define important cellular actors of cell death presumably critical for the nigral degeneration. This review reports recent data concerning the biochemical and molecular apoptotic mechanisms underlying the experimental models of PD and correlates them to the phenomena occurring in human disease.</dcterms:abstract>
        <bib:pages>135-172</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11403877</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60143">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11403877</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60144">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dunn</foaf:surname>
                        <foaf:givenname>P. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Zhong</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Burnstock</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60145"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Autonomic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Sensory</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Purinergic P2</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Purinergic P2X</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>P2X receptors in peripheral neurons</dc:title>
        <dcterms:abstract>P2X receptors are a family of ligand-gated ion channels, activated by extracellular ATP. The seven subunits cloned (P2X1-7) can assemble to form homomeric and heteromeric receptors. Peripheral neurons of neural crest origin (e.g. those in dorsal root, trigeminal, sympathetic and enteric ganglia) and placodal origin (e.g. those in nodose and petrosal ganglia) express mRNAs for multiple P2X subunits. In this review, we summarize the molecular biological, electrophysiological and immunohistochemical evidence for P2X receptor subunits in sensory, sympathetic, parasympathetic, pelvic and myenteric neurons and adrenomedullary chromaffin cells. We consider the pharmacological properties of these native P2X receptors and their physiological roles. The responses of peripheral neurons to ATP show considerable heterogeneity between cells in the same ganglia, between ganglia and between species. Nevertheless, these responses can all be accounted for by the presence of P2X2 and P2X3 subunits, giving rise to varying proportions of homomeric and heteromeric receptors. While dorsal root ganglion neurons express predominantly P2X3 and rat sympathetic neurons express mainly P2X2 receptors, nodose and guinea-pig sympathetic neurons express mixed populations of P2X2 and heteromeric P2X2/3 receptors. P2X receptors are important for synaptic transmission in enteric ganglia, although their roles in sympathetic and parasympathetic ganglia are less clear. Their presence on sensory neurons is essential for some processes including detection of filling of the urinary bladder. The regulation of P2X receptor expression in development and in pathological conditions, along with the interactions between purinergic and other signalling systems, may reveal further physiological roles for P2X receptors in autonomic and sensory ganglia.</dcterms:abstract>
        <bib:pages>107-134</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11403876</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60145">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11403876</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60138">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gottesmann</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60139"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dreams</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electroencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 18th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 19th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 20th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, Ancient</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurobiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep, REM</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The golden age of rapid eye movement sleep discoveries. 1. Lucretius--1964</dc:title>
        <dcterms:abstract>Although there were several premonitory signs of a sleep stage with dreaming, it was only in 1953 that such a stage was identified with certainty. This paper analyses the observations and research related to this dreaming stage (rapid eye movement sleep) until 1964. During these 11 years of research, the main psychological and physiological characteristics of this sleep stage were first described. Where the few results or discussions were later questioned, today's current state of knowledge is briefly outlined.</dcterms:abstract>
        <bib:pages>211-287</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11473789</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60139">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11473789</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60136">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grabowski</foaf:surname>
                        <foaf:givenname>P. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Black</foaf:surname>
                        <foaf:givenname>D. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60137"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alternative Splicing</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neoplasms</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neurotransmitter</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>RNA-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>RNA, Messenger</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spliceosomes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Alternative RNA splicing in the nervous system</dc:title>
        <dcterms:abstract>Tissue-specific alternative splicing profoundly effects animal physiology, development and disease, and this is nowhere more evident than in the nervous system. Alternative splicing is a versatile form of genetic control whereby a common pre-mRNA is processed into multiple mRNA isoforms differing in their precise combination of exon sequences. In the nervous system, thousands of alternatively spliced mRNAs are translated into their protein counterparts where specific isoforms play roles in learning and memory, neuronal cell recognition, neurotransmission, ion channel function, and receptor specificity. The essential nature of this process is underscored by the finding that its misregulation is a common characteristic of human disease. This review highlights the current views of the biological phenomenon of alternative splicing, and describes evidence for its intricate underlying biochemical mechanisms. The roles of RNA binding proteins and their tissue-specific properties are discussed. Why does alternative splicing occur in cosmic proportions in the nervous system? How does it affect integrated cellular functions? How are region-specific, cell-specific and developmental differences in splicing directed? How are the control mechanisms that operate in the nervous system distinct from those of other tissues? Although there are many unanswered questions, substantial progress has been made in showing that alternative splicing is of major importance in generating proteomic diversity, and in modulating protein activities in a temporal and spatial manner. The relevance of alternative splicing to diseases of the nervous system is also discussed.</dcterms:abstract>
        <bib:pages>289-308</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11473790</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60137">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11473790</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60134">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Meldolesi</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60135"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Clocks</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Signaling</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Endoplasmic Reticulum</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mitochondria</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Rapidly exchanging Ca2+ stores in neurons: molecular, structural and functional properties</dc:title>
        <bib:pages>309-338</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Rapidly exchanging Ca2+ stores in neurons</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11473791</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60135">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11473791</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60140">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tanaka</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60141"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acute Disease</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adenylate Cyclase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclic AMP-Dependent Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclic AMP Response Element-Binding Protein</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Second Messenger Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein</dc:title>
        <dcterms:abstract>A variety of neurotransmitters and other chemical substances are released into the extracellular space in the brain in response to acute ischemic stress, and the biological actions of these substances are exclusively mediated by receptor-linked second messenger systems. One of the well-known second messenger systems is adenylate cyclase, which catalyzes the generation of cyclic AMP, triggering the activation of cyclic AMP-dependent protein kinase (PKA). PKA controls a number of cellular functions by phosphorylating many substrates, including an important DNA-binding transcription factor, cyclic AMP response element binding protein (CREB). CREB has recently been shown to play an important role in many physiological and pathological conditions, including synaptic plasticity and neuroprotection against various insults, and to constitute a convergence point for many signaling cascades. The autoradiographic method developed in our laboratory enables us to simultaneously quantify alterations of the second messenger system and local cerebral blood flow (lCBF). Adenylate cyclase is diffusely activated in the initial phase of acute ischemia (&lt; or = 30 min), and its activity gradually decreases in the late phase of ischemia (2-6 h). The areas of reduced adenylate cyclase activity strictly coincide with infarct areas, which later become visible. The binding activity of PKA to cyclic AMP, which reflects the functional integrity of the enzyme, is rapidly suppressed during the initial phase of ischemia in the ischemic core, especially in vulnerable regions, such as the CA1 of the hippocampus, and it continues to decline. By contrast, PKA binding activity remains enhanced in the peri-ischemia area. These changes occur in a clearly lCBF-dependent manner. CREB phosphorylation at a serine residue, Ser(133), which suggests the activation of CREB-mediated transcription of genes containing a CRE motif in the nuclei, remains enhanced in the peri-ischemia area, which is spared of infarct damage. On the other hand, CREB phosphorylation at Ser133 rapidly diminishes in the ischemic core before the histological damage becomes manifest. The Ca2+ influx during membrane depolarization contributes to CREB phosphorylation in the initial phase of post-ischemic recirculation, while PKA activation and other signaling elements seem to be responsible in the later phase. These findings suggest that derangement of cyclic AMP-related intracellular signal transduction closely parallels ischemic neuronal damage and that persistent enhancement of this signaling pathway is important for neuronal survival in acute cerebral ischemia.</dcterms:abstract>
        <bib:pages>173-207</bib:pages>
        <dc:date>Oct 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11403878</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60141">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11403878</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60128">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Grimes</foaf:surname>
                        <foaf:givenname>C. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jope</foaf:surname>
                        <foaf:givenname>R. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60129"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Bipolar Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium-Calmodulin-Dependent Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Enzymologic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Glycogen Synthase Kinase 3</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Glycogen Synthase Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling</dc:title>
        <dcterms:abstract>Glycogen synthase kinase-3beta (GSK3beta) is a fascinating enzyme with an astoundingly diverse number of actions in intracellular signaling systems. GSK3beta activity is regulated by serine (inhibitory) and tyrosine (stimulatory) phosphorylation, by protein complex formation, and by its intracellular localization. GSK3beta phosphorylates and thereby regulates the functions of many metabolic, signaling, and structural proteins. Notable among the signaling proteins regulated by GSK3beta are the many transcription factors, including activator protein-1, cyclic AMP response element binding protein, heat shock factor-1, nuclear factor of activated T cells, Myc, beta-catenin, CCAAT/enhancer binding protein, and NFkappaB. Lithium, the primary therapeutic agent for bipolar mood disorder, is a selective inhibitor of GSK3beta. This raises the possibility that dysregulation of GSK3beta and its inhibition by lithium may contribute to the disorder and its treatment, respectively. GSK3beta has been linked to all of the primary abnormalities associated with Alzheimer's disease. These include interactions between GSK3beta and components of the plaque-producing amyloid system, the participation of GSK3beta in phosphorylating the microtubule-binding protein tau that may contribute to the formation of neurofibrillary tangles, and interactions of GSK3beta with presenilin and other Alzheimer's disease-associated proteins. GSK3beta also regulates cell survival, as it facilitates a variety of apoptotic mechanisms, and lithium provides protection from many insults. Thus, GSK3beta has a central role regulating neuronal plasticity, gene expression, and cell survival, and may be a key component of certain psychiatric and neurodegenerative diseases.</dcterms:abstract>
        <bib:pages>391-426</bib:pages>
        <dc:date>Nov 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11527574</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60129">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11527574</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60132">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kemp</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bashir</foaf:surname>
                        <foaf:givenname>Z. I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60133"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Long-term depression: a cascade of induction and expression mechanisms</dc:title>
        <dcterms:abstract>The aims of this paper are to provide a comprehensive and up to date review of the mechanisms of induction and expression of long-term depression (LTD) of synaptic transmission. The review will focus largely on homosynaptic LTD and other forms of LTD will be considered only where appropriate for a fuller understanding of LTD mechanisms. We shall concentrate on what are felt to be some of the most interesting recent findings concerning LTD in the central nervous system. Wherever possible we shall try to consider some of the disparities in results and possible reasons for these. Finally, we shall briefly consider some of the possible functional consequences of LTD for normal physiological function.</dcterms:abstract>
        <bib:pages>339-365</bib:pages>
        <dc:date>Nov 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Long-term depression</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11527572</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60133">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11527572</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60130">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Makara</foaf:surname>
                        <foaf:givenname>G. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Haller</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60131"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Genome</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glucocorticoids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glucocorticoid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Mineralocorticoid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications</dc:title>
        <dcterms:abstract>Complementing the classical concept of genomic steroid actions, here we (i) review evidence showing that important neural effects of glucocorticoids are exerted by non-genomic mechanisms; (ii) describe known mechanisms that may underlie such effects; (iii) summarize the functions and implications of non-genomic mechanisms and (iv) outline future directions of research. The role of non-genomic mechanisms is to shape the response of the organism to challenges that require a substantial reorganization of neural and somatic functions and involve massive behavioral shifts. Non-genomic effects may (i) prepare the cell for subsequent glucocorticoid-induced genomic changes, (ii) bridge the gap between the early need of change and the delay in the expression of genomic effects and (iii) may induce specific changes that in some instances are opposite to those induced by genomic mechanisms. The latter can be explained by the fact that challenging situations require different responses in early (acute) and later (chronic) phases. Data show that non-genomic mechanisms of glucocorticoid action play a role in both pathological phenomena and the expression of ameliorative pharmacological effects. Non-genomic mechanisms that underlie many glucocorticoid-induced neural changes constitute a for long overlooked controlling factor. Despite the multitude and the variety of accumulated data, important questions remain to be answered.</dcterms:abstract>
        <bib:pages>367-390</bib:pages>
        <dc:date>Nov 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11527573</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60131">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11527573</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60118">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bennett</foaf:surname>
                        <foaf:givenname>M. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hacker</foaf:surname>
                        <foaf:givenname>P. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60119"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Psychological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurosciences</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Perception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Perception and memory in neuroscience: a conceptual analysis</dc:title>
        <dcterms:abstract>Neuroscientists, in the last half of the 20th century, provided major insights into the cellular and molecular mechanisms associated with seeing and remembering. We first identify some of the most important of these discoveries. This is done along lines familiar to neuroscientists who have read many of the recent books and reviews that provide an overview of neuroscientific discoveries. In general, these emphasize the scientific contributions this discipline has made to our understanding of the mechanisms that give rise to the psychological attributes of humans and other animals. In the next sections, we examine the claims made in these overviews; in particular, those by the standard-bearers of neuroscience, in an attempt to clarify what can and what cannot be justified in these claims. This requires a conceptual analysis of a kind that is unfamiliar to most neuroscientists. Our analysis begins with consideration of the conceptual confusions that ensue when neuroscientists attribute seeing, remembering and other psychological attributes to the brain rather than to the creature whose brain it is. Subsequently, we outline what we take to be the appropriate conceptual scheme for neuroscientists to adopt.</dcterms:abstract>
        <bib:pages>499-543</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Perception and memory in neuroscience</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11728643</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60119">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11728643</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60124">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Klemm</foaf:surname>
                        <foaf:givenname>W. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60125"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Behavior</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Clocks</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Movement</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Posture</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Behavioral arrest: in search of the neural control system</dc:title>
        <dcterms:abstract>Scientists have spent hundreds of years trying to understand how the brain controls movement. Why has there been so little interest in knowing how the brain STOPS movement? This review calls attention to behavioral phenomena in which an animal or human undergoes temporary total-body arrest of movement, that is, behavioral arrest (BA). These states can be actively induced by visual stimuli, by body and limb manipulations, and by drugs. Historically, these states have been considered as unrelated, and their literature does not cross-connect. What is known about the causal mechanisms is scant, limited mostly to implication of the brainstem in manipulation-induced BA and dopaminergic blockade in the striatum in the case of drug-induced BA. The possibility has not been experimentally tested that all of these states share with each other not only an active global immobility in which awkward postures are maintained, but also underlying neural mechanisms. This review identifies key brainstem, diencephalic, and basal forebrain areas that seem to be involved in causing BA. We review the evidence that suggest a possible role in BA for the following brain structures: entopeduncular nucleus, medullary and pontine reticular zones, parabrachial region, pedunculopontine nucleus and nearby areas, substantia nigra, subthalamic nucleus, ventromedial thalamic nucleus, and zona incerta. Such areas may operate as a BA control system. Confirmation of which brain areas operate collectively in BA would require testing of several kinds of BA in the same animals with the same kinds of experimental tests. Areas and mechanisms might be elucidated through a strategic combination of the following research approaches: imaging (fMRI, c-fos), lesions (of areas, of afferent and efferent pathways), chemical microstimulation, and electrical recording (of multiple units and field potentials, with an emphasis on testing coherence among areas). We suggest the working hypothesis that BA is created and sustained by coherent, perhaps oscillatory, activity among a group of basal forebrain and brainstem areas that collectively disrupt the normal spinal and supraspinal sequencing controls of reciprocal actions on the extensors and flexors that otherwise produce movement.</dcterms:abstract>
        <bib:pages>453-471</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Behavioral arrest</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11689281</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60125">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11689281</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60116">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lestienne</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60117"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cortical Synchronization</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Evoked Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Processes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Perception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sensation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Spike timing, synchronization and information processing on the sensory side of the central nervous system</dc:title>
        <dcterms:abstract>To what extent is the variability of the neuronal responses compatible with the use of spike timing for sensory information processing by the central nervous system? In reviewing the state of the art of this question, I first analyze the characteristics of this variability with its three elements: synaptic noise, impact of ongoing activity and possible fluctuations in evoked responses. I then review the recent literature on the various sensory modalities: somato-sensory, olfactory, gustatory and visual and auditory processing. I emphasize that the conditions in which precise timing, at the millisecond level, is usually obtained, are conditions that usually require dynamic stimulation or sharp changes in the stimuli. By contrast, situations in which stimulation not belonging to the temporal domain is temporally encoded lead to much coarser temporal coding; although in both cases, neural networks transmit the signals with similarly high precision. Synchronization among neurons is an important tool in information processing in both cases but again seems to act either at millisecond or tens of millisecond levels. Information theory applied to both situations confirms that the average rate of information transmission is much higher in dynamic than in static situations. These facts suggest that channels of precise temporal encoding may exist in the brain but imply populations of neurons working in a yet to be discovered way.</dcterms:abstract>
        <bib:pages>545-591</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11728644</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60117">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11728644</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60122">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakamura</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60123"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Body Patterning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Superior Colliculi</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Regionalisation and acquisition of polarity in the optic tectum</dc:title>
        <dcterms:abstract>The optic tectum differentiates from the alar plate of the mesencephalon and receives retinal fibres in a precise retinotopic manner. Here, mechanisms of tectum polarisation and regionalisation are reviewed. Misexpression of Pax2, Pax5 or En can change the fate of the presumptive diencephalon to that of the tectum. Ephrin A2 and A5 are expressed in a gradient in the tectum, caudal high and rostral low, and may play important roles in the formation of a precise retinotectal projection map. Retinal fibres that express receptors for these ligands, and which come from the temporal retina, are repulsed by the ligands and do not invade the caudal tectum. Both En1 and En2 can regulate posterior characteristics in the tectum by inducing ephrin A2 and A5. Transplantation experiments in chick have indicated that the mes/metencephalic boundary works as an organiser for the tectum and the cerebellum. Fgf8 is a candidate signalling molecule in the organiser. Pax2/5, En, and Fgf8 are in a positive feedback loop for their expression such that misexpression of one of these genes in the diencephalon turns on the feedback loop and can result in induction of an optic tectum. Otx2 and Gbx2 appear to repress each other's expression and contribute to defining the posterior border of the tectum. Misexpression of Otx2 in the metencephalon can change the fate of its alar plate to a tectum, and misexpression of Gbx2 in the mesencephalon can cause anterior shifting of the caudal limit of the tectum. The anterior border of the tectum may be determined as a result of repressive interactions between Pax6 and En1/Pax2. Along the dorsoventral axis of the mesencephalon, Shh contributes to ventralize the tissue; that is, Shh can change the fate of the presumptive tectum to that of the tegmentum that is the ventral structure. It is proposed that the brain vesicle that expresses Otx2, Pax2, and En1 may differentiate into the tectum.</dcterms:abstract>
        <bib:pages>473-488</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11689282</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60123">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11689282</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60120">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schwartz</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60121"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Autoimmune Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Spinal Cord Injuries</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>T-Lymphocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Trauma, Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vaccines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines</dc:title>
        <dcterms:abstract>Immune activity in general, and autoimmunity in particular, have long been considered as harmful in the context of central nervous system (CNS) trauma. Increasing evidence suggests, however, that the injured CNS can benefit from autoimmune manipulations. Active or passive immunization with CNS-associated self antigens was shown to promote recovery from a CNS insult. It is now also evident that this beneficial 'autoimmunity' is not solely an outcome of immune manipulation but is also a physiological response, evoked by a non-pathogenic insult and apparently designed to counteract the insult-related toxicity which is induced in part by essential physiological compounds present in excess of their normal levels. It appears that when the buffering capacity of constitutive local mechanisms (transporters, enzymes, etc.) that normally regulate these compounds is exceeded, assistance is recruited from the immune system. Like the overactive physiological compounds themselves, the immune system needs to be rigorously regulated in order to produce adequate phagocytic activity and the required quantity of cytokines and growth factors at the right time and place. Boosting of this autoimmune response is potentially a powerful strategy for neuroprotective therapy.</dcterms:abstract>
        <bib:pages>489-496</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Protective autoimmunity as a T-cell response to central nervous system trauma</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11689283</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60121">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11689283</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60114">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Skaper</foaf:surname>
                        <foaf:givenname>S. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Moore</foaf:surname>
                        <foaf:givenname>S. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Walsh</foaf:surname>
                        <foaf:givenname>F. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60115"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Adhesion Molecules</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Growth Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Cell signalling cascades regulating neuronal growth-promoting and inhibitory cues</dc:title>
        <dcterms:abstract>During development of the nervous system, neurons extend axons over considerable distances in a highly stereospecific fashion in order to innervate their targets in an appropriate manner. This involves the recognition, by the axonal growth cone, of guidance cues that determine the pathway taken by the axons. These guidance cues can act to promote and/or repel growth cone advance, and they can act either locally or at a distance from their place of synthesis. The directed growth of axons is partly governed by cell adhesion molecules (CAMs) on the neuronal growth cone that bind to CAMs on the surface of other axons or non-neuronal cells. In vitro assays have established the importance of the CAMs (N-CAM, N-cadherin and the L1 glycoprotein) in promoting axonal growth over cells, such as Schwann cells, astrocytes and muscle cells. Strong evidence now exists implicating the fibroblast growth factor receptor tyrosine kinase as the primary signal transduction molecule in the CAM pathway. Cell adhesion molecules are important constituents of synapses, and CAMs appear to play important and diverse roles in regulating synaptic plasticity associated with learning and memory. Negative extracellular signals which physically direct neurite growth have also been described. The latter include the neuronal growth inhibitory proteins Nogo and myelin-associated glycoprotein, as well as the growth cone collapsing Semaphorins/neuropilins. Although less well characterised, evidence is now beginning to emerge describing a role for Rho kinase-mediated signalling in inhibition of neurite outgrowth. This review focuses on some of the major themes and ideas associated with this fast-moving field of neuroscience.</dcterms:abstract>
        <bib:pages>593-608</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11728645</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60115">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11728645</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60126">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>65</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Weinstock</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60127"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Child</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Child Behavior</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Developmental Disabilities</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>pregnancy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Prenatal Exposure Delayed Effects</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Stress, Psychological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Alterations induced by gestational stress in brain morphology and behaviour of the offspring</dc:title>
        <dcterms:abstract>Retrospective studies in humans suggest that chronic maternal stress during pregnancy, associated with raised plasma levels of CRH, ACTH and cortisol may increase the likelihood of preterm birth, developmental delays and behavioural abnormalities in the children. In adulthood, it may contribute to the significant association between the incidence of schizophrenia, increased left or mixed handedness, reduction in cerebral asymmetry and anomalies in brain morphology. Our studies and others have shown that prenatal stress in rats can mimic these developmental and behavioural alterations. These rats show a reduced propensity for social interaction, increased anxiety in intimidating or novel situations and a reduction in cerebral asymmetry and dopamine turnover, consistent with those in schizophrenic humans. Prenatally-stressed (PS) rats also show behaviour consistent with depression, including a phase-shift in their circadian rhythm for corticosterone, sleep abnormalities, a hedonic deficit and greater acquisition of learned helplessness under appropriate conditions. These behavioural abnormalities are associated with impaired regulation of the hypothalamic-pituitary-adrenal axis response to stress and increased CRH activity. PS males may show demasculinisation and feminisation of their sexual behaviour. The developmental and behavioural abnormalities in PS offspring could occur through sensitisation of the foetal brain by maternal stress hormones to the action of glucocorticoid and CRH and to neurotransmitters affected by them. This may have long-lasting consequences and could explain the precipitation of depressive symptoms or schizophrenia by psychosocial stress in later life. The character of the behavioural abnormalities probably depends on the timing of the maternal stress in relation to development of the particular neuronal systems.</dcterms:abstract>
        <bib:pages>427-451</bib:pages>
        <dc:date>Dec 2001</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11689280</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60127">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11689280</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60110">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lazarov</foaf:surname>
                        <foaf:givenname>Nikolai E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60111"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antigens, Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mammals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurons, Afferent</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cell Surface</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Second Messenger Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Trigeminal Ganglion</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Trigeminal Nuclei</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus</dc:title>
        <dcterms:abstract>A characteristic peculiarity of the trigeminal sensory system is the presence of two distinct populations of primary afferent neurons. Most of their cell bodies are located in the trigeminal ganglion (TG) but part of them lie in the mesencephalic trigeminal nucleus (MTN). This review compares the neurochemical content of central versus peripheral trigeminal primary afferent neurons. In the TG, two subpopulations of primary sensory neurons, containing immunoreactive (IR) material, are identified: a number of glutamate (Glu)-, substance P (SP)-, neurokinin A (NKA)-, calcitonin gene-related peptide (CGRP)-, cholecystokinin (CCK)-, somatostatin (SOM)-, vasoactive intestinal polypeptide (VIP)- and galanin (GAL)-IR ganglion cells with small and medium-sized somata, and relatively less numerous larger-sized neuropeptide Y (NPY)- and peptide 19 (PEP 19)-IR trigeminal neurons. In addition, many nitric oxide synthase (NOS)- and parvalbumin (PV)-IR cells of all sizes as well as fewer, mostly large, calbindin D-28k (CB)-containing neurons are seen. The majority of the large ganglion cells are surrounded by SP-, CGRP-, SOM-, CCK-, VIP-, NOS- and serotonin (SER)-IR perisomatic networks. In the MTN, the main subpopulation of large-sized neurons display Glu-immunoreactivity. Additionally, numerous large MTN neurons exhibit PV- and CB-immunostaining. On the other hand, certain small MTN neurons, most likely interneurons, are found to be GABAergic. Furthermore, NOS-containing neurons can be detected in the caudal and the mesencephalic-pontine junction portions of the nucleus. Conversely, no immunoreactivity to any of the examined neuropeptides is observed in the cell bodies of MTN neurons but these are encircled by peptidergic, catecholaminergic, serotonergic and nitrergic perineuronal arborizations in a basket-like manner. Such a discrepancy in the neurochemical features suggests that the differently fated embryonic migration, synaptogenesis, and peripheral and central target field innervation can possibly affect the individual neurochemical phenotypes of trigeminal primary afferent neurons.</dcterms:abstract>
        <bib:pages>19-59</bib:pages>
        <dc:date>Jan 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11897404</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60111">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11897404</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60112">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sommer</foaf:surname>
                        <foaf:givenname>Lukas</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rao</foaf:surname>
                        <foaf:givenname>Mahendra</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60113"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Count</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Division</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stem Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neural stem cells and regulation of cell number</dc:title>
        <dcterms:abstract>Normal CNS development involves the sequential differentiation of multipotent stem cells. Alteration of the numbers of stem cells, their self-renewal ability, or their proliferative capacity will have major effects on the appropriate development of the nervous system. In this review, we discuss different mechanisms that regulate neural stem cell differentiation. Proliferation signals and cell cycle regulators may regulate cell kinetics or total number of cell divisions. Loss of trophic support and cytokine receptor activation may differentially contribute to the induction of cell death at specific stages of development. Signaling from differentiated progeny or asymmetric distribution of specific molecules may alter the self-renewal characteristics of stem cells. We conclude that the final decision of a cell to self-renew, differentiate or remain quiescent is dependent on an integration of multiple signaling pathways and at each instant will depend on cell density, metabolic state, ligand availability, type and levels of receptor expression, and downstream cross-talk between distinct signaling pathways.</dcterms:abstract>
        <bib:pages>1-18</bib:pages>
        <dc:date>Jan 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11897403</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60113">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11897403</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60102">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bigiani</foaf:surname>
                        <foaf:givenname>Albertino</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60103"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Chemoreceptor Cells</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Transport</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Necturus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurons, Afferent</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cell Surface</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taste</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Taste Buds</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Electrophysiology of Necturus taste cells</dc:title>
        <dcterms:abstract>Taste buds are sensory end organs that detect chemical substances occurring in foodstuffs and relay the relative information to the brain. The mechanisms by which the chemical stimuli are converted into biological signals represent a central issue in taste research. Our understanding of how taste buds accomplish this operation relies on the detailed knowledge of the biological properties of taste bud cells-the taste cells-and of the functional processes occurring in these cells during chemostimulation. The amphibian Necturus maculosus (mudpuppy) has proven to be a very useful model for studying basic cellular processes of vertebrate taste reception, some of which are still awaiting to be explored in mammals. The main advantages offered by Necturus are the large size of its taste cells and the relative accessibility of its taste buds, which can therefore be handled easily for experimental manipulations. In this review, I summarize the functional properties of Necturus taste cells studied with electrophysiological techniques (intracellular recordings and patch-clamp recordings). My focus is on ion channels in taste cells and on their role in signal transduction, as well as on the functional relationships among the cells inside Necturus taste buds. This information has revealed to be well suited to outline some of the general physiological processes occurring during taste reception in vertebrates, including mammals, and may represent a useful framework for understanding how taste buds work.</dcterms:abstract>
        <bib:pages>123-159</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11943449</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60103">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11943449</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60108">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Claing</foaf:surname>
                        <foaf:givenname>Audrey</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Laporte</foaf:surname>
                        <foaf:givenname>Stéphane A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Caron</foaf:surname>
                        <foaf:givenname>Marc G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lefkowitz</foaf:surname>
                        <foaf:givenname>Robert J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60109"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Arrestins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Endocytosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GTP-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor Protein-Tyrosine Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cell Surface</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins</dc:title>
        <dcterms:abstract>Sequestration of G protein-coupled receptors from the cell surface is a commonly observed phenomenon following agonist-stimulation. This process is now believed to be important for receptor resensitization as well as for signal transduction. Over the years, numerous studies have aimed at understanding the molecular mechanisms underlying internalization. Proteins such as the G protein-coupled receptor kinases (GRKs) and the beta-arrestins, which were initially characterized as desensitizing molecules, have been shown to be important regulators of the endocytic process. Recently, numerous interacting partners have been identified for each of these two classes of proteins. However, the details regarding the sequence of these interactions and the cross-talk between signaling pathways containing the different protein complexes are just beginning to be uncovered. In this review, we summarize these findings and discuss the role of GRKs and beta-arrestins, two families of key regulatory proteins that regulate G protein-coupled receptor endocytosis.</dcterms:abstract>
        <bib:pages>61-79</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Endocytosis of G protein-coupled receptors</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11900882</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60109">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11900882</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60106">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lima</foaf:surname>
                        <foaf:givenname>Deolinda</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Almeida</foaf:surname>
                        <foaf:givenname>Armando</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60107"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Medulla Oblongata</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nociceptors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain Management</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pain Measurement</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system</dc:title>
        <dcterms:abstract>The endogenous pain control system has long been considered as engaged in pain depression through the commitment of multiple descending actions that reduce the response capacity of spinal dorsal horn nociceptive neurones. Such a pure inhibitory antinociceptive nature was lately questioned by the observation of pronociceptive effects from areas classically regarded as antinociceptive. The thereby raised hypothesis of a more versatile functional arrangement that dynamically adjusts the pain modulatory effect to multiple conditions by balancing several excitatory and inhibitory actions found strong support on the recent discovery of a medullary area particularly dedicated to pain facilitation. Lesioning the medullary dorsal reticular nucleus (DRt) depresses nociceptive responses to acute and inflammatory pain, whereas stimulation produces the inverse effect. The decrease in formalin-induced pain behaviour following DRt lesioning is accompanied by a decrease of spinal noxious-evoked c-fos neuronal activation. DRt blocking by lidocaine results in a decrease of the nociceptive activity of spinal dorsal horn neurones, whereas stimulation by glutamate has the opposite effect. A reciprocal disynaptic putative excitatory circuit that links the DRt and the spinal dorsal horn and conveys nociceptive input through the ascending branch was described, indicating that the DRt pain facilitating action is mediated by a reverberating spino-DRt circuit that promotes the enhancement of the response capacity of spinal neurones to noxious stimulation.The demonstration of a primary pronociceptive centre in the endogenous pain control system brings new important data to the emerging concept of pain modulation as a dynamic and flexible process that integrates nociceptive processing by balancing multiple excitatory and inhibitory actions as the way of adapting to the various unsteady pain determinants.</dcterms:abstract>
        <bib:pages>81-108</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11900883</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60107">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11900883</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60100">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Merighi</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60101"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Afferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Biogenic Amines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain-Derived Neurotrophic Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Compartmentation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Intercellular Junctions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mammals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neuropeptide</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Subcellular Fractions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Costorage and coexistence of neuropeptides in the mammalian CNS</dc:title>
        <dcterms:abstract>The term neuropeptides commonly refers to a relatively large number of biologically active molecules that have been localized to discrete cell populations of central and peripheral neurons. I review here the most important histological and functional findings on neuropeptide distribution in the central nervous system (CNS), in relation to their role in the exchange of information between the nerve cells. Under this perspective, peptide costorage (presence of two or more peptides within the same subcellular compartment) and coexistence (concurrent presence of peptides and other messenger molecules within single nerve cells) are discussed in detail. In particular, the subcellular site(s) of storage and sorting mechanisms within neurons are thoroughly examined in the view of the mode of release and action of neuropeptides as neuronal messengers. Moreover, the relationship of neuropeptides and other molecules implicated in neural transmission is discussed in functional terms, also referring to the interactions with novel unconventional transmitters and trophic factors. Finally, a brief account is given on the presence of neuropeptides in glial cells.</dcterms:abstract>
        <bib:pages>161-190</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11943450</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60101">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11943450</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60104">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rijntjes</foaf:surname>
                        <foaf:givenname>Michel</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Weiller</foaf:surname>
                        <foaf:givenname>Cornelius</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60105"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetic Resonance Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Skills</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Speech</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stroke</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Recovery of motor and language abilities after stroke: the contribution of functional imaging</dc:title>
        <dcterms:abstract>In recent years, functional imaging techniques, like functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and transcranial magnetic stimulation (TMS), have shown that the improvement of motor and language function after ischemic stroke is accompanied by extensive reorganizational changes in the human cortex. To better understand these changes and to judge to what extent they could be responsible for clinical improvement, some basic principles of the organization of the motor and language system are discussed.Non-invasive functional imaging can have only a limited contribution in determining which of the possible underlying neural mechanisms, as they are known from animal experiments, play a role in functional recovery. However, they make it possible to define the functional consequences of anatomical lesions in individual patients and to correlate these functional consequences in the motor and language system with the clinical deficit. They can be used to assess the influence on the cortical reorganization of established and newer physiotherapies, logopedics and medical intervention, and they could be a useful tool in determining prognosis.</dcterms:abstract>
        <bib:pages>109-122</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Recovery of motor and language abilities after stroke</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11900884</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60105">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11900884</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60098">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Torreilles</foaf:surname>
                        <foaf:givenname>François</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Touchon</foaf:surname>
                        <foaf:givenname>Jacques</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60099"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid beta-Peptides</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Arginine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Biopterin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebrospinal Fluid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebrospinal Fluid Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Inflammation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Isoenzymes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurofibrillary Tangles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nitric Oxide Synthase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>oxidative stress</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peroxynitrous Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>phosphorylation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Processing, Post-Translational</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>tau Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease</dc:title>
        <dcterms:abstract>Alzheimer's disease (AD) is an age-dependent dementia characterized by progressive loss of cognitive functions and by characteristic pathological changes in the brain: the formation of aggregates extracellularly by beta-amyloid (Abeta) peptide and intracellularly by tau proteins. The disease presents several major diagnostic difficulties: (1) AD develops slowly; (2) analysis of damaged brain tissues is difficult, requiring a biopsy which poses ethical problems; (3) no biochemical markers are available for the diagnosis and monitoring of the disease progression. Since the cerebrospinal fluid (CSF) is in contact with the extracellular space of the brain, many studies have tried to correlate the levels of the intrathecal peptides and amino acids and the development of dementia. The present review analyzes the main results of intrathecal content analyses in light of pathogenic theories proposed to explain the damage associated with AD and observed in the brain of patients by postmortem examination.</dcterms:abstract>
        <bib:pages>191-203</bib:pages>
        <dc:date>Feb 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11943451</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60099">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11943451</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60092">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Boraud</foaf:surname>
                        <foaf:givenname>Thomas</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bezard</foaf:surname>
                        <foaf:givenname>Erwan</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bioulac</foaf:surname>
                        <foaf:givenname>Bernard</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gross</foaf:surname>
                        <foaf:givenname>Christian E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60093"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Extracellular Space</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinsonian Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control</dc:title>
        <dcterms:abstract>Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects the whole basal ganglia (BG). Various techniques have been used to study BG physiology and pathophysiology. Among these, extracellular single unit recording remains of particular importance. An impressive number of studies of BG electrophysiological activity have been carried out, both in non-human and in human primates, but the data collected show many omissions and disparities. BG activity has been well defined in the physiological situation, but remains far from clear in the Parkinsonian and virtually unexplored in the dopamine (DA)-replacement situation. This paper provides a brief synopsis of (i) recording techniques and (ii) BG electrophysiological activity in normal, Parkinsonian, and dopamine-replacement situations. We have restricted the data used to those obtained in BG structures of human and non-human primates. Only single unit recordings have been reported and four electrophysiological characteristics retained: mean firing frequency, firing pattern, periodic oscillation, and response to both passive and active movement. We have attempted to summarize (i) the commonly accepted characteristics of each BG structure in the three situations, (ii) discrepancies that exist, and (iii) missing elements. Then, the main successive theories aimed to explain the role played by BG in motor control are presented and discussed in the light of the most recently obtained results using the latest technological advances.</dcterms:abstract>
        <bib:pages>265-283</bib:pages>
        <dc:date>Mar 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11960681</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60093">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11960681</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60096">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Isa</foaf:surname>
                        <foaf:givenname>Tadashi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sasaki</foaf:surname>
                        <foaf:givenname>Shigeto</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60097"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Stem</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Head Movements</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Orientation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Brainstem control of head movements during orienting; organization of the premotor circuits</dc:title>
        <dcterms:abstract>When an object appears in the visual field, animals orient their head, eyes, and body toward it in a well-coordinated manner (orienting movement). The head movement is a major portion of the orienting movement. Interest in the neural control of head movements in the monkey and human have increased in the 1990's, however, fundamental knowledge about the neural circuits controlling the orienting head movement continues to be based on a large number of experimental studies performed in the cat. Thus, it is crucial now to summarize information that has been clarified in the cat for further advancement in understanding the neural control of head movements in different animal species. The superior colliculus (SC) has been identified as the primary brainstem center controlling the orienting. Its output signal is transmitted to neck motoneurons via two major separate pathways: one through the reticulospinal neurons (RSNs) in the pons and medulla and the other through neurons in Forel's field H (FFH) in the mesodiencephalic junction. The tecto-reticulo-spinal pathway controls orienting chiefly in the horizontal direction, while the tecto-FFH-spinal pathway controls orienting in the vertical direction. In each pathway, a subgroup of neurons functions as premotor neurons for both extraocular and neck motoneurons, while others are specified for each, which allows both coordinated and separate control of eye and head movements. Head movements almost always produce shifts in the center of gravity that might cause postural disturbances. The postural equilibrium may be maintained by transmitting the orienting command to the limb segments via descending axons of the reticulospinal and long propriospinal neurons. The SC and brainstem relay neurons receive descending inputs from higher order structures such as the cerebral cortex, cerebellum, and basal ganglia. These inputs may serve context-dependent control of orienting by modulating the activities of the primary brainstem pathways.</dcterms:abstract>
        <bib:pages>205-241</bib:pages>
        <dc:date>Mar 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11960679</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60097">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11960679</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60094">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Zitt</foaf:surname>
                        <foaf:givenname>Christof</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Halaszovich</foaf:surname>
                        <foaf:givenname>Christian R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lückhoff</foaf:surname>
                        <foaf:givenname>Andreas</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60095"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ion Channel Gating</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>TRPC Cation Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The TRP family of cation channels: probing and advancing the concepts on receptor-activated calcium entry</dc:title>
        <dcterms:abstract>Stimulation of membrane receptors linked to a phospholipase C and the subsequent production of the second messengers diacylglycerol and inositol-1,4,5-trisphosphate (InsP(3)) is a signaling pathway of fundamental importance in eukaryotic cells. Signaling downstream of these initial steps involves mobilization of Ca(2+) from intracellular stores and Ca(2+) influx through the plasma membrane. For this influx, several contrasting mechanisms may be responsible but particular relevance is attributed to the induction of Ca(2+) influx as consequence of depletion of intracellular calcium stores. This phenomenon (frequently named store-operated calcium entry, SOCE), in turn, may be brought about by various signals, including soluble cytosolic factors, interaction of proteins of the endoplasmic reticulum with ion channels in the plasma membrane, and a secretion-like coupling involving translocation of channels to the plasma membrane. Experimental approaches to analyze these mechanisms have been considerably advanced by the discovery of mammalian homologs of the Drosophila cation channel transient receptor potential (TRP). Some members of the TRP family can be expressed to Ca(2+)-permeable channels that enable SOCE; other members form channels activated independently of stores. TRP proteins may be an essential part of endogenous Ca(2+) entry channels but so far expression of most TRP cDNAs has not resulted in restitution of channels found in any mammalian cells, suggesting the requirement for further unknown subunits. A major exception is CaT1, a TRP channel demonstrated to provide Ca(2+)-selective, store-operated currents identical to those characterized in several cell types. Ongoing and future research on TRP channels will be crucial to understand the molecular basis of receptor-mediated Ca(2+) entry, with respect to the structure of the entry channels as well as to the mechanisms of its activation and regulation.</dcterms:abstract>
        <bib:pages>243-264</bib:pages>
        <dc:date>Mar 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The TRP family of cation channels</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 11960680</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60095">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/11960680</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60090">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kieffer</foaf:surname>
                        <foaf:givenname>Brigitte L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gavériaux-Ruff</foaf:surname>
                        <foaf:givenname>Claire</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60091"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mice, Knockout</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Opioid Peptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Opioid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Exploring the opioid system by gene knockout</dc:title>
        <dcterms:abstract>The endogenous opioid system consists of three opioid peptide precursor genes encoding enkephalins (preproenkephalin, Penk), dynorphins (preprodynorphin, Pdyn) and beta-endorphin (betaend), proopiomelanocortin (POMC) and three receptor genes encoding mu-opiod receptor (MOR), delta-opiod receptor (DOR) and kappa-opiod receptor (KOR). In the past years, all six genes have been inactivated in mice by homologous recombination. The analysis of spontaneous behavior in mutant mice has demonstrated significant and distinct roles of each gene in modulating locomotion, pain perception and emotional behaviors. The observation of opposing phenotypes of MOR- and DOR-deficient mice in several behaviors highlights unexpected roles for DOR to be further explored genetically and using more specific delta compounds. The analysis of responses of mutant mice to exogenous opiates has definitely clarified the essential role of MOR in both morphine analgesia and addiction, and demonstrated that DOR and KOR remain promising targets for pain treatment. These studies also show that prototypic DOR agonists partially require MOR for their biological activity and provide some support for the postulated mu-delta interactions in vivo. Finally, data confirm and define a role for several genes of the opioid system in responses to other drugs of abuse, and the triple opioid receptor knockout mutant allows exploring non-classical opioid pharmacology. In summary, the study of null mutant mice has extended our previous knowledge of the opioid system by identifying the molecular players in opioid pharmacology and physiology. Future studies should involve parallel behavioral analysis of mice lacking receptors and peptides and will benefit from more sophisticated gene targeting approaches, including site-directed and anatomically-restricted mutations.</dcterms:abstract>
        <bib:pages>285-306</bib:pages>
        <dc:date>Apr 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12015197</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60091">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12015197</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60084">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Millan</foaf:surname>
                        <foaf:givenname>Mark J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60085"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Analgesics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Posterior Horn Cells</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Serotonin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sympathetic Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Descending control of pain</dc:title>
        <dcterms:abstract>Upon receipt in the dorsal horn (DH) of the spinal cord, nociceptive (pain-signalling) information from the viscera, skin and other organs is subject to extensive processing by a diversity of mechanisms, certain of which enhance, and certain of which inhibit, its transfer to higher centres. In this regard, a network of descending pathways projecting from cerebral structures to the DH plays a complex and crucial role. Specific centrifugal pathways either suppress (descending inhibition) or potentiate (descending facilitation) passage of nociceptive messages to the brain. Engagement of descending inhibition by the opioid analgesic, morphine, fulfils an important role in its pain-relieving properties, while induction of analgesia by the adrenergic agonist, clonidine, reflects actions at alpha(2)-adrenoceptors (alpha(2)-ARs) in the DH normally recruited by descending pathways. However, opioids and adrenergic agents exploit but a tiny fraction of the vast panoply of mechanisms now known to be involved in the induction and/or expression of descending controls. For example, no drug interfering with descending facilitation is currently available for clinical use. The present review focuses on: (1) the organisation of descending pathways and their pathophysiological significance; (2) the role of individual transmitters and specific receptor types in the modulation and expression of mechanisms of descending inhibition and facilitation and (3) the advantages and limitations of established and innovative analgesic strategies which act by manipulation of descending controls. Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain.</dcterms:abstract>
        <bib:pages>355-474</bib:pages>
        <dc:date>Apr 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12034378</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60085">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12034378</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60088">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Onaivi</foaf:surname>
                        <foaf:givenname>Emmanuel S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Leonard</foaf:surname>
                        <foaf:givenname>Claire M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ishiguro</foaf:surname>
                        <foaf:givenname>Hiroki</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Zhang</foaf:surname>
                        <foaf:givenname>Ping Wu</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lin</foaf:surname>
                        <foaf:givenname>Zhicheng</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Akinshola</foaf:surname>
                        <foaf:givenname>Babatunde E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Uhl</foaf:surname>
                        <foaf:givenname>George R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60089"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cannabinoid Receptor Modulators</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cannabinoids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Endocannabinoids</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Cannabinoid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, Drug</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Endocannabinoids and cannabinoid receptor genetics</dc:title>
        <dcterms:abstract>This review presents the remarkable advances that have been achieved in marijuana (cannabinoid) research, with the discovery of specific receptors and the existence of naturally occurring cannabis-like substances in the human body and brain. The last decade has seen more rapid progress in marijuana research than any time in the thousands of years that marijuana has been used by humans, particularly in cannabinoid genomics. The cDNA and genomic sequences encoding G protein-coupled cannabinoid receptors (Cnrs) from several species have now been cloned. Endogenous cannabinoids (endocannabinoids), synthetic and hydrolyzing enzymes and transporters that define neurochemically-specific cannabinoid brain pathways have been identified. Endocannabinoid lipid signaling molecules alter activity at G protein-coupled receptors (GPCR) and possibly at anandamide-gated ion channels, such as vanilloid receptors. Availability of increasingly-specific CB1 and CB2 Cnr antagonists and of CB1 and CB2 Cnr knockout mice have increased our understanding of these cannabinoid systems and provides tantalizing evidence for even more G protein-coupled Cnrs. Initial studies of the Cnr gene structure, regulation and polymorphisms whet our appetite for more information about these interesting genes, their variants and roles in vulnerabilities to addictions and other neuropsychiatric disorders. Behavioral studies of cannabinoids document the complex interactions between rewarding and aversive effects of these drugs. Pursuing cannabinoid-related molecular, pharmacological and behavioral leads will add greatly to our understanding of endogenous brain neuromodulator systems, abused substances and potential therapeutics. This review of CB1 and CB2 Cnr genes in human and animal brain and their neurobiological effects provide a basis for many of these studies. Therefore, understanding the physiological cannabinoid control system in the human body and brain will contribute to elucidating this natural regulatory mechanism in health and disease.</dcterms:abstract>
        <bib:pages>307-344</bib:pages>
        <dc:date>Apr 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12015198</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60089">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12015198</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60086">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>66</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sah</foaf:surname>
                        <foaf:givenname>Pankaj</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Faber</foaf:surname>
                        <foaf:givenname>E. S. Louise</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60087"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Potassium Channels, Calcium-Activated</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Channels underlying neuronal calcium-activated potassium currents</dc:title>
        <dcterms:abstract>In many cell types rises in cytosolic calcium, either due to influx from the extracellular space, or by release from an intracellular store activates calcium dependent potassium currents on the plasmalemma. In neurons, these currents are largely activated following calcium influx via voltage gated calcium channels active during the action potentials. Three types of these currents are known: I(c), I(AHP) and I(sAHP). These currents can be distinguished by clear differences in their pharmacology and kinetics. Activation of these potassium currents modulates action potential time course and the repetitive firing properties of neurons. Single channel studies have identified two types of calcium-activated potassium channel which can also be separated on biophysical and pharmacological grounds and have been named BK and SK channels. It is now clear that BK channels underlie I(c) whereas SK channels underlie I(AHP). The identity of the channels underlying I(sAHP) are not known. In this review, we discuss the properties of the different types of calcium-activated potassium channels and the relationship between these channels and the macroscopic currents present in neurons.</dcterms:abstract>
        <bib:pages>345-353</bib:pages>
        <dc:date>Apr 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12015199</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60087">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12015199</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60082">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bennett</foaf:surname>
                        <foaf:givenname>M. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hacker</foaf:surname>
                        <foaf:givenname>P. M. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60083"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 15th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 16th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 17th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 18th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 19th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 20th Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, 21st Century</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, Ancient</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>History, Medieval</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurophysiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The motor system in neuroscience: a history and analysis of conceptual developments</dc:title>
        <dcterms:abstract>Neuroscientific reflection on the integrative action of the nervous system was dominated by consideration of the motor system from the time of Aristotle in the 4th century B.C. to that of Sherrington, his contemporaries and proteges in the first-half of the 20th century. We describe the significant discoveries concerning the action of the spinal cord and cortex in motor phenomena during this period. This provides a vivid account of how great neuroscientists, over a period of more than 2000 years, have endeavoured to clarify notions concerning the integrative action of the nervous system in the context of the prevailing philosophical traditions of their times. We examine these traditions as well as the conceptual schemes offered by neuroscientists, especially in relation to the workings of the cortex. It is shown that neuroscientists cleave to this day to a tradition that goes back to Descartes, and that this is the case even for those who explicitly claim to reject such a tradition. The review concludes with what we take to be an appropriate basis for rejecting the Cartesian paradigm that we hope will assist neuroscientists in understanding the integrative action of the nervous system.</dcterms:abstract>
        <bib:pages>1-52</bib:pages>
        <dc:date>May 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The motor system in neuroscience</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12126655</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60083">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12126655</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60080">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nieoullon</foaf:surname>
                        <foaf:givenname>André</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60081"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Adult</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antiparkinson Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Attention</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
                <rdf:value>Attention Deficit Disorder with Hyperactivity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Autistic Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Child</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cognition Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Dopamine Agonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Levodopa</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Limbic System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Middle Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Psychological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Phylogeny</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Dopamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Schizophrenic Psychology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Dopamine and the regulation of cognition and attention</dc:title>
        <dcterms:abstract>Dopamine (DA) acts as a key neurotransmitter in the brain. Numerous studies have shown its regulatory role for motor and limbic functions. However, in the early stages of Parkinson's disease (PD), alterations of executive functions also suggest a role for DA in regulating cognitive functions. Some other diseases, which can also involve DA dysfunction, such as schizophrenia or attention deficit hyperactivity disorder (ADHD) in children, as shown from the ameliorative action of dopaminergic antagonists and agonists, respectively, also show alteration of cognitive functions. Experimental studies showed that selective lesions of the dopaminergic neurons in rats or primates can actually provide cognitive deficits, especially when the mesocorticolimbic component of the dopaminergic systems is altered. Data from the experiments also showed significant alteration in attentional processes, thus raising the question of direct involvement of DA in regulating attention. Since the dopaminergic influence is mainly exerted over the frontal lobe and basal ganglia, it has been suggested that cognitive deficits express alteration in these subcortical brain structures closely linked to cortical areas, more than simple deficit in dopaminergic transmission. This point is still a matter of debate but, undoubtedly, DA acts as a powerful regulator of different aspects of cognitive brain functions. In this respect, normalizing DA transmission will contribute to improve the cognitive deficits not only related to neurologic or psychiatric diseases, but also in normal aging. Ontogenic and phylogenetic analysis of dopaminergic systems can provide evidences for a role of DA in the development of cognitive general capacities. DA can have a trophic action during maturation, which may influence the later cortical specification, particularly of pre-frontal cortical areas. Moreover, the characteristic extension of the dopaminergic cortical innervation in the rostro-caudal direction during the last stages of evolution in mammals can also be related to the appearance of progressively more developed cognitive capacities. Such an extension of cortical DA innervation could be related to increased processing of cortical information through basal ganglia, either during the course of evolution or development. DA has thus to be considered as a key neuroregulator which contributes to behavioral adaptation and to anticipatory processes necessary for preparing voluntary action consequent upon intention. All together, it can be suggested that a correlation exists between DA innervation and expression of cognitive capacities. Altering the dopaminergic transmission could, therefore, contribute to cognitive impairment.</dcterms:abstract>
        <bib:pages>53-83</bib:pages>
        <dc:date>May 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12126656</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60081">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12126656</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60076">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Korpi</foaf:surname>
                        <foaf:givenname>Esa R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gründer</foaf:surname>
                        <foaf:givenname>Gerhard</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lüddens</foaf:surname>
                        <foaf:givenname>Hartmut</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60077"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Drug Interactions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>GABA Agonists</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA-A Receptor Agonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA-A Receptor Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, GABA-A</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Drug interactions at GABA(A) receptors</dc:title>
        <dcterms:abstract>Neurotransmitter receptor systems have been the focus of intensive pharmacological research for more than 20 years for basic and applied scientific reasons, but only recently has there been a better understanding of their key features. One of these systems includes the type A receptor for the gamma-aminobutyric acid (GABA), which forms an integral anion channel from a pentameric subunit assembly and mediates most of the fast inhibitory neurotransmission in the adult vertebrate central nervous system. Up to now, depending on the definition, 16-19 mammalian subunits have been cloned and localized on different genes. Their assembly into proteins in a poorly defined stoichiometry forms the basis of functional and pharmacological GABA(A) receptor diversity, i.e. the receptor subtypes. The latter has been well documented in autoradiographic studies using ligands that label some of the receptors' various binding sites, corroborated by recombinant expression studies using the same tools. Significantly less heterogeneity has been found at the physiological level in native receptors, where the subunit combinations have been difficult to dissect. This review focuses on the characteristics, use and usefulness of various ligands and their binding sites to probe GABA(A) receptor properties and to gain insight into the biological function from fish to man and into evolutionary conserved GABA(A) receptor heterogeneity. We also summarize the properties of the novel mouse models created for the study of various brain functions and review the state-of-the-art imaging of brain GABA(A) receptors in various human neuropsychiatric conditions. The data indicate that the present ligands are only partly satisfactory tools and further ligands with subtype-selective properties are needed for imaging purposes and for confirming the behavioral and functional results of the studies presently carried out in gene-targeted mice with other species, including man.</dcterms:abstract>
        <bib:pages>113-159</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12126658</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60077">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12126658</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60068">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maclennan</foaf:surname>
                        <foaf:givenname>Karyn M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Darlington</foaf:surname>
                        <foaf:givenname>Cynthia L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Smith</foaf:surname>
                        <foaf:givenname>Paul F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60069"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Diseases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Diterpenes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Free Radical Scavengers</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ginkgo biloba</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ginkgolides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Lactones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Plant Extracts</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The CNS effects of Ginkgo biloba extracts and ginkgolide B</dc:title>
        <dcterms:abstract>Ginkgo biloba extracts such as EGb-761 have been suggested to have a multitude of beneficial effects on CNS function, from enhancing cognitive function in dementia to facilitating recovery from acute forms of neural damage such as hypoxia/ischemia. Ginkgolide B, one of the major components of EGb-761, is a potent platelet-activating factor (PAF) receptor antagonist, which is also regarded as having neuroprotective effects in the CNS. The aim of this review is to summarise and to critically evaluate the current evidence on the CNS effects of EGb-761 and ginkgolide B, with particular emphasis on the data relating to their neuroprotective effects.</dcterms:abstract>
        <bib:pages>235-257</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12169298</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60069">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12169298</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60072">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pralong</foaf:surname>
                        <foaf:givenname>Etienne</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Magistretti</foaf:surname>
                        <foaf:givenname>Pierre</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stoop</foaf:surname>
                        <foaf:givenname>Ron</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60073"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Bipolar Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Depressive Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Limbic System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Norepinephrine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Dopamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Serotonin</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>schizophrenia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Serotonin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders</dc:title>
        <dcterms:abstract>Dopaminergic, serotonergic and noradrenergic nuclei form the trimonoamine modulating system (TMMS). This system modulates emotional/motivational activities mediated by the limbic circuitry, where glutamate is the major excitatory neurotransmitter. Two main concepts are the basis of this review. First, since 1950 and the discovery of the antipsychotic activity of the dopamine D2 receptor antagonist chlorpromazine, it appears that drugs that can modulate the TMMS possess therapeutic psychiatric properties. Second, the concept of glutamate/trimonoamine imbalance in the cortico-striato-thalamo-cortical loop that has been so successful in explaining the pathophysiology of Parkinson disease has been applied in the pathophysiology of schizophrenia. This review will focus on the complex interactions between the fast synaptic glutamatergic transmission and the TMMS in specific parts of the limbic lobe and we will try to link these interactions to some psychiatric disorders, mainly depression, schizophrenia and drug addiction.</dcterms:abstract>
        <bib:pages>173-202</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12169296</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60073">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12169296</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60078">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pulvermüller</foaf:surname>
                        <foaf:givenname>Friedemann</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60079"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Language</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>A brain perspective on language mechanisms: from discrete neuronal ensembles to serial order</dc:title>
        <dcterms:abstract>Language is constituted by discrete building blocks, sounds and words, which can be concatenated according to serial order principles. The neurobiological organization of these building blocks, in particular words, has been illuminated by recent metabolic and neurophysiological imaging studies. When humans process words of different kinds, various sets of cortical areas have been found to become active differentially. The old concept of two language centers processing all words alike must therefore be replaced by a model according to which words are organized as discrete distributed neuron ensembles that differ in their cortical topographies. The meaning of a word, more precisely, aspects of its reference, may be crucial for determining which set of cortical areas becomes involved in its processing. Whereas the serial order of sounds constituting a word may be established by serially aligned sets of neurons called synfire chains, different mechanisms are necessary for establishing word order in sentences. The serial order of words may be organized by higher-order neuronal sets, called sequence detectors here, which are being activated by sequential excitation of neuronal sets representing words. Sets of sequence detectors are proposed to process aspects of the syntactic information contained in a sentence. Other syntactic rules can be related to general features of the dynamics of cortical activation and deactivation. These postulates about the brain mechanisms of language, which are rooted in principles known from neuroanatomy and neurophysiology, may provide a framework for theory-driven neuroscientific research on language.</dcterms:abstract>
        <bib:pages>85-111</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>A brain perspective on language mechanisms</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12126657</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60079">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12126657</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60070">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Roux</foaf:surname>
                        <foaf:givenname>Philippe P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Barker</foaf:surname>
                        <foaf:givenname>Philip A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60071"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor, Nerve Growth Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor Protein-Tyrosine Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nerve Growth Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurotrophin signaling through the p75 neurotrophin receptor</dc:title>
        <dcterms:abstract>The neurotrophins are growth factors that play critical roles in the development, maintenance, survival, and death of the nervous system. The signal transducing systems that mediate the diverse biological functions of the neurotrophins are initiated by their interactions with two categories of cell surface receptors, the Trk family of tyrosine kinases and the p75 neurotrophin receptor (p75NTR). While the Trk receptors are responsible for most of the survival and growth properties of the neurotrophins, the actions of p75NTR fall into two categories. First, p75NTR is a Trk co-receptor that can enhance or suppress neurotrophin-mediated Trk receptor activity. Second, p75NTR autonomously activates signaling cascades that result in the induction of apoptosis or in the promotion of survival. The signaling cascades activated by p75NTR remain elusive, but structural and functional differences between p75NTR and other tumor necrosis factor receptor (TNFR) superfamily members suggest that p75NTR employs distinct signaling pathways. p75NTR has been shown to activate the NF-kappaB, Akt, and JNK pathways and interacts with several adaptor proteins. Of these, NRAGE, NADE, and NRIF have been associated with the induction of apoptosis, and FAP-1, RIP2, and TRAF6 appear to promote cellular survival. It remains a major challenge to link the various p75NTR binding proteins to specific p75NTR-dependent functions, but the identification of p75NTR interactors and signaling pathways has sparked new directions in p75NTR research, and will provide a better understanding of this enigmatic receptor.</dcterms:abstract>
        <bib:pages>203-233</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12169297</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60071">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12169297</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60074">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wang</foaf:surname>
                        <foaf:givenname>Chen Xu</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shuaib</foaf:surname>
                        <foaf:givenname>Ashfaq</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60075"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Injuries</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interleukin-1</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tumor Necrosis Factor-alpha</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Involvement of inflammatory cytokines in central nervous system injury</dc:title>
        <dcterms:abstract>Pro-inflammatory cytokines, interleukin (IL) 1 and tumor necrosis factor (TNF), possess a wide range of biological actions in various tissues. In recent years, there has been increasing evidence that these cytokines are involved in inflammatory reactions in central nervous system (CNS) diseases. Although many studies have demonstrated that IL-1, TNF, and their mRNA are up-regulated in the CNS after injury, the functional roles of these cytokines in the injury are far from completely understood. Overexpression of these cytokines, such as observed during the early stage of injury, can be harmful for the injured tissue. However, low levels of these cytokines, observed during the recovery stage after injury, can enhance repair processes of the injured tissues.</dcterms:abstract>
        <bib:pages>161-172</bib:pages>
        <dc:date>Jun 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12126659</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60075">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12126659</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60066">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Felipo</foaf:surname>
                        <foaf:givenname>Vicente</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Butterworth</foaf:surname>
                        <foaf:givenname>Roger F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60067"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ammonia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hyperammonemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurobiology of ammonia</dc:title>
        <dcterms:abstract>Hyperammonemia resulting from inherited urea cycle enzyme deficiencies or liver failure results in severe central nervous system dysfunction including brain edema, convulsions and coma. Neuropathologic evaluation in these disorders reveals characteristic alterations of astrocyte morphology ranging from cell swelling (acute hyperammonemia) to Alzheimer Type II astrocytosis (chronic hyperammonemia). Having no effective urea cycle, brain relies on glutamine synthesis for the removal of excess ammonia and the enzyme responsible, glutamine synthetase, has a predominantly astrocytic localization. Accumulation of ammonia in brain results in a redistribution of cerebral blood flow and metabolism from cortical to sub-cortical structures. In addition to changes in astrocyte morphology, increased brain ammonia concentrations result in alterations in expression of key astrocyte proteins including glial fibrillary acidic protein, glutamate and glycine transporters and &quot;peripheral-type&quot; (mitochondrial) benzodiazepine receptors. Such changes result in alterations of astrocytic volume and increased extracellular concentrations of excitatory and inhibitory substances. In addition, the ammonium ion has direct effects on excitatory-inhibitory transmission via distinct mechanisms involving cellular chloride extrusion and postsynaptic receptor function. Acute ammonia exposure leads to activation of NMDA receptors and their signal transduction pathways. Chronic hyperammonemia also results in increased concentrations of neuroactive L-tryptophan metabolites including serotonin and quinolinic acid. Therapy in hyperammonemic syndromes continues to rely on ammonia-lowering strategies via peripheral mechanisms (reduction of ammonia production in the gastrointestinal tract, increased ammonia removal by muscle).</dcterms:abstract>
        <bib:pages>259-279</bib:pages>
        <dc:date>Jul 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12207972</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60067">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12207972</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60064">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shaw</foaf:surname>
                        <foaf:givenname>Nigel A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60065"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain Concussion</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electroencephalography</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Evoked Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The neurophysiology of concussion</dc:title>
        <dcterms:abstract>Cerebral concussion is both the most common and most puzzling type of traumatic brain injury (TBI). It is normally produced by acceleration (or deceleration) of the head and is characterized by a sudden brief impairment of consciousness, paralysis of reflex activity and loss of memory. It has long been acknowledged that one of the most worthwhile techniques for studying the acute pathophysiology of concussion is by the recording of neurophysiological activity such as the electroencephalogram (EEG) and sensory evoked potentials (EPs) from experimental animals. In the first parts of this review, the majority of such studies conducted during the past half century are critically reviewed. When potential methodological flaws and limitations such as anesthetic protocols, infliction of multiple blows and delay in onset of recordings were taken into account, two general principles could be adduced. First, the immediate post-concussive EEG was excitatory or epileptiform in nature. Second, the cortical EP waveform was totally lost during this period. In the second parts of this review, five theories of concussion which have been prominent during the past century are summarized and supportive evidence assessed. These are the vascular, reticular, centripetal, pontine cholinergic and convulsive hypotheses. It is concluded that only the convulsive theory is readily compatible with the neurophysiological data and can provide a totally viable explanation for concussion. The chief tenet of the convulsive theory is that since the symptoms of concussion bear a strong resemblance to those of a generalized epileptic seizure, then it is a reasonable assumption that similar pathobiological processes underlie them both. Further, it is demonstrated that EPs and EEGs recorded acutely following concussive trauma are indeed the same or similar to those obtained following the induction of a state of generalized seizure activity (GSA). According to the present incarnation of the convulsive theory, the energy imparted to the brain by the sudden mechanical loading of the head may generate turbulent rotatory and other movements of the cerebral hemispheres and so increase the chances of a tissue-deforming collision or impact between the cortex and the boney walls of the skull. In this conception, loss of consciousness is not orchestrated by disruption or interference with the function of the brainstem reticular activating system. Rather, it is due to functional deafferentation of the cortex as a consequence of diffuse mechanically-induced depolarization and synchronized discharge of cortical neurons. A convulsive theory can also explain traumatic amnesia, autonomic disturbances and the miscellaneous collection of symptoms of the post-concussion syndrome more adequately than any of its rivals. In addition, the symptoms of minor concussion (a.k.a. being stunned, dinged, or dazed) are often strikingly similar to minor epilepsy such as petit mal. The relevance of the convulsive theory to a number of associated problems is also discussed. These include the relationship between concussion and more serious types of closed head injury, the utility of animal models of severe brain trauma, the etiology of the cognitive deficits which may linger long after a concussive injury, the use of concussive (captive bolt) techniques to stun farm animals prior to slaughter and the question of why some animals (such as the woodpecker) can tolerate massive accelerative forces without being knocked out.</dcterms:abstract>
        <bib:pages>281-344</bib:pages>
        <dc:date>Jul 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12207973</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60065">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12207973</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60060">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Benveniste</foaf:surname>
                        <foaf:givenname>Helene</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Blackband</foaf:surname>
                        <foaf:givenname>Steve</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60061"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Atlases as Topic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Diseases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Contrast Media</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Fixatives</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetic Resonance Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rodentia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Tissue Fixation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>MR microscopy and high resolution small animal MRI: applications in neuroscience research</dc:title>
        <dcterms:abstract>The application of magnetic resonance (MR) imaging in the study of human disease using small animals has steadily evolved over the past two decades and strongly established the fields of &quot;small animal MR imaging&quot; and &quot;MR microscopy.&quot; An increasing number of neuroscience related investigations now implement MR microscopy in their experiments. Research areas of growth pertaining to MR microscopy studies are focused on (1). phenotyping of genetically engineered mice models of human neurological diseases and (2). rodent brain atlases. MR microscopy can be performed in vitro on tissue specimens, ex vivo on brain slice preparations and in vivo (typically on rodents). Like most new imaging technologies, MR microscopy is technologically demanding and requires broad expertise. Uniform guidelines or &quot;standards&quot; of a given MR microscopy experiment are non-existent. The main focus therefore of this review will be on biological applications of MR microscopy and the experimental requirements. We also take a critical look at the biological information that small animal (rodent) MR imaging has provided in neuroscience research.</dcterms:abstract>
        <bib:pages>393-420</bib:pages>
        <dc:date>Aug 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>MR microscopy and high resolution small animal MRI</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12234501</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60061">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12234501</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60054">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bradley</foaf:surname>
                        <foaf:givenname>John</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Finkbeiner</foaf:surname>
                        <foaf:givenname>Steven</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60055"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Calcium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>An evaluation of specificity in activity-dependent gene expression in neurons</dc:title>
        <dcterms:abstract>Activity-dependent synaptic modification must occur specifically to preserve the large information storage capacity of neurons. Since long-term changes in synaptic strength require gene expression and new protein synthesis we consider the role that gene expression plays in the specificity of synaptic modification. Ca2+ influx is essential for transducing synaptic activity into gene expression. Different temporal profiles of increased global Ca2+ and different types of Ca2+ channel have been demonstrated to produce different effects in the nucleus. It is possible therefore that synaptic activity may produce different programs of gene expression which may in turn control specific long-term changes in synaptic strength. We review recent data which suggest that the spatial properties of Ca2+ influx may provide a mechanism for the selective activation of molecules which signal to the nucleus. In particular, we describe data which suggests that Ca2+ channels may function in signal complexes at the synapse to propagate signals that contribute to distinct nuclear responses.</dcterms:abstract>
        <bib:pages>469-477</bib:pages>
        <dc:date>Aug 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12385865</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60055">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12385865</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60062">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gibbs</foaf:surname>
                        <foaf:givenname>Marie E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Summers</foaf:surname>
                        <foaf:givenname>Roger J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60063"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Chickens</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Locus Coeruleus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Models, Animal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Norepinephrine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prosencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Adrenergic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Role of adrenoceptor subtypes in memory consolidation</dc:title>
        <dcterms:abstract>Noradrenaline release in areas within the forebrain occurs following activation of noradrenergic cells in the locus coeruleus (LoC). Release of noradrenaline by attentional/arousal/vigilance factors appears to be essential for learning and is responsible for the consolidation of memory. Noradrenaline can activate any of nine different adrenoceptor (AR) subtypes in the brain and selectivity of action may be achieved by the spatial location and relative density of the AR subtypes, by different affinities of the different subtypes and by temporal selectivity in terms of when the different ARs are activated in the memory formation process. This review examines the use of selective agonists and antagonists to determine the roles of the AR subtypes in the one-trial discriminated avoidance learning paradigm in the chick. A model is developed that integrates noradrenergic activity in basal ganglia (lobus parolfactorius (LPO)) and association cortex (intermediate medial hyperstriatum ventrale (IMHV)) leading to the consolidation of memory 30 min after training. There is evidence that beta(2)- and beta(3)-ARs are important in the association area but require input from alpha(2)-AR stimulated activity in the basal ganglia for consolidation. On the other hand, alpha(1)-AR activation in the IMHV is inhibitory and prevents consolidation. While there is no role for beta(1)-ARs in memory consolidation, they play a role in short-term memory (STM). The use of the precocial chick has clear advantages in having a temporally discrete learning task which allows for discrimination memory and whose development can be followed at discrete intervals after learning. These studies reveal clear roles for AR subtypes in the formation and consolidation of memory in the chick, which have allowed the development of a model that can now be tested in mammalian systems.</dcterms:abstract>
        <bib:pages>345-391</bib:pages>
        <dc:date>Aug 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12234500</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60063">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12234500</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60058">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>Roberto C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Martini</foaf:surname>
                        <foaf:givenname>Luciano</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Galbiati</foaf:surname>
                        <foaf:givenname>Mariarita</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60059"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gonadotropin-Releasing Hormone</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Growth Substances</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>hormones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hypothalamus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reproduction</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Steroids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Growth factors and steroid hormones: a complex interplay in the hypothalamic control of reproductive functions</dc:title>
        <dcterms:abstract>The mechanisms through which LHRH-secreting neurons are controlled still represent a crucial and debated field of research in the neuroendocrine control of reproduction. In the present review, we have specifically considered two potential signals reaching these hypothalamic neurons: steroid hormones and growth factors. Examples of the relevant physiological role of the interactions between these two families of biologically acting molecules have been provided. In many cases, these interactions occur at the level of hypothalamic astrocytes, which are presently accepted as functional partners of the LHRH-secreting neurons. On the basis of the observations here summarized, we have formulated the hypothesis that a functional co-operation of steroid hormones and growth factors occurring in the hypothalamic astrocytic compartment represents a key factor in the neuroendocrine control of reproductive functions.</dcterms:abstract>
        <bib:pages>421-449</bib:pages>
        <dc:date>Aug 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Growth factors and steroid hormones</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12385863</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60059">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12385863</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60056">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>67</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Miller</foaf:surname>
                        <foaf:givenname>Robert H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60057"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Lineage</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oligodendroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vertebrates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Regulation of oligodendrocyte development in the vertebrate CNS</dc:title>
        <dcterms:abstract>The vertebrate central nervous system (CNS) contains two major classes of macroglial cells, oligodendrocytes and astrocytes. Oligodendrocytes are responsible for the formation of myelin in the central nervous system, while the functions of astrocytes are more diverse and less well established. Recent studies have provided new insights into when, where and how these different classes of cell arise during CNS development. The founder cells of the oligodendrocyte lineage initially arise in distinct regions of the ventricular zone during early development as the result of local signals including sonic hedgehog. In the spinal cord, oligodendrocyte precursors appear to share a developmental lineage with motor neurons, although they may also develop from restricted glial precursors. Immature oligodendrocyte precursors are highly migratory. They migrate from their site of origin to developing white matter tracts using a variety of guidance cues including diffusible chemorepellents. The majority of oligodendrocyte precursor proliferation occurs in developing white matter as a result of the local expression of mitogenic signals. Oligodendrocyte precursor cell proliferation is regulated by a number of distinct growth factors that act at distinct stages in the lineage and whose activity is modulated by synergy with other molecules including chemokines. The final matching of oligodendrocyte and axon number is accomplished through a combination of local regulation of cell proliferation, differentiation and cell death. Not all oligodendrocyte precursors differentiate during development, and the adult CNS contains a significant population of precursors. Understanding the regulation of oligodendrogenesis will facilitate the use of these endogenous precursors to enhance repair in a variety of pathological conditions.</dcterms:abstract>
        <bib:pages>451-467</bib:pages>
        <dc:date>Aug 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12385864</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60057">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12385864</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60052">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nässel</foaf:surname>
                        <foaf:givenname>Dick R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60053"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amino Acid Sequence</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Drosophila</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insect Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Larva</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Sequence Data</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neuropeptide</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neurotransmitter</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuropeptides in the nervous system of Drosophila and other insects: multiple roles as neuromodulators and neurohormones</dc:title>
        <dcterms:abstract>Neuropeptides in insects act as neuromodulators in the central and peripheral nervous system and as regulatory hormones released into the circulation. The functional roles of insect neuropeptides encompass regulation of homeostasis, organization of behaviors, initiation and coordination of developmental processes and modulation of neuronal and muscular activity. With the completion of the sequencing of the Drosophila genome we have obtained a fairly good estimate of the total number of genes encoding neuropeptide precursors and thus the total number of neuropeptides in an insect. At present there are 23 identified genes that encode predicted neuropeptides and an additional seven encoding insulin-like peptides in Drosophila. Since the number of G-protein-coupled neuropeptide receptors in Drosophila is estimated to be around 40, the total number of neuropeptide genes in this insect will probably not exceed three dozen. The neuropeptides can be grouped into families, and it is suggested here that related peptides encoded on a Drosophila gene constitute a family and that peptides from related genes (orthologs) in other species belong to the same family. Some peptides are encoded as multiple related isoforms on a precursor and it is possible that many of these isoforms are functionally redundant. The distribution and possible functions of members of the 23 neuropeptide families and the insulin-like peptides are discussed. It is clear that each of the distinct neuropeptides are present in specific small sets of neurons and/or neurosecretory cells and in some cases in cells of the intestine or certain peripheral sites. The distribution patterns vary extensively between types of neuropeptides. Another feature emerging for many insect neuropeptides is that they appear to be multifunctional. One and the same peptide may act both in the CNS and as a circulating hormone and play different functional roles at different central and peripheral targets. A neuropeptide can, for instance, act as a coreleased signal that modulates the action of a classical transmitter and the peptide action depends on the cotransmitter and the specific circuit where it is released. Some peptides, however, may work as molecular switches and trigger specific global responses at a given time. Drosophila, in spite of its small size, is now emerging as a very favorable organism for the studies of neuropeptide function due to the arsenal of molecular genetics methods available.</dcterms:abstract>
        <bib:pages>1-84</bib:pages>
        <dc:date>Sep 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neuropeptides in the nervous system of Drosophila and other insects</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12427481</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60053">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12427481</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60048">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Auld</foaf:surname>
                        <foaf:givenname>Daniel S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kornecook</foaf:surname>
                        <foaf:givenname>Tom J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bastianetto</foaf:surname>
                        <foaf:givenname>Stéphane</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Quirion</foaf:surname>
                        <foaf:givenname>Rémi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60049"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acetylcholine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Afferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid beta-Peptides</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Brain Tissue Transplantation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cholinergic Fibers</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cholinesterase Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cognition Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Fetal Tissue Transplantation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Genetic Therapy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prosencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Muscarinic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nicotinic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies</dc:title>
        <dcterms:abstract>Alzheimer's disease (AD) is the most common form of degenerative dementia and is characterized by progressive impairment in cognitive function during mid- to late-adult life. Brains from AD patients show several distinct neuropathological features, including extracellular beta-amyloid-containing plaques, intracellular neurofibrillary tangles composed of abnormally phosphorylated tau, and degeneration of cholinergic neurons of the basal forebrain. In this review, we will present evidence implicating involvement of the basal forebrain cholinergic system in AD pathogenesis and its accompanying cognitive deficits. We will initially discuss recent results indicating a link between cholinergic mechanisms and the pathogenic events that characterize AD, notably amyloid-beta peptides. Following this, animal models of dementia will be discussed in light of the relationship between basal forebrain cholinergic hypofunction and cognitive impairments in AD. Finally, past, present, and future treatment strategies aimed at alleviating the cognitive symptomatology of AD by improving basal forebrain cholinergic function will be addressed.</dcterms:abstract>
        <bib:pages>209-245</bib:pages>
        <dc:date>Oct 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Alzheimer's disease and the basal forebrain cholinergic system</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12450488</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60049">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12450488</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60050">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Avoli</foaf:surname>
                        <foaf:givenname>Massimo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>D'Antuono</foaf:surname>
                        <foaf:givenname>Margherita</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Louvel</foaf:surname>
                        <foaf:givenname>Jacques</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Köhling</foaf:surname>
                        <foaf:givenname>Rüdiger</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Biagini</foaf:surname>
                        <foaf:givenname>Giuseppe</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pumain</foaf:surname>
                        <foaf:givenname>René</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>D'Arcangelo</foaf:surname>
                        <foaf:givenname>Giovanna</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tancredi</foaf:surname>
                        <foaf:givenname>Virginia</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60051"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>4-Aminopyridine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Action Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electric Stimulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Entorhinal Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Epilepsy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Epilepsy, Temporal Lobe</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Limbic System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pilocarpine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, GABA-A</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Seizures</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro</dc:title>
        <dcterms:abstract>Seizures in patients presenting with mesial temporal lobe epilepsy result from the interaction among neuronal networks in limbic structures such as the hippocampus, amygdala and entorhinal cortex. Mesial temporal lobe epilepsy, one of the most common forms of partial epilepsy in adulthood, is generally accompanied by a pattern of brain damage known as mesial temporal sclerosis. Limbic seizures can be mimicked in vitro using preparations of combined hippocampus-entorhinal cortex slices perfused with artificial cerebrospinal fluid containing convulsants or nominally zero Mg(2+), in order to produce epileptiform synchronization. Here, we summarize experimental evidence obtained in such slices from rodents. These data indicate that in control animals: (i) prolonged, NMDA receptor-dependent epileptiform discharges, resembling electrographic limbic seizures, originate in the entorhinal cortex from where they propagate to the hippocampus via the perforant path-dentate gyrus route; (ii) the initiation and maintenance of these ictal discharges is paradoxically contributed by GABA (mainly type A) receptor-mediated mechanisms; and (iii) CA3 outputs, which relay a continuous pattern of interictal discharge at approximately 1Hz, control rather than sustain ictal discharge generation in entorhinal cortex. Recent work indicates that such a control is weakened in the pilocarpine model of epilepsy (presumably as a result of CA3 cell damage). In addition, in these experiments electrographic seizure activity spreads directly to the CA1-subiculum regions through the temporoammonic pathway. Studies reviewed here indicate that these changes in network interactions, along with other mechanisms of synaptic plasticity (e.g. axonal sprouting, decreased activation of interneurons, upregulation of bursting neurons) can confer to the epileptic, damaged limbic system, the ability to produce recurrent limbic seizures as seen in patients with mesial temporal lobe epilepsy.</dcterms:abstract>
        <bib:pages>167-207</bib:pages>
        <dc:date>Oct 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12450487</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60051">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12450487</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60046">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Drapeau</foaf:surname>
                        <foaf:givenname>Pierre</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saint-Amant</foaf:surname>
                        <foaf:givenname>Louis</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Buss</foaf:surname>
                        <foaf:givenname>Robert R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chong</foaf:surname>
                        <foaf:givenname>Mabel</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McDearmid</foaf:surname>
                        <foaf:givenname>Jonathan R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brustein</foaf:surname>
                        <foaf:givenname>Edna</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60047"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Zebrafish</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Development of the locomotor network in zebrafish</dc:title>
        <dcterms:abstract>The zebrafish is a leading model for studies of vertebrate development and genetics. Its embryonic motor behaviors are easy to assess (e.g. for mutagenic screens), the embryos develop rapidly (hatching as larvae at 2 days) and are transparent, permitting calcium imaging and patch clamp recording in vivo. We review primarily the recent advances in understanding the cellular basis for the development of motor activities in the developing zebrafish. The motor activities are generated largely in the spinal cord and hindbrain. In the embryo these segmented structures possess a relatively small number of repeating sets of identifiable neurons. Many types of neurons as well as the two types of muscle cells have been classified based on their morphologies. Some of the molecular signals for cellular differentiation have been identified recently and mutations affecting cell development have been isolated. Embryonic motor behaviors appear in sequence and consist of an early period of transient spontaneous coiling contractions, followed by the emergence of twitching responses to touch, and later by the ability to swim. Coiling contractions are generated by an electrically coupled network of a subset of spinal neurons whereas a chemical (glutamatergic and glycinergic) synaptic drive underlies touch responses and swimming. Swimming becomes sustained in larvae once the neuromodulatory serotonergic system develops. These results indicate many similarities between developing zebrafish and other vertebrates in the properties of the synaptic drive underlying locomotion. Therefore, the zebrafish is a useful preparation for gaining new insights into the development of the neural control of vertebrate locomotion. As the types of neurons, transmitters, receptors and channels used in the locomotor network are being defined, this opens the possibility of combining cellular neurophysiology with forward and reverse molecular genetics to understand the principles of locomotor network assembly and function.</dcterms:abstract>
        <bib:pages>85-111</bib:pages>
        <dc:date>Oct 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12450489</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60047">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12450489</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60044">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Friston</foaf:surname>
                        <foaf:givenname>Karl</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60045"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Photic Stimulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Visual Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Functional integration and inference in the brain</dc:title>
        <dcterms:abstract>Self-supervised models of how the brain represents and categorises the causes of its sensory input can be divided into two classes: those that minimise the mutual information (i.e. redundancy) among evoked responses and those that minimise the prediction error. Although these models have similar goals, the way they are attained, and the functional architectures employed, can be fundamentally different. This review describes the two classes of models and their implications for the functional anatomy of sensory cortical hierarchies in the brain. We then consider how empirical evidence can be used to disambiguate between architectures that are sufficient for perceptual learning and synthesis. Most models of representational learning require prior assumptions about the distribution of sensory causes. Using the notion of empirical Bayes, we show that these assumptions are not necessary and that priors can be learned in a hierarchical context. Furthermore, we try to show that learning can be implemented in a biologically plausible way. The main point made in this review is that backward connections, mediating internal or generative models of how sensory inputs are caused, are essential if the process generating inputs cannot be inverted. Because these processes are dynamical in nature, sensory inputs correspond to a non-invertible nonlinear convolution of causes. This enforces an explicit parameterisation of generative models (i.e. backward connections) to enable approximate recognition and suggests that feedforward architectures, on their own, are not sufficient. Moreover, nonlinearities in generative models, that induce a dependence on backward connections, require these connections to be modulatory; so that estimated causes in higher cortical levels can interact to predict responses in lower levels. This is important in relation to functional asymmetries in forward and backward connections that have been demonstrated empirically. To ascertain whether backward influences are expressed functionally requires measurements of functional integration among brain systems. This review summarises approaches to integration in terms of effective connectivity and proceeds to address the question posed by the theoretical considerations above. In short, it will be shown that functional neuroimaging can be used to test for interactions between bottom-up and top-down inputs to an area. The conclusion of these studies points toward the prevalence of top-down influences and the plausibility of generative models of sensory brain function.</dcterms:abstract>
        <bib:pages>113-143</bib:pages>
        <dc:date>Oct 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12450490</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60045">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12450490</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60042">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hinoi</foaf:surname>
                        <foaf:givenname>Eiichi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Balcar</foaf:surname>
                        <foaf:givenname>Vladimir J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kuramoto</foaf:surname>
                        <foaf:givenname>Nobuyuki</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nakamichi</foaf:surname>
                        <foaf:givenname>Noritaka</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yoneda</foaf:surname>
                        <foaf:givenname>Yukio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60043"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>DNA-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nuclear Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Nuclear transcription factors in the hippocampus</dc:title>
        <dcterms:abstract>In the mammalian hippocampus, there is a trisynaptic loop that has been often referred to in studies on learning and memory mechanisms and their physiological correlate, the long-term potentiation (LTP). The three sets of synapses are formed by the fibers of perforant pathway terminating on granule cells and by the mossy fibers and Schaeffer collaterals making connections with the pyramidal cells. Each of the three types of synapses can develop LTP. LTP is accompanied by changes in gene expression and it is the nuclear transcription, involving specific transcription factors, that is the starting point for the series of biological amplifications and consolidations both necessary for such sustained changes. The transcription factors are proteins that control gene expression, development and functional formation in every eukaryotic cell. Two categories of transcription factors have been defined to date: general factors that comprise at least 20 proteins to form multiple preinitiation complex at the TATA box (TATA rich sequence) or regulatory factors that bind to promoter or enhancer regions at specific sites on the DNA close to, or distant from, the TATA box. Transcription factors have been divided into five different major classes according to unique protein motifs. These include basic domain, zinc-finger, helix-turn-helix, beta-Scaffold factors with minor groove contacts and other transcription factors not specifically classified. Much evidence has been accumulating in favor of the participation of several transcription factors in the consolidation of memory in the mammalian hippocampus following a spatial memory task. It is, therefore, of great importance that the involvement of transcription factors in de novo protein synthesis relevant to the synaptic mechanisms that mediate the formation of long-term memory should be summarized and discussed. No specific correlation between transduction of extracellular signals and expression of nuclear transcription factors, however, has been demonstrated to date.</dcterms:abstract>
        <bib:pages>145-165</bib:pages>
        <dc:date>Oct 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12450491</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60043">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12450491</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60040">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Alger</foaf:surname>
                        <foaf:givenname>Bradley E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60041"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cannabinoid Receptor Modulators</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebellum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Endocannabinoids</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Fatty Acids, Unsaturated</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Homeostasis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mammals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Presynaptic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Second Messenger Systems</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids</dc:title>
        <dcterms:abstract>This review covers recent developments in the cellular neurophysiology of retrograde signaling in the mammalian central nervous system. Normally at a chemical synapse a neurotransmitter is released from the presynaptic element and diffuses to the postsynaptic element, where it binds to and activates receptors. In retrograde signaling a diffusible messenger is liberated from the postsynaptic element, and travels &quot;backwards&quot; across the synaptic cleft, where it activates receptors on the presynaptic cell. Receptors for retrograde messengers are usually located on or near the presynaptic nerve terminals, and their activation causes an alteration in synaptic transmitter release. Although often considered in the context of long-term synaptic plasticity, retrograde messengers have numerous roles on the short-term regulation of synaptic transmission. The focus of this review will be on a group of molecules from different chemical classes that appear to act as retrograde messengers. The evidence supporting their candidacy as retrograde messengers is considered and evaluated. Endocannabinoids have recently emerged as one of the most thoroughly investigated, and widely accepted, classes of retrograde messenger in the brain. The study of the endocannabinoids can therefore serve as a model for the investigation of other putative messengers, and most attention is devoted to a discussion of systems that use these new messenger molecules.</dcterms:abstract>
        <bib:pages>247-286</bib:pages>
        <dc:date>Nov 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Retrograde signaling in the regulation of synaptic transmission</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12498988</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60041">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12498988</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60038">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Raiteri</foaf:surname>
                        <foaf:givenname>Luca</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Raiteri</foaf:surname>
                        <foaf:givenname>Maurizio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bonanno</foaf:surname>
                        <foaf:givenname>Giambattista</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60039"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Membrane</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Exocytosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>gamma-Aminobutyric Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Transport Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Vesicles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons</dc:title>
        <dcterms:abstract>Transporters able to recapture released neurotransmitters into neurons can no longer be considered as cell-specific neuronal markers. In fact, colocalization on one nerve terminal of transporters able to selectively recapture the released endogenously synthesized transmitter (homotransporters) and of transporters that can selectively take up transmitters/modulators originating from neighboring structures (heterotransporters) has been demonstrated to occur on several families of nerve terminals. Activation of heterotransporters often increases the release of the transmitter stored in the terminals on which the heterotransporters are localized. The release caused by heterotransporter activation takes place through multiple mechanisms including exocytosis, either dependent on external Ca(2+) or on Ca(2+) mobilized from intraterminal stores, and homotransporter reversal. Homocarrier-mediated release elicited by heterocarrier activation represents a clear case of transporter-transporter interaction. Although the functional significance of transporter coexpression on one nerve terminal remains to be established, it may in some instances reflect cotransmission. In other cases, heterotransporters may mediate modulation of basal transmitter release in addition to the modulation of the evoked release brought about by presynaptic heteroreceptors. Heterotransporters are also increasingly reported to exist on neuronal soma/dendrites. With the exception of EAAT4, the glutamate transporter/chloride channel situated on GABAergic Purkinje cells in the cerebellum, the functions of somatodendritic heterocarriers is not understood.</dcterms:abstract>
        <bib:pages>287-309</bib:pages>
        <dc:date>Nov 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12498989</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60039">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12498989</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60024">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Clifford</foaf:surname>
                        <foaf:givenname>C. W. G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ibbotson</foaf:surname>
                        <foaf:givenname>M. R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60025"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Motion Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Optic Lobe, Nonmammalian</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pattern Recognition, Visual</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Retina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Retinal Ganglion Cells</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Species Specificity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Visual Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Visual Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Fundamental mechanisms of visual motion detection: models, cells and functions</dc:title>
        <dcterms:abstract>Taking a comparative approach, data from a range of visual species are discussed in the context of ideas about mechanisms of motion detection. The cellular basis of motion detection in the vertebrate retina, sub-cortical structures and visual cortex is reviewed alongside that of the insect optic lobes. Special care is taken to relate concepts from theoretical models to the neural circuitry in biological systems. Motion detection involves spatiotemporal pre-filters, temporal delay filters and non-linear interactions. A number of different types of non-linear mechanism such as facilitation, inhibition and division have been proposed to underlie direction selectivity. The resulting direction-selective mechanisms can be combined to produce speed-tuned motion detectors. Motion detection is a dynamic process with adaptation as a fundamental property. The behavior of adaptive mechanisms in motion detection is discussed, focusing on the informational basis of motion adaptation, its phenomenology in human vision, and its cellular basis. The question of whether motion adaptation serves a function or is simply the result of neural fatigue is critically addressed.</dcterms:abstract>
        <bib:pages>409-437</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Fundamental mechanisms of visual motion detection</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12576294</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60025">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12576294</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60034">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Orr</foaf:surname>
                        <foaf:givenname>C. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rowe</foaf:surname>
                        <foaf:givenname>D. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Halliday</foaf:surname>
                        <foaf:givenname>G. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60035"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Gangliosides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Immunologic Surveillance</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Lipopolysaccharides</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Microglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Monitoring, Immunologic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oxidopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rotenone</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>An inflammatory review of Parkinson's disease</dc:title>
        <dcterms:abstract>The symptoms of Parkinson's disease (PD) were first described nearly two centuries ago and its characteristic pathology identified nearly a century ago, yet its pathogenesis is still poorly understood. Parkinson's disease is the most prevalent neurodegenerative movement disorder and research into its pathogenesis recently accelerated following the identification of a number of causal genetic mutations. The mutant gene products all cause dysfunction of the ubiquitin-proteosome system, identifying protein modification and degradation as critical for pathogenesis. Modified non-degraded intracellular proteins accumulate in certain neuronal populations in all forms of the disease. However, neuronal degeneration is more highly selective and associates with substantial activation of microglia, the inflammatory cells of the brain. We review the current change in thinking regarding the role of microglia in the brain in the context of Parkinson's disease and animal models of the disease. Comparison of the cellular tissue changes across a number of animal models using diverse stimuli to mimic Parkinson's disease reveals a consistent pattern implicating microglia as the effector for the selective degeneration of dopaminergic neurons. While previous reviews have concentrated on the intracellular neuronal changes in Parkinson's disease, we highlight the cell to cell interactions and immune regulation critical for neuronal homeostasis and survival in Parkinson's disease.</dcterms:abstract>
        <bib:pages>325-340</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12531233</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60035">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12531233</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60036">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Petty</foaf:surname>
                        <foaf:givenname>Margaret A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lo</foaf:surname>
                        <foaf:givenname>Eng H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60037"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adherens Junctions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Autoimmune Diseases of the Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Blood-Brain Barrier</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Neoplasms</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Inflammation Mediators</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurogenic Inflammation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroimmunomodulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Tight Junctions</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation</dc:title>
        <dcterms:abstract>A wide range of central nervous system (CNS) disorders include neuroinflammatory events that perturb blood-brain barrier (BBB) integrity. Mechanisms by which the BBB responds to physiological and pathological stimuli involve signaling systems in the tight and adherens junctions of the cerebral endothelium. In this review, we examine the molecular composition and regulatory mediators that control BBB permeability and assess how these mediators may be dysregulated in stroke, multiple sclerosis, brain tumors, and meningioencephalitis. An understanding of these molecular substrates in BBB regulation may lead to new approaches for enhancing CNS drug delivery and ameliorating brain edema after injury and inflammation.</dcterms:abstract>
        <bib:pages>311-323</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Junctional complexes of the blood-brain barrier</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12531232</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60037">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12531232</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60028">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ribeiro</foaf:surname>
                        <foaf:givenname>J. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sebastião</foaf:surname>
                        <foaf:givenname>A. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Mendonça</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60029"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>adenosine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Diseases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Homeostasis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Purinergic P1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Adenosine receptors in the nervous system: pathophysiological implications</dc:title>
        <dcterms:abstract>Adenosine is a ubiquitous homeostatic substance released from most cells, including neurones and glia. Once in the extracellular space, adenosine modifies cell functioning by operating G-protein-coupled receptors (GPCR; A(1), A(2A), A(2B), A(3)) that can inhibit (A(1)) or enhance (A(2)) neuronal communication. Interactions between adenosine receptors and other G-protein-coupled receptors, ionotropic receptors and receptors for neurotrophins also occur, and this might contribute to a fine-tuning of neuronal function. Manipulations of adenosine receptors influence sleep and arousal, cognition and memory, neuronal damage and degeneration, as well as neuronal maturation. These actions might have therapeutic implications for neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, as well as for other neurological situations such as epilepsy, idiopathic pain or even drug addition. Peripheral side effects associated with adenosine receptor agonists limit their usefulness in therapeutics; in contrast, adenosine receptor antagonists appear to have less side effects as it is the case of the well-known non-selective antagonists theophylline (present in tea) or caffeine (abundant in coffee and tea), and their emerging beneficial actions in Parkinson's disease and Alzheimer's disease are encouraging. A(1) receptor antagonism may also be useful to enhance cognition and facilitate arousal, as well as in the periphery when deficits of neurotransmitter release occur (e.g. myasthenic syndromes). Enhancement of extracellular adenosine levels through drugs that influence its metabolism might prove useful approaches in situations such as neuropathic pain, where enhanced activation of inhibitory adenosine A(1) receptors is beneficial. One might then consider adenosine as a fine-tuning modulator of neuronal activity, which via subtle effects causes harmonic actions on neuronal activity. Whenever this homeostasis is disrupted, pathology may be installed and selective receptor antagonism or agonism required.</dcterms:abstract>
        <bib:pages>377-392</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Adenosine receptors in the nervous system</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12576292</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60029">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12576292</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60030">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Stangel</foaf:surname>
                        <foaf:givenname>Martin</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hartung</foaf:surname>
                        <foaf:givenname>Hans-Peter</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60031"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Demyelinating Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Growth Substances</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Multiple Sclerosis</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Sheath</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Fibers, Myelinated</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Olfactory Bulb</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Oligodendroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Schwann Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stem Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Stem Cell Transplantation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Remyelinating strategies for the treatment of multiple sclerosis</dc:title>
        <dcterms:abstract>Demyelination is the pathological hallmark of multiple sclerosis (MS) lesions. The concept of remyelination has gained acceptance in recent years, but naturally occurring remyelination is incomplete. To improve repair processes, a number of strategies have been explored experimentally and clinical trials are being carried out. In principle, remyelination can be achieved by either promoting endogenous repair mechanisms or by providing an exogenous source of myelinating cells via transplantation. Both approaches have been successful in animal models of demyelination. Besides, many studies have elucidated principal mechanisms of oligodendrocyte biology and remyelination in the central nervous system (CNS). This progress in knowledge also allowed for more specific interventions. First clinical trials to enhance endogenous remyelination have been performed, unfortunately with disappointingly negative results. This illustrates that experimental data cannot be easily transferred to human disease, and more detailed knowledge on the regulatory mechanisms of remyelination in MS is required. Recently, the first MS patient received a transplant of autologous Schwann cells. Many other cell types are being studied experimentally, including stem cells. Despite the ethical problems associated with an embryonic cell source, new developments in stem cell biology indicate that adult stem cells or bone marrow-derived cells may substitute for embryonic cells in the future. In this review, we describe the current views on oligodendrocyte biology, myelination and remyelination, and focus on recent developments leading to reconstructing, remyelinating strategies in MS.</dcterms:abstract>
        <bib:pages>361-376</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12531235</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60031">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12531235</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60032">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wang</foaf:surname>
                        <foaf:givenname>Ningshan</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Orr-Urtreger</foaf:surname>
                        <foaf:givenname>Avi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Korczyn</foaf:surname>
                        <foaf:givenname>Amos D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60033"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Postsynaptic Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ganglia, Autonomic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mice, Knockout</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Models, Animal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Subunits</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nicotinic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Up-Regulation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice</dc:title>
        <dcterms:abstract>Neuronal nicotinic acetylcholine receptors (nAChR), composed of 12 subunits (alpha2-alpha10, beta2-beta4), are expressed in autonomic ganglia, playing a central role in autonomic transmission. The repertoire of nicotinic subunits in autonomic ganglia includes alpha3, alpha5, alpha7, beta2 and beta4 subunits. In the last 10 years, heterologous expression studies have revealed much about the nature of neuronal nAChRs. However, there is only limited understanding of subunit actions in autonomic system. Functional deletions of subunit by gene knockout in animals could overcome these limitations. We review recent studies on nAChRs on autonomic ganglia for physiological and pharmacological properties and potential locations of the subunits.</dcterms:abstract>
        <bib:pages>341-360</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12531234</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60033">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12531234</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60026">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>68</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yamamoto</foaf:surname>
                        <foaf:givenname>Nobuhiko</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tamada</foaf:surname>
                        <foaf:givenname>Atsushi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Murakami</foaf:surname>
                        <foaf:givenname>Fujio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60027"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Growth Cones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Wiring of the brain by a range of guidance cues</dc:title>
        <dcterms:abstract>During development of the central nervous system, growth cones navigate along specific pathways, recognize their targets and then form synaptic connections by elaborating terminal arbors. To date, a number of developmental and in vitro studies have characterized the nature of the guidance cues that underlie various types of axonal behavior, from initial outgrowth to synapse formation, including pathway selection, polarized growth, orientated growth, termination and branching. New approaches in molecular biology have identified several types of guidance cues, most of which are likely to act as local cues. Moreover, recent studies have indicated that axonal responsiveness to guidance cues changes dynamically, which appears to be elicited by environmental factors encountered by the navigating growth cones. This article addresses what molecular cues are responsible for guidance mechanisms including axonal responsiveness, focusing on axonal behavior in the developmental stages.</dcterms:abstract>
        <bib:pages>393-407</bib:pages>
        <dc:date>Dec 2002</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12576293</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60027">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12576293</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60022">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bass</foaf:surname>
                        <foaf:givenname>Andrew H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McKibben</foaf:surname>
                        <foaf:givenname>Jessica R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60023"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Animal Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Auditory Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Fishes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hearing</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prosencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rhombencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vocalization, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neural mechanisms and behaviors for acoustic communication in teleost fish</dc:title>
        <dcterms:abstract>Sound communication is not unique to humans but rather is a trait shared with most non-mammalian vertebrates. A practical way to address questions of vocal signal encoding has been to identify mechanisms in non-mammalian model systems that use acoustic communication signals in their social behavior. Teleost fishes, the largest group of living vertebrates, include both vocal and non-vocal species that exploit a wide range of acoustic niches. Here, we focus on those vocal species where combined behavioral and neurobiological studies have recently begun to elucidate a suite of adaptations for both the production and the perception of acoustic signals essential to their reproductive success and survival. Studies of these model systems show that teleost fish have the vocal-acoustic behaviors and neural systems both necessary and sufficient to solve acoustic problems common to all vertebrates. In particular, behavioral studies demonstrate that temporal features within a call, including pulse duration, rate and number, can all be important to a call's communicative value. Neurobiological studies have begun to show how these features are produced by a vocal motor system extending from forebrain to hindbrain levels and are encoded by peripheral and central auditory neurons. The abundance and variety of vocal fish present unique opportunities for parallel investigations of neural encoding, perception, and communication across a diversity of natural, acoustic habitats. As such, investigations in teleosts contribute to our delineating the evolution of the vocal and auditory systems of both non-mammalian and mammalian species, including humans.</dcterms:abstract>
        <bib:pages>1-26</bib:pages>
        <dc:date>Jan 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12637170</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60023">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12637170</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60018">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brazel</foaf:surname>
                        <foaf:givenname>Christine Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Romanko</foaf:surname>
                        <foaf:givenname>Michael J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rothstein</foaf:surname>
                        <foaf:givenname>Raymond P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Levison</foaf:surname>
                        <foaf:givenname>Steven W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60019"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Movement</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebral Ventricles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neocortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prosencephalon</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stem Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Roles of the mammalian subventricular zone in brain development</dc:title>
        <dcterms:abstract>There has been enormous progress in uncovering the contributions of the subventricular zone (SVZ) to the developing brain. Here, we review the roles of four anatomically defined embryologic divisions of the SVZ of the mammalian brain: the lateral ganglionic eminence (LGE), the medial ganglionic eminence (MGE), the caudal ganglionic eminence (CGE), and the fetal neocortical SVZ (SVZn), as well as the roles of the two major anatomically defined regions of the postnatal SVZ, the anterior SVZ (SVZa) and the dorsolateral SVZ (SVZdl). We describe the types of cells within each subdivision of the SVZ, the types of brain cells that they generate during embryonic, fetal, and perinatal development, and when known the mechanisms that regulate their differentiation. This review provides a critical analysis of the literature, from which current and future studies on the SVZ can be formulated and evaluated.</dcterms:abstract>
        <bib:pages>49-69</bib:pages>
        <dc:date>Jan 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12637172</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60019">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12637172</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60020">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McAuley</foaf:surname>
                        <foaf:givenname>J. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60021"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Arousal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Attention</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Decision Making</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Eye Movements</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motivation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Movement Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Perception</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Posture</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The physiological basis of clinical deficits in Parkinson's disease</dc:title>
        <dcterms:abstract>Despite the fact that Parkinson's disease (PD) is a relatively common neurological condition, the physiological derangements that result in its clinical features remain unclear. On combining findings from psychophysical, clinical and electrophysiological studies, an overriding theme is proposed that PD deficits are essentially quantitative rather than qualitative in nature. This may arise because the normal function of the basal ganglia is to activate neural processes selectively, providing appropriate diversion of &quot;attentional&quot; resources for decision-making aspects of motor tasks and appropriate &quot;energising&quot; of the executive aspects of such tasks. It is suggested that these concepts of attention, an idea stemming from psychophysical studies, and of energisation, which has derived from kinematic studies, may in fact reflect the same universal process of selective facilitation of particular processes and inhibition of others. In PD, without efficient facilitation, tasks may still be performed but less well than in normal individuals. Possible underlying mechanisms of basal ganglial function are discussed in the context of new findings on direct and indirect pathway actions and the role that oscillatory modulations may play in achieving selective facilitation is explored. Further investigation of disturbances of such mechanisms in PD may prove important in understanding the underlying pathophysiology of the condition.</dcterms:abstract>
        <bib:pages>27-48</bib:pages>
        <dc:date>Jan 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12637171</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60021">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12637171</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60016">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Benington</foaf:surname>
                        <foaf:givenname>Joel H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Frank</foaf:surname>
                        <foaf:givenname>Marcos G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60017"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cells, Cultured</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurobiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cellular and molecular connections between sleep and synaptic plasticity</dc:title>
        <dcterms:abstract>The hypothesis that sleep promotes learning and memory has long been a subject of active investigation. This hypothesis implies that sleep must facilitate synaptic plasticity in some way, and recent studies have provided evidence for such a function. Our knowledge of both the cellular neurophysiology of sleep states and of the cellular and molecular mechanisms underlying synaptic plasticity has expanded considerably in recent years. In this article, we review findings in these areas and discuss possible mechanisms whereby the neurophysiological processes characteristic of sleep states may serve to facilitate synaptic plasticity. We address this issue first on the cellular level, considering how activation of T-type Ca(2+) channels in nonREM sleep may promote either long-term depression or long-term potentiation, as well as how cellular events of REM sleep may influence these processes. We then consider how synchronization of neuronal activity in thalamocortical and hippocampal-neocortical networks in nonREM sleep and REM sleep could promote differential strengthening of synapses according to the degree to which activity in one neuron is synchronized with activity in other neurons in the network. Rather than advocating one specific cellular hypothesis, we have intentionally taken a broad approach, describing a range of possible mechanisms whereby sleep may facilitate synaptic plasticity on the cellular and/or network levels. We have also provided a general review of evidence for and against the hypothesis that sleep does indeed facilitate learning, memory, and synaptic plasticity.</dcterms:abstract>
        <bib:pages>71-101</bib:pages>
        <dc:date>Feb 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12684067</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60017">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12684067</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60014">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Liou</foaf:surname>
                        <foaf:givenname>Anthony K. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Clark</foaf:surname>
                        <foaf:givenname>Robert S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Henshall</foaf:surname>
                        <foaf:givenname>David C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yin</foaf:surname>
                        <foaf:givenname>Xiao-Ming</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chen</foaf:surname>
                        <foaf:givenname>Jun</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60015"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Injuries</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Epilepsy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ischemia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Stress, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways</dc:title>
        <dcterms:abstract>After a severe episode of ischemia, traumatic brain injury (TBI) or epilepsy, it is typical to find necrotic cell death within the injury core. In addition, a substantial number of neurons in regions surrounding the injury core have been observed to die via the programmed cell death (PCD) pathways due to secondary effects derived from the various types of insults. Apart from the cell loss in the injury core, cell death in regions surrounding the injury core may also contribute to significant losses in neurological functions. In fact, it is the injured neurons in these regions around the injury core that treatments are targeting to preserve. In this review, we present our cumulated understanding of stress-activated signaling pathways and apoptotic pathways in the research areas of ischemic injury, TBI and epilepsy and that gathered from concerted research efforts in oncology and other diseases. However, it is obvious that our understanding of these pathways in the context of acute brain injury is at its infancy stage and merits further investigation. Hopefully, this added research effort will provide a more detailed knowledge from which better therapeutic strategies can be developed to treat these acute brain injuries.</dcterms:abstract>
        <bib:pages>103-142</bib:pages>
        <dc:date>Feb 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12684068</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60015">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12684068</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60008">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lubec</foaf:surname>
                        <foaf:givenname>Gert</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Krapfenbauer</foaf:surname>
                        <foaf:givenname>Kurt</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fountoulakis</foaf:surname>
                        <foaf:givenname>Michael</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60009"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteomics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Proteomics in brain research: potentials and limitations</dc:title>
        <dcterms:abstract>The advent of proteomics techniques has been enthusiastically accepted in most areas of biology and medicine. In neuroscience, a host of applications was proposed ranging from neurotoxicology, neurometabolism, determination of the proteome of the individual brain areas in health and disease, to name a few. Only recently, the limitations of the method have been shown, hampering the rapid spreading of the technology, which in principle consists of two-dimensional gel electrophoresis with in-gel protein digestion of protein spots and identification by mass-spectrometrical approaches or microsequencing. The identification, including quantification using specific software, of brain protein classes, like enzymes, cytoskeleton proteins, heat shock proteins/chaperones, proteins of the transcription and translation machinery, synaptosomal proteins, antioxidant proteins, is a clear domain of proteomics. Furthermore, the concomitant detection of several hundred proteins on a gel allows the demonstration of an expressional pattern, rather generated by a reliable, protein-chemical method than by immunoreactivity, proposed by protein-arrays. An additional advantage is that hitherto unknown proteins, so far only proposed from their nucleic acid structure, designated as hypothetical proteins, can be identified as brain proteins. As to shortcomings and disadvantages of the method we would point to the major problem, the failure to separate hydrophobic proteins. There is so far no way to analyse the vast majority of these proteins in gels. Several other analytical problems need to be overcome, but once the latter problem can be solved, there is nothing to stop the method for a large scale analysis of membrane proteins in neuroscience.</dcterms:abstract>
        <bib:pages>193-211</bib:pages>
        <dc:date>Feb 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Proteomics in brain research</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12758110</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60009">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12758110</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60012">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rosenzweig</foaf:surname>
                        <foaf:givenname>Ephron S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Barnes</foaf:surname>
                        <foaf:givenname>Carol A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60013"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aged</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Space Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Impact of aging on hippocampal function: plasticity, network dynamics, and cognition</dc:title>
        <dcterms:abstract>Aging is associated with specific impairments of learning and memory, some of which are similar to those caused by hippocampal damage. Studies of the effects of aging on hippocampal anatomy, physiology, plasticity, and network dynamics may lead to a better understanding of age-related cognitive deficits. Anatomical and electrophysiological studies indicate that the hippocampus of the aged rat sustains a loss of synapses in the dentate gyrus, a loss of functional synapses in area CA1, a decrease in the NMDA-receptor-mediated response at perforant path synapses onto dentate gyrus granule cells, and an alteration of Ca(2+) regulation in area CA1. These changes may contribute to the observed age-related impairments of synaptic plasticity, which include deficits in the induction and maintenance of long-term potentiation (LTP) and lower thresholds for depotentiation and long-term depression (LTD). This shift in the balance of LTP and LTD could, in turn, impair the encoding of memories and enhance the erasure of memories, and therefore contribute to cognitive deficits experienced by many aged mammals. Altered synaptic plasticity may also change the dynamic interactions among cells in hippocampal networks, causing deficits in the storage and retrieval of information about the spatial organization of the environment. Further studies of the aged hippocampus will not only lead to treatments for age-related cognitive impairments, but may also clarify the mechanisms of learning in adult mammals.</dcterms:abstract>
        <bib:pages>143-179</bib:pages>
        <dc:date>Feb 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Impact of aging on hippocampal function</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12758108</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60013">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12758108</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60010">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wise</foaf:surname>
                        <foaf:givenname>Phyllis M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60011"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Estrogen Replacement Therapy</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Estrogens</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Risk Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Estrogens: protective or risk factors in brain function?</dc:title>
        <dcterms:abstract>Over the past century, the average lifespan of women has increased from 50 to over 80 years, but the age of the menopause has remained fixed at 51 years. This &quot;change of life&quot; is marked by a dramatic and permanent decrease in circulating levels of ovarian estrogens. Therefore, more women will live a greater proportion of their lives in a chronic hypoestrogenic state. Ovarian steroid hormones are pleiotropic and have multiple, diverse, and possibly opposing actions in different contexts. In light of recent reports of the possible health risks of hormone replacement therapy (HRT) on several different physiological systems, the question of whether estrogens are protective or risk factors must be carefully re-evaluated.</dcterms:abstract>
        <bib:pages>181-191</bib:pages>
        <dc:date>Feb 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Estrogens</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12758109</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60011">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12758109</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60006">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nishi</foaf:surname>
                        <foaf:givenname>Rae</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60007"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuromuscular Junction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Target-mediated control of neural differentiation</dc:title>
        <dcterms:abstract>The development of the nervous system entails the coordination of the spatial and chemical development of both pre- and postsynaptic elements. This coordination is accomplished by signals passing between neurons and the target cells that they innervate. This review focuses on well-characterized examples of target-mediated neuronal differentiation in the central and peripheral nervous systems. These include control of neurogenesis in the leech by male genitalia, presynaptic differentiation induced by postsynaptic molecules expressed by skeletal muscle, postsynaptic adhesion molecules that induce presynaptic differentiation in the central nervous system (CNS), target-mediated control of neurotransmitter phenotype in peripheral neurons, and target-regulated control of neuronal nicotinic acetylcholine receptors (nAChRs) and large conductance calcium-activated potassium channels (BK). The detailed understanding of these processes will uncover signals critical for the directed differentiation of stem cells as well as identify future targets for therapies in neural regeneration that promote the reestablishment of functional connections.</dcterms:abstract>
        <bib:pages>213-227</bib:pages>
        <dc:date>Mar 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12757747</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60007">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12757747</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60004">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yasuda</foaf:surname>
                        <foaf:givenname>Hitoshi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Terada</foaf:surname>
                        <foaf:givenname>Masahiko</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Maeda</foaf:surname>
                        <foaf:givenname>Kengo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kogawa</foaf:surname>
                        <foaf:givenname>Shuro</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sanada</foaf:surname>
                        <foaf:givenname>Mitsuru</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Haneda</foaf:surname>
                        <foaf:givenname>Masakazu</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kashiwagi</foaf:surname>
                        <foaf:givenname>Atsunori</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kikkawa</foaf:surname>
                        <foaf:givenname>Ryuichi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60005"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Biopsy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Clinical Trials as Topic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Diabetic Neuropathies</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Enzyme Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Growth Substances</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Macrophages</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Fibers</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Protein Kinases</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Skin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Diabetic neuropathy and nerve regeneration</dc:title>
        <dcterms:abstract>Diabetic neuropathy is the most common peripheral neuropathy in western countries. Although every effort has been made to clarify the pathogenic mechanism of diabetic neuropathy, thereby devising its ideal therapeutic drugs, neither convinced hypotheses nor unequivocally effective drugs have been established. In view of the pathologic basis for the treatment of diabetic neuropathy, it is important to enhance nerve regeneration as well as prevent nerve degeneration. Nerve regeneration or sprouting in diabetes may occur not only in the nerve trunk but also in the dermis and around dorsal root ganglion neurons, thereby being implicated in the generation of pain sensation. Thus, inadequate nerve regeneration unequivocally contributes to the pathophysiologic mechanism of diabetic neuropathy. In this context, the research on nerve regeneration in diabetes should be more accelerated. Indeed, nerve regenerative capacity has been shown to be decreased in diabetic patients as well as in diabetic animals. Disturbed nerve regeneration in diabetes has been ascribed at least in part to all or some of decreased levels of neurotrophic factors, decreased expression of their receptors, altered cellular signal pathways and/or abnormal expression of cell adhesion molecules, although the mechanisms of their changes remain almost unclear. In addition to their steady-state changes in diabetes, nerve injury induces injury-specific changes in individual neurotrophic factors, their receptors and their intracellular signal pathways, which are closely linked with altered neuronal function, varying from neuronal survival and neurite extension/nerve regeneration to apoptosis. Although it is essential to clarify those changes for understanding the mechanism of disturbed nerve regeneration in diabetes, very few data are now available. Rationally accepted replacement therapy with neurotrophic factors has not provided any success in treating diabetic neuropathy. Aside from adverse effects of those factors, more rigorous consideration for their delivery system may be needed for any possible success. Although conventional therapeutic drugs like aldose reductase (AR) inhibitors and vasodilators have been shown to enhance nerve regeneration, their efficacy should be strictly evaluated with respect to nerve regenerative capacity. For this purpose, especially clinically, skin biopsy, by which cutaneous nerve pathology including nerve regeneration can be morphometrically evaluated, might be a safe and useful examination.</dcterms:abstract>
        <bib:pages>229-285</bib:pages>
        <dc:date>Mar 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12757748</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60005">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12757748</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59994">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bouchard</foaf:surname>
                        <foaf:givenname>Ron</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pattarini</foaf:surname>
                        <foaf:givenname>Roberto</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Geiger</foaf:surname>
                        <foaf:givenname>Jonathan D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59995"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>calcium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Endoplasmic Reticulum</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Presynaptic Terminals</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Presynaptic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ryanodine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ryanodine Receptor Calcium Release Channel</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Subcellular Fractions</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Presence and functional significance of presynaptic ryanodine receptors</dc:title>
        <dcterms:abstract>Ca(2+)-induced Ca(2+) release (CICR) mediated by sarcoplasmic reticulum resident ryanodine receptors (RyRs) has been well described in cardiac, skeletal and smooth muscle. In brain, RyRs are localised primarily to endoplasmic reticulum (ER) and have been demonstrated in postsynaptic entities, astrocytes and oligodendrocytes where they regulate intracellular Ca(2+) concentration ([Ca(2+)](i)), membrane potential and the activity of a variety of second messenger systems. Recently, the contribution of presynaptic RyRs and CICR to functions of central and peripheral presynaptic terminals, including neurotransmitter release, has received increased attention. However, there is no general agreement that RyRs are localised to presynaptic terminals, nor is it clear that RyRs regulate a large enough pool of intracellular Ca(2+) to be physiologically significant. Here, we review direct and indirect evidence that on balance favours the notion that ER and RyRs are found in presynaptic terminals and are physiologically significant. In so doing, it became obvious that some of the controversy originates from issues related to (i) the ability to demonstrate conclusively the physical presence of ER and RyRs, (ii) whether the biophysical properties of RyRs are such that they can contribute physiologically to regulation of presynaptic [Ca(2+)](i), (iii) how ER Ca(2+) load and feedback gain of CICR contributes to the ability to detect functionally relevant RyRs, (iv) the distance that Ca(2+) diffuses from plasma membranes to RyRs to trigger CICR and from RyRs to the Active Zone to enhance vesicle release, and (v) the experimental conditions used. The recognition that ER Ca(2+) stores are able to modulate local Ca(2+) levels and neurotransmitter release in presynaptic terminals will aid in the understanding of the cellular mechanisms controlling neuronal function.</dcterms:abstract>
        <bib:pages>391-418</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12880633</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59995">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12880633</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59996">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jay</foaf:surname>
                        <foaf:givenname>Thérèse M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59997"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Dopamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Dopamine: a potential substrate for synaptic plasticity and memory mechanisms</dc:title>
        <dcterms:abstract>It is only recently that a number of studies on synaptic plasticity in the hippocampus and other brain areas have considered that a heterosynaptic modulatory input could be recruited as well as the coincident firing of pre- and post-synaptic neurons. So far, the strongest evidence for such a regulation has been attributed to dopaminergic (DA) systems but other modulatory pathways have also been considered to influence synaptic plasticity. This review will focus on dopamine contribution to synaptic plasticity in different brain areas (hippocampus, striatum and prefrontal cortex) with, for each region, a few lines on the distribution of DA projections and receptors. New insights into the possible mechanisms underlying these plastic changes will be considered. The contribution of various DA systems in certain forms of learning and memory will be reviewed with recent advances supporting the hypothesis of similar cellular mechanisms underlying DA regulation of synaptic plasticity and memory processes in which the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway has a potential role. To summarize, endogenous DA, which depends on the activity patterns of DA midbrain neurons in freely moving animals, appears as a key regulator in specific synaptic changes observed at certain stages of learning and memory and of synaptic plasticity.</dcterms:abstract>
        <bib:pages>375-390</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Dopamine</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12880632</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59997">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12880632</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59998">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lessmann</foaf:surname>
                        <foaf:givenname>Volkmar</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gottmann</foaf:surname>
                        <foaf:givenname>Kurt</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Malcangio</foaf:surname>
                        <foaf:givenname>Marzia</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59999"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Line</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Survival</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Forecasting</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Growth Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Peptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurotrophin secretion: current facts and future prospects</dc:title>
        <dcterms:abstract>The proteins of the mammalian neurotrophin family (nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5)) were originally identified as neuronal survival factors. During the last decade, evidence has accumulated implicating them (especially BDNF) in addition in the regulation of synaptic transmission and synaptogenesis in the CNS. However, a detailed understanding of the secretion of neurotrophins from neurons is required to delineate their role in regulating synaptic function. Some crucial questions that need to be addressed include the sites of neurotrophin secretion (i.e. axonal versus dendritic; synaptic versus extrasynaptic) and the neuronal and synaptic activity patterns that trigger the release of neurotrophins. In this article, we review the current knowledge in the field of neurotrophin secretion, focussing on activity-dependent synaptic release of BDNF. The modality and the site of neurotrophin secretion are dependent on the processing and subsequent targeting of the neurotrophin precursor molecules. Therefore, the available data regarding formation and trafficking of neurotrophins in the secreting neurons are critically reviewed. In addition, we discuss existing evidence that the characteristics of neurotrophin secretion are similar (but not identical) to those of other neuropeptides. Finally, since BDNF has been proposed to play a critical role as an intercellular synaptic messenger in long-term potentiation (LTP) in the hippocampus, we try to reconcile this possible role of BDNF in LTP with the recently described features of synaptic BDNF secretion.</dcterms:abstract>
        <bib:pages>341-374</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neurotrophin secretion</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12787574</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59999">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12787574</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59992">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lewis</foaf:surname>
                        <foaf:givenname>Katharine E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Eisen</foaf:surname>
                        <foaf:givenname>Judith S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59993"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Crest</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Zebrafish</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>From cells to circuits: development of the zebrafish spinal cord</dc:title>
        <dcterms:abstract>The ability of an animal to carry out its normal behavioral repertoire requires generation of an enormous diversity of neurons and glia. The relative simplicity of the spinal cord makes this an especially attractive part of the nervous system for addressing questions about the development of vertebrate neural specification and function. The last decade has witnessed an explosion in our understanding of spinal cord development and the functional interactions among spinal cord neurons and glia. Cellular, genetic, molecular, physiological and behavioral studies in zebrafish have all been important in providing insights into questions that remained unanswered by studies from other vertebrate model organisms. This is the case because many zebrafish spinal neurons can be individually identified and followed over time in living embryos and larvae. In this review, we discuss what is currently known about the cellular, genetic and molecular mechanisms involved in specifying distinct cell types in the zebrafish spinal cord and how these cells establish the functional circuitry that mediates particular behaviors. We start by describing the early signals and morphogenetic movements that form the nervous system, and in particular, the spinal cord. We then provide an overview of the cell types within the spinal cord and describe how they are specified and patterned. We begin ventrally with floor plate and proceed dorsally, through motoneurons and oligodendrocytes, interneurons, astrocytes and radial glia, spinal sensory neurons and neural crest. We next describe axon pathfinding of spinal neurons. Finally, we discuss the roles of particular spinal cord neurons in specific behaviors.</dcterms:abstract>
        <bib:pages>419-449</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>From cells to circuits</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12880634</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59993">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12880634</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60002">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lossi</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Merighi</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60003"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Autophagy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Necrosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>In vivo cellular and molecular mechanisms of neuronal apoptosis in the mammalian CNS</dc:title>
        <dcterms:abstract>Apoptosis has been recognized to be an essential process during neural development. It is generally assumed that about half of the neurons produced during neurogenesis die before completion of the central nervous system (CNS) maturation, and this process affects nearly all classes of neurons. In this review, we discuss the experimental data in vivo on naturally occurring neuronal death in normal, transgenic and mutant animals, with special attention to the cerebellum as a study model. The emerging picture is that of a dual wave of apoptotic cell death affecting central neurons at different stages of their life. The first wave consists of an early neuronal death of proliferating precursors and young postmitotic neuroblasts, and appears to be closely linked to cell cycle regulation. The second wave affects postmitotic neurons at later stages, and is much better understood in functional terms, mainly on the basis of the neurotrophic concept in its broader definition. The molecular machinery of late apoptotic death of postmitotic neurons more commonly follows the mitochondrial pathway of intracellular signal transduction, but the death receptor pathway may also be involved.Undoubtedly, analysis of naturally occurring neuronal death (NOND) in vivo will offer a basis for parallel and future studies aiming to elucidate the mechanisms of pathologic neuronal loss occurring as the result of conditions such as neurodegenerative disorders, trauma or ischemia.</dcterms:abstract>
        <bib:pages>287-312</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12787572</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60003">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12787572</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_60000">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>69</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sawynok</foaf:surname>
                        <foaf:givenname>Jana</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Liu</foaf:surname>
                        <foaf:givenname>Xue Jun</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_60001"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>adenosine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Afferent Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nerves</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Adenosine in the spinal cord and periphery: release and regulation of pain</dc:title>
        <dcterms:abstract>In the central nervous system (CNS), adenosine is an important neuromodulator and regulates neuronal and non-neuronal cellular function (e.g. microglia) by actions on extracellular adenosine A(1), A(2A), A(2B) and A(3) receptors. Extracellular levels of adenosine are regulated by synthesis, metabolism, release and uptake of adenosine. Adenosine also regulates pain transmission in the spinal cord and in the periphery, and a number of agents can alter the extracellular availability of adenosine and subsequently modulate pain transmission, particularly by activation of adenosine A(1) receptors. The use of capsaicin (which activates receptors selectively expressed on C-fibre afferent neurons and produces neurotoxic actions in certain paradigms) allows for an interpretation of C-fibre involvement in such processes. In the spinal cord, adenosine availability/release is enhanced by depolarization (K(+), capsaicin, substance P, N-methyl-D-aspartate (NMDA)), by inhibition of metabolism or uptake (inhibitors of adenosine kinase (AK), adenosine deaminase (AD), equilibrative transporters), and by receptor-operated mechanisms (opioids, 5-hydroxytryptamine (5-HT), noradrenaline (NA)). Some of these agents release adenosine via an equilibrative transporter indicating production of adenosine inside the cell (K(+), morphine), while others release nucleotide which is converted extracellularly to adenosine by ecto-5'-nucleotidase (capsaicin, 5-HT). Release can be capsaicin-sensitive, Ca(2+)-dependent and involve G-proteins, and this suggests that within C-fibres, Ca(2+)-dependent intracellular processes regulate production and release of adenosine. In the periphery, adenosine is released from both neuronal and non-neuronal sources. Neuronal release from capsaicin-sensitive afferents is induced by glutamate and by neurogenic inflammation (capsaicin, low concentration of formalin), while that from sympathetic postganglionic neurons (probably as adenosine 5'-triphosphate (ATP) with NA) occurs following more generalized inflammation. Such release is modified differentially by inhibitors of AK and AD. Following nerve injury, there is an alteration in capsaicin-sensitive adenosine release, as spinal release now is less responsive to opioids, while peripheral release is less responsive to inhibitors of metabolism. Following inflammation, adenosine is released from a variety of cell types in addition to neurons (e.g. endothelial cells, neutrophils, mast cells, fibroblasts). ATP is released both spinally and peripherally following inflammation or injury, and may be converted to adenosine by ecto-5'-nucleotidase contributing an additional source of adenosine. Release of adenosine from both spinal and peripheral compartments has inhibitory effects on pain transmission, as methylxanthine adenosine receptor antagonists reduce analgesia produced by agents which augment extracellular levels of adenosine spinally (morphine, 5-HT, substance P, AK inhibitors) and peripherally (AK inhibitors, AD inhibitors). Increases in extracellular adenosine availability also may contribute to antiinflammatory effects of certain agents (methotrexate, sulfasalazine, salicylates, AK inhibitors), and this could have secondary effects on pain signalling in chronic inflammation. The purpose of the present review is to consider: (a). the factors that regulate the extracellular availability of adenosine in the spinal cord and at peripheral sites; and (b). the extent to which this adenosine affects pain signalling in these two distinct compartments.</dcterms:abstract>
        <bib:pages>313-340</bib:pages>
        <dc:date>Apr 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Adenosine in the spinal cord and periphery</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12787573</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_60001">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12787573</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59986">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Henson</foaf:surname>
                        <foaf:givenname>R. N. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59987"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Evoked Potentials</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetic Resonance Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tomography, Emission-Computed</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuroimaging studies of priming</dc:title>
        <dcterms:abstract>This article reviews functional neuroimaging studies of priming, a behavioural change associated with the repeated processing of a stimulus. Using the haemodynamic techniques of functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), priming-related effects have been observed in numerous regions of the human brain, with the specific regions depending on the type of stimulus and the manner in which it is processed. The most common finding is a decreased haemodynamic response for primed versus unprimed stimuli, though priming-related response increases have been observed. Attempts have been made to relate these effects to a form of implicit or &quot;unconscious&quot; memory. The priming-related decrease has also been used as a tool to map the brain regions associated with different stages of stimulus-processing, a method claimed to offer superior spatial resolution. This decrease has a potential analogue in the stimulus repetition effects measured with single-cell recording in the non-human primate. The paradigms reviewed include word-stem completion, masked priming, repetition priming of visual objects and semantic priming. An attempt is made to relate the findings within a &quot;component process&quot; framework, and the relationship between behavioural, haemodynamic and neurophysiological data is discussed. Interpretation of the findings is not always clear-cut, however, given potential confounding factors such as explicit memory, and several recommendations are made for future neuroimaging studies of priming.</dcterms:abstract>
        <bib:pages>53-81</bib:pages>
        <dc:date>May 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12927334</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59987">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12927334</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59988">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Krubitzer</foaf:surname>
                        <foaf:givenname>Leah</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kahn</foaf:surname>
                        <foaf:givenname>Dianna M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59989"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Behavior</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebral Cortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Homeostasis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neocortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Species Specificity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Nature versus nurture revisited: an old idea with a new twist</dc:title>
        <dcterms:abstract>The nature versus nurture debate has recently resurfaced with the emergence of the field of developmental molecular neurobiology. The questions associated with &quot;nature&quot; have crystallized into testable hypotheses regarding patterns of gene expression during development, and those associated with &quot;nurture&quot; have given over to activity-dependent cellular mechanisms that give rise to variable phenotypes in developing nervous systems. This review focuses on some of the features associated with complex brains and discusses the evolutionary and activity-dependent mechanisms that generate these features. These include increases in the size of the cortical sheet, changes in cortical domain and cortical field specification, and the activity-dependent intracellular mechanisms that regulate the structure and function of neurons during development. We discuss which features are likely to be genetically mediated, which features are likely to be regulated by activity, and how these two mechanisms act in concert to produce the wide variety of phenotypes observed for the mammalian neocortex. For example, the size of the cortical sheet is likely to be under genetic control, and regulation of cell-cycle kinetics through upregulation of genes such as beta-catenin can account for increases in the size of the cortical sheet. Similarly, intrinsic signaling genes or gene products such as Wnt, Shh, Fgf2, Fgf8 and BMP may set up a combinatorial coordinate system that guides thalamic afferents. Changes in peripheral morphology that regulate patterned activity are also likely to be under genetic control. Finally, the intracellular machinery that allows for activity-dependent plasticity in the developing CNS may be genetically regulated, although the specific phenotype they generate are not. On the other hand, aspects of neocortical organization such as sensory domain assignment, the size and shape of cortical fields, some aspects of connectivity, and details of functional organization are likely to be activity-dependent. Furthermore, the role of genes versus activity, and their interactions, may be different for primary fields versus non-primary fields.</dcterms:abstract>
        <bib:pages>33-52</bib:pages>
        <dc:date>May 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Nature versus nurture revisited</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12927333</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59989">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12927333</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59990">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Turner</foaf:surname>
                        <foaf:givenname>Paul R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>O'Connor</foaf:surname>
                        <foaf:givenname>Kate</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tate</foaf:surname>
                        <foaf:givenname>Warren P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Abraham</foaf:surname>
                        <foaf:givenname>Wickliffe C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59991"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid beta-Protein Precursor</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Conformation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Subunits</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory</dc:title>
        <dcterms:abstract>Amyloid-beta precursor protein (APP) is a membrane-spanning protein with a large extracellular domain and a much smaller intracellular domain. It is the source of the amyloid-beta (Abeta) peptide found in neuritic plaques of Alzheimer's disease (AD) patients. Because Abeta shows neurotoxic properties, and because familial forms of AD promote Abeta accumulation, a massive international research effort has been aimed at understanding the mechanisms of Abeta generation, catabolism and toxicity. APP, however, is an extremely complex molecule that may be a functionally important molecule in its full-length configuration, as well as being the source of numerous fragments with varying effects on neural function. For example, one fragment derived from the non-amyloidogenic processing pathway, secreted APPalpha (sAPPalpha), is neuroprotective, neurotrophic and regulates cell excitability and synaptic plasticity, while Abeta appears to exert opposing effects. Less is known about the neural functions of other fragments, but there is a growing interest in understanding the basic biology of APP as it has become recognized that alterations in the functional activity of the APP fragments during disease states will have complex effects on cell function. Indeed, it has been proposed that reductions in the level or activity of certain APP fragments, in addition to accumulation of Abeta, may play a critical role in the cognitive dysfunction associated with AD, particularly early in the course of the disease. To test and modify this hypothesis, it is important to understand the roles that full-length APP and its fragments normally play in neuronal structure and function. Here we review evidence addressing these fundamental questions, paying particular attention to the contributions that APP fragments play in synaptic transmission and neural plasticity, as these may be key to understanding their effects on learning and memory. It is clear from this literature that APP fragments, including Abeta, can exert a powerful regulation of key neural functions including cell excitability, synaptic transmission and long-term potentiation, both acutely and over the long-term. Furthermore, there is a small but growing literature confirming that these fragments correspondingly regulate behavioral learning and memory. These data indicate that a full account of cognitive dysfunction in AD will need to incorporate the actions of the full complement of APP fragments. To this end, there is an urgent need for a dedicated research effort aimed at understanding the behavioral consequences of altered levels and activity of the different APP fragments as a result of experience and disease.</dcterms:abstract>
        <bib:pages>1-32</bib:pages>
        <dc:date>May 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12927332</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59991">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12927332</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59982">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Halpern</foaf:surname>
                        <foaf:givenname>Mimi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Martínez-Marcos</foaf:surname>
                        <foaf:givenname>Alino</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59983"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aggression</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Evolution</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Epithelium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pheromones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Odorant</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Species Specificity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Vomeronasal Organ</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Structure and function of the vomeronasal system: an update</dc:title>
        <dcterms:abstract>Several developments during the past 15 years have profoundly affected our understanding of the vomeronasal system (VNS) of vertebrates. In the mid 1990s, the vomeronasal epithelium of mammals was found to contain two populations of receptor cells, based on their expression of G-proteins. These two populations of neurons were subsequently found to project their axons to different parts of the accessory olfactory bulb (AOB), forming the basis of segregated pathways with possibly heterogeneous functions. A related discovery was the cloning of members of at least two gene families of putative vomeronasal G-protein-coupled receptors (GPRs) in the vomeronasal epithelium. Ligand binding to these receptors was found to activate a phospholipase C (PLC)-dependent signal transduction pathway that primarily involves an increase in intracellular inositol-tris-phosphate and intracellular calcium. In contrast to what was previously believed, neuron replacement in the vomeronasal epithelium appears to occur through a process of vertical migration in most mammals. New anatomical studies of the central pathways of the olfactory and vomeronasal systems indicated that these two systems converge on neurons in the telencephalon, providing an anatomical substrate for functional interactions. Combined anatomical, physiological and behavioral studies in mice provided new information that furthered our understanding of one of the most striking pheromonal phenomena, the Bruce effect. Finally, contrary to prior observations, new anatomical studies indicated that a vomeronasal organ (VNO) was present in human adults and reports were published indicating that this system might be functional. These latter observations are still controversial and require confirmation from independent laboratories.</dcterms:abstract>
        <bib:pages>245-318</bib:pages>
        <dc:date>Jun 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Structure and function of the vomeronasal system</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12951145</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59983">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12951145</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59984">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Millan</foaf:surname>
                        <foaf:givenname>Mark J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59985"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anti-Anxiety Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Anxiety</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Models, Animal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptides</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>rats</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The neurobiology and control of anxious states</dc:title>
        <dcterms:abstract>Fear is an adaptive component of the acute &quot;stress&quot; response to potentially-dangerous (external and internal) stimuli which threaten to perturb homeostasis. However, when disproportional in intensity, chronic and/or irreversible, or not associated with any genuine risk, it may be symptomatic of a debilitating anxious state: for example, social phobia, panic attacks or generalized anxiety disorder. In view of the importance of guaranteeing an appropriate emotional response to aversive events, it is not surprising that a diversity of mechanisms are involved in the induction and inhibition of anxious states. Apart from conventional neurotransmitters, such as monoamines, gamma-amino-butyric acid (GABA) and glutamate, many other modulators have been implicated, including: adenosine, cannabinoids, numerous neuropeptides, hormones, neurotrophins, cytokines and several cellular mediators. Accordingly, though benzodiazepines (which reinforce transmission at GABA(A) receptors), serotonin (5-HT)(1A) receptor agonists and 5-HT reuptake inhibitors are currently the principle drugs employed in the management of anxiety disorders, there is considerable scope for the development of alternative therapies. In addition to cellular, anatomical and neurochemical strategies, behavioral models are indispensable for the characterization of anxious states and their modulation. Amongst diverse paradigms, conflict procedures--in which subjects experience opposing impulses of desire and fear--are of especial conceptual and therapeutic pertinence. For example, in the Vogel Conflict Test (VCT), the ability of drugs to release punishment-suppressed drinking behavior is evaluated. In reviewing the neurobiology of anxious states, the present article focuses in particular upon: the multifarious and complex roles of individual modulators, often as a function of the specific receptor type and neuronal substrate involved in their actions; novel targets for the management of anxiety disorders; the influence of neurotransmitters and other agents upon performance in the VCT; data acquired from complementary pharmacological and genetic strategies and, finally, several open questions likely to orientate future experimental- and clinical-research. In view of the recent proliferation of mechanisms implicated in the pathogenesis, modulation and, potentially, treatment of anxiety disorders, this is an opportune moment to survey their functional and pathophysiological significance, and to assess their influence upon performance in the VCT and other models of potential anxiolytic properties.</dcterms:abstract>
        <bib:pages>83-244</bib:pages>
        <dc:date>Jun 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12927745</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59985">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12927745</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59980">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bast</foaf:surname>
                        <foaf:givenname>Tobias</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Feldon</foaf:surname>
                        <foaf:givenname>Joram</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59981"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Anxiety Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine Agents</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>GABA Agents</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Psychomotor Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Psychotic Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reflex, Startle</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Hippocampal modulation of sensorimotor processes</dc:title>
        <dcterms:abstract>While the hippocampus makes unique contributions to memory, it has also long been associated with sensorimotor processes, i.e. innate processes involving control of motor responses to sensory stimuli. Moreover, hippocampal dysfunction has been implicated in neuropsychiatric diseases, such as schizophrenia and anxiety disorders, primarily characterized by non-mnemonic deficits in the processing of and responding to sensory information. This review is concerned with the hippocampal modulation of three sensorimotor processes in rats-locomotor activity, prepulse inhibition (PPI) of the startle reflex, and the startle reflex itself-whose alterations are related to human psychosis or anxiety disorders. Its main purpose is to present and discuss the picture emerging from studies examining the effects of pharmacological manipulations of the dorsal and ventral hippocampus by local drug microinfusions. While a role of the hippocampus in regulating locomotor activity, PPI, and startle reactivity has also been suggested based on the effects of hippocampal lesions, the microinfusion studies have revealed additional important details of this role and suggest modifications of notions based on lesion studies. In summary, the microinfusion studies corroborate that hippocampal mechanisms can directly influence locomotor activity, PPI, and startle reactivity, and that aberrant hippocampal function may contribute to neuropsychiatric diseases, in particular psychosis. The relation between different sensorimotor processes and hippocampal neurotransmission, the role of ventral and dorsal hippocampus, and the extrahippocampal mechanisms mediating the hippocampal modulation of different sensorimotor processes can partly be dissociated. Thus, the hippocampal modulation of these sensorimotor processes appears to reflect multiple operations, rather than one unitary operation.</dcterms:abstract>
        <bib:pages>319-345</bib:pages>
        <dc:date>Jul 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12963091</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59981">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12963091</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59978">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kiehn</foaf:surname>
                        <foaf:givenname>Ole</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Butt</foaf:surname>
                        <foaf:givenname>Simon J. B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59979"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ephrin-A4</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ephrin-B3</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Genetic Techniques</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Interneurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Locomotion</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Research Design</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rodentia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Spinal Cord</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Physiological, anatomical and genetic identification of CPG neurons in the developing mammalian spinal cord</dc:title>
        <dcterms:abstract>The basic motor patterns underlying rhythmic limb movements during locomotion are generated by neuronal networks located within the spinal cord. These networks are called Central Pattern Generators (CPGs). Isolated spinal cord preparations from newborn rats and mice have become increasingly important for understanding the organization of the CPG in the mammalian spinal cord. Early studies using these preparations have focused on the overall network structure and the localization of the CPG. In this review we concentrate on recent experiments aimed at identifying and characterizing CPG-interneurons in the rodent. These experiments include the organization and function of descending commissural interneurons (dCINs) in the hindlimb CPG of the neonatal rat, as well as the role of Ephrin receptor A4 (EphA4) and its Ephrin ligand B3 (EphrinB3), in the construction of the mammalian locomotor network. These latter experiments have defined EphA4 as a molecular marker for mammalian excitatory hindlimb CPG neurons. We also review genetic approaches that can be applied to the mouse spinal cord. These include methods for identifying sub-populations of neurons by genetically encoded reporters, techniques to trace network connectivity with cell-specific genetically encoded tracers, and ways to selectively ablate or eliminate neuron populations from the CPG. We propose that by applying a multidisciplinary approach it will be possible to understand the network structure of the mammalian locomotor CPG. Such an understanding will be instrumental in devising new therapeutic strategies for patients with spinal cord injury.</dcterms:abstract>
        <bib:pages>347-361</bib:pages>
        <dc:date>Jul 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12963092</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59979">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12963092</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59976">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yu</foaf:surname>
                        <foaf:givenname>Shan Ping</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59977"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Homeostasis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mitochondria</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>potassium</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Potassium Channels</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sodium-Potassium-Exchanging ATPase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Regulation and critical role of potassium homeostasis in apoptosis</dc:title>
        <dcterms:abstract>Programmed cell death or apoptosis is broadly responsible for the normal homeostatic removal of cells and has been increasingly implicated in mediating pathological cell loss in many disease states. As the molecular mechanisms of apoptosis have been extensively investigated a critical role for ionic homeostasis in apoptosis has been recently endorsed. In contrast to the ionic mechanism of necrosis that involves Ca(2+) influx and intracellular Ca(2+) accumulation, compelling evidence now indicates that excessive K(+) efflux and intracellular K(+) depletion are key early steps in apoptosis. Physiological concentration of intracellular K(+) acts as a repressor of apoptotic effectors. A huge loss of cellular K(+), likely a common event in apoptosis of many cell types, may serve as a disaster signal allowing the execution of the suicide program by activating key events in the apoptotic cascade including caspase cleavage, cytochrome c release, and endonuclease activation. The pro-apoptotic disruption of K(+) homeostasis can be mediated by over-activated K(+) channels or ionotropic glutamate receptor channels, and most likely, accompanied by reduced K(+) uptake due to dysfunction of Na(+), K(+)-ATPase. Recent studies indicate that, in addition to the K(+) channels in the plasma membrane, mitochondrial K(+) channels and K(+) homeostasis also play important roles in apoptosis. Investigations on the K(+) regulation of apoptosis have provided a more comprehensive understanding of the apoptotic mechanism and may afford novel therapeutic strategies for apoptosis-related diseases.</dcterms:abstract>
        <bib:pages>363-386</bib:pages>
        <dc:date>Jul 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 12963093</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59977">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/12963093</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59968">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Guan</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bennet</foaf:surname>
                        <foaf:givenname>L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gluckman</foaf:surname>
                        <foaf:givenname>P. D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gunn</foaf:surname>
                        <foaf:givenname>A. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59969"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hypoxia-Ischemia, Brain</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Insulin-Like Growth Factor Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Insulin-Like Growth Factor I</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor, IGF Type 1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Insulin-like growth factor-1 and post-ischemic brain injury</dc:title>
        <dcterms:abstract>Insulin-like growth factor-1 (IGF-1) is a naturally occurring neurotrophic factor that plays an important role in promoting cell proliferation and differentiation during normal brain development and maturation. The present review examines recent evidence that endogenous IGF-1 also plays a significant role in recovery from insults such as hypoxia-ischemia and that giving additional exogenous IGF-1 can actively ameliorate damage. It is now well established that neurons and other cell types die many hours or even days after initial injury due to activation of programmed cell death pathways. IGF-1 and its binding proteins and receptors are intensely induced within damaged brain regions following brain injury, suggesting a possible a role for IGF-1 in brain recovery. Exogenous administration of IGF-1 within a few hours after brain injury is now known to be protective in both gray and white matter and leads to improved somatic function. In contrast, pre-treatment is ineffective, likely reflecting limited intracerebral penetration of IGF-1 into the uninjured brain. The neuroprotective effects of IGF-1 are mediated by IGF-1 receptors and its binding proteins and are specific to particular cellular phenotypes and brain regions. The window of opportunity for treatment with IGF-1 is limited to a few hours after normothermic brain injury, reflecting its specific actions on early, intracellular events in the apoptotic cascade. However, injury-associated mild post-hypoxic hypothermia, which delays the development of cell death, can shift and dramatically extend the window of opportunity for delayed treatment with IGF-1. Such a combined approach is likely to be essential for any clinical treatment.</dcterms:abstract>
        <bib:pages>443-462</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14568359</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59969">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14568359</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59974">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Huettner</foaf:surname>
                        <foaf:givenname>James E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59975"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Kainic Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Retina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Kainate receptors and synaptic transmission</dc:title>
        <dcterms:abstract>Excitatory glutamatergic transmission involves a variety of different receptor types, each with distinct properties and functions. Physiological studies have identified both post- and presynaptic roles for kainate receptors, which are a subtype of the ionotropic glutamate receptors. Kainate receptors contribute to excitatory postsynaptic currents in many regions of the central nervous system including hippocampus, cortex, spinal cord and retina. In some cases, postsynaptic kainate receptors are co-distributed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors, but there are also synapses where transmission is mediated exclusively by postsynaptic kainate receptors: for example, in the retina at connections made by cones onto off bipolar cells. Modulation of transmitter release by presynaptic kainate receptors can occur at both excitatory and inhibitory synapses. The depolarization of nerve terminals by current flow through ionotropic kainate receptors appears sufficient to account for most examples of presynaptic regulation; however, a number of studies have provided evidence for metabotropic effects on transmitter release that can be initiated by activation of kainate receptors. Recent analysis of knockout mice lacking one or more of the subunits that contribute to kainate receptors, as well as studies with subunit-selective agonists and antagonists, have revealed the important roles that kainate receptors play in short- and long-term synaptic plasticity. This review briefly addresses the properties of kainate receptors and considers in greater detail the physiological analysis of their contributions to synaptic transmission.</dcterms:abstract>
        <bib:pages>387-407</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14511698</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59975">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14511698</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59972">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Paré</foaf:surname>
                        <foaf:givenname>Denis</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59973"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adrenal Cortex Hormones</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Amygdala</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Arousal</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Emotions</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurotransmitter Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Role of the basolateral amygdala in memory consolidation</dc:title>
        <dcterms:abstract>Typically, emotionally charged events are better remembered than neutral ones. This paper reviews data indicating that the amygdala is responsible for this facilitation of memory by emotional arousal. Pharmacological and behavioral studies have shown that the release of adrenal stress hormones facilitates memory consolidation. The available evidence suggests that this effect depends on a central action of stress hormones involving the release of the neuromodulators noradrenaline (NA) and acetylcholine in the basolateral complex of the amygdala (BLA). Indeed, BLA lesions block the memory modulating effects of stress hormones. Moreover, microdialysis studies have revealed that BLA concentrations of NA and acetylcholine are transiently (2h) elevated following emotionally arousing learning episodes. Last, post-learning intra-BLA injections of beta-adrenergic or muscarinic receptor antagonists reduce retention. These results have led to the hypothesis that NA and acetylcholine increase the activity of BLA neurons in the hours after the learning episode. In turn, the BLA would facilitate synaptic plasticity in other brain structures, believed to constitute the storage sites for different types of memory. Consistent with this, post-learning treatments that reduce or enhance the excitability of BLA neurons respectively decrease or improve long-term retention on various emotionally charged learning tasks. However, a number of issues remain unresolved. Chief among them is how the BLA facilitates synaptic plasticity elsewhere in the brain. The present review concludes with a consideration of this issue based on recent advances in our understanding of the BLA. Among other possibilities, it is suggested that rhythmic BLA activity at the theta frequency during arousal as well as the uniform conduction times of BLA axons to distributed rhinal sites may promote plasticity in co-active structures of the temporal lobe.</dcterms:abstract>
        <bib:pages>409-420</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14511699</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59973">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14511699</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59964">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sarna</foaf:surname>
                        <foaf:givenname>Justyna R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hawkes</foaf:surname>
                        <foaf:givenname>Richard</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59965"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebellar Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebellum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mutation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Purkinje Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Patterned Purkinje cell death in the cerebellum</dc:title>
        <dcterms:abstract>The object of this review is to assemble much of the literature concerning Purkinje cell death in cerebellar pathology and to relate this to what is now known about the complex topography of the cerebellar cortex. A brief introduction to Purkinje cells, and their regionalization is provided, and then the data on Purkinje cell death in mouse models and, where appropriate, their human counterparts, have been arranged according to several broad categories--naturally-occurring and targeted mutations leading to Purkinje cell death, Purkinje cell death due to toxins, Purkinje cell death in ischemia, Purkinje cell death in infection and in inherited disorders, etc. The data reveal that cerebellar Purkinje cell death is much more topographically complex than is usually appreciated.</dcterms:abstract>
        <bib:pages>473-507</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14568361</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59965">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14568361</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59966">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shen</foaf:surname>
                        <foaf:givenname>Yong</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Meri</foaf:surname>
                        <foaf:givenname>Seppo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59967"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Complement Activation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Complement C1</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Complement C1 Inactivator Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Complement C3</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Complement C5</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Complement System Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Heparin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Inflammation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteoglycans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Complement</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vaccination</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Yin and Yang: complement activation and regulation in Alzheimer's disease</dc:title>
        <dcterms:abstract>The spectrum of inflammatory diseases is nowadays considered to include diverse diseases of the central nervous system (CNS). Current evidence suggests that syndromes such as Alzheimer's disease (AD) have important inflammatory and immune components and may be amenable to treatment by anti-inflammatory and immunotherapeutic approaches. Compelling evidence has been reported that complement activation occurs in the brain with Alzheimer's disease, and that this contributes to the development of a local inflammatory state that is correlated with cognitive dysfunction. The complement system is a critical element of the innate immune system recognizing and killing, or targeting for destruction, otherwise pathogenic organisms. In addition to triggering the generation of a membranolytic complex, complement proteins interact with cell surface receptors to promote a local inflammatory response that contributes to the protection and healing of the host. Complement activation causes inflammation and cell damage, yet it is an essential component in trying to eliminate cell debris and potentially toxic protein aggregates. It is the balance of these seemingly competing events--the &quot;Yin&quot; and the &quot;Yang&quot;--that influences the ultimate state of neuronal function. Knowledge of the unique molecular interactions that occur in the development of Alzheimer's disease, the functional consequences of those interactions, and the proportional contribution of each element to this disorder, should facilitate the design of effective therapeutic strategies for this disease.</dcterms:abstract>
        <bib:pages>463-472</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Yin and Yang</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14568360</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59967">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14568360</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59970">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>70</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Weeks</foaf:surname>
                        <foaf:givenname>Janis C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59971"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dendrites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gonadal Steroid Hormones</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Insects</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Metamorphosis, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Muscles</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Thinking globally, acting locally: steroid hormone regulation of the dendritic architecture, synaptic connectivity and death of an individual neuron</dc:title>
        <dcterms:abstract>Steroid hormones act via evolutionarily conserved nuclear receptors to regulate neuronal phenotype during development, maturity and disease. Steroid hormones exert 'global' effects in organisms to produce coordinated physiological responses whereas, at the 'local' level, individual neurons can respond to a steroidal signal in highly specific ways. This review focuses on two phenomena-the loss of dendritic processes and the programmed cell death (PCD) of neurons-that can be regulated by steroid hormones (e.g. during sexual differentiation in vertebrates). In insects such as the moth, Manduca sexta, and fruit fly, Drosophila melanogaster, ecdysteroids orchestrate a reorganization of neural circuits during metamorphosis. In Manduca, accessory planta retractor (APR) motoneurons undergo dendritic loss at the end of larval life in response to a rise in 20-hydroxyecdysone (20E). Dendritic regression is associated with a decrease in the strength of monosynaptic inputs, a decrease in the number of contacts from pre-synaptic neurons, and the loss of a behavior mediated by these synapses. The APRs in different abdominal segments undergo segment-specific PCD at pupation and adult emergence that is triggered directly and cell-autonomously by a genomic action of 20E, as demonstrated in cell culture. The post-emergence death of APRs provides a model for steroid-mediated neuroprotection. APR death occurs by autophagy, not apoptosis, and involves caspase activation and the aggregation and ultracondensation of mitochondria. Manduca genes involved in segmental identity, 20E signaling and PCD are being sought by suppressive subtractive hybridization (SSH) and cDNA microarrays. Experiments utilizing Drosophila as a complementary system have been initiated. These insect model systems contribute toward understanding the causes and functional consequences of dendritic loss and neurodegeneration in human neurological disorders.</dcterms:abstract>
        <bib:pages>421-442</bib:pages>
        <dc:date>Aug 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Thinking globally, acting locally</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14511700</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59971">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14511700</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59960">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garcia-Segura</foaf:surname>
                        <foaf:givenname>Luis M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Veiga</foaf:surname>
                        <foaf:givenname>Sergio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sierra</foaf:surname>
                        <foaf:givenname>Amanda</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>Roberto C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azcoitia</foaf:surname>
                        <foaf:givenname>Iñigo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59961"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Aromatase</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Estradiol</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Aromatase: a neuroprotective enzyme</dc:title>
        <dcterms:abstract>Estradiol, in addition to its participation in neuroendocrine regulation and sexual behavior, has neuroprotective properties. Different types of brain injury induce the expression of the enzyme aromatase in reactive astroglia. This enzyme catalyzes the conversion of testosterone and other C19 steroids to estradiol. Genetic or pharmacological inhibition of brain aromatase results in marked neurodegeneration after different forms of mild neurodegenerative stimuli that do not compromise neuronal survival under control conditions. Furthermore, aromatase mediates neuroprotective effects of precursors of estradiol such as pregnenolone, dehydroepiandrosterone (DHEA) and testosterone. These findings strongly suggest that local formation of estradiol in the brain is neuroprotective and that the induction of aromatase and the consecutive increase in the local production of estradiol are part of the program triggered by the neural tissue to cope with neurodegenerative insults. Aromatase may thus represent an important pharmacological target for therapies conducted to prevent aging-associated neurodegenerative disorders.</dcterms:abstract>
        <bib:pages>31-41</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Aromatase</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611865</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59961">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611865</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59956">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ibanez</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Shields</foaf:surname>
                        <foaf:givenname>S. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>El-Etr</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Leonelli</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Magnaghi</foaf:surname>
                        <foaf:givenname>V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Li</foaf:surname>
                        <foaf:givenname>W.-W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sim</foaf:surname>
                        <foaf:givenname>F. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Baulieu</foaf:surname>
                        <foaf:givenname>E.-E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>R. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schumacher</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Franklin</foaf:surname>
                        <foaf:givenname>R. J. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59957"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Sheath</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Progesterone</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Steroids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Steroids and the reversal of age-associated changes in myelination and remyelination</dc:title>
        <dcterms:abstract>The myelin sheaths that surround all but the smallest diameter axons within the mammalian central nervous system (CNS) must maintain their structural integrity for many years. Like many tissues, however, this function is prone to the effects of ageing, and various structural anomalies become apparent in the aged CNS. Similarly, the regenerative process by which myelin sheaths, lost as a consequence of exposure to a demyelinating insult, are restored (remyelination) is also affected by age. As animals grow older, the efficiency of remyelination progressively declines. In this article, we review both phenomena and describe how both can be partially reversed by steroid hormones and their derivatives.</dcterms:abstract>
        <bib:pages>49-56</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611867</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59957">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611867</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59952">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lambert</foaf:surname>
                        <foaf:givenname>Jeremy J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Belelli</foaf:surname>
                        <foaf:givenname>Delia</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Peden</foaf:surname>
                        <foaf:givenname>Dianne R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vardy</foaf:surname>
                        <foaf:givenname>Audrey W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Peters</foaf:surname>
                        <foaf:givenname>John A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59953"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>phosphorylation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Isoforms</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, GABA-A</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Steroids</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurosteroid modulation of GABAA receptors</dc:title>
        <dcterms:abstract>Certain metabolites of progesterone and deoxycorticosterone are established as potent and selective positive allosteric modulators of the gamma-aminobutyric acid type A (GABA(A)) receptor. Upon administration these steroids exhibit clear behavioural effects that include anxiolysis, sedation and analgesia, they are anticonvulsant and at high doses induce a state of general anaesthesia, a profile consistent with an action to enhance neuronal inhibition. Physiologically, peripherally synthesised pregnane steroids derived from endocrine glands such as the adrenals and ovaries function as hormones by crossing the blood brain barrier to influence neuronal signalling. However, the demonstration that certain neurons and glial cells within the central nervous system (CNS) can synthesize these steroids either de novo, or from peripherally derived progesterone, has led to the proposal that these steroids (neurosteroids) can additionally function in a paracrine manner, to locally influence GABAergic transmission. Steroid levels are known to change dynamically, for example in stress and during pregnancy. Given that GABA(A) receptors are ubiquitously expressed throughout the central nervous system, such changes in steroid levels would be predicted to cause a global enhancement of inhibitory neurotransmission throughout the brain, a scenario that would seem incompatible with a physiological role as a selective neuromodulator. Here, we will review emerging evidence that the GABA-modulatory actions of the pregnane steroids are highly selective, with their actions being brain region and indeed neuron dependent. Furthermore, the sensitivity of GABA(A) receptors is not static but can dynamically change. The molecular mechanisms underpinning this neuronal specificity will be discussed with particular emphasis being given to the role of GABA(A) receptor isoforms, protein phosphorylation and local steroid metabolism and synthesis.</dcterms:abstract>
        <bib:pages>67-80</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611869</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59953">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611869</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59958">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mayo</foaf:surname>
                        <foaf:givenname>Willy</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>George</foaf:surname>
                        <foaf:givenname>Olivier</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Darbra</foaf:surname>
                        <foaf:givenname>Sonia</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bouyer</foaf:surname>
                        <foaf:givenname>Jean-Jacques</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Vallée</foaf:surname>
                        <foaf:givenname>Monique</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Darnaudéry</foaf:surname>
                        <foaf:givenname>Muriel</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pallarès</foaf:surname>
                        <foaf:givenname>Marc</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lemaire-Mayo</foaf:surname>
                        <foaf:givenname>Valérie</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Le Moal</foaf:surname>
                        <foaf:givenname>Michel</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Piazza</foaf:surname>
                        <foaf:givenname>Pier-Vincenzo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Abrous</foaf:surname>
                        <foaf:givenname>Nora</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59959"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acetylcholine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pregnenolone</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Individual differences in cognitive aging: implication of pregnenolone sulfate</dc:title>
        <dcterms:abstract>In humans and animals, individual differences in aging of cognitive functions are classically reported. Some old individuals exhibit performances similar to those of young subjects while others are severely impaired. In senescent animals, we have previously demonstrated a significant correlation between the cognitive performance and the cerebral concentration of a neurosteroid, the pregnenolone sulfate (PREG-S). Neurotransmitter systems modulated by this neurosteroid were unknown until our recent report of an enhancement of acetylcholine (ACh) release in basolateral amygdala, cortex and hippocampus induced by intracerebroventricular (i.c.v.) or intracerebral administrations of PREG-S. Central ACh neurotransmission is known to be involved in the regulation of memory processes and is affected in normal aging and severely altered in human neurodegenerative pathologies like Alzheimer's disease. In the central nervous system, ACh neurotransmission is also involved in the modulation of sleep-wakefulness cycle, and particularly the paradoxical sleep (PS). Relationships between paradoxical sleep and memory are documented in the literature in old animals in which the spatial memory performance positively correlates with the basal amounts of paradoxical sleep. PREG-S infused at the level of ACh cell bodies (nucleus basalis magnocellularis, NBM, or pedunculopontine nucleus, PPT) increases paradoxical sleep in young animals.Finally, aging related cognitive dysfunctions, particularly those observed in Alzheimer's disease, have also been related to alterations of mechanisms underlying cerebral plasticity. Amongst these mechanisms, neurogenesis has been extensively studied recently. Our data demonstrate that PREG-S central infusions dramatically increase neurogenesis, this effect could be related to the negative modulator properties of this steroid at the GABA(A) receptor level. Taken together these data suggest that neurosteroids can influence cognitive processes, particularly in senescent subjects, through a modulation of ACh neurotransmission associated with paradoxical sleep modifications; furthermore, our recent data suggest a critical role for neurosteroids in the modulation of cerebral plasticity, mainly on hippocampal neurogenesis.</dcterms:abstract>
        <bib:pages>43-48</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Individual differences in cognitive aging</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611866</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59959">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611866</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59954">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>R. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Azcoitia</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ballabio</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cavarretta</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gonzalez</foaf:surname>
                        <foaf:givenname>L. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Leonelli</foaf:surname>
                        <foaf:givenname>E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Magnaghi</foaf:surname>
                        <foaf:givenname>V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Veiga</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garcia-Segura</foaf:surname>
                        <foaf:givenname>L. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59955"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Myelin P0 Protein</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Myelin Sheath</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Progesterone</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves</dc:title>
        <dcterms:abstract>The process of aging deeply influences morphological and functional parameters of peripheral nerves. The observations summarized here indicate that the deterioration of myelin occurring in the peripheral nerves during aging may be explained by the fall of the levels of the major peripheral myelin proteins [e.g., glycoprotein Po (Po) and peripheral myelin protein 22 (PMP22)]. Neuroactive steroids, such as progesterone (PROG), dihydroprogesterone (5alpha-DH PROG), and tetrahydroprogesterone (3alpha,5alpha-TH PROG), are able to stimulate the low expression of these two myelin proteins present in the sciatic nerve of aged male rats. Since Po and PMP22 play an important physiological role in the maintenance of the multilamellar structure of PNS myelin, we have evaluated the effect of PROG and its neuroactive derivatives, 5alpha-DH PROG and 3alpha,5alpha-TH PROG, on the morphological alterations of myelinated fibers in the sciatic nerve of 22-24-month-old male rats. Data obtained clearly indicate that neuroactive steroids are able to reduce aging-associated morphological abnormalities of myelin and aging-associated myelin fiber loss in the sciatic nerve.</dcterms:abstract>
        <bib:pages>57-66</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neuroactive steroids influence peripheral myelination</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611868</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59955">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611868</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59962">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schumacher</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Weill-Engerer</foaf:surname>
                        <foaf:givenname>S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Liere</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Robert</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Franklin</foaf:surname>
                        <foaf:givenname>R. J. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Garcia-Segura</foaf:surname>
                        <foaf:givenname>L. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lambert</foaf:surname>
                        <foaf:givenname>J. J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Mayo</foaf:surname>
                        <foaf:givenname>W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Melcangi</foaf:surname>
                        <foaf:givenname>R. C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Parducz</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Suter</foaf:surname>
                        <foaf:givenname>U.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carelli</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Baulieu</foaf:surname>
                        <foaf:givenname>E. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Akwa</foaf:surname>
                        <foaf:givenname>Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59963"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dementia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>hormones</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Steroid hormones and neurosteroids in normal and pathological aging of the nervous system</dc:title>
        <dcterms:abstract>Without medical progress, dementing diseases such as Alzheimer's disease will become one of the main causes of disability. Preventing or delaying them has thus become a real challenge for biomedical research. Steroids offer interesting therapeutical opportunities for promoting successful aging because of their pleiotropic effects in the nervous system: they regulate main neurotransmitter systems, promote the viability of neurons, play an important role in myelination and influence cognitive processes, in particular learning and memory. Preclinical research has provided evidence that the normally aging nervous system maintains some capacity for regeneration and that age-dependent changes in the nervous system and cognitive dysfunctions can be reversed to some extent by the administration of steroids. The aging nervous system also remains sensitive to the neuroprotective effects of steroids. In contrast to the large number of studies documenting beneficial effects of steroids on the nervous system in young and aged animals, the results from hormone replacement studies in the elderly are so far not conclusive. There is also little information concerning changes of steroid levels in the aging human brain. As steroids present in nervous tissues originate from the endocrine glands (steroid hormones) and from local synthesis (neurosteroids), changes in blood levels of steroids with age do not necessarily reflect changes in their brain levels. There is indeed strong evidence that neurosteroids are also synthesized in human brain and peripheral nerves. The development of a very sensitive and precise method for the analysis of steroids by gas chromatography/mass spectrometry (GC/MS) offers new possibilities for the study of neurosteroids. The concentrations of a range of neurosteroids have recently been measured in various brain regions of aged Alzheimer's disease patients and aged non-demented controls by GC/MS, providing reference values. In Alzheimer's patients, there was a general trend toward lower levels of neurosteroids in different brain regions, and neurosteroid levels were negatively correlated with two biochemical markers of Alzheimer's disease, the phosphorylated tau protein and the beta-amyloid peptides. The metabolism of dehydroepiandrosterone has also been analyzed for the first time in the aging brain from Alzheimer patients and non-demented controls. The conversion of dehydroepiandrosterone to Delta5-androstene-3beta,17beta-diol and to 7alpha-OH-dehydroepiandrosterone occurred in frontal cortex, hippocampus, amygdala, cerebellum and striatum of both Alzheimer's patients and controls. The formation of these metabolites within distinct brain regions negatively correlated with the density of beta-amyloid deposits.</dcterms:abstract>
        <bib:pages>3-29</bib:pages>
        <dc:date>Sep 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14611864</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59963">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14611864</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59950">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>2-3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Arendt</foaf:surname>
                        <foaf:givenname>Thomas</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59951"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Cycle</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity</dc:title>
        <dcterms:abstract>Mental actions are based on the dynamic organization of neuronal networks. In particular, phylogenetically young brain areas (e.g., cortical associative circuits) involved in the realization of higher brain functions are continuously re-adjusted to meet environmental demands. The mechanisms of synaptic plasticity, i.e., of structural stabilization and labilization underlying a life-long synaptic remodelling, are largely based on external morphoregulatory cues and internal signalling pathways that non-neuronal cells have phylogenetically acquired to sense their relationship to the local neighbourhood and to control after development is completed proliferation and differentiation in the process of tissue repair and regeneration. After having withdrawn from the cell cycle, differentiated neurons are, thus, able to use molecular mechanisms primarily developed to control proliferation alternatively to control synaptic plasticity. The existence of these alternative effector pathways within a neuron puts it at risk to erroneously convert signals derived from plastic synaptic changes into positional cues that will activate the cell cycle. This cell cycle activation potentially links synaptic plasticity to cell death. Preventing cell cycle activation by locking neurons in a differentiated but still highly plastic phenotype will, thus, be crucial to prevent neurodegeneration.</dcterms:abstract>
        <bib:pages>83-248</bib:pages>
        <dc:date>Oct 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14687983</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59951">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14687983</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59948">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>2-3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Wit</foaf:surname>
                        <foaf:givenname>Joris</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Verhaagen</foaf:surname>
                        <foaf:givenname>Joost</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59949"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Semaphorins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Role of semaphorins in the adult nervous system</dc:title>
        <dcterms:abstract>In the developing nervous system, extending axons are directed towards their appropriate targets by a myriad of attractive and repulsive guidance cues. Work in the past decade has significantly advanced our understanding of these molecules and has made it increasingly clear that their function is not limited to the guidance of growing axons during embryogenesis. Axon guidance cues fulfill additional roles in angiogenesis, cell migration and the immune system, and often display sustained expression in adulthood. Here we focus on the semaphorin (Sema) family and review their proposed functions in the adult nervous system. Several semaphorin family members continue to be expressed in the adult brain and spinal cord, and increasing evidence indicates that their expression is regulated upon nervous system injury in rodents and in neuropathology in humans. The available evidence suggests that semaphorins might significantly contribute to the maintenance and stability of neuronal networks. Furthermore, semaphorins could play important roles in the regeneration, or failure thereof, of neuronal connections. In the future, genetic manipulation of semaphorins and their receptors in the adult intact and injured nervous system should provide a deeper insight into the mechanisms by which semaphorin signaling contributes to structural plasticity and regeneration in the adult brain.</dcterms:abstract>
        <bib:pages>249-267</bib:pages>
        <dc:date>Oct 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14687984</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59949">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14687984</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59944">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Taylor</foaf:surname>
                        <foaf:givenname>John G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59945"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Attention</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Consciousness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Psychomotor Performance</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Paying attention to consciousness</dc:title>
        <dcterms:abstract>An engineering control approach is developed for the movement of attention, based on several features: experimental data indicating separate sites for attention modulation and for the creation of that modulation; the resulting analogy with motor control, to which an engineering approach has been applied; simulation and qualitative results supporting the presence of several of the necessary modules. These features are reviewed in the paper and a control model developed for the movement of attention. The engineering control framework is extended to the attended learning of motor control, again with description of support arising from simulations and qualitative analysis of several paradigms. The framework is even further extended to analyze how consciousness could arise during attentive processing, using the COrollary Discharge of Attention Movement (CODAM) model. This model is extended to encompass the temporal development of activity in various brain sites. Particular signals of the CODAM model are described and related to paradigms such as the attentional blink (AB) and features of simultaneous experience in neglect. A program of future explorations of the CODAM model and a set of open questions conclude the paper.</dcterms:abstract>
        <bib:pages>305-335</bib:pages>
        <dc:date>Nov 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14698766</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59945">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14698766</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59946">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Van der Kloot</foaf:surname>
                        <foaf:givenname>William</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59947"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acetylcholine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Electric Organ</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuromuscular Junction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Vesicles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Torpedo</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Loading and recycling of synaptic vesicles in the Torpedo electric organ and the vertebrate neuromuscular junction</dc:title>
        <dcterms:abstract>In vertebrate motor nerve terminals and in the electromotor nerve terminals of Torpedo there are two major pools of synaptic vesicles: readily releasable and reserve. The electromotor terminals differ in that the reserve vesicles are twice the diameter of the readily releasable vesicles. The vesicles contain high concentrations of ACh and ATP. Part of the ACh is brought into the vesicle by the vesicular ACh transporter, VAChT, which exchanges two protons for each ACh, but a fraction of the ACh seems to be accumulated by different, unexplored mechanisms. Most of the vesicles in the terminals do not exchange ACh or ATP with the axoplasm, although ACh and ATP are free in the vesicle interior. The VAChT is controlled by a multifaceted regulatory complex, which includes the proteoglycans that characterize the cholinergic vesicles. The drug (-)-vesamicol binds to a site on the complex and blocks ACh exchange. Only 10-20% of the vesicles are in the readily releasable pool, which therefore is turned over fairly rapidly by spontaneous quantal release. The turnover can be followed by the incorporation of false transmitters into the recycling vesicles, and by the rate of uptake of FM dyes, which have some selectivity for the two recycling pathways. The amount of ACh loaded into recycling vesicles in the readily releasable pool decreases during stimulation. The ACh content of the vesicles can be varied over eight-fold range without changing vesicle size.</dcterms:abstract>
        <bib:pages>269-303</bib:pages>
        <dc:date>Nov 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14698765</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59947">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14698765</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59934">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.12.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bar-Gad</foaf:surname>
                        <foaf:givenname>Izhar</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Morris</foaf:surname>
                        <foaf:givenname>Genela</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bergman</foaf:surname>
                        <foaf:givenname>Hagai</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59935"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Basal Ganglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Processes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reinforcement (Psychology)</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Information processing, dimensionality reduction and reinforcement learning in the basal ganglia</dc:title>
        <dcterms:abstract>Modeling of the basal ganglia has played a major role in our understanding of this elusive group of nuclei. Models of the basal ganglia have undergone evolutionary and revolutionary changes over the last 20 years, as new research in the fields of anatomy, physiology and biochemistry of these nuclei has yielded new information. Early models dealt with a single pathway through the nuclei and focused on the nature of the processing performed within it, convergence of information versus parallel processing of information. Later, the Albin-DeLong &quot;box-and-arrow&quot; model characterized the inter-nuclei interaction as multiple pathways while maintaining a simplistic scalar representation of the nuclei themselves. This model made a breakthrough by providing key insights into the behavior of these nuclei in hypo- and hyper-kinetic movement disorders. The next generation of models elaborated the intra-nuclei interactions and focused on the role of the basal ganglia in action selection and sequence generation which form the most current consensus regarding basal ganglia function in both normal and pathological conditions. However, new findings challenge these models and point to a different neural network approach to information processing in the basal ganglia. Here, we take an in-depth look at the reinforcement driven dimensionality reduction (RDDR) model which postulates that the basal ganglia compress cortical information according to a reinforcement signal using optimal extraction methods. The model provides new insights and experimental predictions on the computational capacity of the basal ganglia and their role in health and disease.</dcterms:abstract>
        <bib:pages>439-473</bib:pages>
        <dc:date>Dec 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15013228</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59935">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15013228</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59940">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dampney</foaf:surname>
                        <foaf:givenname>R. a. L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Horiuchi</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59941"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Anoxia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Baroreflex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>blood pressure</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Blood Volume</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cardiovascular System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Gene Expression</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Proto-Oncogene Proteins c-fos</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Functional organisation of central cardiovascular pathways: studies using c-fos gene expression</dc:title>
        <dcterms:abstract>Until about 10 years ago, knowledge of the functional organisation of the central pathways that subserve cardiovascular responses to homeostatic challenges and other stressors was based almost entirely on studies in anaesthetised animals. More recently, however, many studies have used the method of the expression of immediate early genes, particularly the c-fos gene, to identify populations of central neurons that are activated by such challenges in conscious animals. In this review we first consider the advantages and limitations of this method. Then, we discuss how the application of the method of immediate early gene expression, when used alone or in combination with other methods, has contributed to our understanding of the central mechanisms that regulate the autonomic and neuroendocrine response to various cardiovascular challenges (e.g., hypotension, hypoxia, hypovolemia, and other stressors) as they operate in the conscious state. In general, the results of studies of central cardiovascular pathways using immediate early gene expression are consistent with previous studies in anaesthetised animals, but in addition have revealed other previously unrecognised pathways that also contribute to cardiovascular regulation. Finally, we briefly consider recent evidence indicating that immediate early gene expression can modify the functional properties of central cardiovascular neurons, and the possible significance of this in producing long-term changes in the regulation of the cardiovascular system both in normal and pathological conditions.</dcterms:abstract>
        <bib:pages>359-384</bib:pages>
        <dc:date>Dec 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Functional organisation of central cardiovascular pathways</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14757116</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59941">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14757116</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59942">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gutiérrez</foaf:surname>
                        <foaf:givenname>Rafael</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59943"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Carrier Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dentate Gyrus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>GABA Plasma Membrane Transport Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>gamma-Aminobutyric Acid</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Glutamate Decarboxylase</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Isoenzymes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Membrane Transport Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mossy Fibers, Hippocampal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Organic Anion Transporters</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, GABA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The GABAergic phenotype of the &quot;glutamatergic&quot; granule cells of the dentate gyrus</dc:title>
        <dcterms:abstract>The granule cells of the dentate gyrus (DG), origin of the mossy fibers (MFs), have been considered to be glutamatergic. However, data obtained with different experimental approaches in recent years may be calling for a redefinition of their phenotype. Although they indeed release glutamate for fast neurotransmission, immunohistological and molecular biology evidence has revealed that these glutamatergic cells also express GABAergic markers. The granule cell expression of a GABAergic phenotype is developmentally regulated. Electrophysiological studies reveal that during the first 3 weeks of age, mossy fiber stimulation provokes monosynaptic fast inhibitory transmission mediated by GABA, besides the monosynaptic excitatory glutamatergic transmission, onto their targets in CA3. After this age, mossy fiber GABAergic transmission abruptly disappears and the GABAergic markers are undetected. In the adult, the GABAergic markers are upregulated and GABA-mediated transmission emerges after induction of hyperexcitability. The simultaneous glutamate- and GABA-mediated signals share the same plastic and pharmacological characteristics that correspond to neurotransmission of mossy fiber origin. This intriguing evidence gives rise to two fundamental points of discussion. The first is the plausible fact that glutamate and GABA, two neurotransmitters of opposing actions, are coreleased from the mossy fibers. The second relates to its functional implications that can be immediately inferred, as the dentate gyrus can exert direct GABA-mediated excitatory actions early in life and inhibitory actions in young and adult hippocampus. This evidence poses the need to reevaluate and reinterpret some aspects of the physiology of the mossy fiber pathway under normal and pathological conditions. This work reviews the recent evidence that supports the assumption that glutamate and GABA can be coreleased from a single pathway, the mossy fibers, and makes some considerations about its functional implications.</dcterms:abstract>
        <bib:pages>337-358</bib:pages>
        <dc:date>Dec 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14757115</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59943">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14757115</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59936">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.12.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nguyen</foaf:surname>
                        <foaf:givenname>P. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Woo</foaf:surname>
                        <foaf:givenname>N. H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59937"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cyclic AMP-Dependent Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Synaptic Depression</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases</dc:title>
        <dcterms:abstract>Protein kinases critically regulate synaptic plasticity in the mammalian hippocampus. Cyclic-AMP dependent protein kinase (PKA) is a serine-threonine kinase that has been strongly implicated in the expression of specific forms of long-term potentiation (LTP), long-term depression (LTD), and hippocampal long-term memory. We review the roles of PKA in activity-dependent forms of hippocampal synaptic plasticity by highlighting particular themes that have emerged in ongoing research. These include the participation of distinct isoforms of PKA in specific types of synaptic plasticity, modification of the PKA-dependence of LTP by multiple factors such as distinct patterns of imposed activity, environmental enrichment, and genetic manipulation of signalling molecules, and presynaptic versus postsynaptic mechanisms for PKA-dependent LTP. We also discuss many of the substrates that have been implicated as targets for PKA's actions in hippocampal synaptic plasticity, including CREB, protein phosphatases, and glutamatergic receptors. Future prospects for shedding light on the roles of PKA are also described from the perspective of specific aspects of synaptic physiology and brain function that are ripe for investigation using incisive genetic, cell biological, and electrophysiological approaches.</dcterms:abstract>
        <bib:pages>401-437</bib:pages>
        <dc:date>Dec 2003</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15013227</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59937">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15013227</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59938">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>71</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sousa</foaf:surname>
                        <foaf:givenname>Mónica Mendes</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Saraiva</foaf:surname>
                        <foaf:givenname>Maria João</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59939"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Amyloid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid Neuropathies, Familial</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Degeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>oxidative stress</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peripheral Nerves</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Prealbumin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Immunologic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Schwann Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling</dc:title>
        <dcterms:abstract>Familial amyloid polyneuropathy (FAP) is an autosomal dominant neurodegenerative disorder related to the systemic deposition of mutated transthyretin (TTR) amyloid fibrils, particularly in peripheral nervous system (PNS). TTR fibrils are diffusely distributed in the PNS of FAP patients, involving nerve trunks, plexuses and ganglia. In peripheral nerves, amyloid deposits are prominent in the endoneurium, near blood vessels, Schwann cells and collagen fibrils. Fiber degeneration is axonal, beginning in the unmyelinated and low diameter myelinated fibers. Several hypotheses have been raised to explain axonal and neuronal loss: (i) compression of the nervous tissue by amyloid; however, a cause-effect relationship between amyloid deposition, structural nerve changes and degeneration was never clearly made; (ii) role of nerve ischemia secondary to lesions caused by perivascular amyloid, which is also doubtful as compromised blood flow was never demonstrated; (iii) lesions in the dorsal root ganglia neurons or Schwann cells. Recently, evidence for the presence of toxic non-fibrillar TTR aggregates early in FAP nerves constituted a first step to unravel molecular signaling related to neurodegeneration in FAP. The toxic nature of TTR non-fibrillar aggregates, and not mature TTR fibrils, was evidenced by their ability to induce the expression of oxidative stress and inflammation-related molecules in neuronal cells, driving them into apoptotic pathways. How these TTR aggregates exert their effects is debatable; interaction with cellular receptors, namely, the receptor for advanced glycation endproducts (RAGE), is a probable candidate mechanism. The pathology and the yet unknown molecular signaling mechanisms responsible for neurodegeneration in FAP are discussed.</dcterms:abstract>
        <bib:pages>385-400</bib:pages>
        <dc:date>Dec 2003</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neurodegeneration in familial amyloid polyneuropathy</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 14757117</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59939">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/14757117</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59932">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.12.005</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Becker</foaf:surname>
                        <foaf:givenname>Esther B. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bonni</foaf:surname>
                        <foaf:givenname>Azad</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59933"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Biological Markers</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Cycle</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nervous System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cell cycle regulation of neuronal apoptosis in development and disease</dc:title>
        <dcterms:abstract>Apoptosis of neurons is indispensable to the normal development of the nervous system and contributes to neuronal loss in neurologic injury and disease. Life and death decisions are imposed upon neurons by extracellular and intracellular stimuli including the lack of trophic support, exposure to neurotoxins, oxidative stress, and DNA damage. These stimuli induce signaling pathways that are integrated at the mitochondrial apoptotic machinery culminating in cell survival or death. Growing evidence suggests that cell cycle proteins are expressed in dying neurons in the developing and adult brain. However, the role and mechanisms by which re-activation of cell cycle pathways in postmitotic neurons propagates an apoptotic signal to the cell death machinery are just beginning to be characterized. Here, we will review the molecular mechanisms of neuronal cell death and survival with a focus on recent findings on cell cycle regulation of neuronal apoptosis in primary cultures of neurons, mouse models of neuronal diseases, and human neurodegenerative diseases.</dcterms:abstract>
        <bib:pages>1-25</bib:pages>
        <dc:date>Jan 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15019174</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59933">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15019174</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59928">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.11.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Faingold</foaf:surname>
                        <foaf:givenname>Carl L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59929"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Acoustic Stimulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Anticonvulsants</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Epilepsy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Excitatory Amino Acid Antagonists</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Emergent properties of CNS neuronal networks as targets for pharmacology: application to anticonvulsant drug action</dc:title>
        <dcterms:abstract>CNS drugs may act by modifying the emergent properties of complex CNS neuronal networks. Emergent properties are network characteristics that are not predictably based on properties of individual member neurons. Neuronal membership within networks is controlled by several mechanisms, including burst firing, gap junctions, endogenous and exogenous neuroactive substances, extracellular ions, temperature, interneuron activity, astrocytic integration and external stimuli. The effects of many CNS drugs in vivo may critically involve actions on specific brain loci, but this selectivity may be absent when the same neurons are isolated from the network in vitro where emergent properties are lost. Audiogenic seizures (AGS) qualify as an emergent CNS property, since in AGS the acoustic stimulus evokes a non-linear output (motor convulsion), but the identical stimulus evokes minimal behavioral changes normally. The hierarchical neuronal network, subserving AGS in rodents is initiated in inferior colliculus (IC) and progresses to deep layers of superior colliculus (DLSC), pontine reticular formation (PRF) and periaqueductal gray (PAG) in genetic and ethanol withdrawal-induced AGS. In blocking AGS, certain anticonvulsants reduce IC neuronal firing, while other agents act primarily on neurons in other AGS network sites. However, the NMDA receptor channel blocker, MK-801, does not depress neuronal firing in any network site despite potently blocking AGS. Recent findings indicate that MK-801 actually enhances firing in substantia nigra reticulata (SNR) neurons in vivo but not in vitro. Thus, the MK-801-induced firing increases in SNR neurons observed in vivo may involve an indirect effect via disinhibition, involving an action on the emergent properties of this seizure network.</dcterms:abstract>
        <bib:pages>55-85</bib:pages>
        <dc:date>Jan 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Emergent properties of CNS neuronal networks as targets for pharmacology</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15019176</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59929">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15019176</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59930">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.12.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hopp</foaf:surname>
                        <foaf:givenname>J. Johanna</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fuchs</foaf:surname>
                        <foaf:givenname>Albert F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59931"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adaptation, Physiological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Feedback</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Saccades</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Visual Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The characteristics and neuronal substrate of saccadic eye movement plasticity</dc:title>
        <dcterms:abstract>Saccadic eye movements are shifts in the direction of gaze that rapidly and accurately aim the fovea at targets of interest. Saccades are so brief that visual feedback cannot guide them to their targets. Therefore, the saccadic motor command must be accurately specified in advance of the movement and continually modified to compensate for growth, injury, and aging, which otherwise would produce dysmetric saccades. When a persistent dysmetria occurs in subjects with muscle weakness or neural damage or is induced in normal primates by the surreptitious jumping of a target forward or backward as a saccade is made to acquire the target, saccadic amplitude changes to reduce the dysmetria. Adaptation of saccadic amplitude or direction occurs gradually and is retained in the dark, thus representing true motor plasticity. Saccadic adaptation is more rapid in humans than in monkeys, usually is incomplete in both species, and is slower and less robust for amplitude increases than decreases. Adaptation appears to be motor rather than sensory. In humans, adaptation of saccades that would seem to require more sensory-motor processing does not transfer to saccades that seem to require less, suggesting the existence of distributed adaptation loci. In monkeys, however, transfer from more simple to more complex saccades is robust, suggesting a common adaptation site. Neurophysiological data from both species indicate that the oculomotor cerebellum is crucial for saccadic adaptation. This review shows that the precise, voluntary behaviors known as saccadic eye movements provide an alternative to simple reflexes for the study of the neuronal basis of motor learning.</dcterms:abstract>
        <bib:pages>27-53</bib:pages>
        <dc:date>Jan 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15019175</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59931">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15019175</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59914">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.02.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Aouizerate</foaf:surname>
                        <foaf:givenname>Bruno</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Guehl</foaf:surname>
                        <foaf:givenname>Dominique</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cuny</foaf:surname>
                        <foaf:givenname>Emmanuel</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rougier</foaf:surname>
                        <foaf:givenname>Alain</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bioulac</foaf:surname>
                        <foaf:givenname>Bernard</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tignol</foaf:surname>
                        <foaf:givenname>Jean</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Burbaud</foaf:surname>
                        <foaf:givenname>Pierre</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59915"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Diagnostic Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Obsessive-Compulsive Disorder</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Pyramidal Tracts</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology</dc:title>
        <dcterms:abstract>Obsessive-compulsive disorder (OCD) is characterized by repetitive intrusive thoughts and compulsive time-consuming behaviors classified into three to five distinct symptom dimensions including: (1) aggressive/somatic obsessions with checking compulsions; (2) contamination concerns with washing compulsions; (3) symmetry obsessions with counting/ordering compulsions; (4) hoarding obsessions with collecting compulsions; and (5) sexual/religious concerns. Phenomenologically, OCD could be thought of as the irruption of internal signals centered on the erroneous perception that &quot;something is wrong&quot; in a specific situation. This generates severe anxiety, leading to recurrent behaviors aimed at reducing the emotional tension. In this paper, we examine how the abnormalities in brain activity reported in OCD can be interpreted in the light of physiology after consideration of various approaches (phenomenology, neuropsychology, neuroimmunology and neuroimagery) that contribute to proposing the central role of several cortical and subcortical regions, especially the orbitofrontal cortex (OFC), the anterior cingulate cortex (ACC), the dorsolateral prefrontal cortex (DLPC), the head of the caudate nucleus and the thalamus. The OFC is involved in the significance attributed to the consequences of action, thereby subserving decision-making, whereas the ACC is particularly activated in situations in which there are conflicting options and a high likelihood of making an error. The DLPC plays a critical part in the cognitive processing of relevant information. This cortical information is then integrated by the caudate nucleus, which controls behavioral programs. A dysfunction of these networks at one or several stages will result in the emergence and maintenance of repetitive thoughts and characteristic OCD behavior.</dcterms:abstract>
        <bib:pages>195-221</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Pathophysiology of obsessive-compulsive disorder</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15130710</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59915">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15130710</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59920">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2003.12.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Furness</foaf:surname>
                        <foaf:givenname>John B.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Jones</foaf:surname>
                        <foaf:givenname>Clare</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nurgali</foaf:surname>
                        <foaf:givenname>Kulmira</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Clerc</foaf:surname>
                        <foaf:givenname>Nadine</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59921"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Enteric Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Intestines</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurons, Afferent</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Intrinsic primary afferent neurons and nerve circuits within the intestine</dc:title>
        <dcterms:abstract>Intrinsic primary afferent neurons (IPANs) of the enteric nervous system are quite different from all other peripheral neurons. The IPANs are transducers of physiological stimuli, including movement of the villi or distortion of the mucosa, contraction of intestinal muscle and changes in the chemistry of the contents of the gut lumen. They are the first neurons in intrinsic reflexes that influence the patterns of motility, secretion of fluid across the mucosal epithelium and local blood flow in the small and large intestines. In the guinea pig small intestine, where they have been characterized in detail, IPANs have Dogiel type II morphology, that is they are large round or oval neurons with multiple processes, some of which end close to the luminal surface of the intestine, and some of which form synapses with enteric interneurons, motor neurons and with other IPANs. The IPANs have well-defined ionic currents through which their excitability, and their functions in enteric nerve circuits, is determined. These include voltage-gated Na(+) and Ca(2+) currents, a long lasting calcium-activated K(+) current, and a hyperpolarization-activated cationic current. The IPANs exhibit long-term changes in their states of excitation that can be induced by extended periods of low frequency activity in synaptic inputs and by inflammatory mediators, either applied directly or released during an inflammatory challenge. The IPANs may be involved in pathological changes in enteric function following inflammation.</dcterms:abstract>
        <bib:pages>143-164</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15063530</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59921">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15063530</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59922">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.01.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hinkle</foaf:surname>
                        <foaf:givenname>David</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Glanzer</foaf:surname>
                        <foaf:givenname>Jason</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sarabi</foaf:surname>
                        <foaf:givenname>Arezou</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pajunen</foaf:surname>
                        <foaf:givenname>Tiina</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Zielinski</foaf:surname>
                        <foaf:givenname>Jennifer</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Belt</foaf:surname>
                        <foaf:givenname>Brian</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Miyashiro</foaf:surname>
                        <foaf:givenname>Kevin</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McIntosh</foaf:surname>
                        <foaf:givenname>Tracy</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Eberwine</foaf:surname>
                        <foaf:givenname>James</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59923"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cells, Cultured</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Profiling</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>In Vitro Techniques</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Biology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Polymerase Chain Reaction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>RNA, Messenger</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Single neurons as experimental systems in molecular biology</dc:title>
        <dcterms:abstract>The cellular and the inter-connective complexity of the central nervous system (CNS) necessitate's analysis of functioning at both the system and single cell levels. Systems neuroscience has developed procedures that facilitate the analysis of multicellular systems including multielectrode arrays, dye tracings and lesioning assays, and at the single cell level there have been significant strides in assessing the physiology and morphology of individual cells. Until recently little progress had been made in understanding the molecular biology of single neuronal cells. This review will highlight the development of PCR and aRNA procedures for analysis of mRNA abundances in single cells. Also, other procedures for the analysis of protein abundances as well as the association of RNA with proteins will also be summarized. These procedures promise to provide experimental insights that will help unravel the functional mechanisms regulating the cellular components of the CNS.</dcterms:abstract>
        <bib:pages>129-142</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15063529</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59923">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15063529</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59926">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.02.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lee</foaf:surname>
                        <foaf:givenname>Wang-Tso</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chang</foaf:surname>
                        <foaf:givenname>Chen</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59927"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Convulsants</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Huntington Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Magnetic Resonance Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mitochondria</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nitro Compounds</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Propionates</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, N-Methyl-D-Aspartate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Spectrum Analysis</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease</dc:title>
        <dcterms:abstract>Huntington's disease (HD) is an inherited neurodegenerative disease, in which there is progressive motor and cognitive deterioration, and for which the pathogenesis of neuronal death remains controversial. Mitochondrial toxins like 3-nitropropionic acid (3-NP) and malonate, functioning as the inhibitors of the complex II of mitochondrial respiratory chain, have been found to effectively induce specific behavioral changes and selective striatal lesions in rats and non-human primates mimicking those in HD. Furthermore, several kinds of transgenic mouse models of HD have been recently developed, and used in the development and assessment of novel treatments for HD. In the past, most studies evaluating the animal models for HD were based on histological changes or in vitro neuronal cultures. With the emergence of advanced magnetic resonance technologies, non-invasive magnetic resonance imaging (MRI) and spectroscopy provide more detail of cerebral alterations, including the changes of cerebral structure, function and metabolites. These studies support the hypothesis that mitochondrial dysfunction with increased excitation of N-methyl-D-aspartate (NMDA) receptors can replicate the neurobehavioral changes, selective brain injury and neurochemical alterations in HD. The present review focuses on our work as well as that of others regarding 3-NP-induced neurotoxicity and other animal models of HD. Using both conventional and advanced MRI and spectroscopy, we summarize the pathogenesis and possible therapeutic strategies in chemical and transgenic models of HD. The results show magnetic resonance techniques to be powerful techniques in the evaluation of pathogenesis and therapeutic intervention for both chemical and transgenic models of HD.</dcterms:abstract>
        <bib:pages>87-110</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15063527</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59927">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15063527</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59924">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.02.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Takuma</foaf:surname>
                        <foaf:givenname>Kazuhiro</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Baba</foaf:surname>
                        <foaf:givenname>Akemichi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Matsuda</foaf:surname>
                        <foaf:givenname>Toshio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59925"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Astrocytes</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuroprotective Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Astrocyte apoptosis: implications for neuroprotection</dc:title>
        <dcterms:abstract>Astrocytes, the most abundant glial cell types in the brain, provide metabolic and trophic support to neurons and modulate synaptic activity. Accordingly, impairment in these astrocyte functions can critically influence neuronal survival. Recent studies show that astrocyte apoptosis may contribute to pathogenesis of many acute and chronic neurodegenerative disorders, such as cerebral ischemia, Alzheimer's disease and Parkinson's disease. We found that incubation of cultured rat astrocytes in a Ca(2+)-containing medium after exposure to a Ca(2+)-free medium causes an increase in intracellular Ca(2+) concentration followed by apoptosis, and that NF-kappa B, reactive oxygen species, and enzymes such as calpain, xanthine oxidase, calcineurin and caspase-3 are involved in reperfusion-induced apoptosis. Furthermore, we demonstrated that heat shock protein, mitogen-activated protein/extracellular signal-regulated kinase, phosphatidylinositol-3 kinase and cyclic GMP phosphodiesterase are target molecules for anti-apoptotic drugs. This review summarizes (1) astrocytic functions in neuroprotection, (2) current evidence of astrocyte apoptosis in both in vitro and in vivo studies including its molecular pathways such as Ca(2+) overload, oxidative stress, NF-kappa B activation, mitochondrial dysfunction, endoplasmic reticulum stress, and protease activation, and (3) several drugs preventing astrocyte apoptosis. As a whole, this article provides new insights into the potential role of astrocytes as targets for neuroprotection. In addition, the advance in the knowledge of molecular mechanisms of astrocyte apoptosis may lead to the development of novel therapeutic strategies for neurodegenerative disorders.</dcterms:abstract>
        <bib:pages>111-127</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Astrocyte apoptosis</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15063528</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59925">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15063528</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59916">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tojima</foaf:surname>
                        <foaf:givenname>Takuro</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ito</foaf:surname>
                        <foaf:givenname>Etsuro</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59917"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Biosynthesis</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Signal transduction cascades underlying de novo protein synthesis required for neuronal morphogenesis in differentiating neurons</dc:title>
        <dcterms:abstract>Differentiating neurons must acquire many unique morphological and functional characteristics in creating the precise neural circuits of the mature nervous system. The phenomenon of 'neuronal differentiation' includes a special set of simple, separate processes, that is, neuritogenesis, neurite outgrowth, pathfinding, targeting and synaptogenesis. All of these processes are critically dependent on the reorganization of actin cytoskeleton by many actin-binding proteins that function downstream of Rho-family GTPases. Furthermore, de novo synthesis of key proteins are critically involved in the reorganization of actin cytoskeleton during neuronal differentiation. In this article, we review recent progresses in the general mechanisms that control actin dynamics by various actin-binding proteins in differentiating neurons, including a series of recent studies from our laboratory on de novo synthesis of several key proteins that are essential for actin reorganization induced by second messengers. We demonstrated that dual regulation of cyclic AMP and Ca2+ determines cofilin (an actin-binding protein) phosphorylation states and LIM kinase 1 (a cofilin kinase) expression level during neuritogenesis.</dcterms:abstract>
        <bib:pages>183-193</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15130709</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59917">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15130709</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59918">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Will</foaf:surname>
                        <foaf:givenname>Bruno</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Galani</foaf:surname>
                        <foaf:givenname>Rodrigue</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kelche</foaf:surname>
                        <foaf:givenname>Christian</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rosenzweig</foaf:surname>
                        <foaf:givenname>Mark R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59919"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Injuries</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Environment</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Physical Conditioning, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Recovery from brain injury in animals: relative efficacy of environmental enrichment, physical exercise or formal training (1990-2002)</dc:title>
        <dcterms:abstract>In the 1960s, it was shown for the first time that enriched housing enhances functional recovery after brain damage. During the 1970s and 1980s, many findings similar to this initial one have been reported, enlarging greatly its generality. Over the last 13 years, many different kinds of brain damage were modelled in animals or even directly studied in humans. Overall, these recent studies corroborated earlier findings, although occasional exceptions were reported. Other critical data, obtained mainly in intact animals, showed that enriched housing increases neurogenesis in the adult hippocampus. Recent evidence that this neurogenesis is involved in hippocampal-dependent learning supports the original interpretation of the enrichment effects as being the result of an accumulation of informal learning experiences (e.g., [. Heredity, environment, brain biochemistry, and learning. In: Current Trends in Psychological Theory. University of Pittsburgh Press, Pittsburgh, pp. 87-110;. Brain changes in response to experience. Sci. Am. 226, 22-29]). Other components of enriched environment, such as physical exercise, may have additive effects with those of training. The comparison of the relative effectiveness of enriched experience, of physical exercise and of training on structural and/or functional assessments of recovery, shows that training/learning is generally more effective than physical exercise and that enriched experience is a more potent therapy than either of these two other treatments. The combination of enriched experience with some other neurosurgical and/or neuropharmacological treatments may further improve its therapeutic effectiveness. Finally, other recent reports emphasize that the treatment parameters may be changed in order to approximate clinical/rehabilitation conditions and, nevertheless, remain effective.</dcterms:abstract>
        <bib:pages>167-182</bib:pages>
        <dc:date>Feb 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Recovery from brain injury in animals</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15130708</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59919">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15130708</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59912">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.005</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nybo</foaf:surname>
                        <foaf:givenname>Lars</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Secher</foaf:surname>
                        <foaf:givenname>Niels H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59913"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebrovascular Circulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>exercise</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Fatigue</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Physical Endurance</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Time Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cerebral perturbations provoked by prolonged exercise</dc:title>
        <dcterms:abstract>This review addresses cerebral metabolic and neurohumoral alterations during prolonged exercise in humans with special focus on associations with fatigue. Global energy turnover in the brain is unaltered by the transition from rest to moderately intense exercise, apparently because exercise-induced activation of some brain regions including cortical motor areas is compensated for by reduced activity in other regions of the brain. However, strenuous exercise is associated with cerebral metabolic and neurohumoral alterations that may relate to central fatigue. Fatigue should be acknowledged as a complex phenomenon influenced by both peripheral and central factors. However, failure to drive the motorneurons adequately as a consequence of neurophysiological alterations seems to play a dominant role under some circumstances. During exercise with hyperthermia excessive accumulation of heat in the brain due to impeded heat removal by the cerebral circulation may elevate the brain temperature to &gt;40 degrees C and impair the ability to sustain maximal motor activation. Also, when prolonged exercise results in hypoglycaemia, perceived exertion increases at the same time as the cerebral glucose uptake becomes low, and centrally mediated fatigue appears to arise as the cerebral energy turnover becomes restricted by the availability of substrates for the brain. Changes in serotonergic activity, inhibitory feed-back from the exercising muscles, elevated ammonia levels, and alterations in regional dopaminergic activity may also contribute to the impaired voluntary activation of the motorneurons after prolonged and strenuous exercise. Furthermore, central fatigue may involve depletion of cerebral glycogen stores, as signified by the observation that following exhaustive exercise the cerebral glucose uptake increases out of proportion to that of oxygen. In summary, prolonged exercise may induce homeostatic disturbances within the central nervous system (CNS) that subsequently attenuates motor activation. Therefore, strenuous exercise is a challenge not only to the cardiorespiratory and locomotive systems but also to the brain.</dcterms:abstract>
        <bib:pages>223-261</bib:pages>
        <dc:date>Mar 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15142684</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59913">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15142684</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59910">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Wright</foaf:surname>
                        <foaf:givenname>John W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Harding</foaf:surname>
                        <foaf:givenname>Joseph W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59911"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Adhesion Molecules</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>extracellular matrix</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Extracellular Matrix Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Matrix Metalloproteinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Angiotensin</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Renin-Angiotensin System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Tissue Inhibitor of Metalloproteinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory</dc:title>
        <dcterms:abstract>The brain renin-angiotensin system (RAS) has long been known to regulate several classic physiologies including blood pressure, sodium and water balance, cyclicity of reproductive hormones and sexual behaviors, and pituitary gland hormones. These physiologies are thought to be under the control of the angiotensin II (AngII)/AT1 receptor subtype system. The AT2 receptor subtype is expressed during fetal development and is less abundant in the adult. This receptor appears to oppose growth responses facilitated by the AT1 receptor, as well as growth factor receptors. Recent evidence points to an important contribution by the brain RAS to non-classic physiologies mediated by the newly discovered angiotensin IV (AngIV)/AT4 receptor subtype system. These physiologies include the regulation of blood flow, modulation of exploratory behavior, and a facilitory role in learning and memory acquisition. This system appears to interact with brain matrix metalloproteinases in order to modify extracellular matrix molecules thus permitting the synaptic remodeling critical to the neural plasticity presumed to underlie memory consolidation, reconsolidation, and retrieval. There is support for an inhibitory influence by AngII activation of the AT1 subtype, and a facilitory role by AngIV activation of the AT4 subtype, on neuronal firing rate, long-term potentiation, associative and spatial learning. The discovery of the AT4 receptor subtype, and its facilitory influence upon learning and memory, suggest an important role for the brain RAS in normal cognitive processing and perhaps in the treatment of dysfunctional memory disease states.</dcterms:abstract>
        <bib:pages>263-293</bib:pages>
        <dc:date>Mar 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15142685</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59911">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15142685</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59900">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.010</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Boldogköi</foaf:surname>
                        <foaf:givenname>Zsolt</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sík</foaf:surname>
                        <foaf:givenname>Attila</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dénes</foaf:surname>
                        <foaf:givenname>Adám</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Reichart</foaf:surname>
                        <foaf:givenname>Anikó</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Toldi</foaf:surname>
                        <foaf:givenname>József</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gerendai</foaf:surname>
                        <foaf:givenname>Ida</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kovács</foaf:surname>
                        <foaf:givenname>Krisztina J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Palkovits</foaf:surname>
                        <foaf:givenname>Miklós</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59901"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Genetic Engineering</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Herpesvirus 1, Human</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Models, Genetic</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects</dc:title>
        <dcterms:abstract>The mammalian CNS is composed of an extremely complex meshwork of highly ordered interconnections among billions of neurons. To understand the diverse functions of this neuronal network we need to differentiate between functionally related and nonrelated elements. A powerful labeling method for defining intricate neural circuits is based on the utilization of neurotropic herpesviruses, including pseudorabies virus and herpes simplex virus type 1. The recent development of genetically engineered tracing viruses can open the way toward the conception of novel tract-tracing paradigms. These new-generation tracing viruses may facilitate the clarification of problems, which were inaccessible to earlier approaches. This article first presents a concise review of the general aspects of neuroanatomical tracing protocols. Subsequently, it discusses the molecular biology of alpha-herpesviruses, and the genetic manipulation and gene expression techniques that are utilized for the construction of virus-based tracers. Finally, it describes the current utilization of genetically modified herpesviruses for circuit analysis, and the future directions in their potential applications.</dcterms:abstract>
        <bib:pages>417-445</bib:pages>
        <dc:date>Apr 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Novel tracing paradigms--genetically engineered herpesviruses as tools for mapping functional circuits within the CNS</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15177785</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59901">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15177785</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59904">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.007</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Carulli</foaf:surname>
                        <foaf:givenname>Daniela</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Buffo</foaf:surname>
                        <foaf:givenname>Annalisa</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Strata</foaf:surname>
                        <foaf:givenname>Piergiorgio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59905"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Axons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebellar Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>GAP-43 Protein</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Gene Expression</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Fibers</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Proto-Oncogene Proteins c-jun</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Reparative mechanisms in the cerebellar cortex</dc:title>
        <dcterms:abstract>In the adult brain, different neuronal populations display different degrees of plasticity. Here, we describe the highly different plastic properties of inferior olivary neurones and Purkinje cells. Olivary neurones show a basal expression of growth-associated proteins, such as GAP-43 and Krox24/EGR-1, and remarkable remodelling capabilities of their terminal arbour. They also regenerate their transected neurites into growth-permissive territories and may reinnervate the lost target. Sprouting and regrowing olivary axons are able to follow specific positional information cues to establish new connections according to the original projection map. In addition, they set a strong cell body reaction to injury, which in specific olivary subsets is regulated by inhibitory target-derived cues. In contrast, Purkinje cells do not have a constitutive level of growth-associated genes, and show little cell body reaction, no axonal regeneration after axotomy, and weak sprouting capabilities. Block of myelin-derived signals allows terminal arbour remodelling, but not regeneration, while selective over-expression of GAP-43 induces axonal sprouting along the axonal surface and at the level of the lesion. We suggest that the high constitutive intrinsic plasticity of the inferior olive neurones allows their terminal arbour to sustain the activity-dependent ongoing competition with the parallel fibres in order to maintain the post-synaptic territory, and possibly underlies mechanisms of learning and memory. Such a plasticity is used also as a reparative mechanism following axotomy. In contrast, in Purkinje cells, poor intrinsic regenerative capabilities and myelin-derived signals stabilise the mature connectivity and prevent axonal regeneration after lesion.</dcterms:abstract>
        <bib:pages>373-398</bib:pages>
        <dc:date>Apr 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15177783</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59905">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15177783</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59906">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.006</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kringelbach</foaf:surname>
                        <foaf:givenname>Morten L.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rolls</foaf:surname>
                        <foaf:givenname>Edmund T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59907"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Diagnostic Imaging</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Frontal Lobe</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Meta-Analysis as Topic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroanatomy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurophysiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropsychology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reinforcement (Psychology)</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology</dc:title>
        <dcterms:abstract>The human orbitofrontal cortex is an important brain region for the processing of rewards and punishments, which is a prerequisite for the complex and flexible emotional and social behaviour which contributes to the evolutionary success of humans. Yet much remains to be discovered about the functions of this key brain region, and new evidence from functional neuroimaging and clinical neuropsychology is affording new insights into the different functions of the human orbitofrontal cortex. We review the neuroanatomical and neuropsychological literature on the human orbitofrontal cortex, and propose two distinct trends of neural activity based on a meta-analysis of neuroimaging studies. One is a mediolateral distinction, whereby medial orbitofrontal cortex activity is related to monitoring the reward value of many different reinforcers, whereas lateral orbitofrontal cortex activity is related to the evaluation of punishers which may lead to a change in ongoing behaviour. The second is a posterior-anterior distinction with more complex or abstract reinforcers (such as monetary gain and loss) represented more anteriorly in the orbitofrontal cortex than simpler reinforcers such as taste or pain. Finally, we propose new neuroimaging methods for obtaining further evidence on the localisation of function in the human orbitofrontal cortex.</dcterms:abstract>
        <bib:pages>341-372</bib:pages>
        <dc:date>Apr 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The functional neuroanatomy of the human orbitofrontal cortex</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15157726</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59907">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15157726</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59902">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.008</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Scheler</foaf:surname>
                        <foaf:givenname>Gabriele</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59903"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Long-Term Potentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Neurotransmitter</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Regulation of neuromodulator receptor efficacy--implications for whole-neuron and synaptic plasticity</dc:title>
        <dcterms:abstract>Membrane receptors for neuromodulators (NM) are highly regulated in their distribution and efficacy-a phenomenon which influences the individual cell's response to central signals of NM release. Even though NM receptor regulation is implicated in the pharmacological action of many drugs, and is also known to be influenced by various environmental factors, its functional consequences and modes of action are not well understood. In this paper we summarize relevant experimental evidence on NM receptor regulation (specifically dopamine D1 and D2 receptors) in order to explore its significance for neural and synaptic plasticity. We identify the relevant components of NM receptor regulation (receptor phosphorylation, receptor trafficking and sensitization of second-messenger pathways) gained from studies on cultured cells. Key principles in the regulation and control of short-term plasticity (sensitization) are identified, and a model is presented which employs direct and indirect feedback regulation of receptor efficacy. We also discuss long-term plasticity which involves shifts in receptor sensitivity and loss of responsivity to NM signals. Finally, we discuss the implications of NM receptor regulation for models of brain plasticity and memorization. We emphasize that a realistic model of brain plasticity will have to go beyond Hebbian models of long-term potentiation and depression. Plasticity in the distribution and efficacy of NM receptors may provide another important source of functional plasticity with implications for learning and memory.</dcterms:abstract>
        <bib:pages>399-415</bib:pages>
        <dc:date>Apr 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15177784</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59903">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15177784</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59908">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>72</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Sotelo</foaf:surname>
                        <foaf:givenname>Constantino</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59909"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Physiological Phenomena</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cerebellum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Gene Expression Regulation, Developmental</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Molecular Biology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Fibers</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Cellular and genetic regulation of the development of the cerebellar system</dc:title>
        <dcterms:abstract>Recent advances in molecular biology have drastically changed our vision on the development of the nervous system, the cerebellum in particular. After a classical descriptive period, we are now in a modern mechanistic epoch as we begin to answer crucial questions in our quest to understand the mechanisms underlying the emergence of brain complexity. This review begins with an analysis of the role of the &quot;isthmic organizer&quot; in the induction and specification of the cerebellar territory and progresses through cerebellar development to the formation of cerebellar maps. It gathers information about the control of the proliferation of granule cell precursors by Purkinje cells and the role of Shh/Gli-patched signaling. The migratory routes for cerebellar and precerebellar neurons, together with the long-range and short-range cues guiding gliophilic and, particularly, neurophilic migrations, are also discussed. Because these cues are similar to those involved in axon guidance, both processes are under the same molecular constraints. Finally, using primarily the olivocerebellar projection as a model, the cellular and molecular mechanisms involved in the formation of cerebellar maps are discussed. During embryonic development, Purkinje cells in the cerebellum and neurons in the inferior olive follow a simultaneous, but independent, process of intrinsic parcellation, giving rise to subsets of biochemically different cortical compartments. The occurrence of positional information shared between olivary axons and their postsynaptic targets, the Purkinje cells, provides a molecular code for the formation of coarse-grained maps. Activity-dependent mechanisms are required for the transition from crude to fine-grained maps. This important refinement, which confers ultimate specificity to the maps, is under the regulation of parallel fiber-Purkinje cell synaptic activity.</dcterms:abstract>
        <bib:pages>295-339</bib:pages>
        <dc:date>Apr 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15157725</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59909">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15157725</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59898">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.03.009</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Morimoto</foaf:surname>
                        <foaf:givenname>Kiyoshi</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fahnestock</foaf:surname>
                        <foaf:givenname>Margaret</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Racine</foaf:surname>
                        <foaf:givenname>Ronald J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59899"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Epilepsy, Temporal Lobe</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Kindling, Neurologic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Status Epilepticus</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Kindling and status epilepticus models of epilepsy: rewiring the brain</dc:title>
        <dcterms:abstract>This review focuses on the remodeling of brain circuitry associated with epilepsy, particularly in excitatory glutamate and inhibitory GABA systems, including alterations in synaptic efficacy, growth of new connections, and loss of existing connections. From recent studies on the kindling and status epilepticus models, which have been used most extensively to investigate temporal lobe epilepsy, it is now clear that the brain reorganizes itself in response to excess neural activation, such as seizure activity. The contributing factors to this reorganization include activation of glutamate receptors, second messengers, immediate early genes, transcription factors, neurotrophic factors, axon guidance molecules, protein synthesis, neurogenesis, and synaptogenesis. Some of the resulting changes may, in turn, contribute to the permanent alterations in seizure susceptibility. There is increasing evidence that neurogenesis and synaptogenesis can appear not only in the mossy fiber pathway in the hippocampus but also in other limbic structures. Neuronal loss, induced by prolonged seizure activity, may also contribute to circuit restructuring, particularly in the status epilepticus model. However, it is unlikely that any one structure, plastic system, neurotrophin, or downstream effector pathway is uniquely critical for epileptogenesis. The sensitivity of neural systems to the modulation of inhibition makes a disinhibition hypothesis compelling for both the triggering stage of the epileptic response and the long-term changes that promote the epileptic state. Loss of selective types of interneurons, alteration of GABA receptor configuration, and/or decrease in dendritic inhibition could contribute to the development of spontaneous seizures.</dcterms:abstract>
        <bib:pages>1-60</bib:pages>
        <dc:date>May 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Kindling and status epilepticus models of epilepsy</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15193778</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59899">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15193778</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59896">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.04.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schaechter</foaf:surname>
                        <foaf:givenname>Judith D.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59897"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hemiplegia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Motor Activity</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Rehabilitation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stroke</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Motor rehabilitation and brain plasticity after hemiparetic stroke</dc:title>
        <dcterms:abstract>This review intends to begin to build a bridge between our understanding of the effect of motor rehabilitation and brain plasticity on recovery after hemiparetic stroke. It discusses the impact of intensive post-stroke motor rehabilitation on motor recovery. This is followed by an overview of our current understanding, based on human brain mapping technologies, of brain plasticity underlying spontaneous recovery after hemiparetic stroke. These discussions lead to a descriptive review of human brain mapping studies that have begun to provide an understanding of the neural basis of rehabilitation-induced gains in motor function after stroke. Finally, it speculates on how a solid understanding of the neural underpinnings of spontaneous and rehabilitation-induced motor recovery will permit brain mapping technologies to be applied toward optimizing post-stroke motor rehabilitation.</dcterms:abstract>
        <bib:pages>61-72</bib:pages>
        <dc:date>May 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15193779</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59897">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15193779</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59892">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.04.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fouad</foaf:surname>
                        <foaf:givenname>Karim</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pearson</foaf:surname>
                        <foaf:givenname>Keir</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59893"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Physical Education and Training</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Spinal Cord Injuries</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Walking</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Restoring walking after spinal cord injury</dc:title>
        <dcterms:abstract>One of the most obvious deficits following a spinal cord injury is the difficulty in walking, forcing many patients to use wheelchairs for locomotion. Over the past decade considerable effort has been directed at promoting the recovery of walking and to find effective treatments for spinal cord injury. Advances in our knowledge of the neuronal control of walking have led to the development of a promising rehabilitative strategy in patients with partial spinal cord injury, namely treadmill training with partial weight support. The current focus is on developing more efficient training protocols and automating the training to reduce the physical demand for the therapists. Mechanisms underlying training-induced improvements in walking have been revealed to some extent in animal studies. Another strategy for improving the walking in spinal cord injured patients is the use of functional electric stimulation of nerves and muscles to assist stepping movements. This field has advanced significantly over the past decade as a result of developments in computer technology and the miniaturization of electronics. Finally, basic research on animals with damaged spinal cords has focused on enhancing walking and other motor functions by promoting growth and regeneration of damaged axons. Numerous important findings have been reported yielding optimism that techniques for repairing the injured spinal cord will be developed in the near future. However, at present no strategy involving direct treatment of the injured spinal cord has been established for routine use in spinal cord injured patients. It now seems likely that any successful protocol in humans will require a combination of a treatment to promote re-establishing functional connections to neuronal networks in the spinal cord and specialized rehabilitation training to shape the motor patterns generated by these networks for specific behavioral tasks.</dcterms:abstract>
        <bib:pages>107-126</bib:pages>
        <dc:date>Jun 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15201036</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59893">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15201036</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59886">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Paredes</foaf:surname>
                        <foaf:givenname>Raúl G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Agmo</foaf:surname>
                        <foaf:givenname>Anders</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59887"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine Agents</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Electrophysiology</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Female</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Male</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Progesterone</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptor Cross-Talk</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sex Factors</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sexual Behavior</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Sexual Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence</dc:title>
        <dcterms:abstract>The role of dopaminergic systems in the control of sexual behavior has been a subject of study for at least 40 years. Not surprisingly, reviews of the area have been published at variable intervals. However, the earlier reviews have been summaries of published research rather than a critical analysis of it. They have focused upon the conclusions presented in the original research papers rather than on evaluating the reliability and functional significance of the data reported to support these conclusions. During the last few years, important new knowledge concerning dopaminergic systems and their behavioral functions as well as the possible role of these systems in sexual behavior has been obtained. For the first time, it is now possible to integrate the data obtained in studies of sexual behavior into the wider context of general dopaminergic functions. To make this possible, we first present an analysis of the nature and organization of sexual behavior followed by a summary of current knowledge about the brain structures of crucial importance for this behavior. We then proceed with a description of the dopaminergic systems within or projecting to these structures. Whenever possible, we also try to include data on the electrophysiological actions of dopamine. Thereafter, we proceed with analyses of pharmacological data and release studies, both in males and in females. Consistently throughout this discussion, we make an effort to distinguish pharmacological effects on sexual behavior from a possible physiological role of dopamine. By pharmacological effects, we mean here drug-induced alterations in behavior that are not the result of the normal actions of synaptically released dopamine in the untreated animal. The conclusion of this endeavor is that pharmacological effects of dopaminergic drugs are variable in both males and females, independently of whether the drugs are administered systemically or intracerebrally. We conclude that the pharmacological data basically reinforce the notion that dopamine is important for motor functions and general arousal. These actions could, in fact, explain most of the effects seen on sexual behavior. Studies of dopamine release, in both males and females, have focused on the nucleus accumbens, a structure with at most a marginal importance for sexual behavior. Since accumbens dopamine release is associated with all kinds of events, aversive as well as appetitive, it can have no specific effect on sexual behavior but promotes arousal and activation of non-specific motor patterns. Preoptic and paraventricular nucleus release of dopamine may have some relationship to mechanisms of ejaculation or to the neuroendocrine consequences of sexual activity or they can be related to other autonomic processes associated with copulation. There is no compelling indication in existing experimental data that dopamine is of any particular importance for sexual motivation. There is experimental evidence showing that it is of no importance for sexual reward.</dcterms:abstract>
        <bib:pages>179-226</bib:pages>
        <dc:date>Jun 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Has dopamine a physiological role in the control of sexual behavior?</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15236835</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59887">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15236835</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59894">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.04.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tolbert</foaf:surname>
                        <foaf:givenname>Leslie P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Oland</foaf:surname>
                        <foaf:givenname>Lynne A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Tucker</foaf:surname>
                        <foaf:givenname>Eric S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gibson</foaf:surname>
                        <foaf:givenname>Nicholas J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Higgins</foaf:surname>
                        <foaf:givenname>Mark R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Lipscomb</foaf:surname>
                        <foaf:givenname>Brian W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59895"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Communication</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Embryonic and Fetal Development</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroglia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Olfactory Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Bidirectional influences between neurons and glial cells in the developing olfactory system</dc:title>
        <dcterms:abstract>Olfactory systems serve as excellent model systems for the study of numerous widespread aspects of neural development and also for the elucidation of features peculiar to the formation of neural circuits specialized to process odor inputs. Accumulated research reveals a fine balance between developmental autonomy of olfactory structures and intercellular interactions essential for their normal development. Recent findings have uncovered evidence for more autonomy than previously realized, but simultaneously have begun to reveal the complex cellular and molecular underpinnings of key interactions among neurons and glial cells at several important steps in olfactory development. Striking similarities in the functional organization of olfactory systems across vertebrate and invertebrate species allow the advantages of different species to be used to address common issues. Our own work in the moth Manduca sexta has demonstrated reciprocal neuron-glia interactions that have key importance in two aspects of development, the sorting of olfactory receptor axons into fascicles targeted for specific glomeruli and the creation of glomeruli. Studies in vertebrate species suggest that similar neuron-glia interactions may underlie olfactory development, although here the roles have not been tested so directly. Similar cellular interactions also are likely to play roles in development of some other systems in which axons of intermixed neurons must sort according to target specificity and systems in which reiterated modules of synaptic neuropil develop.</dcterms:abstract>
        <bib:pages>73-105</bib:pages>
        <dc:date>Jun 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15201035</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59895">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15201035</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59888">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>von Bohlen und Halbach</foaf:surname>
                        <foaf:givenname>O.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Schober</foaf:surname>
                        <foaf:givenname>A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Krieglstein</foaf:surname>
                        <foaf:givenname>K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59889"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>alpha-Synuclein</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Antigens, CD45</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Carrier Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Death</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>DNA-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Parkinson Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synucleins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Ubiquitin-Protein Ligases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Genes, proteins, and neurotoxins involved in Parkinson's disease</dc:title>
        <dcterms:abstract>Parkinson's disease (PD) is a common neurodegenerative disorder. The etiology of PD is likely due to combinations of environmental and genetic factors. In addition to the loss of neurons, including dopaminergic neurons in the substantia nigra pars compacta, a further morphologic hallmark of PD is the presence of Lewy bodies and Lewy neurites. The formation of these proteinaceous inclusions involves interaction of several proteins, including alpha-synuclein, synphilin-1, parkin and UCH-L1. Animal models allow to get insight into the mechanisms of several symptoms of PD, allow investigating new therapeutic strategies and, in addition, provide an indispensable tool for basic research. In animals PD does not arise spontaneously, thus, characteristic and specific functional changes have to be mimicked by application of neurotoxic agents or by genetic manipulations. In this review we will focus on genes and gene loci involved in PD, the functions of proteins involved in the formation of cytoplasmatic inclusions, their interactions, and their possible role in PD. In addition, we will review the current animal models of PD.</dcterms:abstract>
        <bib:pages>151-177</bib:pages>
        <dc:date>Jun 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15236834</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59889">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15236834</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59890">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.04.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yang</foaf:surname>
                        <foaf:givenname>Xiong-Li</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59891"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, GABA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Retina</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Characterization of receptors for glutamate and GABA in retinal neurons</dc:title>
        <dcterms:abstract>Glutamate and gamma-aminobutyric acid (GABA) are major excitatory and inhibitory neurotransmitters in the vertebrate retina, &quot;a genuine neural center&quot; (Ramón y Cajal, 1964, Recollections of My Life, C.E. Horne (Translater) MIT Press, Cambridge, MA). Photoreceptors, generating visual signals, and bipolar cells, mediating signal transfer from photoreceptors to ganglion cells, both release glutamate, which induces and/or changes the activity of the post-synaptic neurons (horizontal and bipolar cells for photoreceptors; amacrine and ganglion cells for bipolar cells). Horizontal and amacrine cells, which mediate lateral interaction in the outer and inner retina respectively, use GABA as a principal neurotransmitter. In recent years, glutamate receptors and GABA receptors in the retina have been extensively studied, using multi-disciplinary approaches. In this article some important advances in this field are reviewed, with special reference to retinal information processing. Photoreceptors possess metabotropic glutamate receptors and several subtypes of GABA receptors. Most horizontal cells express AMPA receptors, which may be predominantly assembled from flop slice variants. In addition, these cells also express GABAA and GABAC receptors. Signal transfer from photoreceptors to bipolar cells is rather complicated. Whereas AMPA/KA receptors mediate transmission for OFF type bipolar cells, several subtypes of glutamate receptors, both ionotropic and metabotropic, are involved in the generation of light responses of ON type bipolar cells. GABAA and GABAC receptors with distinct kinetics are differentially expressed on dendrites and axon terminals of both ON and OFF bipolar cells, mediating inhibition from horizontal cells and amacrine cells. Amacrine cells possess ionotropic glutamate receptors, whereas ganglion cells express both ionotropic and metabotropic glutamate receptors. GABAA receptors exist in amacrine and ganglion cells. Physiological data further suggest that GABAC receptors may be involved in the activity of these neurons. Moreover, responses of these retinal third order neurons are modulated by GABAB receptors, and in ganglion cells there exist several subtypes of GABAB receptors. A variety of glutamate receptor and GABA receptor subtypes found in the retina perform distinct functions, thus providing a wide range of neural integration and versatility of synaptic transmission. Perspectives in this research field are presented.</dcterms:abstract>
        <bib:pages>127-150</bib:pages>
        <dc:date>Jun 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15201037</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59891">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15201037</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59884">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Johnston</foaf:surname>
                        <foaf:givenname>Jennifer A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Madura</foaf:surname>
                        <foaf:givenname>Kiran</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59885"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cysteine Endopeptidases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Endocytosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Multienzyme Complexes</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neurodegenerative Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Proteasome Endopeptidase Complex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ubiquitin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Rings, chains and ladders: ubiquitin goes to work in the neuron</dc:title>
        <dcterms:abstract>Our understanding of neuronal cell biology in the last 10 years has exploded. In parallel, our grasp of basic cellular processes, such as protein synthesis and protein degradation has also grown exponentially. In this review, we provide an in-depth background to details of current knowledge of the Ub/proteasome pathway. We also provide examples of recent experiments in neurobiology that suggest a central role for targeted protein degradation by the Ub/proteasome pathway to ensure proper neuronal function. From the examples provided, it is clear the activity of the proteasome is required for neuronal pathfinding during development, regulation of synaptic branching and number, and synaptic plasticity. We conclude with a discussion of how defects in proteasome pathway function may lead to neuronal dysfunction, with specific emphasis on diseases characterized by the accumulation of ubiquitin (Ub)-positive inclusions. Our goal is to excite the expert neurobiologist to the myriad ways that specific neuronal functions could be regulated (or dysregulated) by mechanisms involving the Ub/proteasome pathway.</dcterms:abstract>
        <bib:pages>227-257</bib:pages>
        <dc:date>Jul 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Rings, chains and ladders</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15261394</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59885">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15261394</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59882">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Straka</foaf:surname>
                        <foaf:givenname>H.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dieringer</foaf:surname>
                        <foaf:givenname>N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59883"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Auditory Pathways</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Stem</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ear, Inner</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Eye Movements</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Networks (Computer)</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ranidae</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Reflex, Vestibulo-Ocular</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Visual Perception</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Basic organization principles of the VOR: lessons from frogs</dc:title>
        <dcterms:abstract>Locomotion is associated with a number of optical consequences that degrade visual information processing in the absence of appropriate compensatory movements. The resulting retinal image flow is counteracted by coordinated eye-head reflexes that are initiated by optokinetic and vestibular inputs. The contribution of the vestibulo-ocular reflex (VOR) for stabilizing retinal images is relatively small in amplitude in frogs but important in function by compensating for the non-linearities of the neck motor system. The spatial tuning of the VOR networks underlying the angular (AVOR) and linear (LVOR) with respect to canal and extraocular motor coordinates is organized in a common, canal-related reference frame. Thereby, the axes of head and eye rotation are aligned, principle and auxiliary VOR connections transform vestibular into motor signals and parallel AVOR and LVOR circuits mediate vergence and version signals separately. Comparison of these results with data from other vertebrates demonstrates a number of fundamental organization principles common to most vertebrates. However, the fewer degrees of behavioral freedom of frogs are reflected by the absence of, e.g. a functioning velocity storage network or of a fixation suppression of the VOR. In vitro experiments with the isolated brainstem and branches of N.VIII attached were used to study the putative transmitters of vestibular nerve afferent inputs, the postsynaptic receptor subtypes of second-order vestibular neurons and their dynamic response properties. Evidence is presented that suggests that afferent vestibular nerve fibers with different dynamic response properties activate different subtypes of glutamate receptors. The convergence pattern of monosynaptic afferent nerve inputs from different labyrinthine organs onto second-order vestibular neurons is remarkably specific. As a rule, second-order vestibular neurons receive converging afferent nerve inputs from one semicircular canal and from a specific sector of hair cells on one otolith organ. This convergence pattern remains malleable even in adulthood and reorganization is initiated by activity-related changes in vestibular nerve afferent fibers. The output of second-order vestibular neurons is modified by at least three inhibitory control loops. Uncrossed inhibitory vestibular side loops appear to control specifically the dynamic response tuning, whereas coplanar commissural inhibitory inputs improve mainly the spatial tuning and the cerebellar feedback loop controls the response gain. Among the targets of second-order vestibular projection neurons are extraocular motoneurons and internuclear neurons. Extraocular motoneurons differ among each other by the presence of very different response dynamics. These differences may represent a co-adaptation to the response dynamics of twitch and non-twitch extraocular muscle fibers. Different dynamical properties are required for a rapid acceleration of the globe at the one end and for the maintenance of a stable eccentric eye position over long periods of time at the other end of a continuum of variations in dynamic response properties. The maintenance of a given eccentric eye position over long periods of time is especially well developed in frogs and assists visual surveillance during lurking in the absence of saccades.</dcterms:abstract>
        <bib:pages>259-309</bib:pages>
        <dc:date>Jul 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Basic organization principles of the VOR</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15261395</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59883">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15261395</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59876">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.06.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Basheer</foaf:surname>
                        <foaf:givenname>Radhika</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Strecker</foaf:surname>
                        <foaf:givenname>Robert E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Thakkar</foaf:surname>
                        <foaf:givenname>Mahesh M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McCarley</foaf:surname>
                        <foaf:givenname>Robert W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59877"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>adenosine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Purinergic P1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Sleep</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Wakefulness</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Adenosine and sleep-wake regulation</dc:title>
        <dcterms:abstract>This review addresses three principal questions about adenosine and sleep-wake regulation: (1) Is adenosine an endogenous sleep factor? (2) Are there specific brain regions/neuroanatomical targets and receptor subtypes through which adenosine mediates sleepiness? (3) What are the molecular mechanisms by which adenosine may mediate the long-term effects of sleep loss? Data suggest that adenosine is indeed an important endogenous, homeostatic sleep factor, likely mediating the sleepiness that follows prolonged wakefulness. The cholinergic basal forebrain is reviewed in detail as an essential area for mediating the sleep-inducing effects of adenosine by inhibition of wake-promoting neurons via the A1 receptor. The A2A receptor in the subarachnoid space below the rostral forebrain may play a role in the prostaglandin D2-mediated somnogenic effects of adenosine. Recent evidence indicates that a cascade of signal transduction induced by basal forebrain adenosine A1 receptor activation in cholinergic neurons leads to increased transcription of the A1 receptor; this may play a role in mediating the longer-term effects of sleep deprivation, often called sleep debt.</dcterms:abstract>
        <bib:pages>379-396</bib:pages>
        <dc:date>Aug 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15313333</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59877">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15313333</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59874">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.06.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Erecinska</foaf:surname>
                        <foaf:givenname>Maria</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Cherian</foaf:surname>
                        <foaf:givenname>Shobha</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Silver</foaf:surname>
                        <foaf:givenname>Ian A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59875"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Adenosine Triphosphate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Blood Vessels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Body Water</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Chemistry</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cholesterol</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>DNA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Energy Metabolism</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Extracellular Space</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ion Channels</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Kinetics</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mitochondria</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Tissue Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Energy metabolism in mammalian brain during development</dc:title>
        <dcterms:abstract>Production of energy for the maintenance of ionic disequilibria necessary for generation and transmission of nerve impulses is one of the primary functions of the brain. This review attempts to link the plethora of information on the maturation of the central nervous system with the ontogeny of ATP metabolism, placing special emphasis on variations that occur during development in different brain regions and across the mammalian species. It correlates morphological events and markers with biochemical changes in activities of enzymes and pathways that participate in the production of ATP. The paper also evaluates alterations in energy levels as a function of age and, based on the tenet that ATP synthesis and utilization cannot be considered in isolation, investigates maturational profiles of the key processes that utilize energy. Finally, an attempt is made to assess the relevance of currently available animal models to improvement of our understanding of the etiopathology of various disease states in the human infant. This is deemed essential for the development and testing of novel strategies for prevention and treatment of several severe neurological deficits.</dcterms:abstract>
        <bib:pages>397-445</bib:pages>
        <dc:date>Aug 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15313334</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59875">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15313334</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59878">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.06.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Haddad</foaf:surname>
                        <foaf:givenname>John J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59879"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Enzyme Inhibitors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mitogen-Activated Protein Kinases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Mitogen-activated protein kinases and the evolution of Alzheimer's: a revolutionary neurogenetic axis for therapeutic intervention?</dc:title>
        <dcterms:abstract>Alzheimer's disease (AD) is a neurogenetic condition that affects the processes via which the brain functions. Major observable hallmarks of AD are accumulated clusters of proteins in the brain. These clusters, termed neurofibrillary tangles (NFT), resemble pairs of threads wound around each other in a helix fashion accumulating within neurons. These tangles consist of a protein called Tau, which binds to tubulin, thus forming microtubules. Unlike NFTs, deposits of amyloid precursor protein (beta-APP) gather in the spaces between nerve cells. The nearby neurons often look swollen and deformed, and the clusters of protein are usually accompanied by reactive inflammatory cells, microglia, which are part of the brain's immune system responsible for degrading and removing damaged neurons or plaques. Since phosphorylation/dephosphorylation mechanisms are crucial in the regulation of Tau and beta-APP, a superfamily of mitogen-activated protein kinases (MAPKs) has recently emerged as key regulators of the formation of plagues, eventually leading to dementia and AD. The complex molecular interactions between MAPKs and proteins (plagues) associated with the evolution of AD form a cornerstone in the knowledge of a still burgeoning field of neurodegenerative diseases and ageing. This review overviews current understanding of the molecular pathways related to MAPKs and their role in the development of AD and, possibly, dementia. MAPKs, therefore, may constitute a neurogenetic, therapeutic target for the diagnosis and evolution of a preventative medical strategy for early detection, and likely treatment, of Alzheimer's.</dcterms:abstract>
        <bib:pages>359-377</bib:pages>
        <dc:date>Aug 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Mitogen-activated protein kinases and the evolution of Alzheimer's</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15312913</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59879">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15312913</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59880">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>73</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.005</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hegde</foaf:surname>
                        <foaf:givenname>Ashok N.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59881"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Proteasome Endopeptidase Complex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Denaturation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ubiquitin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity</dc:title>
        <dcterms:abstract>A proteolytic pathway in which attachment of a small protein, ubiquitin, marks the substrates for degradation by a multi-subunit complex called the proteasome has been shown to function in synaptic plasticity and in several other physiological processes of the nervous system. Attachment of ubiquitin to protein substrates occurs through a series of highly specific and regulated steps. Degradation by the proteasome is subject to multiple levels of regulation as well. How does the ubiquitin-proteasome pathway contribute to synaptic plasticity? Long-lasting, protein synthesis-dependent, changes in the synaptic strength occur through activation of molecular cascades in the nucleus in coordination with signaling events in specific synapses. Available evidence indicates that ubiquitin-proteasome-mediated degradation has a role in the molecular mechanisms underlying synaptic plasticity that operate in the nucleus as well as at the synapse. Since the ubiquitin-proteasome pathway has been shown to be versatile in having roles in addition to proteolysis in several other cellular processes relevant to synaptic plasticity, such as endocytosis and transcription, this pathway is highly suited for a localized role in the neuron. Because of its numerous roles, malfunctioning of this pathway leads to several diseases and disorders of the nervous system. In this review, I examine the ubiquitin-proteasome pathway in detail and describe the role of regulated proteolysis in long-term synaptic plasticity. Also, using synaptic tagging theory of synapse-specific plasticity, I provide a model on the possible roles and regulation of local protein degradation by the ubiquitin-proteasome pathway.</dcterms:abstract>
        <bib:pages>311-357</bib:pages>
        <dc:date>Aug 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15312912</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59881">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15312912</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59872">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.006</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Seamans</foaf:surname>
                        <foaf:givenname>Jeremy K.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yang</foaf:surname>
                        <foaf:givenname>Charles R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59873"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Prefrontal Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Dopamine</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>schizophrenia</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The principal features and mechanisms of dopamine modulation in the prefrontal cortex</dc:title>
        <dcterms:abstract>Mesocortical [corrected] dopamine (DA) inputs to the prefrontal cortex (PFC) play a critical role in normal cognitive process and neuropsychiatic pathologies. This DA input regulates aspects of working memory function, planning and attention, and its dysfunctions may underlie positive and negative symptoms and cognitive deficits associated with schizophrenia. Despite intense research, there is still a lack of clear understanding of the basic principles of actions of DA in the PFC. In recent years, there has been considerable efforts by many groups to understand the cellular mechanisms of DA modulation of PFC neurons. However, the results of these efforts often lead to contradictions and controversies. One principal feature of DA that is agreed by most researchers is that DA is a neuromodulator and is clearly not an excitatory or inhibitory neurotransmitter. The present article aims to identify certain principles of DA mechanisms by drawing on published, as well as unpublished data from PFC and other CNS sites to shed light on aspects of DA neuromodulation and address some of the existing controversies. Eighteen key features about DA modulation have been identified. These points directly impact on the end result of DA neuromodulation, and in some cases explain why DA does not yield identical effects under all experimental conditions. It will become apparent that DA's actions in PFC are subtle and depend on a variety of factors that can no longer be ignored. Some of these key factors include distinct bell-shaped dose-response profiles of postsynaptic DA effects, different postsynaptic responses that are contingent on the duration of DA receptor stimulation, prolonged duration effects, bidirectional effects following activation of D1 and D2 classes of receptors and membrane potential state and history dependence of subsequent DA actions. It is hoped that these factors will be borne in mind in future research and as a result a more consistent picture of DA neuromodulation in the PFC will emerge. Based on these factors, a theory is proposed for DA's action in PFC. This theory suggests that DA acts to expand or contract the breadth of information held in working memory buffers in PFC networks.</dcterms:abstract>
        <bib:pages>1-58</bib:pages>
        <dc:date>Sep 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15381316</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59873">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15381316</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59870">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>1</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.06.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Yannielli</foaf:surname>
                        <foaf:givenname>P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Harrington</foaf:surname>
                        <foaf:givenname>M. E.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59871"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Cycle Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Circadian Rhythm</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Light</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Lighting</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Molecular</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuropeptide Y</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nuclear Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Period Circadian Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Photic Stimulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Serotonin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Suprachiasmatic Nucleus</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Let there be &quot;more&quot; light: enhancement of light actions on the circadian system through non-photic pathways</dc:title>
        <dcterms:abstract>Circadian rhythms are internally generated circa 24 h rhythms. The phase of the circadian pacemaker in mammals can be adjusted by external stimuli such as the daily cycle of light, as well as by internal stimuli such as information related to the physiological and behavioral status of the organism, collectively called &quot;non-photic stimuli&quot;. We review a large number of studies regarding photic-non-photic interactions on the circadian system, with special focus on two widely described neurotransmitters associated with non-photic input pathways: neuropeptide Y (NPY) and serotonin 5-HT. Both neurotransmitters are capable of phase advancing the master pacemaker oscillation when applied during the subjective day, as do several behavioral manipulations. Also, both are capable of inhibiting light-induced phase shifts during the subjective night, suggesting a dynamic interaction between photic and non-photic stimuli in the fine-tuning of the pacemaker function. Suppression of the NPYergic and/or serotonergic non-photic input pathways can in turn potentiate the phase-shifting effects of light. These findings pose new questions about the possibility of a physiological role for the dynamic interaction between photic and non-photic inputs. This might be particularly important in the case of circadian system adjustments under certain conditions, such as depression, shift work or jet lag.</dcterms:abstract>
        <bib:pages>59-76</bib:pages>
        <dc:date>Sep 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Let there be &quot;more&quot; light</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15381317</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59871">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15381317</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59860">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Beane</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Marrocco</foaf:surname>
                        <foaf:givenname>R. T.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59861"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acetylcholine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Attention</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
                <rdf:value>Attention Deficit Disorder with Hyperactivity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mental Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neuroanatomy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Norepinephrine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Pharmacology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Reflex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Norepinephrine and acetylcholine mediation of the components of reflexive attention: implications for attention deficit disorders</dc:title>
        <dcterms:abstract>Attention deficit hyperactivity disorders (ADHD) create major learning barriers for children and significant social and legal handicaps for adults worldwide. Important advances in the genetic basis of the disease have been made, but reliable, biological, diagnostic markers remain elusive. This review takes the position that future progress in treating the core symptom of attention deficits requires a clearer understanding of the neuroscience of attention in normal individuals. Two important achievements in this direction have been the development of tasks that identify activity in the orienting, alerting and conflict networks, and the identification of neurotransmitters that mediate these components. The proven ability of these tasks to identify and characterize response components of &quot;normal&quot; attention argues that they could be used advantageously with patient populations. The categorization of neurotransmitter abnormalities in those with ADHD could clarify whether attention deficits occur within or across attention networks. To realize these goals, we evaluate laboratory studies of attention in humans and animals that address the underlying neurotransmitter systems, primarily norepinephrine and acetylcholine. We propose that key facts about deficits in reflexive and voluntary attention may be understood by a model that includes deficits in brain norepinephrine release and its effects on cholinergic activity in the parietal cortex.</dcterms:abstract>
        <bib:pages>167-181</bib:pages>
        <dc:date>Oct 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Norepinephrine and acetylcholine mediation of the components of reflexive attention</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15556286</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59861">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15556286</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59864">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.08.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Benavides-Piccione</foaf:surname>
                        <foaf:givenname>R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Ballesteros-Yáñez</foaf:surname>
                        <foaf:givenname>I.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Lagrán</foaf:surname>
                        <foaf:givenname>M. Martínez</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Elston</foaf:surname>
                        <foaf:givenname>G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Estivill</foaf:surname>
                        <foaf:givenname>X.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fillat</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Defelipe</foaf:surname>
                        <foaf:givenname>J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dierssen</foaf:surname>
                        <foaf:givenname>M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59865"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cognition Disorders</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dendrites</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Down Syndrome</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Genetic Therapy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>mice</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>On dendrites in Down syndrome and DS murine models: a spiny way to learn</dc:title>
        <dcterms:abstract>Since the discovery in the 1970s that dendritic abnormalities in cortical pyramidal neurons are the most consistent pathologic correlate of mental retardation, research has focused on how dendritic alterations are related to reduced intellectual ability. Due in part to obvious ethical problems and in part to the lack of fruitful methods to study neuronal circuitry in the human cortex, there is little data about the microanatomical contribution to mental retardation. The recent identification of the genetic bases of some mental retardation associated alterations, coupled with the technology to create transgenic animal models and the introduction of powerful sophisticated tools in the field of microanatomy, has led to a growth in the studies of the alterations of pyramidal cell morphology in these disorders. Studies of individuals with Down syndrome, the most frequent genetic disorder leading to mental retardation, allow the analysis of the relationships between cognition, genotype and brain microanatomy. In Down syndrome the crucial question is to define the mechanisms by which an excess of normal gene products, in interaction with the environment, directs and constrains neural maturation, and how this abnormal development translates into cognition and behaviour. In the present article we discuss mainly Down syndrome-associated dendritic abnormalities and plasticity and the role of animal models in these studies. We believe that through the further development of such approaches, the study of the microanatomical substrates of mental retardation will contribute significantly to our understanding of the mechanisms underlying human brain disorders associated with mental retardation.</dcterms:abstract>
        <bib:pages>111-126</bib:pages>
        <dc:date>Oct 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>On dendrites in Down syndrome and DS murine models</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15518956</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59865">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15518956</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59866">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.08.005</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Curtis</foaf:surname>
                        <foaf:givenname>Marco</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Paré</foaf:surname>
                        <foaf:givenname>Denis</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59867"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Entorhinal Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Epilepsy</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neocortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Inhibition</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Synaptic Transmission</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>The rhinal cortices: a wall of inhibition between the neocortex and the hippocampus</dc:title>
        <dcterms:abstract>Anatomical data indicate that the parahippocampal region, comprised of the perirhinal (PRC), postrhinal (POR) and entorhinal (ERC) cortices, is an essential link between neocortex and hippocampus. Lesion studies demonstrated that memory functions previously ascribed to the hippocampus depend on the integrity of the rhinal cortices. This review will consider recent data suggesting that the ERC and PRC, far from being passive relay stations, actively gate impulse traffic between neocortex and hippocampus, because they are endowed with a powerful intrinsic inhibitory system. It is proposed that the cross-talk between PRC and ERC is not organized to unrestrictedly transfer information, but to select relevant inputs. The implication of these new evidences for the propagation of epileptiform activity will be considered.</dcterms:abstract>
        <bib:pages>101-110</bib:pages>
        <dc:date>Oct 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The rhinal cortices</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15518955</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59867">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15518955</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59862">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>3</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pan</foaf:surname>
                        <foaf:givenname>Wei-Xing</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>McNaughton</foaf:surname>
                        <foaf:givenname>Neil</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59863"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Behavior, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Mapping</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cognition</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Emotions</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Hippocampus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Mammillary Bodies</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurobiology</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>The supramammillary area: its organization, functions and relationship to the hippocampus</dc:title>
        <dcterms:abstract>The supramammillary area of the hypothalamus, although small in size, can have profound modulatory effects on the hippocampal formation and related temporal cortex. It can control hippocampal plasticity and also has recently been shown to contain cells that determine the frequency of hippocampal rhythmical slow activity (theta rhythm). We review here its organization and anatomical connections providing an atlas and a new nomenclature. We then review its functions particularly in relation to its links with the hippocampus. Much of its control of behaviour and its differential activation by specific classes of stimuli is consistent with a tight relationship with the hippocampus. However, its ascending connections involve not only caudal areas of the cortex with close links to the hippocampus but also reciprocal connections with more rostral areas such as the infralimbic and anterior cingulate cortices. These latter areas appear to be the most rostral part of a network that, via the medial septum, hippocampus and lateral septum, is topographically mapped into the hypothalamus. The supramammillary area is thus diffusely connected with areas that control emotion and cognition and receives more topographically specific return information from areas that control cognition while also receiving ascending information from brain stem areas involved in emotion. We suggest that it is a key part of a network that recursively transforms information to achieve integration of cognitive and emotional aspects of goal-directed behaviour.</dcterms:abstract>
        <bib:pages>127-166</bib:pages>
        <dc:date>Oct 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>The supramammillary area</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15556285</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59863">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15556285</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59868">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>2</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.07.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Romanko</foaf:surname>
                        <foaf:givenname>Michael J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Rola</foaf:surname>
                        <foaf:givenname>Radoslaw</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fike</foaf:surname>
                        <foaf:givenname>John R.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Szele</foaf:surname>
                        <foaf:givenname>Francis G.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dizon</foaf:surname>
                        <foaf:givenname>Maria L. V.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Felling</foaf:surname>
                        <foaf:givenname>Ryan J.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Brazel</foaf:surname>
                        <foaf:givenname>Christine Y.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Levison</foaf:surname>
                        <foaf:givenname>Steven W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59869"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Antineoplastic Agents</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain Injuries</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Differentiation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Cell Movement</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cell Proliferation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Cerebral Ventricles</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Hypoxia-Ischemia, Brain</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mammals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nerve Regeneration</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Radiation Injuries</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Recovery of Function</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Stem Cells</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Roles of the mammalian subventricular zone in cell replacement after brain injury</dc:title>
        <dcterms:abstract>The subventricular zones (SVZs) are essential sources of new cells in the developing brain and remnants of these germinal zones persist into adulthood. As these cells have the capacity to replenish neurons and glia that are turning over, many investigators have assessed the SVZ's role in replacing neural cells eliminated by brain injuries. A review of the literature reveals that the progenitors within the SVZs are vulnerable to chemical, radiation and ischemia-induced damage, whereas the neural stem cells are resilient. With moderate insults, the SVZ can recover, but it cannot recover after more severe injury. Thus, the vulnerability of these cells has important ramifications when considering therapeutic interventions for the treatment of brain tumors and for the prospect of recovery after ischemia. The cells of the perinatal and adult SVZ not only have the capacity to replenish their own numbers, but they also have the capacity to replace neurons and glia after ischemic and traumatic brain injuries. Moreover, the mechanisms underlying these regenerative responses are beginning to be revealed. By reviewing, comparing and contrasting the responses of the SVZs to different injuries, our goal is to provide a foundation from which current and future studies on the potential of the SVZs for cell replacement can be evaluated.</dcterms:abstract>
        <bib:pages>77-99</bib:pages>
        <dc:date>Oct 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15518954</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59869">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15518954</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59856">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.002</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Castro-Alamancos</foaf:surname>
                        <foaf:givenname>Manuel A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59857"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neocortex</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Nerve Net</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Synapses</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Thalamus</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Vibrissae</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Dynamics of sensory thalamocortical synaptic networks during information processing states</dc:title>
        <dcterms:abstract>The thalamocortical network consists of the pathways that interconnect the thalamus and neocortex, including thalamic sensory afferents, corticothalamic and thalamocortical pathways. These pathways are essential to acquire, analyze, store and retrieve sensory information. However, sensory information processing mostly occurs during behavioral arousal, when activity in thalamus and neocortex consists of an electrographic sign of low amplitude fast activity, known as activation, which is caused by several neuromodulator systems that project to the thalamocortical network. Logically, in order to understand how the thalamocortical network processes sensory information it is essential to study its response properties during states of activation. This paper reviews the temporal and spatial response properties of synaptic pathways in the whisker thalamocortical network of rodents during activated states as compared to quiescent (non-activated) states. The evidence shows that these pathways are differentially regulated via the effects of neuromodulators as behavioral contingencies demand. Thus, during activated states, the temporal and spatial response properties of pathways in the thalamocortical network are transformed to allow the processing of sensory information.</dcterms:abstract>
        <bib:pages>213-247</bib:pages>
        <dc:date>Nov 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15556288</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59857">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15556288</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59858">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>4</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.05.007</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Knapska</foaf:surname>
                        <foaf:givenname>Ewelina</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Kaczmarek</foaf:surname>
                        <foaf:givenname>Leszek</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59859"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Brain</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>DNA-Binding Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Early Growth Response Protein 1</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Immediate-Early Proteins</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Transcription Factors</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?</dc:title>
        <dcterms:abstract>Zif268 is a transcription regulatory protein, the product of an immediate early gene. Zif268 was originally described as inducible in cell cultures; however, it was later shown to be activated by a variety of stimuli, including ongoing synaptic activity in the adult brain. Recently, mice with experimentally mutated zif268 gene have been obtained and employed in neurobiological research. In this review we present a critical overview of Zif268 expression patterns in the naive brain and following neuronal stimulation as well as functional data with Zif268 mutants. In conclusion, we suggest that Zif268 expression and function should be considered in a context of neuronal activity that is tightly linked to neuronal plasticity.</dcterms:abstract>
        <bib:pages>183-211</bib:pages>
        <dc:date>Nov 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>A gene for neuronal plasticity in the mammalian brain</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15556287</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59859">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15556287</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59846">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.10.003</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Dahlem</foaf:surname>
                        <foaf:givenname>M. A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Chronicle</foaf:surname>
                        <foaf:givenname>E. P.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59847"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Computer Simulation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Migraine with Aura</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Neurological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>A computational perspective on migraine aura</dc:title>
        <dcterms:abstract>The classical visual aura of migraine is characterized by a unilateral hallucination, composed of a zigzag fortification pattern followed by a trailing scotoma. This pattern usually starts in central vision, expands and spreads to the periphery, and then disappears. We review a number of historical attempts to explain the migraine aura in terms of brain events, then summarize recent theories of the pathophysiology of the aura. We describe an approach to the computational modeling of migraine aura, based on the principles of (a) cortical organization, and (b) active wave propagation in an excitable medium. We demonstrate correspondences between properties of the model system and aspects of the pathophysiology of the aura. The simulations produced by the model are in agreement with descriptions and drawings of visual aura from migraine patients. We outline several testable predictions stemming from the implementation of the model, and explain how model-based empirical research has the capacity to (a) improve recording of the phenomena of the visual aura, (b) improve understanding of the spatio-temporal dynamics of other types of aura, in particular somatosensory and dysphasic aurae, and (c) clarify the theoretical requirements for the initiation of aura in the brain.</dcterms:abstract>
        <bib:pages>351-361</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15649581</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59847">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15649581</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59854">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.10.001</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>de Vrij</foaf:surname>
                        <foaf:givenname>F. M. S.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Fischer</foaf:surname>
                        <foaf:givenname>D. F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>van Leeuwen</foaf:surname>
                        <foaf:givenname>F. W.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Hol</foaf:surname>
                        <foaf:givenname>E. M.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59855"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Amyloid beta-Peptides</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Apolipoproteins E</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Learning</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Mutation</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>oxidative stress</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Proteasome Endopeptidase Complex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Processing, Post-Translational</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>tau Proteins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Ubiquitin</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:title>Protein quality control in Alzheimer's disease by the ubiquitin proteasome system</dc:title>
        <dcterms:abstract>The ubiquitin proteasome system (UPS) is the major protein quality control system in eukaryotic cells. Many neurodegenerative diseases are characterized by aggregates and inclusions of aberrant proteins, implying a sub-optimal functioning or defective UPS. The last few years have seen increasing evidence for the involvement of the UPS in neurodegenerative disorders, including Alzheimer's disease (AD). Notably, decreases in proteasome activity were detected in several cortical areas in AD patients. In addition, proteins that accumulate in the classical hallmarks of AD were linked to UPS function. This review specifically discusses the involvement of the UPS in AD pathogenesis. First, a detailed overview of the UPS is presented, after which AD pathology and its relation to the UPS is discussed.</dcterms:abstract>
        <bib:pages>249-270</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15582222</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59855">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15582222</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59844">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.006</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gotti</foaf:surname>
                        <foaf:givenname>C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Clementi</foaf:surname>
                        <foaf:givenname>F.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59845"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>aging</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Animals, Genetically Modified</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Bungarotoxins</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Central Nervous System</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Molecular</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Conformation</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Protein Subunits</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Nicotinic</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Neuronal nicotinic receptors: from structure to pathology</dc:title>
        <dcterms:abstract>Neuronal nicotinic receptors (NAChRs) form a heterogeneous family of ion channels that are differently expressed in many regions of the central nervous system (CNS) and peripheral nervous system. These different receptor subtypes, which have characteristic pharmacological and biophysical properties, have a pentameric structure consisting of the homomeric or heteromeric combination of 12 different subunits (alpha2-alpha10, beta2-beta4). By responding to the endogenous neurotransmitter acetylcholine, NAChRs contribute to a wide range of brain activities and influence a number of physiological functions. Furthermore, it is becoming evident that the perturbation of cholinergic nicotinic neurotransmission can lead to various diseases involving nAChR dysfunction during development, adulthood and ageing. In recent years, it has been discovered that NAChRs are present in a number of non-neuronal cells where they play a significant functional role and are the pathogenetic targets in several diseases. NAChRs are also the target of natural ligands and toxins including nicotine (Nic), the most widespread drug of abuse. This review will attempt to survey the major achievements reached in the study of the structure and function of NAChRs by examining their regional and cellular localisation and the molecular basis of their functional diversity mainly in pharmacological and biochemical terms. The recent availability of mice with the genetic ablation of single or double nicotinic subunits or point mutations have shed light on the role of nAChRs in major physiological functions, and we will here discuss recent data relating to their behavioural phenotypes. Finally, the role of NAChRs in disease will be considered in some details.</dcterms:abstract>
        <bib:pages>363-396</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Neuronal nicotinic receptors</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15649582</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59845">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15649582</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59852">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.005</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Gubellini</foaf:surname>
                        <foaf:givenname>Paolo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pisani</foaf:surname>
                        <foaf:givenname>Antonio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Centonze</foaf:surname>
                        <foaf:givenname>Diego</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Bernardi</foaf:surname>
                        <foaf:givenname>Giorgio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Calabresi</foaf:surname>
                        <foaf:givenname>Paolo</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59853"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Acetylcholine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Corpus Striatum</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Disease Models, Animal</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Glutamic Acid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Nervous System Diseases</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neural Networks (Computer)</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Neuronal Plasticity</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Receptors, AMPA</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Receptors, Metabotropic Glutamate</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases</dc:title>
        <dcterms:abstract>Long- and short-term changes in the efficacy of synaptic transmission are known as synaptic plasticity. Phenomena such as long-term depression (LTD) and long-term potentiation (LTP) are two classical forms of synaptic plasticity that are expressed in several brain areas, including the striatum. Bi-directional changes in corticostriatal synaptic transmission, i.e. LTD and LTP, have been proposed to represent the cellular mechanisms underlying the physiological processes of motor learning and behavior. In parallel, other forms of synaptic plasticity induced by different experimental pathological conditions have been described in the striatum; these changes are presumed to represent the cellular processes underlying several neurological disorders, including Parkinson's disease and Huntington's chorea. A considerable number of receptor and post-receptor systems participate in the mechanisms of synaptic plasticity in the striatum, where glutamate plays a primary role through its ionotropic and metabotropic receptors (mGluRs). These latter constitute a group of recently characterized molecules, which have been shown to modulate synaptic transmission by acting on cellular excitability, ionic conductances and neurotransmitter release. These receptors have also been involved in several neuronal pathophysiological processes. The role of mGluRs in synaptic transmission and synaptic plasticity has been recently deeply studied and characterized in the striatum, in both physiological and pathological conditions. These findings open new and interesting perspectives in the study of basal ganglia function, and introduce new possible pharmacological approaches for the treatment of neurological disorders in which mGluRs have been experimentally involved.</dcterms:abstract>
        <bib:pages>271-300</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:shortTitle>Metabotropic glutamate receptors and striatal synaptic plasticity</z:shortTitle>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15582223</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59853">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15582223</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59848">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>6</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.10.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Morgan</foaf:surname>
                        <foaf:givenname>Carlos</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Colombres</foaf:surname>
                        <foaf:givenname>Marcela</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Nuñez</foaf:surname>
                        <foaf:givenname>Marco Tulio</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Inestrosa</foaf:surname>
                        <foaf:givenname>Nibaldo C.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59849"/>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Alzheimer Disease</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Amyloid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Apoptosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Biological</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Models, Molecular</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Necrosis</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Peptide Fragments</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Plaque, Amyloid</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>signal transduction</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Structure and function of amyloid in Alzheimer's disease</dc:title>
        <dcterms:abstract>This review is focused on the structure and function of Alzheimer's amyloid deposits. Amyloid formation is a process in which normal well-folded cellular proteins undergo a self-assembly process that leads to the formation of large and ordered protein structures. Amyloid deposition, oligomerization, and higher order polymerization, and the structure adopted by these assemblies, as well as their functional relationship with cell biology are underscored. Numerous efforts have been directed to elucidate these issues and their relation with senile dementia. Significant advances made in the last decade in amyloid structure, dynamics and cell biology are summarized and discussed. The mechanism of amyloid neurotoxicity is discussed with emphasis on the Wnt signaling pathway. This review is focused on Alzheimer's amyloid fibrils in general and has been divided into two parts dealing with the structure and function of amyloid.</dcterms:abstract>
        <bib:pages>323-349</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15649580</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59849">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15649580</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
    <bib:Article rdf:about="#item_59850">
        <z:itemType>journalArticle</z:itemType>
        <dcterms:isPartOf>
            <bib:Journal>
                <dc:title>Progress in Neurobiology</dc:title>
                <prism:volume>74</prism:volume>
                <prism:number>5</prism:number>
                <dcterms:alternative>Prog. Neurobiol.</dcterms:alternative>
                <dc:identifier>DOI 10.1016/j.pneurobio.2004.09.004</dc:identifier>
                <dc:identifier>ISSN 0301-0082</dc:identifier>
            </bib:Journal>
        </dcterms:isPartOf>
        <bib:authors>
            <rdf:Seq>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Pezze</foaf:surname>
                        <foaf:givenname>Marie A.</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
                <rdf:li>
                    <foaf:Person>
                        <foaf:surname>Feldon</foaf:surname>
                        <foaf:givenname>Joram</foaf:givenname>
                    </foaf:Person>
                </rdf:li>
            </rdf:Seq>
        </bib:authors>
        <link:link rdf:resource="#item_59851"/>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Animals</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Conditioning (Psychology)</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Dopamine</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Fear</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Humans</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Limbic System</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Memory</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neural Pathways</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
           <z:AutomaticTag><rdf:value>Neurons</rdf:value></z:AutomaticTag>
        </dc:subject>
        <dc:subject>
            <z:AutomaticTag>
               <rdf:value>Prefrontal Cortex</rdf:value>
            </z:AutomaticTag>
        </dc:subject>
        <dc:title>Mesolimbic dopaminergic pathways in fear conditioning</dc:title>
        <dcterms:abstract>One of the most common paradigms used to study the biological basis of emotion, as well as of learning and memory, is Pavlovian fear conditioning. In the acquisition phase of a fear conditioning experiment, an emotionally neutral conditioned stimulus (CS)--which can either be a discrete stimulus, such as a tone, or a contextual stimulus, such as a specific environment--is paired with an aversive unconditioned stimulus (US), for example a foot shock. As a result, the CS elicits conditioned fear responses when subsequently presented alone during the expression phase of the experiment. While considerable work has been done in relating specific circuits of the brain to fear conditioning, less is known about its regulation by neuromodulators; the understanding of which would be of therapeutic relevance for fear related diseases such as phobia, panic attacks, post traumatic stress disorder, obsessive compulsive disorder, or generalized anxiety disorder. Dopamine is one of the neuromodulators most potently acting on the mechanisms underlying states of fear and anxiety. Recently, a growing body of evidence has suggested that dopaminergic mechanisms are significant for different aspects of affective memory, namely its formation, expression, retrieval, and extinction. The aim of this review is to clarify the complex actions of dopamine in fear conditioning with respect to the wide-spread distribution of dopaminergic innervation over structures constituting the fear related circuitry. A particular effort is made to understand how dopamine in the amygdala, medial prefrontal cortex and nucleus accumbens--target structures of the mesolimbic dopamine system originating from the ventral tegmental area--could relate to different aspects of fear conditioning.</dcterms:abstract>
        <bib:pages>301-320</bib:pages>
        <dc:date>Dec 2004</dc:date>
        <z:language>eng</z:language>
        <z:libraryCatalog>NCBI PubMed</z:libraryCatalog>
        <dc:description>PMID: 15582224</dc:description>
    </bib:Article>
    <z:Attachment rdf:about="#item_59851">
        <z:itemType>attachment</z:itemType>
        <dc:title>PubMed entry</dc:title>
        <dcterms:dateSubmitted>2015-02-17 00:38:41</dcterms:dateSubmitted>
        <dc:identifier>
            <dcterms:URI>
               <rdf:value>http://www.ncbi.nlm.nih.gov/pubmed/15582224</rdf:value>
            </dcterms:URI>
        </dc:identifier>
        <link:type>text/html</link:type>
    </z:Attachment>
</rdf:RDF>
